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Abstract 
Drug addiction can now be considered a global epidemic with considerable psychological, 
physical, social and economic costs. Substantial research remains focused upon furthering our 
understating of the disorder, for which current treatments are limited in their effectiveness. 
More recently there has been an increased interest in the multidimensional construct of 
impulsivity and its association with addiction. Impulsivity is a hallmark feature of drug 
addiction, with drug users frequently displaying a preference for immediate over delayed 
gratification (impulsive choice) and a loss of inhibitory control (disinhibition) (Madden et al., 
1997). To date, our understanding of the complex association between impulsivity and drug 
addiction has been hindered by the cross sectional nature of the majority of research conducted. 
As a result of this it has been unclear whether impulsivity is a risk factor or a consequence of 
drug abuse. Ile experiments of this thesis were primarily concerned with exploring the latter of 
these theories, in the hope of elucidating the role of drug induced impulsivity in the 
establishment, maintenance and relapse of drug dependence. This was achieved by exploring the 
effects of nicotine in two animal paradigms of impulsivity; the delayed reward paradigm which 
assessed impulsive choice, and the symmetrically reinforced go/no-go visual discrimination task 
which measured behavioural disinhibition. A series of preliminary experiments confirmed the 
suitability of both tasks for exploring the relationship between impulsivity and nicotine 
dependence. Behavioural disinhibition in the go/no-go task was stable, lacked sensitivity to 
changes in primary motivation and furthermore appeared not to be dependent on timing 
mechanisms. Impulsive choice in the delay discounting task was stable and delay sensitive. 
Whilst decreasing primary motivation was without effect on impulsive choice, increasing 
motivation for food reward was found to reduce levels of impulsivity. Acutely, nicotine 
increased both disinhibition (0.5mg/kg, s. c. ) and impulsive choice (0.125,0.25,0.5mg/kg, s. c. ). 
The acute effects of nicotine on both components of impulsivity were effectively antagonised by 
the centrally acting antagonist mecamylamine, which alone was without effect in either model. 
Adopting a longitudinal design, the effects of chronic nicotine administration (3.16mg/kg/day 
for seven days, osmotic mini pumps), nicotine withdrawal and the residual sensitivity to 
nicotine following a sustained period of abstinence were then explored. Chronic nicotine 
administration enhanced disinhibition and impulsive choice, an effect that was greatest at the 
initial stages of treatment, suggesting that drug tolerance may have developed. Nicotine 
withdrawal had differential effects on impulsive choice and disinihibition. In the delay 
discounting task both initial and long-term withdrawal was associated with enhanced sensitivity 
to delayed reward. This effect, however, was restricted to low "trait" impulsive animals. 
Conversely, initial withdrawal induced a short-lived rebound increase in inhibitory control, 
following which a gradual decrease in inhibitory control was observed that reached significance 
during the second week of withdrawal. Evidence that the effects of nicotine on impulsivity were 
temporary was shown, with behaviour returning to base line levels three weeks following 
termination of treatment. Finally, acute nicotine challenges (0.125,0.25,0.5mg/kg, s. c. ) 
demonstrated that chronic nicotine exposure rendered animals hypersensitive to the effects of 
nicotine on disinhibition. Overall the present experimental investigations provide evidence to 
suggest that impulsivity may be a key component at both the initial and end stages of addiction. 
Bchavioural and pharmacological treatments that target impulsivity may prove to be effective 
future treatments for the disorder. 
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CHAPTER 1 
Impulsivity and drug addiction: Review and 
integration of the human and animal literature 
1.1. DRUG ADDICTION 
Drug addiction is now considered a global epidemic. It is a deeply complex disorder that has 
profound consequences at the psychological, physical, social and economic level (Altman et al., 
1996). Current estimates suggest that approximately 34.1% of the adult population within the 
United Kingdom (UK) has sampled one or more illicit drugs in their lifetime, while 2.5 million 
of these individuals are believed to currently meet the diagnostic criteria for dependence (Office 
of National Statistics, 2005; British Crime Survey, 2006). In terms of licit addictive agents, it is 
believed that 25% of the UK population are currently sm9kers and 7% of the population are 
currently dependent on alcohol. At an individual level, substance misuse is associated with 
significant morbidity and mortality while the costs to society are substantial. Including both 
alcohol and nicotine, a staggering 124,000 deaths a year in UK are drug related, while the 
annual economic impact arising from health care costs and drug related crime is in excess of 18 
billion pounds (Office of National Statistics, 2005). 
The considerable burden of drug addiction and dependence on society has meant significant 
research effort remains focused upon extending our understanding of the neurobiological and 
psychological mechanisms underlying the disorder. With current treatments for the disorder 
being limited in their effectiveness, such research is crucial for the development of more 
successful treatment and prevention strategies (Nestler et al., 2003). 
1.1.1. Theories of Drug Addiction 
Conceptualisation and knowledge of addiction is evolving rapidly. Despite this, the precise 
definition of the disorder remains controversial. Earlier attempts encompassed both tolerance 
and withdrawal as major features of drug addiction (Kalant, 1987). Both these physiological 
phenomena however can occur without addictive behaviour (O'Brien and Volkow, 2006), 
leading to more recent definitions focusing on the more behavioural aspects of the disorder. 
Addiction typically involves the uncontrollable compulsive pattern of drug-seeking and drug- 
taking behaviour that takes place at the expense of most other activities and in the face of 
damaging health and social consequences (Robinson and Berridge, 2003; West, 2006). It is 
important to recognise that casual drug taking does not always lead to the progression of 
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addiction. Drug addiction, it seems, arises as a result of complex interactions between drug 
effects, environmental and neurobiological factors (e. g. Meaney, Brake and Gratton, 2002). 
Earlier theoretical explanations of addiction focused upon the drive to experience the positive 
affective states associated with the use of the abused drugs as a key mechanism underlying the 
disorder (e. g. Markou et al., 1993). The ability of addictive drugs to produce euphoria through 
activation of the brains natural reward circuitry has been the focus of much theory and research 
in attempt to further understanding of addiction. Despite drugs of abuse such as cocaine, 
amphetamine, opioids, nicotine, alcohol and marijuana having varying initial targets, their 
common ability to enhance extracellular levels of dopamine (DA) in the nucleus accumbens 
(NAc) and related areas of the mesolimibic-mesocortical DA pathway is believed to be critical 
for their acute reinforcing actions (e. g. Koob and Bloom, 1988; Robbins and Everitt, 1996; 
Everitt et al., 2001; Nestler, 2005). It is argued that once the rewarding properties have been 
experienced this promotes repeated use of the addictive drug. While it is highly probable that 
initial drug use may be associated with their euphoric and pleasurable effects, and that in some 
instances addicted individuals abuse drugs solely to achieve these positive effects, the theory 
cannot however account for the continuation of drug abuse when the pleasurable effects are 
minimal or not present (e. g. Lamb et al., 1991; Robinson and Berridge, 1993). 
Further theories have instead focused on the avoiding of aversive withdrawal in an attempt 
understand the behavioural and neurobiological processes involved in drug dependence and 
addiction. Withdrawal is believed to arise. as a consequence of chronic drug use. Repeated drug 
exposure is known to produce complex neuroadaptations of the DA system in an attempt to 
maintain internal homeostasis in response to the over activation caused by addictive drugs (eg. 
Koob and Le Moal, 2001). A common disruption across drug addictions is the observed DA 
hypoactivity (e. g. Dakis and O'Brien 2005), believed to be associated with the withdrawal 
experienced following termination of use or between drug intakes (Altman et al., 1996). Drug 
withdrawal is associated with a number of avcrsivc symptoms both emotional and physical 
(Hughes et al., 1984; Hughes et al., 1991). The avoidance of these symptoms is argued to be a 
powerful motivation to continue to abuse drugs. However, as previously discussed, the 
avoidance of withdrawal alone as an explanation of addiction fails to account for the 
dependence of substances, such as amphetamine, that do not induce a withdrawal syndrome 
following termination of use. More importantly, this explanation of the disorder cannot account 
for relapse into drug taking that can occur months or even years after abstinence by which time 
the symptoms of withdrawal, at least in terms of physical signs, have long dissipated (Robinson 
and Berridge, 2000). 
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The failure of these theories to account for the complexity of addiction has prompted 
researchers to explore fiirthcr the neurobiological and psychological mechanisms of disorder. 
The inccntive-sensitisation theory proposed by Robinson and Berridge (1993) is an example of 
such a theory. Central to theory is that with chronic drug exposure ncuroadaptations are 
produced that scnsitisc DA and other neurotransmittcr systems in the NAc circuitry. This in turn 
is believed to cause an enhancement of ncurotransmission in response to both the drug of abuse 
and drug related stimuli (Robinson and Berridge, 2000; 2003). The ncuroadaptations within this 
system arc independent from those mediating drug induced pleasure and withdrawal and are 
argued instead to underlie the incentive salience or 'wanting' aspect of reward (Robinson and 
Bcrridgc, 2000). With repeated drug exposure, incentive value becomes associated to drug 
related stimuli making them increasingly 'wanted' leading to intense drug craving and 
ultimately compulsive drug seeking and taking behaviour in their presence. These 
neuroadapations have furthermore been found to persist long after termination of drug exposure 
in both humans and animals (e. g. Strakowski et al., 1996; Castner and Goldman-Rakic 1999). 
This persistent sensitisation therefore renders previously dependent individuals susceptible to 
relapse long after drug cessation. 
This theory of addiction and relapse has received extensive support both in the human and 
animal literature (Robinson and Berridge, 2000; 2003). Whilst the model effectively provides a 
theoretical account of the compulsive drug use as well as the involuntary nature of craving 
associated with addiction, it fails however, to adequately encompass the loss of control over 
behaviour that is additionally observed in this population (Goldstein and Volkow, 2002). Drug 
dependent individuals frequently display a loss of control over drug intake and fail repeatedly in 
their ability to successfully abstain despite the potentially harmful consequences. More recent 
theories of addiction have therefore begun to focus on inhibitory control, or impulsivity, in an 
attempt to understand further the disorder of drug addiction. Considerable evidence from 
neuroirnaging studies has demonstrated that chronic drug abusers display abnormalities in both 
the structure and function of the prefrontal cortex in regions of the orbitofrontal cortex (OFC) 
and anterior cingulate cortex (ACC) (e. g. Franklin et al., 2002; Goldstein and Volkow, 2002; 
Rose et al., 2003). These regions are known to be involved in decision making, the processing 
of affective and reward value of stimuli (OFC) and the inhibitory control over behaviour (ACC) 
(e. g. Aron et al., 2004). 
Jentsh and Taylor (1999) were amongst the first to hypothesise that chronic drug abuse is 
associated with dysfunctions of the PFC, thereby leading to a loss of control of future drug use 
and the maintenance of addiction. More specifically, it was proposed that long term drug 
exposure leads to impaired inhibitory control over the appetitive responses elicited by the 
abused drug and drug related stimuli, thus increasing the likelihood of drug relapse. More 
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recently Goldstein and Volkow (2002) have described addiction as a disorder of impaired 
response inhibition and salience attribution (I-RISA). The I-RISA model of addiction postulates 
that the disorder is associated with increased salience of drug rewards and associated stimuli, 
decreased salience of alternative natural reinforcers, and weakened inhibitory control over 
responding to drug related stimuli (Goldstein and Volkow, 2002). Comparably Lubman et al. 
(2004) conceptualise the syndrome of addiction as 'compulsive', arguing that the loss of control 
over drug use and continual drug seeking and taking behaviour is mediated by the impaired 
prefrontal cortex circuitry which gives rise to a disorder of inhibitory dysregulation. 
Yet to be fully established by these theoretical accounts of addiction, is whether the observed 
abnormalities in the PFC circuitry, which lead to impairments in inhibitory control, reflect a 
vulnerability to the development of addiction or instead are a consequence of chronic drug 
exposure (Goldstein and Volkow, 2002; Olmstead 2006). Despite this, what these models have 
successfully achieved is to extend traditional theories of addiction to incorporate impulsivity as 
a key feature of the disorder. The recent acknowledgement of the critical role of inhibitory 
control in addiction has led to an increased interest in the multidimensional construct of 
impulsivity and its association with drug dependence. It is the relationship between impulsivity 
and drug dependence that is the focus of the current thesis. 
1.2. IMPULSIVITY: A MULTIDIMENSIONAL CONCEPT 
Impulsivity is a concept that plays a major role in normal human behaviour and as Evcnden 
(1999) states "adds important colour to everyday life. " Actions of impulsivity in everyday 
existence are relatively easy to identify e. g. spur of the moment purchasing or taking the risk of 
having an extra drink. For theorists however, definition of the concept is not an easy task and 
there is limited consensus over a precise definition. A number of characterisations of 
impulsivity have been proposed. Impulsivity has been equated to; the inability to sustain 
attention (Dickman, 1993), as part of the personality dimension of extraversion, (Eysenck, 
1983), a tendency to engage in risky behaviours (Eysenck, 1993), and the seeking of novel 
sensations (Zuckerman, Eysenck , Eysenck, 1978). It has furthermore been described as an act 
of behaviour which is spur of the moment and lacking adequate attention (Barrett and Patton 
1983), the propensity to engage in rapid information processing which is error-prone (Dickman, 
1990) and the preference for immediate over delayed gratification (Rachlin and Green, 1972; 
Logue, 1988). From these diverse definitions what becomes clear is that impulsivity is not a 
unitary behaviour, but instead a multidimensional concept incorporating a variety of related 
phenomena of impulsiveness, that moreover may be mediated by contrasting ncurobiological 
mechanisms (Hollander and Stein 1995; Evenden, 1999a). In an attempt to incorporate the 
variety of features of impulsivity within its definition, Moeller and colleagues (2001) stated that 
impulsivity is "a predisposition toward rapid, unplanned reactions to internal or external stimuli 
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without regard to the negative consequences of these reactions to the impulsive individual or to 
others". 
Impulsivity has been greatly studied both as a normal personality trait and as a dysfunctional 
behaviour (Stein et al., 1993). While many personality theorists consider impulsive behaviour to 
be a basic measurable dimension of personality (e. g. Barratt, 1985; Dickman, 1993; Eysenck, 
1993), impulsivity in its pathological form is a clinical symptom in a diverse number of 
psychiatric illnesses. The syndromes in which impulsive behaviour is most associated with are 
substance abuse disorders, conduct disorder and its adult variant antisocial personality disorder, 
borderline personality disorder (e. g. Barratt et al., 1997; Links et al. 1999; Casillas and Clark, 
2002), mania (e. g. Harmon-Jones et al., 1997; Swann et al., 2001) and attention 
deficit/hyperactivity disorder (e. g. Tannock et al., 1989; Sunohara et al., 1999; Solanto et al., 
2001; Salbach et al., 2002). Furthermore, disorders such as kleptomania, pyromania and 
pathological gambling have been classified within the DSMIV as 'impulsive control disorders'. 
1.3. SUBSTANCE ABUSE AND IMPULSIVITY 
Impulsivity is a hallmark feature of substance abuse disorders. According to the diagnostic 
criteria of the DSM IV the disorder can be defined as a dysfunction of impulsive control. 
Substance abuse can be conceptualised'as a problem of impulsivity in that firstly drug 
dependent individuals frequently display a failure in the ability to refrain from inappropriate 
drug seeking and taking behaviour, continuing to administer the drug despite repeated efforts to 
abstain. Furthermore, they display an incapacity to wait, a change in the perception of time, and 
predominately select the more immediate drug rewards or the relief of drug withdrawal over 
various prosocial, often larger delayed rewards associated with a drug free lifestyle (Madden et 
al., 1997). The fact that impulsiveness is a prominent feature within substance abuse disorders 
has increasingly led research to focus on the possible role of the construct in the initiation, 
maintenance and relapse of the disorder. There are two broad approaches to human research 
exploring the relationship between impulsivity and substance abuse. They differ in techniques 
utilised to assess impulsivity using either; (i) self report personality questionnaires or (ii) 
behavioural state measures. 
1.3.1. Impulsivity: Trait Approaches 
Personality assessments of impulsivity are a widely used to explore impulsiveness in drug 
dependent populations. The most commonly adopted self-report measures include the Barratt 
Impulsivity Scale (BIS), Eysenck Impulsivity Questionnaire (EIQ), and the Eysenck 
Impulsiveness-Venturesomeness-Empathy questionnaire (EIVE). 
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The BIS (Barratt, 1985) has three subscales which each measure independent aspects of 
impulsivity; 'non-planning', or lack of future orientation, 'cognitive impulsiveness ', or rapid, 
unstable thoughts and lack of cognitive patience, and 'motor impulsiveness', or a tendency to 
act recklessly. Studies adopting this scale have reported higher levels of trait impulsivity in 
substance abusers in comparison to matched controls (e. g. Patton, Stanford and Barratt, _1995; 
Swann, Dougherty, Pazzaglia, et al., 2004). More specifically individuals that are dependent on 
cocaine (Moeller et al., 2002; Patkar et al., 2002; Coffey et al., 2003), opioids (Kirby et al., 
1999), alcohol (Soloff, Lynch and Moss, 2000; Bjork et al., 2004) and nicotine (Mitchell, 1999; 
Heyman and Gibb, 2006) have consistently demonstrated higher scores of impulsivity on the 
BIS relative to non-abusers. Furthermore, 'scores of impulsivity on the BIS appear to be 
associated with substance use severity. Levels of trait impulsivity have been found to positively 
correlate with the number of cigarettes smoked in males (Skinner, Aubin and Berlin, 2004), 
frequency of past alcohol consumption (Fishbein and Reuland, 1994), daily cocaine use 
(Moeller et al., 2001) and scores on the addiction severity index in polysubstance abusers 
(Reilly, Roll and Downey, 2000). 
By utilising this scale, the importance of focusing on impulsivity in drug dependence treatment 
has also been highlighted. Smokers scoring higher on the BIS tend to relapse more rapidly 
following a one day cessation work shop (Doran et al., 2004), and more impulsive cocaine 
dependent people remain in a twelve week treatment programme for a significantly shorter 
period (Moeller et al., 200 1). 
Moreover, the BIS is able to differentiate between schizophrenic patients with or without 
substance abuse disorder (Blanchard et al., 2001; Dervaux et al., 2001; Gut-Fayand et al., 2001). 
Comparably, higher scores on impulsivity have additionally been observed in substance abusing 
pathological gamblers in comparison to non-abusing gamblers (Petry, 2001b). The finding that 
both gambling groups also differed from control subjects on impulsivity, suggests that perhaps 
an additive effect of substance abuse on self-reported trait impulsivity may be present in 
diagnosed gamblers. 
The EIQ is an adapted subscale from the Eysenck Personality questionnaire (Eysenck and 
Eysenck 1978). Comparable reports of heightened trait levels of impulsivity have also been 
reported with this scale. Students that reported greater use of substances, including alcohol and 
cannabis, displayed higher scores on the scale in 'comparison to students that reported less 
frequent use (Golding and Cornish, 1987). In female social drinkers a positive correlation was 
furthermore shown between level of alcohol consumption and impulsivity score (Grau and 
Ortet, 1999). In dependent users, alcoholics, cocaine and opioid abusers have scored higher on 
impulsivity than matched controls on this measure (Madden et al., 1997; Conrod, Pihl, Stewart 
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and Dongier, 2000; Petry, 2001). The scale was furthennore able to differentiate between 
smokers, non-smokers (Bickel, et al., 1999; Mitchell, 1999) and ex-smokers (Bickel et al., 
1999) on levels of impulsivity, with smokers being significantly more impulsive. 
The EIVE questionnaire (Eysenck and Eysenck 1978; Eysenck, Pearson, Easting and Allsopp, 
1985) has three subscales; impulsivity, venturesomeness and empathy. The impulsivity scale is 
reflective of a general tendency toward lack of planning, quick decision making and impulsive 
action. Studies adopting this self report measure have demonstrated that polydrug use is 
associated with higher scores of impulsiveness in comparison to matched controls (Parrott, Sisk 
and Tuner, 2000; Butler and Montgomery, 2004). Research has in addition shown that opioid 
dependent individuals score significantly higher on the impulsiveness subscale relative to 
matched controls (Kirby et al., 1999), although to a lesser extent than inner city crack cocaine 
users (Lejeuz, Bomovalova, Daughters and Curtin, 2005). The scale has also been able to 
differentiate between heavy ecstasy users and non ecstasy users (Morgan 1998; Parrot et al., 
2000) and high and low consumers of caffeine (Jones and Lejuez, 2005), with heavier users of 
both drugs displaying significantly higher trait levels of impulsivity. Among substance abusers, 
higher levels of impulsivity on this scale have been associated with greater severity of use and 
dependence. More specifically, impulsivity scores correlate positively with abuse symptoms in 
methamphetamine users (Simons et al., 2005) and polydrug abusers score significantly higher 
than single drug users (McGowan, 1988). 
Finally, EIVE has demonstrated that substance abuse disorder has an additive effect on 
measures of impulsivity in patients with co-existing psychopathologies, including suffers of 
pathological gambling (Petry, 2001), antisocial personality disorder (Petry, 2002) and bulimia 
(Kane, Loxton, Staiger and Dawe, 2004). Whilst patients of these disorders display heightened 
scores in comparison to controls, when co-morbid with substance abuse more extreme scores 
are demonstrated. 
Trait measures of impulsivity have provided substantial evidence of heightened self reported 
impulsivity, a finding common across abusers of varying drugs. These studies however are 
unable to disentangle the causal relationship between impulsivity and substance abuse and 
dependence. These measures assess trait impulsivity, argued to be a relatively stable trait. It is 
therefore plausible that heightened impulsivity may develop early in ones life and can thus be 
associated with a susceptibility to substance abuse. It could however, be the case that 
impulsivity is less stable than originally theorised, and is instead a consequence of substance 
abuse. Support for the former theory is demonstrated from indications of continued heightened 
impulsivity following discontinuation of abuse in previous substance abusers (e. g. Allen, 
Moeller, Rhoades, Cherek, 1998; Blanchard et al., 2001). However, no definitive conclusions 
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can be made due the possibility that previous chronic exposure to drugs and alcohol could have 
increased impulsivity levels permanently in these subjects. 
1.3.2. Impulsivity: Behavioural Approaches 
Behavioural measures of impulsivity can be classified into two broad categories. Each category 
attempts to measure a distinctive component of impulsivity and represents an independent 
operational definition of the construct (White et al., 1994; Kindlon et al., 1995; Ho et al., 1999; 
McDonald et al., 2003; Reynolds et al., 2006a; Winstanley, Eagle and Robbins, 2006; Dom et 
al., 2007). The first are laboratory measures that define impulsivity as a failure in inhibitory 
control. The second are measures that characterise impulsivity as a preference for immediate 
over delayed gratification, even during instances when the immediate reward is less valuable, or 
smaller than the delayed reward. A range of tasks have been devised to measure each of the two 
dimensions of impulsivity, many of which have been modelled in animals with some success. 
These animal models of impulsivity provide the opportunity to explore the neurobiological 
mechanisms modulating impulsivity and its association with addiction (Olmstead, 2006). 
1.3.2.1. Behavioural Tasks Measuring Inhibitory Control 
Behavioural inhibition has been defined as the ability to appropriately withhold or terminate 
thoughts and actions (Logan, Cowan and Davis, 1984). As previously discussed a dysfunction 
in this ability has been argued to be a core component of addiction (Jentsch and Taylor, 1999; 
Lyvers, 2000; Goldstein and Volkow, 2002). Readily observed in abusers is the apparent loss of 
control over compulsive drug seeking and taking behaviour despite awareness of the negative 
consequences. An inability to effectively control one's behaviour thus leads to the continual 
failure of chronically addicted individuals to cease or regulate drug intake. 
One of the most common tasks adopted in both humans and animals to assess inhibitory control 
is the go/no-go paradigm. Successful performance on the task requires subjects to inhibit 
prepotent behaviours (Newman and Kosson 1986). Subjects learn, by a process of trial and 
error, to respond as quickly as possible (normally made by a key press, or lever press in the case 
of animals subjects) to a particular discriminative stimulus, such as, a symbol displayed on a 
computer screen, a light or a tone. Correct responses to the 'Go signal' are normally rewarded 
and for humans can be in the form of small monetary rewards (e. g. gain M 10), points or social 
rewards. In the case of food restricted animals' food rewards are utilised. Occasionally during 
the task subjects are required to inhibit a response when the 'Go signal' is absent and instead a 
'No-go signal' is presented. In human versions of the task, dependent on the variant of the 
paradigm being utilised, incorrect responses during the presentation of the 'No-go signal' can 
lead to either no reinforcement, or punishment, through the reduction of reward (e. g. loss 
LO. 10). Comparably, both asymmetrical and symmetrically reinforced go/no-go paradigms have 
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been developed with the use of animals. In the latter of the models, successful inhibition of 
responding, in addition to correct go responding during No-go trials, is also reinforced (e. g. 
Harrison, Everitt and Robbins, 1999). Across all variants of the task that have been developed, 
inappropriately responding during the absence of a 'Go signal', is argued to be a valid index of 
degree of impulsiveness (Newman and Kosson, 1986). These inappropriate responses are 
commonly known as errors of commission or false alarms. 
Within the human literature a second commonly utilised paradigm that attempts to measure 
behavioural inhibition is the stop signal task (SST) (Logan, Schachar and Tannock, 1997). More 
complex than the aforementioned task, the task is based on the theory that inhibited behaviour is 
governed by two systems; one which activates and one which inhibits behaviour (Gray, 1976; 
Logan and Cowan, 1984; Fowles, 1987). A loss of control over behaviour can be the cause of 
either an over stimulated activation system or a weakened inhibitory system. The task measures 
inhibitory control by modelling the net effect of the counteracting activational and inhibitory 
systems, through the measurement of the participant's ability to inhibit a prepotent motoric 
response. During the task participants are required to rapidly respond to go signals. However on 
a percentage of trials the go signal is followed by a stop signal (e. g. auditory tone) requiring the 
participant to inhibit an already initiated response. As the go signal is reliably presented across 
all trials this produces a prepotency to respond. 'Me delay between both signals varies across the 
task between 10 and 300 milliseconds. The need for longer latencies between the go and no-go 
signal in order to successfully inhibit a response, correlates significantly with the frequency of 
failures to withhold responding on the task and therefore is associated with poor inhibitory 
control (Logan et al., 1997). Longer reaction times to inhibit responses are argued to be 
indicative of a weakened inhibitory system. 
The SST has more recently been replicated in animals subjects with some success (e. g. Feola, 
Richards and de Wit 2000; Eagle and Robbins, 2003). In the animal version of the SST animals, 
normally rodents, are required to respond to a visual go-signal. However, as with human task a 
no-go signal, an auditory tone, is randomly presented shortly following the go signal. Inhibition 
of the pre-potent behavioural response is then necessary and dependent on the version of the 
task requires the animal to either perform an alternative response (e. g. FePla et al., 2000) or 
withhold from responding further in order to be food rewarded (Eagle and Robbins 2003). As 
with human SST impulsivity is measured as the time required to inhibit responding, with longer 
RTs deemed more impulsive. 
A third task used with human participants is the continuous performance task (CPT). Although 
arguably more a model of sustained attention, the task additionally assesses impulsive verses 
controlled motor behaviour. The test requires participants to respond as rapidly as possible to a 
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series of specified targets that are presented both briefly (less than 500msec duration) and 
rapidly (e. g. Rosvold et al., 1956; Dougherty et al., 1999). Impulsive responding is measured 
once again as the failure to suppress responding to non-specified targets, referred to as false 
alarms. A widely adopted task in the animal literature based on the human CPT is the five 
choice serial reaction time task (SCSRTT) (Carli, Robbins, Eveden and Everitt, 1983). This 
task, as with the CPT, is primarily used to assess sustained and divided attention in rodents. To 
be food rewarded, animals in the task are required to correctly respond, by nose poking, in one 
of five apertures that becomes illuminated. Impulsive behaviour can be assessed by the number 
of premature inappropriate responses that occur prior to the illumination of an aperture and 
commonly lead to a punished time out period (Robbins, 2002). The anticipatory response rate is 
paralleled to the false alarms made in the human CPT. 
A final paradigm more commonly adopted with animal subjects to measure inhibitory 
responding is the differential reinforcement of low rate procedure (DRL) (e. g. van den Broek et 
al., 1987). In this operant model responses are only rewarded if the behaviour occurs following 
a fixed time interval. For example in a DRL 72", reinforcement is contingent on animals 
withholding a response for a minimum period of 72 seconds. Impulsive, premature responses 
are not rewarded and the fixed interval time is reset, usually following a time out period. The 
paradigm however, has been have heavily criticised to be influenced by a number of factors 
other that inhibitory control, including motor performance (e. g. Evenden, 1998a) and timing 
ability (e. g. Paulc, Meck and McMillan et al., 1999; Wiley, Compton and Golden, 2000). A 
variant of this procedure that attempts to dissociate the effects of drug induced activating or 
sedating effects on motor ability from impulsive responding is the fixed consecutive number 
procedure (FCN) (Mechner and Latranyi, 1963; Evenden, 1998a). Here the animal has to make 
a chain of responses on a lever before pressing a second lever to obtain a reward. Terminating 
the chain of responses before completion of the FCN results in no reward being delivered, and 
can be considered an impulsive act. More impulsive animals will perform fewer responses, 
switching to the second lever more prematurely. 
1.3.2.2. Behavioural Tasks Measuring Impulsive Choice 
Preference for smaller more immediate rewards over larger, more delayed rewards is argued to 
be a robust behavioural index of impulsivity (e. g. Rachlin and Green, 1972; Ainslie, 1974). In 
contrast 'self control' is regarded as the opposite preference where the ability to wait for the 
larger delayed reward is demonstrated. From this perspective impulsive behaviour is readily 
observed in drug abusers in that they frequently select the immediate acute reinforcing effects, 
or relief of drug withdrawal achieved from drug consumption over the long term larger social 
and health benefits associated with a drug free life style (Madden et al., 1997). One approach to 
the investigation and understanding of impulsive choices in drug dependence is the notion and 
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analysis of delayed discounting (DD) (Bickel and Marsh, 2001). Based on behavioural 
economics, DD refers to the fact that the subjective value of an outcome depreciates when it is 
delayed (Green, Fry and Myerson, 1994). Although the psychological assessment of DD 
originated from nonhuman-animal research (e. g. Chung and Ilermstein, 1967; Rachlin and 
Green, 1972; Ainslie, 1974), a number of procedures have been developed to assess delay 
aversion in human subjects. 
Typically measures of DD are based on psychophysical choice procedures (e. g. Mazur, 1987; 
Richards et al., 1997). Tasks require human participants to make a choice between two rewards 
to enable the determination of the rate of discounting of the larger delayed reward over time. 
This can be achieved by either adjusting the magnitude or delay of rewards across the task to 
enable determination of the value of rewards at which reversal of reward preference takes place. 
In adjusted amount procedures for example (e. g. Richards et al., 1997; Mitchell, 1999; 
Reynolds, 2006b) participants are presented with two rewards, one of which is a larger, delayed 
reward (e. g. LIOOO delivered in year), and the other, a smaller immediate reward the magnitude 
of which is adjusted until the preference of the immediate and delay rewards are approximately 
equal. This point of equal preference is referred to as the indifference point of that particular 
delay interval. During both tasks indifference points can be determined across a number of 
delays which can then be plotted to provide information of the rate in which the subjective value 
of the reward decreases with increasing delays of its delivery. Two models have dominated the 
literature that attempt to describe the affect of delay on discounting of rewards (eg. Ainslie, 
1975; 1992). The exponential model, predicts that the subjective value of the delayed reward is 
discounted exponentially; that is for equal increments in delay of the production of the reward, 
there is a fixed proportion of decreased reward value (Kirby 1997) (1). 
(1) V= AeD 
In the exponential function (1) V is the current subjective value of a delayed reward, (the 
indifference point), A is the value of the delayed reward, k is an cmpirically-dcrived constant 
proportional to the degree of delay discounting and D is the duration of delay of the reward. The 
larger the degree of discounting the more impulsive an individual is argued to be. 
The second model instead argues that delayed reward is discounted hyperbolically; that is, 
devaluation of delayed rewards is proportional to their delay (Ainslie, 1992). For each unit of 
time that comprises the delay of delivery, the reward's current value decreases by an 
increasingly smaller quantity (2). 
(2) V= A/(I + kD) 
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The majority of research comparing both models however has suggested that the hyperbolic 
function may be more effective at accounting for the discounting of delayed reward in both 
animal and humans subjects (e. g. Kirby, 1997; Richards et al., 1997; 1999a; Mazur, 2001; 
Frederick et al., 2003; Kirby and Santiesteban, 2003). More recently, in addition to the 
hyperbolic function researchers have began to adopt area under the curve measurements as a 
further assessment of delay aversion (e. g. Myerson et al., 2001; Ohmura et al., 2005). 
For most delay discounting laboratory procedures subjects make choices between 'hypothetical' 
outcomes, usually presented in the form of questions. Selection can be made for example of 
hypothetical monetary, drug or health outcome rewards (e. g. Madden et al., 1997; Odum et al., 
2000; Chapman et al., 2001). The use of hypothetical outcomes enables the exploration of the 
impact of substantially larger rewards (e. g. EIOOO) and longer delays (e. g. one year) on 
impulsive choice which would be impossible to simulate with 'real' reward and delays. 
Furthermore, hypothetical rewards enable the ethical investigation of drug choices in human 
subjects (e. g. Petry and Bickel, 1998). In an attempt to both increase validity and reduce 
potential limitations associated with adopting hypothetical rewards, researchers in some 
instances have participants actually receive the outcome they preferred on one randomly 
selected choice trial from all choices made during the task (e. g. Kirby, 1997). More recently, 
tasks have been developed where both the rewards and delays are experienced, rewards however 
have been monetary and of considerably less value, with amounts for instance being less than EI 
and delay to their delivery being no longer than an hour duration (e. g. Flom et al., 2003; Lane et 
al., 2003; Rcynolds 2006a). 
Animal models designed to assess impulsive choice as in human research are grounded in the 
temporal discounting theory of impulsivity. Although a number of variant delayed reward 
paradigms have been developed with the use of animals, in all models animals typically make a 
choice between a smaller reward and a delayed, larger reward. Thiebot et al. (1985) introduced 
this model using a maze-procedure, where at the end of one arm rats could consume two pellets 
immediately or at the end of the other arm animals were able to consume ten pellets only after 
the animal had been detained for a short period of time. The increased choice of the smaller 
immediate reinforcer is argued to be evidence of impulsivity. The model was later automated 
and delay of the reinforcer varied in order to achieve a delay function, which could be 
manipulated by drug treatment (e. g. Mazur, 1987; Evenden and Ryan, 1996; Richards et al., 
1997). Such models can be divided into "systematic" and "adjusting" tasks. In the former 
animals, usually a rat, are trained to choose between one of two levers, one delivers a single 
food pellet immediately, the other delivers several pellets after a programmed delay. The delay 
to delivery of the larger reinforcer is under experimenter control and is increased systematically 
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during the testing session (e. g. Evenden and Ryan, 1996; Cardinal et al., 2000). Percent choice 
of delayed reward, across varying delays, is taken as index of impulsive choice. In contrast 
"adjusting" paradigms the magnitude of the immediate reward (Richards et al., 1997) or delay to 
the delivery of the larger reward (e. g. Mazur, 1987) is adjusted dependent on the animals choice 
behaviour, continuing across trials until the animal's choice becomes indifferent between the 
two rewards. This point of indifference indexes the tolerance to delayed gratification, the 
smaller the magnitude of inunediate reward or shorter the adjusted delay at this point the more 
impulsive the animal can be classified. Such models differ slightly from "systematic" delayed 
rewards measures, in that they measure the extent to which a subject values the standard 
alternative rather than which alternative reward is preferred. 
Research that has adopted behavioural tasks in the attempt to define further the relationship 
between impulsivity and drug dependence can generally be categorised into those that have (i) 
compared levels of impulsivity in current substance abusers and non-substance abusers, (ii) 
compared amongst abusers'levels pf impulsivity across different pattern of substance misuse, 
(iii) compared levels of impulsivity in Current users, ex-users and non-users, (iv) examined the 
acute and chronic effects of drugs of abuse on impulsivity, (v) examined the effects of acute 
drug deprivation on impulsivity and (vi) examined impulsivity as a predictor of drug abuse. 
Each of these categories will be reviewed incorporating findings from research that has focused 
upon both licit and illicit drug use. 
1.3.2.3. Comparison of Levels of Impulsivity in Substance Abusers and Non-substance 
Abusers 
A growing body of literature exists that suggest that substance abusers, of both licit and illicit 
drugs, display a greater sensitivity to delayed gratification in comparison to non-substance 
abusers. Madden and colleagues (1997; 1999) provided evidence of steeper discounting of 
hypothetical monetary rewards in opioid dependent individuals in comparison to matched 
controls. To reduce the subjective value of $1000 by 60%, required a delay of one year for 
heroin abusers, in contrast to five years for the control group (Madden et al., 1997). Greater 
intolerance to delayed reward in heroin abusers was later replicated using a DD task, where 
participants were given the opportunity to win one of the reward choices selected during the 
task (Kirkby et al., 1999). In cocaine abusers comparable findings of heightened impulsive 
choice have in addition been found (Moeller et al., 2002; Coffey et al; 2003). A study conducted 
by Petry (2003) furthermore demonstrated that abusers of both cocaine and heroin discounted 
delayed gratification more rapidly than matched control regardless of the outcomes being 
presented. Steeper discounting was presented not only for hypothetical monetary rewards but 
also for commodities of health and freedom (although to a lesser extent). These findings may 
begin to explain the high risk behaviours shown by dependent users of illicit substances. 
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Abusers may engage in criminal behaviour to feed a drug habit or share needles to administer 
drugs due to the consequence of these behaviours possibly being delayed in time, and as a result 
being highly discounted (Petry, 2003). 
Greater discounting of delayed reward has in addition been observed in abusers of licit drugs in 
comparison to control subjects, although arguably the findings have been less consistent. Whilst 
Petry (2001) found that alcoholics displayed a significantly greater intolerance to delayed 
monetary rewards in comparison to matched controls, these findings have failed to be replicated 
in a later study that compared the discounting rates of heroin, cocaine and alcohol abusers 
(Kirby and Petry 2004). Abusers of cocaine and heroin were found to display similar rates of 
discounting of delayed gratification that were significantly steeper than both alcoholics and 
matched controls, who displayed similar discounting rates. The lack of a significant difference 
between these two groups was argued to possibly be attributed to the self-selcction bias of the 
participants, in that less impulsive individuals would more likely volunteer to take part in 
research and were therefore not representative of the general population of alcohol abusers 
(Kirby and Petry 2004). 
Significant differences in DD have almost uniformly been found between smokers and non- 
smokers. Higher levels of impulsive choice of future monetary rewards have been demonstrated 
across a number of studies (e. g. Bickel et al., 1999; Mitchell 1999; Reynolds et al., 2004; 
Reynolds 2006a). Research has furthermore displayed a pervasiveness of the heightened 
impulsive choice in smokers. Higher levels of discounting in smokers have been found across 
differing reward magnitudes, during the consideration of both losses and gains (Baker et al., 
2003), and when making choices of varying commodities including health outcomes (Odurn et 
al., 2002). Two studies however have failed to demonstrate heightened impulsive choice in 
cigarette smokers. Firstly, no differences in discounting of monetary rewards were found 
between adolescent smokers between the ages of 14 and 16 and matched controls (Reynolds et 
al., 2003). Similarly, Ohmura and colleagues (2005) failed to demonstrate a difference between 
university students who smoked and non-smoking students. The average number of cigarettes 
smoked by participants across these studies varied, possibly accounting for the discrepancy in 
findings. In both of these studies participants were relatively "mild" smokers, with participants 
smoking an average 7 and 14 cigarettes a day in Baker et al., and Ohmura et al., studies 
respectively. By contrast, in those studies where highly significant differences were found, 
participants could be classified as "heavy" smokers, smoking no less than 20 cigarettes per day 
(e. g. Bickel et al., 1999; Mitchell 1999; Reynolds et al., 2004; Reynolds 2006a). These findings 
suggest that perhaps only individuals who are more dependent on tobacco display heightened 
sensitivity to delayed gratification. 
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Sensitivity to delayed reward has furthermore been examined in substance abusers with co- 
existing psychopathology. Comparable to findings adopting self report trait measures of 
impulsivity, evidence has been shown that substance abuse may inter-act with such disorders to 
have additive effect on intolerance to delayed reward. Petry and co-workers have demonstrated 
this association in problem gamblers with and without symptoms of substance abuse. Non- 
substance abusing pathological gamblers discounted more greatly delayed hypothetical rewards 
than matched controls (Petry, 2001b), and the substance abusing gamblers to an even greater 
degree than non-substance abusing gamblers (Petry and Casarella, 1999; Petry, 2001b). A 
comparable additive association has been demonstrated with substance abusers co-morbid with 
APD (Petry, 2002). Substance abusers, including those of cocaine, heroin and alcohol, 
additionally diagnosed with APD discounted delayed monetary rewards at a more rapid rate 
than substance abusers without APD. Both groups of substance abusers displayed more extreme 
impulsive choice relative to control subjects. 
A further robust finding of empirical research is the significantly more rapid DD during choices 
involving the drug of dependence in comparison to other reward commodities. Hypothetical 
drug rewards have been found to be discounted to a much greater extent than monetary rewards 
across drug abusers including smokers (Bickel et al., 1999; Baker et al., 2003; Johnson et al., 
2007), alcoholics (Petry 2001), cocaine (Coffey et al., 2003) and heroin abusers (Madden ct al., 
1997; 1999). To control for the effect of reward magnitude on delay discounting, the monetary 
value of the drugs were equated to the amount of the money utilised in the DD tasks. 
It has been suggested that the negative reinforcement properties of drugs may account for the 
steeper discounting. Drugs are abused partly to relieve the aversive symptoms of withdrawal. 
For addicted individuals avoiding of these unpleasant symptoms may lead them to discount the 
delayed drug of abuse to a greater extent as such outcome would offer no immediate relief of 
withdrawal or prevention of its onset (Madden et al., 1997; Bickel et al., 1999; Petty 2001). 
Indeed, indirect evidence demonstrates that humans will make more impulsive choices when the 
reward allows them to avoid aversive consequences in comparison to when these consequences 
are pleasant (eg. Solnick et al., 1980). This explanation however cannot account for the steeper 
rates of discounting also found in both light smokers (Johnson et al., 2007) and social drinkers 
(Petry 2001) who arguably do not experience severe withdrawal symptoms. Increased 
discounting of drug rewards in comparison to monetary rewards could instead be explained by 
the fact that drugs are primary consumable reinforcers which tend to be discounted to a greater 
extent than conditioned, non-consumable reinforcers such as money. Odum and Rainaud (2003) 
demonstrated in non-addicted participants that both food and alcohol (primary, consumable 
reinforcers) were discounted similarly but to a much greater degree than monetary outcomes. 
Comparable findings were demonstrated in college students who were shown to discount pizza 
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more highly then money (Kirby and Guastello 2001). Related to this mechanism is the 
possibility that unlike money, drugs are perceived as a perishable commodity, that for example 
can stale over time, thus reducing more greatly their future value. Regardless of the mechanism 
involved, the discounting of the drug of abuse is extreme relative to other outcomes and is a 
common behavioural process observed across users of both licit and illicit drugs. 
A potential criticism of the majority of the studies discussed is that subjects make choices 
regarding hypothetical rewards. Participants do not experience the delays associated with their 
reward choice as the outcomes are never delivered. There is however, growing evidence to 
suggest that discounting of both actual and hypothetical rewards are quantitatively similar. 
Across studies, hyperbolic functions have both consistently and accurately accounted for the 
discounting data of hypothetical rewards. Comparable hyperbolic functions have been 
furthermore displayed in studies adopting actual outcomes in both humans and animals (Mazur 
1987, Richards et al., 1997). Although an earlier review of the discounting literature suggested 
that using hypothetical rewards may provide an underestimation of discounting rates (Kirby 
1997), research has since concluded that within subjects there are no significant differences in 
the discounting rates of real and hypothetical rewards (Johnson and Bickel 2002; Madden et al., 
2003; 2004; Lagorio and Madden 2005; Johnson, Bickel and Baker, 2007). Hypothetical 
rewards can therefore offer a valid methodology to assess levels of DD. 
A significant amount of research has furthermore assessed levels of bchavioural inhibition in 
individuals diagnosed with substance use disorders. Inhibitory control has been most widely 
studied in cocaine abusers in comparison to matched controls. Chronic cocaine abusers have 
consistently displayed a lower probability of successfully inhibiting responses on the SST and 
furthermore required significantly longer than matched controls to inhibit prepotent responses 
(Fillmore and Rush, 2002; Li et al., 2006). Compared to control subjects active cocaine abusers 
have in addition demonstrated evidence of a dysfunction in inhibitory control on the go/no-go 
task. Whilst no differences between groups were observed in the speed at which responses were 
executed, cocaine abusers made a significantly greater number of commission errors on the task, 
an impairment that has been found to be augmented with increasing demands on working 
memory (Kaufman et al., 2003; Hester and Garaven 2004). 
Comparable inhibitory deficits have also been shown in opiate and methamPhetamine 
dependent individuals, with poorer performance displayed on the go/no-go and SST task 
relative to demographically matched controls respectively (Forman et al., 2004; Monterosso et 
al., 2005). In contrast, no significant impairments in behavioural inhibition have been reliably 
shown in heavy ecstasy users utilising the go/no-go task (Fox et al., 2002; Quendow et al., 
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2007). This suggests perhaps that abusers of this particular illicit drug may display minimal 
disruption in this particular component of impulsivity. 
Research that has assessed differences in inhibitory control between current abusers of licit 
drugs and control non-abusing subjects has been limited. In smokers Spinella (2002) 
demonstrated that smoker status was significantly related to the number inhibitory errors on the 
go/no-go task, with smokers displaying a greater frequency of errors in comparison to non- 
smokers. No significant differences in performance on the go/no-go task were however found 
between college student smokers and non-smokers, despite smokers scoring significantly higher 
on the BIS non-planning sub-scale (Dinn, Aycicegi and Harris, 2004). As with the investigation 
of sensitivity to delayed reward in smokers, the relatively mild abusers in Dinn ct al. sample, 
consuming on average 5.8 cigarettes per day, may account for the lack of significant 
relationship between smoking and impulsivity found in this study. Indeed a later study 
conducted by Yakir and colleagues (2007) using heavier female smokers, the majority of which 
smoked between 11-20 cigarettes per day, did provide evidence of significantly poorer 
inhibitory control on the CPT in comparison to matched controls. 
In summary, the majority of research reviewed has demonstrated robust group differences 
between active abusers and non-abusers in both discounting of delayed reward and behavioural 
inhibition. Evidence has been displayed that both components of impulsivity are heightened in 
currently dependent individuals across illicit drugs of abuse, with the exception of ecstasy. In 
terms of licit drug abusers, a limited number of studies have assessed levels of impulsivity in 
currently abusing alcoholics and those that have been conducted have provided a discrepancy in 
findings. Clearly more research is needed to determine the relationship between impulsivity and 
active abusers of alcohol. In contrast, smokers have displayed significant evidence of both 
heightened impulsive choice and a dysfunction inhibitory control, an effect however perhaps 
limited to more heavy smokers. Despite evidence of the clear association between both 
components of impulsivity and addiction, once again the cross sectional design of the above 
studies does not enable the determination of whether heightened impulsivity is a consequence of 
the chronic abuse of these drugs, or contributes to the establishment and maintenance of 
addiction or both. 
13.2.4. Comparison of Levels of Impulsivity Across Different Patterns of Substance 
Misuse Amongst Abusers 
A limited number of studies have additionally assessed the relationship between impulsivity 
and the level and duration of drug abuse. The majority of research has focused upon different 
patterns of drinking and smoking behaviour. Vuchnich and Simpson (1998) for example 
compared the rates of discounting between light and heavy drinkers and light and problem 
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drinkers in college students. Findings demonstrated that in comparison to light drinkers higher 
levels of impulsive choice were shown in both'heavy and problem drinkers. The greatest rate of 
delay discounting was observed in the most severe drinkers providing support for a dose 
dependent type relationship between drinking behaviour and impulsive choice. Field et al. 
(2007) have since replicated these findings in adolescent light and heavy drinkers were a more 
pronounced discounting of delayed reward was shown in participants with higher levels of 
alcohol consumption. 
Within alcohol dependent individuals differences have in addition been found. Individuals 
diagnosed with early onset alcoholism were shown to display greater levels of discounting of 
delayed hypothetical rewards in comparison to late onset alcoholics, who failed to differ from 
matched controls in levels of impulsive choice (Dom et al., 2006). The lack of significant 
correlation displayed between years of abuse or dependence and rate of discounting led to 
authors concluding that findings suggested that heightened impulsive choice may be a risk 
factor in the development of early onset alcoholism. 
Whilst no comparable studies have compared different patterns of alcohol abuse on measures of 
disinhibition, using a variant of the go/no-go task significant positive relationships between the 
severity of alcoholism and the inability to inhibit inappropriate responding have been reported 
(Noel et al., 2007). In a further study Bolla et al., (2000) found a significant relationship 
between the number of errors of commission on the go/no-go task and self reported level of 
alcohol use, findings consistent with a dose dependent type relationship between inhibitory 
control and alcohol consumption. 
Less consistent findings, have been displayed between social smokers, also referred to as 
'chippers' and heavy smokers. Chippers are individuals who smoke cigarettes on a regular 
basis, normally within social environments, yet do not become addicted to tobacco. In a study 
where participants experienced both real rewards and delay to their delivery, individuals whom 
smoked more than 40 cigarettes per week displayed significantly higher rates of discounting of 
monetary rewards in comparison to both matched control non-smokers and lighter smokers who 
consumed in contrast less than 40 per week (Ilyinan and Gibb, 2006). The lighter smokers 
failed to differ from controls. In contrast, the lighter smokers in a study conducted by Johnson et 
al., (2007), failed to differ from heavy smokers with both smoker groups displaying 
significantly higher levels of impulsive choice of monetary rewards in comparison to never 
smokers. Furthermore, discounting of delayed reward was qualitatively similar across smoking 
groups, both in terms of magnitude and sign. Lower magnitudes of delayed monetary rewards 
were discounted to greater extent and discounting of both delayed health and monetary rewards 
were discounted greater when presented as gains rather than losses. The inconsistency in results 
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once again may be attributed to the varying classification of what is considered a light smoker. . 
Smokers in Johnson et al., (2007) were considered light abusers if they smoked less than 10 
cigarettes per day. This gave them opportunity to smoke more 70 per week, which is 
considerably higher than the classification for light smokers in Hyman and Gibb's study. 
The absence of heightened impulsiveness in chipper smokers has in addition been replicated 
comparing heavy and occasional smokers on a possible measure of disinhibition, the CPT 
(Yakir et al., 2007). Heavy smokers in the study made significantly more errors of commission 
than both control and chippers, who reported smoking on average less than 10 cigarettes per 
week. Moreover, chippers actually displayed a significantly greater ability to withhold pre- 
prepotent responses than the control participants (Yakir et al., 2007). As the CPT is a paradigm 
that primarily assesses attention, the positive effects observed on performance in light smokers 
may reflect more the enhancing attentional and vigilance properties of nicotine that have been 
established at lower more infrequent doses of the stimulant (e. g. Fan et al., 2002; Hahn and 
Stolerman, 2002). As previously discussed however, support for the lack of association between 
light smoking and disinhibition has been shown within a model principally utilised to measure 
inhibitory control, the go/no-go task. Adopting this task Dirm and colleagues (2004) failed to 
find a difference in performance between non-smokers and relatively mild smokers. 
Further evidence that impulsivity not only discriminates between smoker and non-smokers but 
also within smokers, is demonstrated by the significant positive correlations reported across 
studies between self reported cigarette consumption and level of both discounting of delayed 
reward and frequency of commission errors (e. g. Spinella et al., 2002; Reynolds 2004; Reynolds 
et al., 2004; Ohmura et al., 2005; Reynolds, 2006a; Johnson et al., 2007). 
Taken together, these data suggest that occasional, or light smokers and drinkers display little 
evidence of heightened impulsivity. This may be due to the lower levels of alcohol or nicotine 
these individuals have been exposed to relative to heavier abusers. Conversely, lower levels of 
impulsiveness prior to the initiation of smoking or drinking may protect these individuals from 
progressing from occasional use to more regular heavier use and dependence. The research 
conducted to date does not allow the direction of the relationship to be determined. 
1.3.2.5. Comparison of Levels of Impulsivity in Current Users, Ex-Users and Non-Users 
A number of studies have explored levels of impulsivity in individuals that are currently 
abstinent, from drug use. Three studies, for example, have compared current substance abusers 
to former ex-users of the drug on tolerance to delayed gratification. Bickel and colleagues 
(1999) showed strong evidence of a reduction in sensitivity to the value of delayed rewards 
following the termination of smoking. In their study, smokers displayed significantly greater 
19 
Chapter Ia Impulsivity and Drug Addiction 
sensitivity to delayed reward in comparison to not only non-smokers but also ex-smokcrs whom 
displayed similar discounting rates to controls. These findings suggest that the increased degree 
of discounting of rewards in smokers may be a reversible effect of nicotine dependence (Bickel 
and Marsch 2001). In contrast, further studies have found that former users display discounting 
rates intermediary between active users and controls. This has been observed when comparing 
alcoholics and currently abstinent alcoholics (Petry 2001) and active heroin/amphetamine 
injectors relative to former users (Bretteville-Jensen 1999). While these findings also suggest 
that drugs of abuse may result in an increase in impulsivity, an effect which is reduced with 
abstinence, they differ from that of Bickel et al., in that ex-users continue to differ significantly 
from never users. There are two plausible explanations for the discrepancy. Firstly, both former 
and current smokers in comparison to other drugs of abuse may simply display lower rates of 
discounting. Secondly, variations in the length of abstinence in former users across studies may 
account for the differences. In Bickel et al., study ex smokers had to have remained successfully 
abstinent for a least 12 months. Although Brettcville-Jensen did not report length of abstinence, 
former alcohol abusers had to have abstained from drinking for only aI month period. It could 
be that a critical period of abstinence is required before changes in DD reach comparable levels 
of non-users. 
It is important to highlight here that a further interpretation across these studies is highly 
plausible. The fact that all former abusers did display lower levels of discounting of delayed 
reward than current abusers of the drug, could have resulted instead from a selection bias. A 
trait characteristic of low levels of impulsive choice may have allowed these individuals to 
successful abstain from the drug of abuse. Further research is essential to determine the 
direction of effect of low levels of impulsive choice and drug abstinence. 
If it is the case, however, that with increasing length of abstinence a reduction in impulsive 
choice is observed, then according to this theory individuals that have abstained for a lesser 
period than the participants in the above studies should display levels of DD more comparable 
to that of current users. Indeed following 14 days of no drug use both abstinent cocaine and 
alcohol abusers were found not to differ in their degree of discounting relative to active users of 
each of these drugs (Kirby and Petry, 2004). Conversely, active and abstinent heroin abusers in 
the same study were found to differ, with lower levels of discounting shown by the ex users that 
were more comparable to the control group. The greater time that abstinent heroin abusers had 
been in treatment in comparison to ex cocaine and alcohol abusers, was argued possibly to have 
led to the differences found across abusers (Kirby and Petry 2004). Support for heightened 
impulsivity during early stages of abstinence has further been shown in methamphetamine 
users, who following one week abstinence continued to display significantly more extreme 
levels of discounting than matched controls (Hoffman et al., 2006). If it is to be argued that with 
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longer abstinence these participants will display greater tolerance to delayed reward, it does 
however have to be assumed that these individuals will continue to successfully remain 
abstinent. Due to the cross sectional design of the above studies no firm conclusions can 
therefore be made. Research is necessary that assesses, within subjects, impulsive choice from 
the point of termination of drug consumption through to long term abstinence (Mitchell, 2004; 
Reynolds, 2006b). 
Whilst evidence has shown less extreme levels of discounting with long term abstinence for ex 
smokers (Bickel et al., 1999), alcoholics (Petry, 2001), heroin and amphetamine users 
(Bretteville-Jensen, 1999) comparable findings have not yet been indicated for ex cocaine users. 
Heil et al. (2006) demonstrated that no differences in sensitivity to delayed gratification were 
observed between active and ex users of cocaine who had been abstinent for a 30 day period. 
Furthermore, former cocaine users displayed significantly higher levels of impulsive choice 
relative ex users of heroin who had abstained from drug use for a comparable time period 
(Bomovalova et al., 2005). These findings suggest that, in contrast to other drugs of abuse, 
cocaine may not display a lesser reduction in impulsive choice following termination. Two 
possible explanations can account for these findings; firstly, the neuroadaptations that modulate 
the decrease in rates of DD may take a significantly longer period following chronic cocaine 
exposure relative to other drugs of abuse, secondly, in contrast, these findings may suggest 
instead that heightened impulsive choicd in cocaine abusers is a pre-existing abnormality rather 
than a consequence of drug abuse. 
In regards to changes in levels of behavioural inhibition with abstinence, only one study within 
the literature has directly compared both active and abstinent abusers on this aspect of 
impulsivity. Yakir et al., (2007) compared the performance of current smokers and ex-smokers 
who had abstained from smoking for at least six months on the CPT. Current smokers 
performed poorer on CPT than matched controls, making a significantly greater number of 
errors of commission. However, the greater impairment in the ability to inhibit pre-potent 
responses in smokers failed to differ from past smokers, who performed at an intermediate level, 
between active smokers and controls on the task. The comparable levels of heightened 
impulsivity in ex-smokers led to the authors concluding that evidence had been provided that 
impaired inhibitory control may be a vulnerability that can influence the initiation of smoking 
(Yakir et al., 2007). As with delay discounting research, no firm conclusions can however be 
made until further longitudinal studies determine whether with continued abstinence ex-smokers 
continue to improve in their ability to inhibit behaviour. As shown in the case of impulsive 
choice, following a longer period of abstinence (one year) ex smokers did display significantly 
lower levels of impulsivity in comparison to current smokers (Bickel et al., 1999). 
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Whilst limited studies have been conducted comparing disinhibited behaviour of current and ex 
users, more extensive research has compared populations of abstinent users to control subjects. 
Following 15 days of abstinence, cocaine but not heroin dependent individuals, displayed a 
greater dysfunction in the ability to inhibit inappropriate responding on a version of the go/no- 
go task in comparison to matched control participants (Verdejo-Garcia, Perales and Peres- 
Garcia 2007). The more extreme levels of impulsivity demonstrated by abstinent cocaine users 
compare to findings exploring sensitivity to delayed gratification, where cocaine but not heroin 
dependent individuals once again demonstrated significant differences relative to controls 
(Kirby and Petry, 2004). The greater neurological impairment in chronic cocaine abusers has 
been argued to possibly underlie variations in performance between abusers (Lyoo et al., 2004). 
Whether impairments in inhibitory control in cocaine abusers persist with longer abstinence 
however, is unclear. 
Evidence of heightened impulsive control has furthermore been demonstrated in abstinent 
alcoholics in comparison to non-alcohol dependent individuals. Following a minimum 
abstinence period of two weeks, detoxified alcoholics continued to display greater deficits in 
response inhibition on a modified go/no-go task where both neutral and alcohol related words 
represented go target signals (Noel et al., 2005; 2007). Evidence of continued impairment with 
longer term abstinence has also been shown. Heightened disinhibition, as measured by 
commission errors, has been demonstrated in alcoholics at 28 days of abstinence on the CPIT 
(Bjork et al., 2004) and 3 months following termination of drinking on the go/no-go task 
(Goudriaan et al., 2005). Taken together these findings suggest that in alcoholics dysfunctions 
of inhibitory control persist long after termination of consumption. Whether this impairment 
predated alcoholism or is instead a consequence of chronic alcohol exposure is unclear. It is 
important to acknowledge, however, that in many of the studies smoking behaviour was not 
controlled for. The loss of inhibitory control associated with smoking could therefore account 
for the continued heightened impulsivity observed in these subjects. 
In summary, studies that have included current and past, abusers suggest that heightened 
impulsivity, in particular intolerance to delayed reward, may be a reversible effect of drug 
dependence. Furthermore, there may be a critical period of abstinence, that varies across drugs 
of abuse, before a reduction in DD can be shown. However, due to the cross sectional nature of 
the research a further plausible interpretation of findings is that lower levels of impulsivity has 
enabled successful abstinence. No firm conclusions can be made regarding the association 
between disinhibition and abstinence from drug abuse due to the sparse number of studies 
including both an active and abstinent drug group. However, with the exception of heroin 
abusers, studies that have compared users in both early and later stages of abstinence to non 
drug users have demonstrated consistent poorer levels of inhibitory control. This suggests the 
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possibility that unlike heightened impulsive choice, chronic drug exposure may lead to long 
term changes in inhibitory control, that persist following the termination of drug abuse. 
Conversely, these findings could indicate that impairments in behavioural control could have 
predated drug exposure and constituted instead a vulnerability for developing addiction. Only 
research that assesses levels of both components of impulsivity longitudinally prior to, during 
and following drug abuse will enable conclusively to determine the temporal association 
between impulsivity and drug dependence. 
1.3.2.5. Examination of the Acute and Chronic Effects of Drugs of Abuse on Impulsivity 
For many of the reviewed aforementioned studies it is unclear whether participants during the 
completion of tasks are under the acute influence of the abused drug or in a state of withdrawal 
and importantly to what extent these drug states may be affecting perfonnance. In attempt to 
explore more directly the impact of drugs of abuse on both impulsive choice and disinhibition, a 
number of studies have examined the acute, and to a lesser extent chronic, drug effects in both 
human and animal models of impulsivity. Table 1.1-1.4 summarise the acute and chronic 
effects of drugs of abuse on impulsivity. 
Repeated cocaine administration has been shown to increase preference for the immediate 
smaller reinforcer in a rodent model of DD (Logue et al., 1992). Comparably, Paine and 
colleagues (2003) later demonstrated evidence of heightened impulsive choice during a two 
week period of cocaine administration. Animals treated three times a day with 15mg/kg cocaine 
displayed reduced indifference points in comparison to saline treated animals in the first seven 
days of treatment. This effect however recovered and returned to baseline levels during the final 
seven days of treatment, explained by the authors as an increased tolerance to cocaine's effects 
on impulsive behaviour (Paine, Dringenberg and Olmstead, 2003). No comparable assessments 
of cocaine administration on DD have been studied in human subjects. 
Acute cocaine has furthermore been studied in models of inhibitory control. In rodents acute 
cocaine has been found to increase the inability to withhold inappropriate responding as 
assessed in DRL (Cheng, MacDonald and Meck, 2006), asymmctrically reinforced go/no-go 
paradigm (Painc and Olmstead 2004) and the 5CSRTT (Van Gaalen, Brueggeman, Bronius et 
al., 2006). The induced increase in impulsive responding parallels the impaired inhibitory 
control found in chronic cocaine abusers on following oral consumption of low doses of cocaine 
hydrochloride on the SST (50-150mg/kg) (Fillmore et al., 2002). 
More recently, however, within the human literature, reports by the same authors have been 
made of a decrease in impulsivity following cocaine consumption. In chronic cocaine abusers 
oral consumption of cocaine hydrochloride across doses of 100,200, and 300mg/kg led to an 
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linear increased aýility to inhibit responding in a cued dependent version of the go/no-go task 
(Fillmore, Rush and Hays, 2005; 2006a). Furthermore reaction time to inhibit responses was 
also found to be reduced in the SST, indicative of an increase in inhibitory control, under 100 
and 200mg/kg but not the highest cocaine dose (Fillmore, Rush and Hays, 2006b). Authors 
suggest that perhaps a nonlinear, U-shaped affect of acute cocaine on impulsive behaviour may 
exist. Lower and possibly higher doses of cocaine may impair inhibitory control whilst 
intermediary doses may have a more positive effect on impulsivity (Fillmore et al., 2005). As 
already outlined chronic abusers of cocaine have consistently demonstrated heightened 
dysfunctions in inhibitory control (e. g. Hester and Garaven, 2004; Li ct al., 2006). Drug users 
may initially abuse moderate doses of cocaine as a form of self medication, to perhaps aid in the 
control of disinhibited behavioural tendencies (e. g. Khantzian, 1985). With repeated cocaine 
exposure however, this may give rise to neuroadaptations that lead to greater impairments of 
inhibitory mechanisms, resulting in a loss of control over drugýlntake and sustaining of drug 
abuse (e. g. Fillmore et al., 2005). In support of this theory repeated cocaine treatment for a 14 
day period in monkeys led to an increase in perseverative responding on an object 
discrimination task, indicative of disinhibited behaviour (Jentsh, Olausson, Garza et al., 2002). 
Evidence was furthermore provided that these impairments were still present 30 days following 
termination of treatment. The persistence of performance deficits following long term 
termination of treatment are comparable to the continued impaired inhibitory control observed 
in abstinent cocaine users (e. g. Verdejo-Garcia et al., 2007). 
The effect of a further psychostimulant extensively studied on impulsive behaviour is that of 
amphetamine and its derivatives. In the animal literature acute doses of the stimulant drug, as 
well as its analogue niethamphetarnine, have yielded inconsistent results in models of sensitivity 
to delayed reward. Both a suppression (Richards et al., 1999a; Cardinal et al., 2000; Wade et al., 
2000; Winstanley et al., 2003a; Van Gaalen et al., 2006) and enhancement of impulsive choice 
has been reported in rodents (Charrier and Thiebot, 1996; Evenden and Ryan, 1996; Cardinal et 
al., 2000; Isles, Humby and Wikinson 2003; Helms, Reeves and Mitchell 2006). The 
discrepancy in findings following acute administration may possibly be accounted for by 
procedural differences across studies. Studies that reported a significant increase in impulsive 
choice have utilised food reinforcements in systematic delayed reward paradigms. In contrast, 
water rewards were adopted in adjusted amount procedures that conversely demonstrated a 
reduction in impulsivity. The anorectic properties of the stimulant (e. g. McPhail and Gollub, 
1974) may have resulted in varying effects on the motivation for food and water rewards 
leading to differential effects on the choice of reinforcement in each of the paradigms. 
Furthermore, the differences in findings may be accounted for by the presence or absence of a 
reward-predicting cue during the delay to delivery of the larger reward. In studies where 
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amphetamine suppressed impulsive choice a reward-predicting cue (a tone, or light) was 
presented during the duration of delay to the delivery of the larger reward (Richards et al., 1997; 
1999a; Wade et al., 2000). The cue-dependent effect of amphetamine to increase tolerance to 
delayed reward was supported later by Cardinal and colleagues who directly compared the acute 
effects of d-amphetamine on choice of both signalled and unsignalled delayed reward tasks 
(Cardinal et al., 2000). In support of previous research, amphetamine displayed differential 
effects dependent on the presence or absence of a cue, with a reduction and enhancement of 
impulsive choice demonstrated respectively. Authors argued that the signal presented in cued 
paradigms becomes a conditioned reinforcer to the delivery of the larger reward. Amphetamines 
ability to therefore promote choice of the delayed reward is through the stimulants potentiation 
of the conditioned reinforcing properties of this signal, thus leading to the enhanced selection of 
the associated reward (Cardinal et al., 2000). 
More recently, Isles and colleagues (2003) have indicated that the promotion of impulsive 
choice or increase in self control by d-amphetamine may be dependent on the dose 
administered. A biphasic response to the psychostimulant was evident in mice. Indication of a 
decrease in impulsivity was observed at the lower dose range in contrast to enhanced impulsive 
responding at the higher doses tested. Support for the theory that low doses of amphetamine 
might promote tolerance of delayed reward has been provided by the single study that has been 
conducted with human subjects. In healthy subjects a low 20mg dose of d-amphetamine 
increased preference for the larger more delayed reward (de Wit et al., 2002). These findings 
suggest that perhaps low to moderate, infrequent doses of d-amphetamine may reflect the 
known therapeutic effects of the stimulant on impulse control in ADIID diagnosed patients (e. g. 
Tannock et al., 1989). In contrast higher doses, more comparable to those administered in 
methamphetamine dependent individuals, may lead to heightened levels of impulsive choice. 
Indeed Richards et al. (1999a) demonstrated a significant increase in impulsive choice following 
chronic 14 day administration of high doses (4. Omg/kg) of methamphetamine in mts, a 
treatment regime more comparable to the pattern of drug use observed in dependent individuals. 
The dose dependent effect of acute amphetamine treatment has additionally been indicated in 
models of inhibitory control. Consistent to the drug effects on increasing tolerance to delayed 
reward low to moderate doses of the stimulant have been shown to facilitate inhibitory control. 
In healthy participants the stimulant drug (10 and 20mg/kg), has been shown to both selectively 
decrease frequency of inhibitory failures on the go/no-go task and to reduce time taken to inhibit 
a response on the SST (de Wit et al., 2000; 2002). The improvement in inhibitory control 
however is restricted to those individuals displaying a poor baseline level of inhibitory control 
(de Wit et al., 2000; 2002; Fillmore et al., 2005). The baseline rate dependent effect is consistent 
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once again with the therapeutic properties of the drug in individuals with already poor inhibitory 
control (e. g. Tannock et al., 1989). 
Parellel to these findings, adopting a rat version on the SST low doses of 0.25 and 0.5mg/kg of 
d-amphetamine improved inhibitory control, an effect restricted to animals exhibiting a low 
baseline level of performance (Feola, de Wit and Richards, 2000). Higher doses tested in animal 
models have in contrast demonstrated evidence of the drugs ability to induce impulsive 
responding. At doses across the range of 0.8-2.4g/kg, a reduction in inter response time in the 
DRL (Wiley, Compton and Golden, 2000) as well as an increase in extreme premature 
responding in FCN (Evenden 1998a; 1998b) have been shown. Further-more, following acute 
amphetamine both impairments in performance on an asymmetrically reinforced go/no-go task 
(Ridley et al., 1980) and enhanced anticipatory responding in the 5CSRTT have been reported 
(Harrison et al., 1997; Van Gaalen et al., 2006). 
State changes in impulsivity have in addition been examined following consumption and 
administration of licit substances. Firstly, the assessment of alcohol intoxification has revealed 
no changes in sensitivity to delayed reward in social drinkers following the consumption of 
alcohol (Richards et al., 1999b; Reynolds et al., 2006b), although one study did report evidence 
of perhaps a slight decrease in levels of impulsive choice (Ortner ct al., 2003). It has been 
argued however that DD measures where delay to the delivery of reward is not experienced may 
lack sensitivity to the acute effects of alcohol (McDonald et al. 2003; Reynolds and Schifibauer, 
2004). This was supported by a later study by Reynolds and colleagues (2006b) who adopted a 
DD measure, the Experiential Discounting Task (EDT), where both reward and delay to its 
delivery were experienced by the participant. The highest 0.8g/kg alcohol dose tested was found 
to significantly increase impulsive choice relative to the placebo condition. Comparably, in 
animal models of delayed reward, where subjects also receive selected rewards and are exposed 
to delays, acute ethanol has led to a significant increase in preference for the smaller more 
immediate reward across DD models in rats (Tomie et al., 1998; Evenden and Ryan, 1999; 
Hellmans, Nobrega and Olmstead, 2005). 
Explored more extensively are the effects of alcohol intoxication on the ability to inhibit 
inappropriate responding as a measure of impulsivity. A selective increase in inhibitory failure 
on the SST has been observed following both moderate doses of alcohol in social drinkers (e. g. 
Mulvihill et al., 1997; Fillmore and Vogel-Sprott, 1999; De Wit, Crean and Richards et al., 
2000; Easdon and Vogel-Sprott 2000; Reynolds et al., 2006b) and ethanol in rats (Feola et al., 
2000). Comparable increases in impulsivity moreover have been demonstrated in a more 
challenging version of the CPT, the immediate and delayed memory tasks. Both moderate 
(0.20g/kg) and higher doses (I. Og/kg) of alcohol increased frequency of commission errors, 
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although at the higher dose a decrease in attention was also shown which could have accounted 
for the poorer performance on the task (Dougherty et al., 1999; 2000). Evenden (1998a; 1998b) 
in rats further demonstrated decrease in chain length of responses in an FCN procedure at doses 
1.0 and 3. Omg/kg, although once again, effects have not always been selective with a reduction 
in total responding also observed at the highest dose (Evenden, 1998b). 
In contrast, less consistent findings have been found with acute effects of alcohol on the go/no- 
go task. Reports of both an increase in inhibitory failure (Finn et al., 1999; Easdon et al., 2005) 
and a lack of an effect of alcohol on performance have been made (Ortner et al., 2003; Reynolds 
et al., 2006b). The lack of consistency of the effects of alcohol in the go/no-go task relative to 
the SST has led authors to argue that both tasks may differ in their underlying processes (e. g. 
Reynolds et al., 2006b). Unlike the SST, where an already initiated response has to be retracted, 
reflecting perhaps more motor impulsivity, the go/no-go task requires instead participants to 
both remember go-signal targets and to decide whether or not to respond. The latter task 
therefore is arguably a more cognitively demanding paradigm. When not under the influence of 
drugs, however, performance on both tasks have been found to be positively related, thus 
supporting common underlying processes of both behavioural inhibition tasks (Reynolds et al., 
2006a). Interestingly, in cue dependent versions of the go/no-go paradigm alcohol has reliably 
increased disinhibition. In such paradigms prior to Go and No-go signals- cues are presented that 
either have an 80% reliability of either a presentation of Go and No-go signal then following 
(e. g. Marczinski and Fillmore, 2003a; Marczinski and Fillmore, 2003b; Fillmore and Weafer, 
2004; Marczinski and Fillmore, 2005; Marczinski et al., 2005). Alcohol has been found to dose 
dependently increase failures to inhibit responses only during trials where incorrect Go but not 
correct No-go cues are presented, prior to the signal. These findings suggest that under drug 
influence individuals may become more reliant on cues to inhibit behaviour, and that 
impairments in inhibitory behaviour are most likely to occur when there is a particular strong 
responding tendency. 
The effects of nicotine have also been explored. Only one study has however assessed the 
effects of nicotine in a model of DD. In rats Dallery and Locey (2005) demonstrated that across 
the acute dose range tested (0.03-1. Omg/kg), a dose dependent increase in intolerance to the 
delayed larger reward was shown. In the same study, animals then received 0.3mg/kg of 
nicotine for a duration of 65 days, following which the acute dose regime was then repeated. 
Impulsive choice was substantially heightened following all doses, including saline, providing 
evidence of greater levels of discounting during chronic exposure. Interestingly, following the 
termination of chronic treatment animals remained more impulsive for approximately four 
weeks before a return to baseline levels was shown. These findings compare to that of Bickel et 
al. (1999), that. displayed differences in impulsive choice between human smokers and ex- 
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smokers, supporting the interpretation that nicotine dependence may lead to reversible increases 
in impulsivity. 
Nicotine has more frequently been examined in models of inhibitory control. Findings are 
complex however, with mixed results reported. In a group of healthy non-smokers 
administration of nicotine for 4.5 hours via a transdermal patch had little effect on inhibitory 
control whilst significantly improving sustained attention on a CPT task (Levin et al., 1998). 
Comparably, in moderate smokers acute nicotine (7 and 21mg) had no effects on impulsive 
responding following overnight abstinence, as assessed by both the CPT and SST (Bekker et al., 
2005). As with amphetamine, evidence has however been demonstrated of positive effects of 
the stimulant on inhibitory control in populations associated with disinhibited behaviour at 
baseline. For example, in non-smoking adolescents diagnosed with ADHD acute nicotine 
(7mg/day) was found to significantly increase inhibitory control as measured by the decrease in 
reaction time taken to inhibit responses on the SST (Potter and Newhouse, 2004). Schizophrenia 
is a further psychopathology associated with heightened impulsivity (e. g. Dervaux et al., 2004), 
where high doses (21mg) of nicotine have been shown to markedly reduce commission errors 
on the CPT in patients (Levin et al., 1996). In the same group of patients under the influence of 
lower dose of nicotine (7mg) impulsive responding was however enhanced, with an increase in 
commission errors shown (Levin et al., 1996). The potential therapeutic effects of nicotine on 
inhibitory control in such patient groups is believed to be associated with the high prevalence of 
smoking observed in these populations (de Leon et al., 1995; Pomerleau et al., 1995; Dervaux. et 
al., 2004; Gehricke et al., 2006). If this is indeed the case, then heightened impulsivity, at least 
in these patient groups, may predispose these individuals more vulnerable to the development of 
nicotine addiction. 
Within the animal literature nicotine has in addition yielded mixed results. The drug has been 
most extensively been examined in the 5CSRTr. Although the ffiain focus of such research was 
the exploration of acute nicotine's enhancing properties on attention, the stimulant has 
demonstrated heightened anticipatory responding following its administration in both mice and 
rats (e. g. Mirza and Stolerman, 1998; Blondel, Sanger and Moser, 2000; Stolerman, Mirza, 
Hahn, Shoaib, 2000; Hahn, Shoaib and Stolerman, 2002; Bizarro, Patel, Murtagh, Stolerman, 
2004; Bruin, Fransen, Duytschaever, Grantham and Megens, 2006). The increased inability to 
withhold inappropriate responding was generally observed following low doses of nicotine 
(0.03-0.3mg/kg) and under conditions of high attentional demand. Other research however has 
failed to demonstrate an effect on anticipatory responding in nicotine naive animals, yet have 
reliably displayed an increase in impulsive responding in animals previously treated with 
nicotine (Grottick and Higgins 2000; 200 1; Day, Pan and Buckley, et al., 2007). Comparably, in 
a further study where the effects of repeated nicotine exposure were assessed over a seven day 
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period, no effect on anticipatory responding was observed during initial treatment. With 
continued exposure however a more impulsive behavioural profile then predominated (Blondel, 
Simon, Sanger and Moser, 1999). Caution must however be given in interpreting these findings 
as evidence of heightened impulsivity. The increase in anticipatory responding could potentially 
reflect nicotine induced hyperactivity, an effect well established in animals chronically exposed 
to nicotine (e. g. Clarke and Kumar, 1983). Particularly in studies where combined decreases in 
response latency are exhibited, it becomes increasingly difficult to dissociate nicotine's effects 
on sensitisation of motor functions from that of inhibitory control (Blondel et al., 1999; Grottick 
and Higgins 2000; 2001). 
Further support for a nicotine induced reduction in inhibitory control has been demonstrated 
following its administration in the DRL paradigm. An increased inability to withhold 
responding indicated by a greater response rate and premature responding has reliably been 
shown across studies (Monison, 1968; Bizot 1998; Popke, Mayorga, Fogle and Paule 2000a; 
2000b). The DRL model is however additionally sensitive to both changes in motor, and timing 
ability, both factors known to be affected by nicotine (e. g. Clarke and Kumar, 1983; Carrasco et 
al., 1998). It is therefore difficult to validly interpret these findings as evidence of nicotine 
induced loss of inhibitory control. 
Overall the effects of nicotine on inhibitory control appear to be complex and dependent on a 
number of factors including dose, length of exposure and baseline level of impulsivity. The 
reported positive effects of nicotine in the human literature on inhibitory control appear 
seemingly in contrast to the poor impulse control evident in smokers (e. g. Spinella, 2002; Yakir 
et al., 2007). It should be noted however that these findings were demonstrated in individuals 
with diagnosed psychopathology, limited studies have been conducted exploring the effects of 
acute nicotine in both healthy smokers and non smokers therefore making it difficult for valid 
conclusions to be made. It may however be the case, unlike sensitivity to delayed reward which 
has shown to increase with nicotine treatment, that poor inhibitory control may be risk factor in 
the development of smoking. As argued with cocaine, individuals may initially smoke as a form 
of self medicating and controlling of disinhibitcd behaviour. However, with repeated nicotine 
exposure, this may lead to neuroadaptations that lead to greater dysfunctions in inhibitory 
control as supported by the chronic exposure to nicotine in animals (e. g. Blondel et al., 1999). 
Further research is necessary that explores the impact of acute and chronic nicotine in both 
healthy smokers and non-smokers, whilst the need for animal research to assess nicotine 
treatment in models explicitly designed to measure inhibitory control is essential. 
The impact of additional drugs of abuse has also been examined in models of impulsivity, 
however to a much lesser extent. For example the opiate morphine has demonstrated a dose 
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dependent increase in discounting of delayed reward following its acute administration in rats, 
an effect blocked by the opioid antagonist naloxone (Kieres, Hausknecht, Farrar, et al., 2004). 
In models of behavioural inhibition acute treatment with the commonly abused drug, THC, has 
furthermore displayed evidence of increased levels of disinhibition, as indicated by the 
augmented impulsive responding on a SST in human subjects reporting previous use of the drug 
(McDonald et al., 2003), and enhanced levels of premature responding in a DRL task in rats 
(Wiley et al., 2000). Despite reported alterations in inhibitory control, no significant effects 
have however been reported on impulsive choice following the intake of TIIC (McDonald et al., 
2003). 
In. summary, abused drugs have been shown to have distinctive effects on measures of 
impulsivity. Increasing evidence across drugs of abuse suggests that both administration and 
consumption may lead to an increased sensitivity to delayed gratification, these effects however 
may be restricted to both higher and chronic doses more comparable to the abuse of drugs in 
dependent individuals. The effects of drugs on inhibitory control appear to be less consistent 
and more complex. In the case of the stimulants, cocaine, amphetamine and nicotine their 
effects on inhibitory control appear to dependent on a number of factors including dose level, 
length of drug exposure and baseline impulsivity. Acute low to moderate doses have 
demonstrated positive enhancing effects of inhibitory control. These potential benefits are 
specific however to individuals whose basal levels of inhibitory control are sub-optimal. 
Alihough limited, evidence does suggest that more long term chronic exposure to high doses of 
such stimulants may lead to substantial deficits in inhibitory control, more consistent with the 
levels of impulsivity observed in drug dependent individuals. When considering the relationship 
between impulsivity and drug dependence, these findings, to some extent, suggest evidence that 
drugs of abuse may directly impact upon levels of impulsive behaviour, although the initial and 
long term effects may differ. It is essential that future research in both human and animals 
explore the effects of drug regimes more comparable to that adopted by drug dependent 
individuals. Such investigations will enable determination of the required length and amount of 
drug exposure necessary to elicit the neuroadaptations that may mediate the heightened 
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13.2.6. Examination of the Effects of Acute Withdrawal on Impulsivity 
Only a limited number of studies have explored the effect of acute drug withdrawal or drug 
deprivation on impulsive choice and to an even lesser extent, inhibitory control. For example 
Giordano and colleagues (2002) compared in opioid dependent patients, maintained on 
buprenorphine, rates of discounting of delayed reward when both mildly opioid deprived and 
opioid sated. When opioid deprived, subjects discounted both delayed heroin and monetary 
rewards to a greater extent then when opioid sated. Heroin was discounted to the greatest degree 
during both stages, with discounting rates shown to be two to three times more rapid than that of 
delayed monetary rewards. 
Comparable findings have since been observed in short term deprived smokers (Field et al., 
2006). Smokers deprived for a period of- 13h discounted both delayed hypothetical monetary 
and cigarettes to a greater degree relative to when completing the task 5 minutes following the. 
smoking of a cigarette. Once again, the drug of abuse displayed the steepest rates of 
discounting. Inconsistent with these findings, smokers deprived of nicotine for 24h 
demonstrated no evidence of an increase in intolerance to delayed reward when choices were 
made regarding monetary rewards (Mitchell 2004). Impulsive choice in Mitchell's study was 
only increased for cigarettes during acute deprivation, leading authors to conclude that findings 
demonstrated more of an increased preference for cigarettes rather than evidence of a greater 
intolerance to delay. The discrepancy in findings in smokers can possibly be attributed to both 
the lack of power (N= 11) in Mitchell's study, and the variation in a DD tasks utilised across 
studies. 
In models of inhibitory control, both overnight and 24h smoking abstinence was associated with 
a poorer ability to withhold inappropriate responding on the CPT (Hatsukami et al., 1989; 
Dawkins et al., 2007). This impaired performance furthermore was attenuated by administration 
of nicotine (Dawkins et al., 2007). 
In the animal literature reports have only been made on the effects of drug withdrawal on 
inhibitory control. In rats, Dalley and co-workers (2005a) demonstrated no significant changes 
in impulsive responding in the 5CSR'IT when tested at 24 hours post termination of six 
consecutive days of cocaine self administration. Comparably, in the same task a lack of effect 
on impulsivity has also been shown following the withdrawal from both heroin and 
amphetamine intravenous self administration (Dalley et al., 2005a; 2005b). More recently, a 
further study examined differences in response to intermittent withdrawal from cocaine between 
high and low trait impulsive animals based on the level of anticipatory responding in the 
5CSRTr. Findings demonstrated a contrasting normalisation in impulsive responding in high 
trait impulsive animals relative to the low impulsive group (Dalley et al., 2007). Within the 
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animal literature it has yet to be elucidated whether comparable effects of drug withdrawal will 
be observed in animal models that are designed more specifically to measure behavioural 
inhibition, or models that assess different forms of impulsive behaviour such as sensitivity to 
delayed reward. 
The augmented levels of impulsivity, in particular impulsive choice, during early withdrawal 
may play an important role in the maintenance and relapse of drug dependence. The deficits in 
self control during early abstinence may lead to the increased likelihood of dependent 
individuals choosing once again the immediate rewarding effects of the drug, or relief of 
withdrawal as the larger delayed rewards associated with a drug free lifestyle will be discounted 
to the greatest extent during this stage. As a result, attempts to abstain will continue to fail and 
drug taking behaviour will be maintained. Interestingly when alcohol and cocaine dependent 
individuals were asked the subjective reasons for relapse, 41% reported it was an 'impulsive 
action', or loss of control, with only 7% reporting reasons of craving (Miller and Gold, 1994). It 
is crucial that future research explores further the role of impulsivity during acute withdrawal 
which may aid further our understanding of cessation failures amongst dependent individuals. 
Indeed recent research is beginning to highlight the importance of impulsivity in relapse and 
thus demonstrating the essentiality of the need of both behavioural and pharmacological 
interventions to target impulsivity in the treatment of substance dependence. For example, 
alcoholics who displayed greater deficits in inhibitory control were more likely to relapse during 
the two months following a detox programme (Noel et al., 2002). Comparably, the level of 
impulsive choice and disihibition, as assessed on the EDT and CPT respectively, was found to 
be significantly greater in adolescents who failed to successfully abstain from smoking during a 
fourteen week smoking cessation programme (Krishnan-Sarin et al., 2007). 
Findings of the effect of short term deprivation on impulsive responding if taken together with 
results from research assessing longer term abstinence suggest that perhaps a biphasic 
relationship between abstinence and impulsivity may exist, at least in the case with impulsive 
choice behaviour (Reynolds, 2006b). Initial abstinence from the drug and early onset 
withdrawal may result in a heightening of impulsivity, during which time individuals are at a 
potentially higher risk of relapse. With continued abstinence levels of impulsive responding 
may then begin to decrease (e. g. Bickel et al., 1999; Petry et al., 2001). Such conclusions cannot 
however be made until research assesses impulsivity over time; commencing at the point of 
initial withdrawal and continuing through to long term abstinence within subjects. 
1.3.2.7. Examination of Impulsivity as a Predictor of Drug Abuse 
Research that has explored the theory that high levels of impulsivity may predispose the abuse 
of drugs is limited. In a study that explored the predictors of cigarette smoking in adolescence, 
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sensitivity to delayed reward at 9" grade was not associated with the progression of smoking 
during the following four years (Audrian-McGovern et al., 2004). DD however did indirectly 
influence the initiation of smoking through complementary reinforcers such as peer smoking, 
alcohol and drug use, which alone increased the likelihood of smoking. This may suggest that 
sensitivity to delayed gratification may be more of a risk factor for the use of other drugs of 
abuse. Whilst DD was not a predictor of future smoking, at baseline sensitivity to delayed 
reward was significantly higher in adolescents who were currently regular smokers, supporting 
the theory that perhaps impulsivity is instead augmented by smoking (Audrian-McGovem et al., 
2004). 
In a further study that assessed the role of disinhibition, findings demonstrated that whilst the 
level of inhibitory control at the age 10-12 years did not influence the use of drugs at 16, it did 
significantly predict the development of substance use disorder at 19 years of age (Tarter et al., 
2003). These finding suggest that this subcomponent of impulsivity may play little role in the 
initiation of substance taking, but instead significantly predict the future progression to 
substance use disorder once these substances have been used. In a comparable study Aytyaclar 
et al., (1999) provided evidence that impaired executive functioning in childhood, which 
included the'impaired ability to inhibit responding, was a valid predictor of substance misuse in 
adolescence. More specifically, smoking, cannabis use, and the number of drugs that had been 
experimented were reliably predicted. 
Evidence has additionally been provided in the animal literature that impulsivity may predispose 
the abuse of drugs. Baseline levels of sensitivity to delayed reward and levels of anticipatory 
responding, as measured in a adjusting amount DD procedure and 5CSRTT respectively, have 
both predicted levels of cocaine self-administration in rats (Perry et al., 2005; Dalley et al., 
2007). Higher trait levels of impulsivity on both measures led to greater rates of cocaine self 
administration relative to the low impulsive group. Comparably, animals exhibiting the greatest 
intolerance to delayed reward consumed significantly more freely available ethanol compared to 
both medium and low level impulsive groups (Poulos, Le and Parker, 1995). Furthermore, mice 
strains that exhibited more impulsive responding on an appetitive signalled nose poke task, a 
paradigm comparable to the 5CSRTT, also drank more ethanol (Bowers and Weliner, 2001). 
Taken together, these findings suggest that heightened impulsivity may precede and act as 
predisposing factor to substance misuse and possibly substance use disorder. The difficulties 
associated with administering behavioural tasks in longitudinal research combined with the lack 
of knowledge concerning the stability of performance in such tasks has meant that research in 
this area is lacking considerably (Mitchell, 2004). The strongest argument that impulsivity may 
be a risk factor of substance dependence comes instead from indirect evidence that indicates 
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children diagnosed with impulse control problems, such as ADHD and conduct disorder, are 
significantly more likely to abuse both licit and illicit agents (e. g. Biederman et al., 1997; Burke, 
Loeber and Lahey, 2001; Moss and Lynch, 2001; Molina and Pelham, 2003). If one therefore 
considers the evidence together, it is highly probable that heightened impulsivity may act as 
predisposing factor drug dependence and therefore highlights the importance of future 
prevention strategies to consider managing both impulsive choices and disinhibited behaviour. 
1.4. NEUROBIOLOGICAL MECHANISMS OF IMPULSIVITY AND ITS RELATION 
TO DRUG DEPENDENCE 
An abundance of research has focused upon revealing the neural mechanisms underlying 
impulsivity. In the following sections both the neurochemical and neuroanatomical evidence 
will be reviewed and how these mechanisms may modulate the heightened impulsivity 
associated with drug dependence additionally explored. 
1.4.1. Neurochemical Basis of Impulsivity 
1.4.1.1. The Role of Serotonin 
One of the most predominant neurobiological theories of impulsivity argues that serotonin (5- 
HT) plays a central role in its mediation, whereby an inverse relationship exists between 5-11T 
functioning and impulsive behaviour (e. g. Soubri6,1986; Logue, 1988). Drive for this theory 
came from the influential studies of Linnoila (1983) on violent behaviour and Asberg et al., 
(1976) on suicide, who argued that low levels of serotonergic function may be related to 
pathological impulsivity. Linnoila (1983) found that ccrebrospinal fluid (CSF) 5- 
hydroxytryptamine (5-HIAA) was reduced in aggressive individuals only if the aggression was 
impulsive. Similar findings were reported in suicide attempters with depression (Asberg et al., 
1976), violent suicide attempters (Coccaro, 1989) children with conduct disorders (e. g. Stoff et 
al., 1987) and normal individuals with high impulsivity as a personality trait (Roy et al., 1988). 
Further support is provided by findings in non-human primates where aggression and impaired 
impulsive control is associated with lower levels of 5-11T (Raleigh, McGuire, Brammer and 
Yuwiler, 1984; McGuire and Raleigh, 1987; Higley et al., 1997; Westergaard, Suomi, Higley 
and Mehlman, 1999). 
Research that has directly manipulated 5-11T activity has additionally provided, to some extent, 
evidence of the neurochemical substrate's implication in impulsive behaviour. In animal 
models of delayed reward, dysfunction of the 5-11T pathways has been associated with 
alterations in impulsive behaviour in rats (Ho et al., 2002). Bizot et al. (1999) demonstrated that 
forebrain 5-HT depletion resulted in an increase in the choice of the smaller immediate reward 
in comparison to sham lesioned rats. Moreover, in the T-maze, the lesion was found not to 
affect the discrimination between the magnitude of the two rewards. These findings are 
51 
Chapter I- Impulsivity and Drug Addiction 
consistent to those of Thiebot (1992) where a reduction of 5-11T, induced by p- 
chlorophenylalanine (PCPA), increased impulsive behaviour in the same model. In operant 
paradigms of delayed reward parallel findings have also been shown. Reduced concentrations of 
5-HT and its metabolite 5-HIAA, induced by 5,7-dihydroxytryptamine (5,7-DIIT), increased 
preference for the smaller immediate reward in comparison to the sham-lesioned controls 
(Wogar, Bradshaw and Szabadi, 1993; Richards and Seiden, 1995; Ho et al., 1998; Al-Ruwaitea 
et al., 1999; Mobini et al. 2000a; 2000b). Findings furthermore, suggest that the increase in 
impulsive choice demonstrated can be attributed to the increases in sensitivity to delay rather 
than changes in sensitivity to reward magnitude (Ho et al., 1999; Mobini et al., 2000b). 
Conversely, enhancing 5-HT function, through either augmenting its release (d-flenfluramine) 
or by selectively blocking its reuptake (fluvoxamine, fluoxetine, clomipramine, zimeldine) has 
been shown to increase preference for the delayed larger reward in the T-maze procedure in rats 
(Bizot et al., 1988; Poulos, Parker and Le, 1996; Bizot et al., 1999). More recently, further 
evidence of a decrease in impulsivity has been shown following 17 days of chronic treatment 
with the selective serotonin reuptake inhibitors (SSRIS) fluoxetine, citalopram and paroxetine in 
an adjusted delay paradigm in pigeons (Wolff and Leander, 2002). Comparably, Adriani et al. 
(2004) demonstrated that increasing 51IIAA/5-IIT ratio in medial frontal cortex and cingulate 
cortex through chronic treatment of acetyl-L-carnitine led to a decrease in impulsive choice in 
animals highly sensitive to delayed gratification at baseline. 
Findings however have not been entirely consistent. The heightened impulsivity demonstrated 
following infusion of 5,7-DHT has in some instances only been a temporary effect (e. g. Bizot 
et al., 1999) and in more recent studies global 5-11T depletion failed to alter impulsive choice 
(Winstanley et al., 2003; 2004b; 2005). Charrier and Thiebot (1996) also failed to demonstrate 
an effect of PCPA on choice behaviour in a "systematic" operant delayed reward task. In direct 
opposition, Evenden and Ryan, (1996) actually displayed a decrease in impulsive choice 
following treatment with the non-selective 5-11T antagonist metergoline. A number of 
differences across studies may account for the discrepancy in finding, including varying DD 
paradigms and methodological procedures. For instance, research that demonstrated a lack of 
effect, explored the effects of 5-HT depletion on performance following the acquisition of a 
"systematic" DD task (Winstanley et al., 2003; 2004b). In contrast, research that reported 
significant increases in discounting of delayed reward adopted "adjusting" DD paradigms and 
examined the effect of depletion during the acquisition of the paradigm (e. g. Wogar et al., 1993; 
Mobini et al., 2000a; 2000b). 
Manipulation of 5-HT activity has additionally provided support for the role of 5-11T in 
behavioural disinhibition. Global decreases in serotonergic function in rodents have been shown 
to increase impulsive responding during No-go trials in both asymmetric (Fletcher, 1993) and 
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symmetric go/no-go paradigms (Harrison, Everitt and Robbins, 1999). Further comparable 
findings of induced disinhibition following 5-HT depletion have been observed in DRL (e. g. 
Thornton and Goudie, 1978; Wogar, Bradshaw and Szabadi, 1992; 1993), FCN procedures 
(Evenden, 1998a) and the 5CSRIT (Harrison et al., 1997a; 1997b; Winstanley et al., 2004d). 
Whilst serotonergic disruption in timing behaviour may account for increased premature 
responses in DRL procedure (Wogar et al., 1992; Morrissey et al., 1993), this interpretation 
cannot explain the impaired control over responding observed during the go/no-go task. In the 
latter of these tasks, explicit visual exteroccptive cues are available indicating when to respond 
or withhold a response, thus eliminating the need for timing and allowing clearer conclusions to 
be reached on the role of 5-HT on response disinhibition (Harrison et al., 1999). 
Further support for the role of 5-HT in the modulation of response inhibition is evident from the 
decrease in 
, premature responding 
in rodents following treatments that enhance 5-IIT 
neurotransmission. The SSRI, fluoxetine, decreased early responding in a DRL task (Richards et 
al., 1993) whilst monoamine reuptake inhibitor, imipramine, reduced impulsive responding in 
the FCN procedure (Evenden, 1998b; but see also Evenden, 1998a). The latter finding implies 
the possibility that stimulation of noradrencrgic and dopaminergic in addition to serotonergic 
systems may be implicated in this aspect of impulsivity. 
In human studies the effects of 5-11T reduction have additionally been examined by 
methodology of dietary rapid tryptophan depletion (RTD) which effectively decreases 511T 
metabolites in CSF (e. g. Williams et al., 1999). A reduction in 5-11T has decreased inhibitory 
control on a range of tasks including the SST, CPT and go/no-go task in healthy males and in 
subjects with a family history of alcoholism (Le Marquand et al., 1999; Crean, Richards and de 
Wit, 2002; Walderhaug et al., 2002; Walderhaug et al., 2005; but see also Clark et al., 2005). In 
terms of the effects of RTD on impulsive decision making, no significant effects have been 
reported in a hypothetical DD paradigm (Crean et al., 2002). Taken together, following 5-11T 
depletion more consistent increases in disinhibition have been demonstrated relative to the 
effects observed on impulsive decision making. On this basis, it could argued that findings 
support the theory that these two components of impulsivity are perhaps neurobiologically 
dissociated (Evenden, 1999), whereby the serotonergic system plays a more prominent role in 
the modulation of inhibitory control. However, the animal research that has implicated 5-11T in 
impulsive choice cannot be ignored. Although no effect of serotonergic manipulation was 
observed in human participants, this may be accounted for by the hypothetical version of the 
task being less sensitive to acute state changes in impulsivity induced by RTD. As previously 
highlighted human tasks such as the EDT where rewards and their delay to their delivery are 
experienced, display greater sensitivity to acute drug effects than hypothetical DD paradigms 
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(Reynolds et al., 2006b). 5-HT manipulations may therefore induce more substantial effects on 
impulsive choice in such paradigms and should be an essential avenue of future research. 
Research that has, however, examined selective serotonergic drugs have demonstrated 
alterations in both sensitivity to delayed gratification and behavioural inhibition. These effects 
are complex and suggest that 5-HT may modulate varying aspects of impulsive behaviour 
through mediation of different receptor subtypes. However, activation of the 5-11TIA receptor 
has yielded comparable results on both components of impulsivity. In the DD paradigm in 
rodents, increased choice of the immediate reward has been, reported following the 
administration of the 5-HTIA receptor agonist 8-hydroxy-2(di-n-propylamino) (8-011-DPAT), in 
both a "systematic" DD paradigm (Winstanley et al., 2005) and the T-maze procedure (Poulos 
et al., 1996). Evenden and Ryan (1999) furthermore demonstrated that 8-011-DPAT can 
increase preference for the immediate reward; the effect however was restricted to the beginning 
of the test session, during which the delayed larger reward was delivered following shorter time 
periods. At higher delays a contrasting decrease in impulsive choice was shown (Evenden and 
Ryan, 1996). A comparable delay related effect has since been replicated with the 5-11TIA 
receptor agonist flesinoxan (van den Bergh et al., 2006). 
Partial agonists at this receptor such buspirone, ipsapirone and MDL 73005EF, have 
additionally displayed evidence of induced heightened impulsive decision making following 
acute administration (Bizot et al., 1999; Liu et al., 2004), whilst following chronic buspirone an 
opposite decrease in impulsivity has been shown (Liu et al., 2004). The evident increase in 
impulsive choice following the acute administration of 541TIA full and partial agonists can 
possibly be attributed to the decrease in 5-HT neurotransmission via the agonist activation of the 
somatodentratic 5-HTIA autoreceptors (e. g. Sprouse and Aghajanian, 1988; Bonvento et al., 
1992). The contrasting decrease in impulsive choice following the chronic administration of 
buspirone is difficult to interpret, but may be attributed to the sensitisation of 5-11TIA Post 
synaptic receptors following chronic exposure (De Vry, 1995). To date it is unknown whether 
comparable anti-impulsive choice effects are shown following the chronic treatment of other 5- 
HTIA agonists. 
Treatment doses of 8-OH-DPAT in the tasks that assess behavioural disinhibition have 
additionally provided evidence of heightened impulsive choice. Injection into the median raphe 
nucleus disinhibited responding in a go/no-go operant procedure (Fletcher, 1993) whilst 
subcutaneous administration of the agonist increased premature responding in 5CSRIT via 
action at the presynaptic 5-HTIA receptors (Carli and Samanin, 2000). Mixed results however 
have been yielded following the administration of the 8-OH-DPAT in FCN procedures in rats, 
with both an increase (Mele et al., 1994) and decrease (Evenden, 1998c) in impulsive 
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responding been obtained. Furthermore, Evenden (1998c) displayed an increase in premature 
responding following antagonism of the 5-HTIA receptor with WAY100635. The discrepancy in 
findings was attributed to the contrasting paced (Evenden, 1998c) and unpaced (Mele et al., 
1994) FCN procedures adopted across studies. 
Increasing interest has also been given to the potential role of the 511TIB receptor in the 
mediation of impulsivity, with knockout mice lacking this receptor subtype demonstrating 
heightened levels of im. ulsive behaviour (Brunner and Hen, 1997). Since then, activation of P 
this receptor by the agonist eltoprazine, has demonstrated an increase preference for the larger 
delayed reward, however the effect was modest and found only at one dose tested (van den 
Bergh et al., 2006). In contrast, following stimulation of this receptor by the 511TIA/13 agonist 
RU-24969 in a model of response inhibition, the FCN, an increase in premature responding was 
observed (Evenden, 1998c). The opposing effects in each of these models of impulsivity 
corroborate perhaps the neurochemical dissociation of differing aspects of impulsivity at this 
receptor (Evenden, 1999). 
Subtypes of the 5-HT2 receptor have additionally been studied in animal models of impulsivity. 
The 5-HT2 agonist DOI has been reported to increase impulsive responding across paradigms. 
Enhanced sensitivity to delayed reward (Evenden and Ryan, 1999), increased premature 
responding in 5CSRTT (Koskinen et al., 2000a; Koskienen and Sirvio, 2001), and reduction in 
length of responses in an FCN procedure (Evenden, 1998c) have been observed following its 
administration. Furthermore, blockade of this receptor subtype, by the 5-IIT2A/C antagonist 
ketanserin, has displayed evidence of a decrease in premature responding in the 5CSRTT 
following its administration both peripherally or into the medial frontal cortex (Koskinen et al., 
2000a; 2000b; Passetti et al., 2003). In contrast, no significant modification in performance was 
earlier reported following the administration 5-IIT2 antagonist, ritanserin, on a delayed reward 
task (Evenden and Ryan, 1999). A more recent study by Talpos and co-workers (2006) 
however, demonstrated differential effects of 5-IIT2 antagonists on the two distinct measures of 
impulsivity. As previously demonstrated, the administration of 5-IIT2A/c antagonist ketanserin 
led to a decrease in premature responding in the 5CSRIT, an effect however that was not 
observed in a delayed reward paradigm. Conversely, the 5-IIT2C/B antagonist, SER-082, 
decreased impulsive decision making without significantly affecting premature responding in 
the 5-CSRTr. Research has shown that ketanserin and SER-082 can be administered to 
dissociate the role of the 5-HT2c subtype receptor from 5-IIT2A on measures sensitive to 
serotonergic manipulation (e. g. Currie et a., 2002). On this basis authors concluded that 
evidence had been provided that independent components of impulsivity are mediated by 
differing neurochemical substrates, supporting further their dissociation at a behavioural level. 
Findings suggest that the 5-HT2A receptor is. implicated in behavioural inhibition, a theory 
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further supported further by the decrease in premature responding in 5CSRTT shown following 
selective blockade of this receptor by M100907 (Higgins et al., 2003; Winstanley et al., 2003b; 
2004d). Sensitivity to delayed reward instead appears to be modulated by the 5-HT2c receptor 
subtype (Talpos et al., 2006). It is important to also to highlight that investigations of the 5-HT2 
receptor subtypes have provided findings that are contrary to the general theory that heightened 
impulsivity is associated with decreased serotonergic function (e. g. Soubri6,1986; Harrison et 
al., 1997; Mobini et al., 2000a). Clearly the role of 5-HT in the mediation of impulsivity is 
complex. The fact that these receptors are also involved in the regulation of DA activity (e. g. Di 
Matteo et al., 1998; 1999; Gobert and Millan, 1999), may begin to explain the discrepancy in 
findings and suggest more importantly that a complex interaction between DA and 5-HT may 
exist in the modulation of impulsive behaviour (e. g. Winstanley 2003b). 
Exploration of the involvement of further 5-HT receptor subtypes has indicated minimal or no 
evidence of their potential role in the modulation of impulsivity. Antagonism of the 5-IIT3 
receptor had no effect on either impulsive choice or response inhibition as measured by a 
discrete trial delayed reward task and FCN procedure (Evenden 1998c; Evenden and Ryan, 
1999). The 5-HT6 receptor antagonist, SB-270146-A, furthermore displayed no modification on 
premature responding in the 5CSRTT or sensitivity to delayed reward following its systemic 
administration (Talpos et al., 2006). 
Upon reviewing the research, there is strong evidence suggesting that impulsivity is related to 
impaired 5-HT functioning. The underlying mechanisms however are considerably more 
complex than previously acknowledged (e. g. Soubri6,1986), with perhaps a dissociation of the 
role of 5-11T in differing aspects of impulsivity at the receptor subtype level. With alterations in 
serotonergic function being recognised as a core mechanism of drug addiction (e. g. Koob, 
2000), it may therefore be via this neurochemical mechanism that dysfunctions impulsive 
control are mediated in this population. Drugs of abuse including cocaine (e. g. Andrews and 
Lucki, 2001; Mangiavacchi et al., 2001), amphetamine and its derivatives (e. g. Kuczenski et al., 
1995; Millan et al., 1999; Hedou et al., 2000), MDMA (e. g. Kankaanpaa ct al., 1998), nicotine 
(e. g. Ribeiro et al., 1993; Summer et at., 1996) and alcohol (e. g. Weiss et al., 1996; Uzbay, 
Usanmaz and Akarsu, 2000) have demonstrated increases in extracellular levels of 5-11T in 
several brain regions following their administration. In contrast, at baseline drug dependent 
individuals display reduced levels of 5-HT functioning. Lower baseline 5-11T has been observed 
in excessive alcohol drinkers (Fils-Aime et al., 1996), whilst evidence of reduced peripheral 5- 
HT activity has been shown in cocaine abusers (Patkar et al., 2003a) and heavy smokers (Patkar 
et al., 2003b). Similarly, an earlier study by von Knorring and colleagues (1984) demonstrated 
that low platelet monoamine oxidase (MAO) activity, a biological marker of 5-HT activity, was 
associated with greater tobacco and alcohol use and as well as symptoms of possible alcohol 
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dependence. With evidence implicating also lowered 5-11T functioning in impulsivity, it is 
likely therefore that the 5-HT dysfunction evident in abusers may play a mediating role in the 
associated augmented impulsivity. In support of this theory, self reported BIS scores of 
impulsivity in both cocaine and heavier smokers, were found to be negatively correlated with 5- 
HT transporter (5-HTT) availability (Patkar et al., 2003a; 2003b). It remains unclear from such 
research however, whether the 5-HT abnormalities precede dug abuse, or are instead a 
consequence of chronic drug exposure. If the former of these theories is true, then 5-11T 
dysfunction may therefore represent a possible biological trait marker for heightened 
impulsivity and risk for the development of addiction. If instead drug use leads to 5-11T 
abnormalities, then this may mediate the subsequent loss of inhibitory control and impulsive 
choice in abusers, leading to maintenance and relapse of the disorder. Support for the latter 
direction has been provided from evidence indicating that chronic treatment with addictive 
drugs, such as cocaine, has been associated with a decrease in neuronal response to 5-11T 
neurotransmission (e. g. Levy et al., 1993; Buydens-Branchey et al., 1999). 
Irrespective of the direction of the relationship, evidence of a reduction in impulsivity following 
the enhancement of 5-HT neurotransmission provides a potential pharmacological treatment 
mechanism for reducing impulsivity in substance abuse (e. g. Wolff and Leander, 2002). Indeed, 
preclinical research has demonstrated that increasing levels of 541T attenuates self 
administration of drugs such as amphetamine (eg. Lyness, 1983), cocaine (cg. Carroll et al., 
1990; Glatz et al., 2002) alcohol (e. g. Zabik et al., 1982; Naranjo and Knokc, 2001) and nicotine 
(Opitz and Weischcr, 1988). The reduction in self administration of these drugs may possibly be 
via a strengthening of self control. To date however, no strong evidence has yet been provided 
to demonstrate the efficacy of SSRIs in treatment of substance abuse disorder, despite evidence 
of their ability to reduce both impulsive choice and inhibitory control (e. g Grabowski et al., 
1995; Kranzler et al., 1995; Ciraulo et al., 2005). The serotoncrgic neuroadaptations associated 
with long term drug exposure could potentially reduce the effectiveness of such medications on 
reducing impulsivity in long term drug abusers. 
Each of the 5-HT receptor subtypes argued to play a role in the mediation of impulsivity have 
furthermore been implicated in the ncurobiological mechanisms of drug addiction, in particular 
the 5-HTIA-receptor (e. g. Rocha et al., 1998; Filip, Nowak, Papla, 2001; Davidson et al., 2002; 
Muller and Cary, 2006; Muller et al., 2007). For example, stimulation of the 5-11TIAreceptor by 
the agonist 8-OH-DPAT hasý been' shown to facilitate cocaine administration and ethanol 
drinking whilst antagonism of this receptor has demonstrated an attenuation of both these 
behaviours (e. g. Schenk, 2000; McKenzie-Quirk and Miczek, 2003; Czoty et al., 2005). The 
enhancement of impulsive responding following activation of this receptor suggests that perhaps 
the observed augmentation of drug self administration may in part be via an induced loss of 
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control over behaviour. Blockade of this receptor may therefore offer a potential therapeutic 
target that would decrease abuse through increasing self control. 
1.4.1.1. The Role of Dopamine 
Research examining the pharmacological basis of impulsivity has additionally assessed the role 
of DA. The effect of increases in synaptic levels of DA has been most widely studied through 
the administration of the powerful doparninergic agonist, amphetamine. As previously 
discussed, in both the human and animal literature acute doses of d-amphetamine have yielded 
mixed results in delayed reward models; both increases (Charrier and Thiebot, 1996; Evendcn 
and Ryan, 1996; Cardinal et al., 2000; Isles et al., 2003; Helms et al., 2006) and decreases 
(Richards et al., 1999a; 1997; Cardinal et al., 2000; Wade et al., 2000; de Wit ct al., 2002; 
Winstanley et al., 2003a; van Gaalen et al., 2006) in impulsivity have been found. Chronic 
administration of methamphetamine, which is more comparable to the pattern of drug use in 
dependent individuals, has however been found to promote choice of the immediate smaller 
reward in rodents (Richards et al., 1999a). The contradictory findings following acute treatment 
were attributed to a number of procedural differences across studies, including differences in 
rewards utilised, dose level (e. g. Isles ct al., 2003) and presence or absence of a reward- 
predicting cue during the delay to delivery of the larger reward (Cardinal et al., 2000). 
Evidence of a relationship between behavioural disinhibition and DA has in addition been 
provided. In human subjects increasing synaptic levels of DA, through administration of low to 
moderate doses of d-amphetamine, led to a significant increase in inhibitory control in the 
go/no-go task and SST procedures. This effect, however, was restricted to individuals with a 
poor baseline level of inhibitory control (de Wit et al., 2000; 2002). Comparable findings have 
been demonstrated in the animal literature following low doses of 0.25mg/kg and O. 5mg/kg of 
d-amphetamine in a rat version of the SST (Feola et al., 2000). In contrast, strong evidence has 
been provided in rodents that higher doses of the DA agonist, as in the DD paradigm (e. g. Isles 
et al., 2003), has an opposite effect on inhibitory control. Significant increases in impulsive 
responding in the DRL (Wiley, Compton and Golden, 2000), FCN (Evenden 1998a; 1998b), 
assymetrical go/no-go (Ridley et al., 1980) and 5CSRTT procedures (Cole and Robbins, 1987; 
Harrison et al., 1997; Van Gaalen et al., 2006) have been demonstrated. 
The ability of amphetamine to alter levels of both forms of impulsivity has however been shown 
to be partially dependent on serotonergic neurotransmission. The ability of the psychostimulant 
to decrease impulsive choice in a delayed reward paradigm was found to be significantly 
attenuated in ICV 5,7-DHT lesioned animals (Winstanley et al., 2003a). In a further study, 
although an opposite increase in premature responding in 5CSRTT was shown following 
amphetamines administration, 5-HT neurotransmission was once again essential for the 
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expression of amphetamines effects (Harrison et al., 1997). These data suggest that both 
sensitivity to delayed reward and behavioural inhibition are modulated through complex 
interactions between the 5-HT and DA systems. 
Few studies have investigated the neurochemical basis of impulsive choice at the level of 
individual DA receptors. The systemic administration of the D2 antagonist raclopride and the 
DI/D2 antagonist flupenthixol (Cardinal et al., 2000; Wade et al., 2000), but not DI antagonist 
SCH23390 (Wade et al., 2000), increased preference for the immediate, smaller reward, 
supporting the importance of the possible role of the D2 receptor in the intolerance to delayed 
reward. More recently however, in a systematic DD paradigm, impulsivity was increased 
following the administration of DI antagonist SC1123390 whilst treatment with the D2 
antagonist eticlopride was without effect (van Gaalen et al., 2006). Once again, the contrasting 
roles found of the DA receptors in the modulation of impulsive choice may be accounted for by 
the differing adjusting verses systematic delayed reward task being utilised across studies. The 
potential role of the D3 receptor in the modulation of delay aversion has additionally been 
explored. At the lowest dose tested activation of this receptor by the agonist 7-011-DPAT led to 
an increased choice of the immediate smaller reward (van den Bergh et al., 2006). 
The role of D1 and D2 receptors in the modulation of motoric impulsivity has furthermore been 
assessed. In direct contrast to the effects of the DI receptor antagonist SC1123390 in an 
adjusting amount DD procedure, the antagonist has been shown to decrease premature 
responding in the 5CSRTT (Harrsion et al., 1997; Koskinen and Sirvio 2000; Hahn, Shoaib and 
Stolerman, 2002; van Gaalen et al., 2006) while acti-ýation of the receptor following high doses 
the DI agonist SKF 38393 increased premature responding (Pezze, Dalley and Robbins, 2007). 
Furthermore, pre-treatment with the DI antagonist led to a reversal of increased premature 
responding on the task following treatment with cocaine, nicotine and amphetamine (van 
Gaalcn et al., 2006) and moreover reduced heightened impulsivity expressed in 5-11T depleted 
animals (Harrison et al., 1997). The Dl/D2 receptor antagonist fupenthixol, and D2 antagonist 
raclopride have also demonstrated evidence of a dose dependent decrease in premature 
responding (e. g. Koskinen and Sirvio 2000; Halm et al., 2002). In a further study, whilst the D2 
antagonist eticlopride had no effect on impulsive responding in the 5CSRTT, blockade of the 
D2 receptor did however significantly attenuate the heightened impulsive responding following 
treatment with cocaine, amphetamine and nicotine (van Gaalen et al., 2006). 
In further models of behavioural inhibition, less consistent findings have been established. In 
the FCN blockade of the D2 receptor by the antipsychotic drug, haloperidol, significantly 
decreased the number of chain responses, consistent with an increase in impulsivity (Evenden 
1998a). This finding however is inconsistent with a more recent study conducted by Liao and 
59 
Chapter I- Impulsivity and Drug Addiction 
Cheng (2005) who demonstrated that the D2 antagonist raclopride and DI antagonist 
SCH23390, decreased significantly the frequency of non-reinforced burst responses in a 
comparable FCN procedure in rodents. In contrast, in the SST DA DI/D2 receptors appear to 
play little role in the stop process within the task, with administration of the antagonist 
fupenthixol displaying no effect on stop signal reaction time in rats (Eagle, Tuft, Goodchild and 
Robbins, 2007). 'Me absence of effect is further supported in the human literature with no 
significant changes observed in stop signal reaction time following treatment with L-DOPA in 
children diagnosed with ADHD (Overtoorn et al., 2003). These findings reveal that DA may 
mediate more the ability to wait and withhold inappropriate premature responding, as measured 
in FCN and 5CSRRT, while playing no critical role in the ability to stop an already initiated 
response and switch to an alternative behaviour. 
It is clear from the literature that modulation of DA neurotransmission affects both impulsive 
choice and disinhibition assessed in terms of the ability to wait and withhold inappropriate and 
premature responding. DA's neurochemical control over impulsivity furthermore appears to 
depend on the complex interaction with the serotonergic system (e. g. Harrsion et al., 1997; 
Winstanley 2003a). At the DA receptor level particular importance of the role DI, and D2 and 
possibly D3 receptor has been highlighted. Supporting further that impulsivity is not a unitary 
construct, the DI and D2 receptors furthermore appear to have distinctive and opposing roles in 
the modulation of impulsive choice and disinhibition. 
DA is also a central neurotransmitter in drug addiction, and it is therefore highly plausible to 
suggest that DA plays a vital role in the neurochemical control of the relationship between 
impulsivity and addiction. As previously discussed, the ability of the majority of misused drugs, 
with the exception of benzodiazepines, to increase dopaminergic function in the mesolimbic 
system is considered crucial for their rewarding effects (Koob et al., 1994; DiChiara, 1999; 
Koob and Le Moal, 2001). Studies in the neurobiology of addiction have more recently 
suggested that DA increases alone fail to explain the complexity of addiction (Volkow et al., 
2002), as dopamine levels are raised in both addicted and non-addicted individuals following 
administration of abused drugs (Volkow et al., 1997a). Rather it is the distinct increases in DA 
followed by DA decreases and the resultant interference of both the mesolimbic and 
mesocortical DA circuits that it regulates, that underlies the process of addiction (eg. Goldstein 
and Volkow 2002; Volkow et al., 2002). Low DA levels are associated with withdrawal 
(Lingford-Hughes and Nutt, 2003) and abstinence from the drug of abuse, with neuroimaging 
studies displaying evidence of for example of 50% less dopamine cell activity in detoxified 
cocaine addicts in comparison to controls (Volkow et al., 1997b). 
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The DI, D2, and D3 receptors that have been implicated in the modulation of impulsivity have 
furthermore demonstrated a important role in the addiction of a number of abused subýtances 
including cocaine, heroin, methamphetamine, nicotine and ethanol (e. g. Comings and Blum, 
2000; Thanos et al., 2001; Volkow et al., 2002; Heidbreder et al., 2004; 2005; Nader et al., 
2006; Schmidt, Anderson and Pierce, 2006; Schmidt and Pierce, 2006; Vengeliene et al., 2006; ). 
More specifically, the activation DI receptor in the NAc shell promotes reinstatement of 
cocaine seeking behaviour in rats (e. g. Schmidt et al., 2006; Schmidt and Pierce, 2006), while 
antagonism of this receptor by SCH23390 reduces the reinforcing properties of the stimulant 
(Barli and Pierce, 2005). Interestingly, activation of the DI receptor as previously discussed 
increased premature responding in the 5CSRTr (Pezze et al., 2007), whilst blockade of the 
receptor attenuated the heightened impulsive responding following treatment with cocaine, 
amphetamine and nicotine (van Gaalen et al., 2006). It appears that activation of the DI receptor 
is highly likely to mediate the lack of inhibitory control displayed by drug dependent 
individuals. This receptor may therefore prove to be a potential target for the treatment of the 
pathological impulsiveness observed in these individuals. 
The D2 receptor has also received extensive interest within the field of drug addiction literature 
with this receptor found to be significantly reduced in the striatuni in cocaine, opiate and alcohol 
abusers (Volkow et al., 1996; 1997b; 2001; Wang et al., 1997). Furthermore the downregulation 
of D2 receptors is an abnormality that has been found to persist for months following abstinence 
(e. g. Volkow et al., 1993; 1997b). D2 receptors have been implicated in both inhibitory control 
and sensitivity to delayed gratification, alterations in D2 receptor availability may therefore be a 
common abnormality relating impulsivity to drug dependence across a number of abused drugs. 
Moreover, evidence of the persistent dysfunction in impulsive control observed in addicts 
following long term abstinence (e. g. Petry, 2001; Kirby and Petry, 2004; Hoffman, 2006), in 
particular in cocaine abusers (e. g. Kirby and Petry, 2004; Heil et al., 2006), may be possibly 
mediated by the continual down regulation of D2 receptors that is observed in abusers. 
A major limitation of these studies however is that they fail to determine whether, a dysfunction 
in dopamine and D2 receptors, linked to both the modulation of impulsive behaviour and 
addiction, is a secondary effect of chronic drug abuse possibly leading to the increase in 
impulsivity observed or is instead a predisposing factor to future drug abuse which would place 
already more impulsive individuals at a greater risk of drug addiction. Dalley and colleagues 
(2007) however have recently successfully connected impulsive responding, DA and addiction 
in rodents. Strong evidence was provided indicating that high impulsive rats, as assessed in 
5CSRTIP, displayed a significant reduction in D2 availability in NAc that rendered them more 
susceptible to increased rates of cocaine self administration (Dalley et al., 2007). The study 
supported earlier findings that both D2 receptor knockout mice and non-human primates with 
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low D2 receptor availability display higher rates of cocaine self administration (Caine et al., 
2002; Nader et al., 2006). Human genetic studies have furthermore indicated evidence that 
variation in D2 receptor in polysubstances, opiate and nicotine abusers is linked to the D2 Taq 
IAI and BI allele (e. g. Smith et al., 1992; Comings and Blum, 2000; Xu et al., 2004; Gelernter 
et al., 2006). Taken together, these findings offer strong evidence of low D2 receptor 
availability being a biological trait that predisposes individuals more vulnerable to drug 
addiction, possibly through poor baseline levels of inhibitory control over behaviour. High 
levels of DA D2 receptors may therefore provide a defensive role against the abuse of drugs, 
through promotion of greater self control (Volkow et al., 2002). Indeed, delivery of D2 receptor 
gene into the NAc has been found to significantly reduce alcohol consumption in rats (Thanos et 
al., 2001). These findings should not be taken, however, as evidence that relationship between 
DA, impulsivity and addiction is unidirectional, as it is also possible that chronic drug exposure 
also ftirther exacerbates an already dysfunctional DA system leading to the loss of control and 
compulsive intake that is observed in addicted individuals. Furthermore, it is yet to be 
established whether reduced D2 availability is a genetic trait that underlies heightened 
sensitivity to delayed gratification. 
Finally, the D3 receptor is a receptor that is in addition receiving increased interest in addiction 
literature. The receptor which is mainly expressed in the mesolimbic brain, particularly the 
accumbens has been implicated in a number of addictive behaviours across drugs of abuse. For 
example, antagonism of the receptor appears to reduce nicotine induced conditioned place 
preference and locomotor activity (Pak et al., 2006), alcohol seeking behaviour (Vengelienc ct 
al., 2006) and the self administration of cocaine in rodents (Xi et al., 2006). Although research 
is limited in terms of the role of this receptor in impulsivity recent evidence suggests that 
stimulation of the receptor by the agonist 7-011-DPAT resulted in heightened impulsive choice 
in a DR paradigm (van den Bergh et al., 2006). D3 receptor antagonism may therefore constitute 
a promising novel pharmacological approach to treatment which may significantly reduce a 
number of addictive behaviours including intolerance to delayed reward. 
1.4.2. Neuroanatomical Basis of Impulsivity 
Research investigating the neuroanatomy underlying impulsivity has focused greatly upon areas 
of the both the ventral striatum (VS) and frontal cortex (FC), both regions of which have been 
implicated in addiction (e. g. Everitt et al., 1999; Jentsch and Taylor, 1999; Kalvias and Volkow, 
2005). 
1.4.2.1. The Role of the Ventral Striatum 
The VS has been implicated in both the regulation of impulsive choice and inhibitory control. 
Research investigating the neurobiology of impulsive choice has demonstrated, using functional 
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magnetic resonance imaging (fMRI), that the activity of the VS is significantly elevated in 
healthy human subjects during the selection of the smaller, immediate reward during a delayed 
reward task (McClure et al., 2004). Hariri et al., (2006) have since extended these findings 
indicating that activity of the VS can furthermore discrininate between individuals of high and 
low impulsive choice, with hyper reactive VS circuitry associated with greater preference for 
the immediate reward. Authors concluded that abnormalities in the VS may contribute as a risk 
factor in the development of addiction. 
More specific regions of VS have been associated with impulsive choice, most greatly the NAc. 
Cardinal and colleagues (2001) demonstrated that rats with lesions to the NAc core displayed 
heightened levels of discounting of delayed reward that could be attributed to an increase 
sensitivity to delay rather than magnitude of reward (Cardinal and Cheung, 2005). More recent 
evidence has furthermore suggested that the NAc role in impulsive choice is specific to the 
distinct subregion of the dorsolateral core with a lack effect on sensitivity to delayed reward 
shown following lesions. to the ventromedial shell (Pothuizen et al., 2005). Lesions to the 
basolateral amygdala (BLA), a region strongly associated with NAc, had additionally increased 
impulsiveness of rats in DD pardigm (Winstanley et al., 2004a), suggesting that both the BLA 
and NAc may interact to modulate impulsive choice behavior. It is argued that both structures 
may be important in the representing and maintaining of the subjective value of reward across 
delay (Winstanley et al., 2004a). Failure in this ability in lesioned animals would therefore 
result in more impulsive choice. 
Studies have moreover provided evidence that regions of the VS contribute to inhibitory control. 
Lesions to the NAc for example have demonstrated increased premature responding in a DRL 
procedure that was specified by later studies to be attributed to lesions the NAc core but not the 
shell (Reading and Dunnett, 1995; Pothuizen et al., 2005). Comparable findings of increased 
impulsive responding has additionally been shown in rats in the 5CSRTT (Christakou, Robbins 
and Everitt, 2004) but not the SST (Eagle and Robbins, 2003). 
A further structure closely connected to the NAc whose role has additionally been explored in 
impulsivity is the subthalamic nucleus (STN) within the basal ganglia. Strong evidence for the 
role of the STN in inhibitory control has been provided with damage to the STN leading to a 
profound increase in premature anticipatory responding, as assessed in both the 5CSRTT 
(Baunez and Robbins, 1997) and DRL procedure (Uslaner and Robbins, 2006). In further 
support for the dissociated neurobiological. modulation of varying forms of impulsivity, 
following lesions to this structure an opposite decrease in impulsive choice has however been 
shown (Winstanley et al., 2005; Uslaner and Robbins, 2006), suggesting that STN may 
differentially control subcomponents of impulsivity. 
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The VS, and more specifically the NAc, have long been implicated in the neurobiology of 
addiction. The region contributes and responds to both the anticipation and receipt of reward 
related stimuli, with hyperactivity of the region associated with a range of addictive behaviours 
including drug seeking, craving and reactivity to drug related cues (Robbins and Everitt, 1996; 
Everitt et al., 1999; Kalivas and Volkow, 2005). The region is recipient of both DA and 5-HT 
neurons and is a major terminal area of the mesolimbic DA system. The ability of drugs of 
abuse to stimulate the release of doparnine in the NAc is considered one of the most vital 
neurobiological process underlying addiction (Robinson and Becker, 1986; Kalivas and Stewart, 
1991). The release of DA in this brain region is critical in the mediation of positive reward 
(Wise, 1990; Koob, 1992; Self and Nestler, 1995) relapse to drug seeking behaviour (Di Ciano 
et al., 1996; Shaham and Stewart, 1996; Self 1997) and psychostimulant drug craving (e. g. 
Robinson and Berridge, 1993) and motor effects (e. g. Berridge and Robinson, 1998; Salome et 
al., 2005). 
The role of the VS in the regulation of range of addictive behaviour makes it a prime 
neuroanatomical location that may mediate the heightened impulsivity associated with drug 
dependent individuals. More direct evidence that NAc may be a candidate structure in the 
modulation of the relationship between addiction and impulsivity has been provided by a recent 
study of Pattij and colleagues (2007). Amphetamine induced disinhibited behaviour in a 
5CSR17 was successfully blocked by the bilateral administration of the D2 antagonist 
eticlopride in NAc core but not the shell. Once again the importance of the D2 receptor in the 
NAc in the modulation of inhibitory control in addiction has been highlighted. 
1.4.2.2. The Role of the Frontal Cortex 
It is well established that prefrontal cortical mechanisms are heavily involved in impulse 
control, the subregions of which however may be differentially involved in different 
components of the behaviour (e. g. Aron et al., 2004). Humans with focal lesions to the medial 
prefrontal cortex (mPFC) have displayed a significantly greater inability to withhold responding 
on a go/no-go task (Picton et al., 2007), a finding much earlier demonstrated in monkeys 
(Iversen and Mishkin, 1970). Damage to the anterior ACC, prelimbic (PLC), 
-infralimbic 
cortex 
(ILQ in rats, furthermore increased perseverative and premature responding, indicative of 
disinhibition, in the 5CSRTT (Muir et al., 1996; Chudasama and Muir, 2001, Passetti et al., 
2002; 2003; Christiakou et al., 2004; Chudasama et al., 2004). Dalley et al., (2002), have in 
addition, highlighted the importance of 5-11T in the PFC in the modulation of baseline 
inhibitory responding. Rats exhibiting greater levels of premature responding displayed 
heightened extracellular levels of 5-HT in this region. 
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The OPFC has additionally been implicated in disinhibited responding. Lesions to this area of 
the PFC has led to augmented preservative responding in rats in the 5CSRTr (Chudasama et al., 
2003), whilst in monkeys an increase in commission errors was observed during performance on 
the go/no-go task (Iversen and Mishkin, 1970; Butter et al., 1973). 
In contrast, the ACC and m. PFC appear to play little role in the regulation of impulsive choice 
(Cardinal et al., 2001). Selective excitotoxic lesions to both regions failed to affect choice that 
was indicative of alterations in sensitivity to delayed gratification, suggesting that these 
subregions of the prefrontal cortex contribute more to inhibitory control rather than impulsive 
choice. A further subregion of PFC, the OPFC, does in contrast, appear to contribute to 
impulsive choice. In rats lesions to the OPFC has led to both an increase (Kheramin et al., 2002; 
2004; Mobini et al., 2002) and decrease (Winstanley et al., 2004) in the choice of the smaller 
immediate reward in systematic delayed reward paradigms. Whilst discrepancies in findings can 
be attributed to procedural differences across studies such as the time point of animal lesioning, 
quantitative analysis of choice behaviour has demonstrated that alterations in impulsivity can be 
attributed to changes in sensitivity of both magnitude of reward and delay as a result of damage 
to the OPFC (Kheramin et al., 2002; 2004). 
As previously highlighted dysfunction within the regions of the frontal cortex is in addition 
considered a key neurological mechanism underlying addiction which may result in the 
associated loss of self control (e. g. Jentsch and Taylor, 1999; Goldstein and Volkow, 2002; 
Lubman et al., 2004). For example, imaging studies have shown evidence of reduced gray 
matter volumes and densities within the region in polysubstance, cocaine, methamphetamine, 
alcohol and nicotine abusers (e. g. Pfefferbaurn et al., 1997; Liu et al., 1998; Franklin et al., 
2002; Brody et al., 2004). Furthermore, drug intoxification, bingeing and craving are associated 
with activation of orbitofrontal and anterior cingulate cortices across addicts of varying drugs of 
abuse, whilst hypoactivation of these subregions are associated with long term withdrawal 
believed to be related the downregulation of D2 receptors (Brody et al., 2002; Goldstein and 
Volkow 2002; Rose et al., 2003; Neuhaus et al., 2006). More recently, greater hypoactivation in 
both the dorsolateral prefrontal cortex and parietal cortex has furthermore predicted relapse in 
methamphetamine users (Paulus et al., 2007). 
Further evidence of impaired ftinctioning of the OPFC in drug dependent individuals has 
additionally been provided using neuropsychological measures on which high performance is 
dependent on the normal functioning of this PFC region. An example of such a measure is the 
Bechara's Gambling task which assesses sensitivity to future outcomes of decisions. Significant 
impairments in performance have been observed in abusers of cocaine, methamphetamine and 
alcohol relative to control participants, with a high percentage of abuser's performance 
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moreover being found to be within the range of subjects with bilateral lesions to the OPFC 
(Bechara et al., 2001; Bechara and Damasio, 2002). In a further study, a causal relationship has 
been indicated between performance on this task and length of chronic abuse. Poorer 
performance on the task (indicative of a greater dysfunction of OPFC) was found to be 
positively correlated with years of amphetamine abuse (Rogers et al., 1999). 
In summary, there is a growing body of evidence that both regions of the ventral striatum and 
frontal cortex are involved in the regulation of impulsive behaviour. Subregions however, 
appear to be differentially associated with impulsive choice and inhibitory control, with the 
NAc, and possibly the OPFC, appearing to be the only structures that control comparably both 
forms of impulsivity. The ACC and mPFC appear to be only strongly associated with inhibitory 
control while evidence of differential role of the STN in the control of both impulsive choice 
and disinhibition has been demonstrated. These brain regions are considered central to 
neurobiology underlying addiction with evidence of chronic drug exposure furthermore being 
associated with neural adaptations within these regions (Koob et al., 1998; Goldstein and 
Volkow, 2002). Abnormalities within these regions are highly likely, therefore, to underlie the 
heightened impulsivity associated with addiction. A causal association between these 
neurological mechanisms and impulsivity and or addiction however, cannot be corroborated 
from the majority of studies, leaving the direction of the relationship between these variables to 
be yet fully determined. It is possible that the neurobiological changes associated with drug 
abuse in these regions (e. g. Koob et al., 1998) may lead to a loss of control over drug intake and 
insensitivity to delayed consequences resulting in recurrent drug seeking, taking, and relapsing 
behaviour. Instead, these neurobiological abnormalities may reflect a vulnerability to drug 
abuse, -a theory recently supported by Dalley and co-workers (2007). It is essential that future 
research continues in the attempt to disentangle this relationship. 
1.5. OVERALL SUMMARY AND FUTURE DIRECTIONS 
Impulsivity is a multifactorial concept, which in addition to being an important aspect of human 
personality and behaviour, in its pathological form is a symptom in a number of psychiatric 
disorders including substance abuse. Extensive research has demonstrated that heightened 
impulsivity, both in terms of an increase in sensitivity to delayed gratification and loss of 
inhibitory control, is strongly associated with drug dependence across different pharmacological 
classes of drugs of abuse suggesting that both subcomponents of impulsivity are key aspects of 
addiction. 
Despite the continued growing body of evidence of the relationship between drug addiction and 
impulsivity an understanding of the complex nature of this association remains to be fully 
determined. As highlighted across the reviewed research one of the greatest limitations of the 
66 
Chapter I- Impulsivity and Drug Addiction 
majority of studies is that their cross sectional design does not permit inferences to be made 
regarding the causality or temporality of the relationship. Consistency of research demonstrating 
dose dependent type relations between pattems of abuse and impulsivity provides strong 
evidence that the association may be causal (e. g. Vuchinich and Simpson, 1998; Yakir et al., 
2007). It is therefore possible that heightened impulsivity may be a risk factor that contributes to 
the establishment and maintenance of drug addiction or is instead a consequence of chronic drug 
abuse. The relationship between impulsivity and drug addiction may also be reciprocal; whilst 
trait impulsivity may be involved in the initiation of drug taking, with continued drug exposure 
the resultant neuroadaptions may cause further dysfunction in inhibitory control and decision 
making contributing to the maintenance of drug seeking and taking behaviour. From reviewing 
the current literature it is arguable that potential evidence has been provided for each of these 
directions, although currently no valid conclusions can as yet be made. 
Research that has utilised self report personality measures (e. g. BIS) to discriminate between 
drug users and non-users support the theory that individuals with a more impulsive personality 
trait are at greater risk of developing addiction (e. g. Allen et al., 1998; Swann et al., 2004). This 
interpretation is based upon the premise that these measures are typically considered to assess 
long term stable behavioural traits. Unfortunately however, the abusers in the majority of such 
studies were not abstinent from the drug of abuse at the time of testing (eg. Moeller et al., 2002). 
Consideration therefore must be given to the possibility that it may have been the acute effects 
of the drug, or being in a state of withdrawal which led to higher scores of impulsivity on these 
measures being reported. 
Research that has instead utilised behavioural tasks, argued to be sensitive to more subtle state 
changes in impulsiveness, have provided evidence that impulsivity may be a consequence of 
drug abuse. Administration of drugs of abuse have led to significant changes in levels of 
impulsivity, the effects of which have been shown to be dependent on a range of factors 
including the subcomponent of impulsivity being tested, dose level, length of drug exposure and 
basal level of impulsivity. Across stimulant drugs such as cocaine, nicotine and amphetamine, 
evidence of potential positive effects on impulsive behaviour have been shown, an effect 
however specific to low moderate doses and in individuals demonstrating heightened 
impulsivity at baseline. Unfortunately, a limited amount of research has assessed the effects of 
drug regimes more comparable to the pattern of drug use in dependent individuals. Those 
conducted however suggest that higher more chronic dosages may lead to the poorer inhibitory 
control and heightened impulsive choice observed in the drug dependent population (e. g. 
Richards et al., 1999a; Jentsch et al., 2002; Dallery and Locey, 2005). 
67 
Chapter I- Impulsivity and Drug Addiction 
Evidence has been additionally provided suggesting that initial drug deprivation may lead to the 
augmentation of impulsivity, at least in the case of impulsive choice (e. g. Field et al., 2006). 
Research has furthermore suggested that perhaps a bi-phasic relationship between drug 
abstinence and impulsive choice may exist. Initial drug deprivation may increase sensitivity to 
delayed gratification while longer term abstinence is associated with a reduction in levels of 
impulsivity (e. g. Bickel et al., 1999; Petry, 2001). It is yet to be elucidated conclusively whether 
impulsivity is indeed a reversible effect of dependence or, conversely, whether lower rates of 
impulsive responding may enable individuals to successfully remain abstinent (Bickel and 
Marsch 2001). The latter of these theories has been recently corroborated by findings suggesting 
that individuals with greater levels of DD are at greater risk of future relapse (Krishnan-Sarin et 
al., 2006). Long term abstinence, has in contrast, been associated with persistent impairments in 
inhibitory control relative to never abusers (e. g. Gourdriaan et al., 2005). These findings 
however were demonstrated in models primarily adopted to assess attention and no direct 
comparison of curTent and long term abstinent abusers were made. Despite this, if indeed 
chronic drug exposure induces impulsivity, then in terms of inhibitory control evidence suggests 
that these effects may persist for longer following abstinence. In contrast, impairments in 
behavioural control could have predated drug exposure and constitute instead a vulnerability for 
developing addiction. 
Of the limited prospective human research that has been conducted support has been provided 
that both intolerance to delayed gratification and disinhibition are salient predictors of future 
substance use and possibly dependence (e. g. Tarter et al., 2003). Having no knowledge 
regarding the long term stability of performance on behavioural tasks of impulsivity, however, 
makes valid interpretation of such research currently difficult. On the contrary, more promising 
support for the role of impulsivity as a risk factor in the development of drug dependence has 
been provided from animal research indicating that highly impulsive animals self administer 
greater levels of cocaine and consume larger amounts of ethanol (e. g. Poulos et al., 1995; 
Dalley et al., 2007). 
Research investigating the neural processes underlying impulsivity suggests that the adaptations 
of the serotonergic and dopaminergic systems associated with chronic drug abuse may mediate 
the heightened impulsivity in this population. The neurochemical processes underlying the 
relationship are, however, complex involving interactions of both systems and a dissociation of 
the role of receptor subtypes in the mediation of both impulsive choice and disinhibition. The 5- 
HTIA and D2 receptors in particular, appear to play a crucial role, and provide promising targets 
for future pharmacological treatments of impulsivity in drug dependence (Liu et al., 2004; 
Dalley et al., 2007). Strong evidence furthermore suggests that abnormalities within regions of 
the VS and PFC, considered central to the neurobiology of addiction, are involved in the 
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regulation of the loss of control and sensitivity to delayed gratification in abusers (e. g. Jentsch 
and Taylor, 1999; Cardinal et al., 2001). Subregions of these brain areas moreover, appear to be 
differentially associated with each of the subcomponents of impulsivity, providing further 
support of their dissociation at neurobiological level (e. g. Uslaner and Robinson, 2006). Yet to 
be fully elucidated is whether the dysfunctions in neurobiology reflect a biological trait 
vulnerability leading to heightened impulsivity and the development of drug dependence, or 
conversely abnormalities arise from chronic drug exposure promoting disinhibited behaviour 
and impulsive choice resulting in the maintenance of drug use. Presently, support for each of 
these directions has been provided (e. g. Levy et al., 1993; Dalley et al., 2007). 
It is important that future research adopt more prospective designs that allow causal inferences 
to be made regarding the relationship between impulsivity and drug abuse. Research that 
assesses, within subjects, subcomponents of impulsivity both prior to and during chronic 
exposure, will enable questions to be answered regarding the extent to which impulsivity 
constitutes a risk factor to drug abuse and furthermore the possibility that drug exposure 
augments impulsiveness. Furthermore, exploring levels of impulsivity both at the point of 
initial withdrawal through to longer term abstinence will additionally further elucidate the 
potential role of impulsivity in relapse and determine whether drug induced changes in 
impulsivity are a permanent effect. The implications of such research in the field of addiction 
are substantial. If impulsivity is discovered to be a risk factor in the development of substance 
abuse, then those vulnerable may be identified and prevention strategies put in place. If it is 
determined that substance abuse enhances impulsiveness, which may play a role in the 
maintenance and relapse of the disorder, then behavioural and pharmacological treatments 
targeting impulsivity may lead to effective interventions for drug dependence (Nestler, 2003). In 
terms of human research, only long term longitudinal research will enable definitive answers to 
begin to emerge regarding the causality of the association between impulsivity and drug 
dependence. The importance of future preclinical research to additionally attempt to establish 
the nature of the relationship is essential. Such research will vitally provide the opportunity to 
further explore the neurobiological processes underlying the complex relationship between 
impulsivity and addiction. 
1.6. THESIS AIMS AND OBJECTIVES 
Despite the establishment of the association between impulsivity and drug addiction, research 
directly examining the nature of this relationship is limited. Research utilising animal models of 
impulsivity provides the opportunity to both disentangle the causality of the relationship and 
explore further the biological mechanisms underlying this association (Olmstead, 2006). It does 
this by overcoming some of the disadvantages associated with human longitudinal research such 
as attrition, time and costs. Additionally the precision of preclinical experimentation in animal 
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models has critical advantages. Firstly, such research enables the controlled manipulation of 
drug exposure. Secondly, animal models of impulsivity overcome limitations associated with 
the complex patterns of polysubstance abuse and sometimes co-existing psychopathology in 
human drug abusers; factors that make valid conclusions regarding the relationship between 
addiction and substance dependence often difficult, The main aim of the present thesis was to 
explore further fundamental aspects of the relationship between impulsivity and addiction 
through the adoption of animal paradigms of impulsive choice and inhibitory control. 
1.6.1. Nicotine 
The drug selected to explore the relationship between impulsivity and drug dependence in the 
present thesis is the psychoactive drug nicotine. Nicotine is the main addictive component of 
tobacco that is critical for the drive and maintenance of smoking behaviour (Kumar and Lader, 
1981; Stepeny, 1982; Stolerman and Jarvis, 1995; Balfour ct al., 2000). Although nicotine is not 
classed as one of the 'harder' drugs of abuse, cigarette smoking is a prototypic drug addictive 
disorder sharing common features at both the behavioural and neurobiological level. 
Comparable to other drugs of abuse, nicotine elicits drug seeking behaviour under controlled 
laboratory conditions, supported by the self administration and conditioned place preference 
observed in animals (e. g. Corrigall, 1999; Di Chiara, 2000). The drugs ability to indirectly 
enhance DA release in the NAc, is believed be central to the psychostimulants rewarding and 
motivational properties, a neurobiological pathway shared by the majority of abused substances 
(e. g. Stolcrinan, 1997; Piciotto, 1998; Di Chiara, 2000). Chronic nicotine cessation is 
furthermore associated with a withdrawal syndrome that has been identified in both humans 
(Hughes et al., 1991; Hughes 2007a; 2007b) and animals (e. g. Malin et al., 1992; Epping- 
Jordan, Watkins, Koob and Markou., 1998; Harrison, Liem and Markou, 2001) that manifests 
both somatic and affective symptoms. The fact that classic features of addiction are associated 
with nicotine dependence is of particular importance in that findings of the present thesis may 
elucidate also the complexity of the association between impulsivity and drug abuse in other 
addictive disorders. 
Focusing on nicotine in an attempt to further current understanding of the relationship between 
impulsivity and dependence is well warranted for a number of reasons. Firstly, tobacco smoking 
is currently the world's most prevalent substance dependence with research estimating that 
currently a third of the population are smokers. (Centres for Disease Control and Prevention, 
1999; WHO, 2005). Secondly, cigarette smoking is a major health problem, representing the 
largest preventable risk factor for premature death in the western world (Peto et al., 1996; 
Bergen and Caporaso, 1999; Leshner, 2000). It is a key cause of cardiac, vascular and 
pulmonary diseases, as well as a variety of cancers leading researchers to estimate that 
approximately 6.5 million people worldwide will perish per annum from smoking related 
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diseases by 2015 (Mathcrs and Loncer, 2006). Thirdly, nicotine addiction is a chronic relapsing 
disorder. Despite the recent advances in the current pharmacological and behavioural treatment 
for nicotine dependence, a high percentage of individuals who express a desire to quit smoking 
are continuing to fail in their ability to successfully abstain (Baer and Marlatt, 1991; Balfour and 
Fagerstrom, 1996; Hughes et al., 1999; Ebbert et al., 2007; Mitrouska, Bouloukaki and Siafakas, 
2007). 
The substantial associated human and economic harm of smoking and lack of effective current 
interventions for nicotine dependence therefore warrants continued research investigating both 
the psychological and biological mechanisms of nicotine addiction in the hope of informing 
prevention and treatment efforts for the disorder. Surprisingly, despite the consistent heightened 
impulsivity associated with heavy smoking, limited research in the animal literature has 
explored the relationship between impulsivity and nicotine addiction, focusing instead on the 
effects of illicit agents. Only one study has reported the effects of nicotine in an animal 
paradigm of DD (Dallery and Locey 2005), whilst the effects on inhibitory control have been 
limited to models primarily used to assess sustained and divided attention (e. g. Blondel et al., 
1999). The lack of preclinical research coupled with the huge societal costs of nicotine 
addiction therefore makes the research of this thesis both novel and an essential avenue of 
investigation. 
The principal aim of this thesis was to therefore further current understanding of the relationship 
between impulsivity and nicotine addiction through a series of preclinical studies. As previously 
argued, the heightened impulsivity observed in smokers relative to non-smokers could be 
attributed to either a pre-existing difference or to the direct effects of nicotine (e. g. Bickel et al., 
1999; Spinella, 2002). This thesis is primarily concerned with exploring the latter of these 
theories. If augmented impulsivity is induced by nicotine, this could be due to either the direct 
acute effects of the drug, the long term exposure to nicotine, or to the effects of nicotine 
withdrawal, each of which could play a role in the maintenance and relapse of the disorder. 
Each of these possibilities was explored in Lister Hooded rats in two operant paradigms, each 
measuring a distinct component of impulsivity. A systematic delayed reward paradigm was 
adopted to assess impulsive choice (Evenden and Ryan, 1996; Cardinal et al., 2000), whilst the 
symmetrically reinforced conditioned visual discrimination go/no-go task (e. g. Harrison et al., 
1999) was utilised to measure inhibitory control. Impulsive choice and inhibitory control have 
demonstrated often dissociable relationships with addiction at both the behavioural and 
neurobiological level (e. g. Reynolds et al., 2006a; Talpos et al., 2006); it was therefore essential 
to adopt multiple measures of impulsivity to allow a more accurate understanding of the effects 
of nicotine on impulsivity to be gained. 
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Prior to drug experimentation a series of preliminary control studies were first conducted. These 
studies enabled the assessment of the suitability of both models for the investigation of acute 
and long term nicotine administration and nicotine withdrawal. 
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The main objectives of the present thesis were more specifically: 
i) To assess the suitability of the symmetrically reinforced go/no-go conditioned visual 
discrimination task (Experiment 1) and the delayed reward task (Experiment 5) as models 
to explore the relationship between nicotine addiction and impulsivity. 
H) To assess the acute effects of nicotine in animals with no prior exposure to the drug on 
inhibitory control (Experiment 2) and impulsive choice (Experiment 6). Furthermore, in 
order to verify that the effects of nicotine were mediated by central nicotinic receptors, 
attempts were made to block effects with the nicotinic receptor antagonist mecamylamine. 
M) To assess, adopting a longitudinal design, the effects of chronic nicotine exposure and 
initial and long term nicotine withdrawal on inhibitory control (Experiment 3) and 
impulsive choice (Experiment 7). Such research designs permitted investigation of a) 
more comparable patterns of drug use of dependent smokers on impulsivity, b) of the 
potential role of impulsivity in relapse during withdrawal and c) the permanence of 
nicotine induced effects on impulsivity. 
iv) To assess changes in responsivity to nicotine following a period of sustained abstinence. 
This was achieved through assessment of the effects of a series of acute nicotine 
challenges in animals previously exposed to chronic nicotine and nicotine withdrawal on 
inhibitory control (Experiment 4) and impulsive choice (Experiment 8). Such research 
enabled further exploration of the role of impulsivity in relapse. 
v) Finally, in view of the clear identification of high versus low trait impulsive animals, as 
assessed by the model of delayed reward, preliminary exploration was made of the 
differences in response to chronic nicotine and withdrawal based upon basal levels of 
impulsive choice (Experiment 7). Furthermore, exploration of differences between high 
and low impulsive animals in response to acute nicotine challenges following a period of 




The following methodology sections refer to standard procedures that apply to the majority of 
studies in this thesis. Any variation in the standard methodology will be highlighted in the 
reports of individual experiments. 
2.1. ETHICS 
All animals were treated in accordance with the UK Animals (Scientific Procedures) Act 1986. 
Prior to conducting experimental procedures, the experimenter passed four Home Office- 
accredited training courses (modules 1- 4) at the University of Leeds, leading to the granting of 
a Personal Licence (PIL 40n373). Experiments 1-8 were conducted under the Project Licence 
of Dr. Amanda Harrison (PPL 40/2711). The health of all animals was monitored daily. 
Animals displaying any signs of ill health or distress were immediately removed from study. 
2.2. SUBJECTS 
The subjects in all studies were adult male Lister hooded rats (Charles River, UK) weighing 
approximately 300-320g at the start of testing. Animals were housed in pairs (cage size; 46 X 
26.5 X 26cm) on arrival at the laboratory. To induce motivation for food reward, all subjects 
undertaking operant testing were food restricted in order to maintain them at 85% of their free 
feeding adult body weights (BW) throughout the testing period. Water was available ad libitum 
in home cages. Feeding occurred at the end of each experimental day, during which, animals 
were separated. 
Animals were maintained under a 12 hour light/dark (LD) cycle (lights on at 0700h; lights off at 
1900h) at a controlled environmental temperature of 21.5 *C +5 *C and relative humidity of 
50% ± 10. Air changes occurred twenty times per hour. During the light phase, the holding 
room was illuminated by artificial lighting (approximately 193 lux). On the rare occasion when 
animals were tested during the dark phase, this was conducted under low intensity red light 
(approximately 2 lux). 
2.3. DRUGS 
All drug doses were selected on the basis of previous literature reporting behavioural. effects 
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(e. g. Turek, Kang, Campbell and Sullivan., 1995; Hildebrand et al., 1997; Bizot et al., 1998; 
Epping-Jordan et al., 1998; Blondel et al., 2000; Popke, et al., 2000a; Stolerman et al., * 2000; 
Watkins, Stinus, Koob and Markou, 2000; Harrison et al., 2001; Dallery and Locey, 2005). All 
drug solutions were prepared on the day of administration. 
2.3.1. Nicotinic Acetylcholine Receptor Agonist 
(-)-Nicotine Hydrogen tartrate salt ((-)-l-Methyl-2-(3-pyridyl)pyrrolidine(-)-Nicotine(+)- 
bitaratrate salt) was purchased from Sigma-Aldrich Inc (Poole, UK). The compound was 
dissolved in 0.9% saline and the pH adjusted to approximately 6, using 0.1 M sodium 
hydroxide. Nicotine was administered s. c. in a volume of I ml/kg at doses 0.125,0.25,0.5 and 
I. Omg/kg. Drug dosage was calculated as free base. An active measure of 0.3508mg nicotine 
was present in I mg of nicotine hydrogen tartrate salt. 
Acute nicotine treatments were administered 10 minutes prior to behavioural testing. The 
injection test-interval was selected on the basis that nicotine is both rapidly absorbed and has a 
short half life of 60-90 minutes following systemic injection (Schechter and Jellinek, 1975). 
Nicotine was administered chronically through subcutaneous osmotic mini pumps (length: 
5.1cm; diameter: 1.4cm; weight: 5.1g) (Model 2MLI; Alzet, Charles River, UK). The nicotine 
concentration was adjusted to compensate for differences in BW, resulting in a delivery of a 
dose of 3.16mg/kg/day for a duration of seven days. This daily dose maintains plasma levels of 
nicotine at approximately -44ng mr' -a level which is similar to smokers who consume 30 
cigarettes per day (Murrin, Ferrer, Zeng and Hayley, 1987; Benowitz 1988). The drug solution 
was released at a rate of 101tl/hr across a seven-day period. Due to the start up gradient of 
pumps, drug release began approximately six hours following implantation. 
2.3.2. Nicotinic Acetylcholine Receptor Antagonist 
Mecamylamine hydrochloride (2-Methylamino isocamphane hydrochloride Inversine N, 2,3,3- 
Tetramethylbicyclo[2.2.1]heptan-2-amine hydrochloride) was purchased from Sigma-Aldrich. 
This centrally acting non-competitive receptor antagonist was dissolved in 0.9% saline and 
administered s. c. in a volume of Iml/kg at doses 0.1,0.3, and I. Omg/kg. Doses were calculated 
as free base. In lmg of mecamylamine hydrochloride, 0.82mg of mecamylamine was present. 
On the basis of past literature data and the rapid diffusion of mecamylamine across the blood- 
brain barrier (e. g. Debruyne et al., 2003), the nicotinic antagonist was administered 20 minutes 
prior to testing. 
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2.4. SURGERY 
Alzet osmotic mini pumps were surgically implanted to deliver nicotine chronically. Osmotic 
mini pumps are a commonly used preclinical research tool for the chronic delivery of addictive 
agents such as nicotine (e. g. Epping-Jordan et al; 1998; Harrison et al., 2001). Unlike repeated 
injections, osmotic pumps permit the continuous delivery of"drugs at controlled rates. 'Mis 
ensures the maintenance of constant plasma drug levels throughout the study, which is vital 
when attempting to mimic the nicotine intake of smokers. Evidence suggests, that smokers 
attempt to maintain a constant blood level of nicotine, through varying both the quantity of 
cigarettes consumed and actual smoking behaviour (e. g. Chait and Griffiths, 1982; McMorrow 
and Foxx 1983; Chait, Ross and Griffiths, 1985). Mini pump implantation has the further 
advantage of eliminating the stress associated with repeated handling and injections, which may 
impact on results. 
2.4.1. Subcutaneous Implantation 
Pumps were implanted under general anaesthesia. Induction of anaesthesia was achieved 
through the delivery of a concentration of 4% isoflurane into an induction chamber. Once 
anaesthetised, animals were maintained on a mixture of 1.5-3% isoflurane and oxygen 
throughout the surgical procedure. The pumps were implanted subcutaneously, to the right of 
the lboracic vertebra. A mid-scapular incision of approximately 2cm in length was made, and 
through a blunt dissection, a secure pocket was made for the pump. The filled pump was 
implanted and the incision closed with 9mm steel wound clips (Vet-Tech, UK). The topical 
antibiotic Cicatrin (Vet-Tech, UK) was applied to the wound. All pumps were weighed prior to 
implantation. 
2.4.2. Subcutaneous Explantation 
Animals were anaesthetised as above. Surgical explantation of the pump involved making a 
scapular incision across the previous skin opening. The pump was removed and during this 
procedure the incision closed with Vetbond surgical adhesive (Vet-Tech, UK). Following 
removal, in order to verify that the drug was delivered, pumps were re-weighed and the residual 
volume in all pumps recorded. 
During both surgical procedures, animals were normally under anaesthesia for no longer than a 
duration of 15 minutes. Both the adoption of inhalation gases and the short surgical procedure 
meant that the recovery time for animals was rapid, thus having limited impact on behavioural 
test procedures. 
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2.5. OPERANT TESTING 
Two operant paradigms were adopted to measure impulsivity. The symmetrically reinforced 
go/no-go conditional visual discrimination task was utilised to measure inhibitory control 
(Harrison et al., 1999), and the delayed reward paradigm was adopted to assess leviels of 
impulsive choice (Evenden and Ryan, 1996; Cardinal et al., 2000). Each of these tasks were 
conducted in operant test chambers. 
2.5.1. Apparatus 
Two sets of four operant test chambers were used for behavioural paradigms (dimensions 30.5 
X 24.1 X 29.2cm and 30.5 X 24.1 X 21cm; Med Associates Inc., USA). Each aluminium 
chamber was enclosed within a soundproof wooden box, and this was fitted with a ventilator fan 
to provide air circulation. The chamber was illuminated by a 2.8 W stimulus house light and 
fitted with two retractable levers on the front wall of the chamber. Above each lever was a 2.8 
W stimulus light. Located between the centre of the two levers was a food magazine to which 
45mg sucrose pellets (Noyes pellets, Sandown Scientific, UK) were delivered from a pellet 
dispenser. The magazine was illuminated by a white LED and head entries into the magazine 
were detected by a horizontal infrared photobeam across the entrance. All programs controlling 
the apparatus and collecting the data were written by the experimenter using Med-PC software 
running on a Pentium 3 Processor computer. 
2.5.2. Operant Testing Procedure 
Animals for all studies were habituated to laboratory conditions and handled for two weeks 
prior to training. During the first week, animals were given free access to food and water. 
Following this a food deprivation schedule of 18.6g/per day (inclusive of food reward gained in 
the operant chamber) was implemented in order to maintain animals at 85% of their free feeding 
adult bodyweights. Bodyweights were recorded daily (approximately 0800h), beginning one 
week before training, and continuing throughout the study. 
Each experimental day, animals were transported in their home cages from the holding room to 
the test laboratory and placed in the operant chambers. The test chamber and time of testing 
remained constant throughout the study for each animal. Between animals, fresh wood shavings 
were placed on the floor of the operant chamber. Once animals had finished testing, they were. 
returned to their holding room in their home cage. Animals, unless otherwise stated, were tested 
once a day during the light phase of their LD cycle. Testing took place between 0800h and 
1800h. Feeding took place at the end of each experimental day, during which time, animals 
were separated to ensure they consumed the calculated amount of normal rat chow. One animal 
from each pair was removed from the home cage and placed in an adjacent feeding cage; 
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separating the animals during feeding aided the maintenance of body weights. During feeding, 
animals were separated no longer than one hour per day. 
2.6. NICOTINE ABSTINENCE SYNDROME 
A nicotine withdrawal syndrome has been observed in humans following the cessation of 
smoking (e. g. Hughes and Hatsukami, 1986; Hughes et al., 1991) and in rats following both the 
termination of chronic nicotine treatment and the administration of the centrally acting 
antagonist mecamylamine (Malin, 1992; Malin et al., 1994; Hildebrand et al., 1997; Epping- 
Jordan et al., 1998; Harrison et al., 2001). In order to assess nicotine withdrawal, the animal 
model of nicotine abstinence, which is based upon the spontaneous somatic signs shown in 
animals in withdrawal, was adopted (Malin, 1992). Using a nicotine abstinence scale, developed 
by Malin (1992), the intensity of withdrawal can be quantified by assessing the frequency of 
somatic signs shown. 
2.6.1. Apparatus 
During the observation of somatic withdrawal signs, each animal was placed in a glass 
observation tank (dimensions 40.5 X 37 XII cm). The size enabled animals to express a range 
of abstinence signs, but was also limited in an attempt to discourage exploratory behaviour. The 
same tank was used for all animals. Behaviours were recorded by a video camera (JVC TK- 
1280E) positioned horizontally in front of the observation tank. The camera was relayed to a 
monitor (TM-150OPS) in an adjacent laboratory. 
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2.6.2. Assessment of Somatic Withdrawal Signs Procedure 
During the observation of somatic signs, animals were transferred in their home cages to the 
observation laboratory. Both saline and nicotine treated rats were observed for somatic 
withdrawal signs. All animals were habituated to both the test room and observation chamber 
prior to testing. During habituation, animals were placed in the observation chamber for 10 
minutes on two consecutive days prior to the first baseline assessment of somatic signs. During 
this period, the experimenter remained in the observation test laboratory to accustom animals to 
the presence of the experimenter. 
Animals were assessed individually by being placed in a glass observation chamber and the 
frequency of behaviours was recorded by the experimenter for a period of 10 minutes. The 
experimenter remained seated at a distance of approximately 1.5 metres away from the 
observation chamber. In addition, the behaviours were recorded by a video camera. This 
enabled, when necessary, to verify observations made. The same tank was used for all animals. 
The floor of the tank was covered with wood shavings. Between animals, the observation tank 
was thoroughly cleaned and fresh wood shavings provided. The number of somatic signs, 
including gasps, writhes, body shakes, head shakes, chews, teeth chattering, cheek tremors, paw 
tremors, genital grooming, foot licks, yawns, ptosis and scratches were recorded. A description 
of these behaviours is summarised in Table 2.1. For convenience in statistical analysis, gasps 
and writhes were aggregated, as were teeth chatters and chews, and all categories of shakes and 
tremors. Ile remaining behavioural categories were combined to form a category of 
"miscellaneous somatic signs". 
Somatic signs were assessed the day before pump implantation, the final day of chronic drug 
infusion, and during the week following the termination of drug treatment. For specific timings 
of assessment during withdrawal see individual study methodologies. For the majority of 
observations, somatic symptoms w; re recorded immediately following operant behavioural 
testing and under normal laboratory illumination during the light phase of their LD cycle. The 
exception to this was during the early onset of withdrawal, when somatic signs were also 
observed during the animals dark phase of their LD cycle. During this time, the test laboratory 
was illuminated under low intensity red light (approximately 0.01 lux). 
2.7. STATISTICAL ANALYSIS 
All statistical analyses were conducted using SPSS (Statistical Package for Social Sciences 
Version 14.0) and Microsoft Excel (Microsoft Office 2000) 
Appropriate descriptive statistics were performed on all data and evaluated for homogeneity of 
variance, sphericity and assumptions of normality prior to analysis. Homogeneity of variance 
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was assessed by Levene's test (between-subject designs) and Mauchly's test of sphericity 
(within-subject designs). Normal distribution of scores was explored through both histograms 
and Shapiro-Wilks tests. Any data that violated these assumptions were subjected to the 
appropriate transformations. In the case of proportional data (e. g. percentage correct trials and 
percentage choice) data was subjected to arcsine transformations. All other dependent measures 
were subjected to either square root, loglO or inverse transformations (Tukey, 1977; Howell 
1992; Tabchnick and Fidell, 2007). For detailed information on the statistical analyses 
performed refer to individual study methodologies. 
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Table 2.1: Behavioural somatic measures of nicotine abstinence syndrome 
Behavioural. Dependent Variables I 
Measure 
Gasps An accordion-like movement of the animal's chest along the long axis of the 
body. 
Writhes Contraction of the abdominal muscle wall in the form of the animal either 
pressing or flattening its abdomen against the chamber floor, or lifting or 
drawing its abdomen in (sometimes while arching its back). 
Body Shake A rapid, repetitive movement of the head, neck and trunk along the animal's 
central axis. 
Head Shake A rapid, repetitive movement of the head and neck along the animal's 
central axis. 
Chew Three or more consecutive opening and closing motions of the animal's 
mouth. Chewing is not recorded again unless there has been a distinct pause 
between episodes or unless 15 seconds of continuous chewing has passed. 
Teeth Chatter An audible clicking sound, made when the animal's teeth come together 
rapidly. Teeth chatter is recorded if it occurs simultaneously with chewing 
or cheek tremors. 
Cheek Obvious tremor occurring in the fleshy part of animal's cheek, almost 
Tremor directly below its eye. Cheek tremor is not recorded again unless there 
has been a distinct pause between episodes or unless 15 seconds of 
continuous tremors has passed. 
Paw Tremor Obvious quiver of the forepaw while lifted off the chamber floor. Not 
recorded if the animal begins grooming immediately after. 
Foot Lick Animal licks hind legs. Front legs are not included because they are 
commonly a part of grooming activity. 
Genital Licks/ Grooming movements of the head toward the genital region so that the 
Seminal head points between the hind legs. The top of the head is almost 
Ejaculation parallel to the chamber floor. Penis may be unsheathed and visible. 
Scratches Animal uses the hind leg to scratch anywhere on its body. Scratches on or 
close to healing wound area are not recorded. 
Ptosis At least one of the eyelids droop. Recorded when the eyelids narrow 
to a virtual slit for a longer duration than a normal eye blink. Not recorded 
again until one minute has passed. 
Yawn Animal opens its mouth, lowering its jaw and tensing muscles around 
the mouth area. Tongue curls downward into the jaw. 
Overall Somatic signs accumulated across all categories. 
Signs I I 
Adapted from Malin et al., (1992). 
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Validation of the symmetrically reinforced go/no-go 
conditional visual discrimination paradigm 
3.1. INTRODUCTION 
3.1.1. General Introduction 
Disinhibition is one aspect of the multifactorial construct of impulsivity (Evcnden, 1999), and 
has been defined as the inability to appropriately withhold or terminate thoughts and actions 
(Logan, Cowan and Davis, 1984). Disinhibition is often referred to as motoric impulsivity 
(Brunner and Hen, 1997), and as previously discussed in Chapter 1a variety of paradigms 
haven been devised in both the human and animal literature to assess this form of impulsivity. 
One of the most commonly utilised paradigms, which has been successfully modelled in 
preclinical research for use with animals, is the symmetrically reinforced go/no-go visual 
discrimination task (Newman, 1987; Newman and Kosson, 1987; Fletcher, 1993). Unlike many 
other animal models argued to measure disinhibition, such as the DRL and 5CSRTT, this task 
was designed primarily to assess levels of motoric impulsivity. For this reason, the go/no-go 
task was the paradigm chosen to explore the relationship between inhibitory control and 
nicotine dependence in the present thesis. The rodent version of the inhibitory task has been 
described in detail previously (see section 1.3.2.1). In brief, to be food rewarded animals are 
required to learn to discriminate between two visual stimuli; one requiring active lever 
responding during Go trials, the second the requiring of withholding of a lever response during 
No-go trials. More impulsive animals display a greater difficulty in withholding responding 
during No-go trials (Fletcher, 1993). The task employed is symmetrically reinforced, therefore 
both discriminative stimuli represent the availability of reward and responding impulsively 
during No-go trials consequently leads to the loss of reinforcement. This task differs from 
assymetrical paradigms where only active responding during Go trials is rewarded. The 
importance of utilising a symmetrically rewarded procedure is that it enables dysfunctions in 
inhibitory control to be dissociated from that of attenuated aversiveness to non-reward 
(Newman, 1987; Harrison et al., 1999). 
A further advantage of the go/no-go paradigm is that in addition to accuracy of performance 
during Go and No-go trials, measurement of speed of responding and anticipatory behaviour 
during task performance can also be made. Although the primary measure of disinhibition in the 
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task is the inability to withhold responding during No-go trials, anticipatory early responding 
and inappropriate magazine entries are also arguably further indexes of impulsive behaviour 
(Harrison et al., 1999; Paine and Olmstead, 2004). Having an array of behavioural parameters 
on which the effects of drug manipulations can be observed allows a more accurate profile of 
the drug induced effects on disinhibition to be gained. 
3.1.2. Stability of Disinhibition 
A main objective of this thesis was to adopt chronic long-term research designs that afford 
causal interpretation of the relationship between inhibitory control and drug dependence. 
However, in order to assume that any changes in behaviour during chronic preclinical studies 
are attributable to the pharmacological manipulations conducted, verification is needed of the 
stability of behaviour in the absence of these manipulations. To date, information regarding the 
stability of impulsive behaviour is minimal, in particular in relation to levels of inhibitory 
control (Mitchell, 2004). Research has been conducted that suggests that the level of 
anticipatory responding in the 5CSRTT varies extensively across rats but is however a stable 
'trait' that remains unchanged throughout adulthood (Robbins, 2002; Dalley et al., 2007). 
Utilising a comparable go/no-go task as in the present research, Harrison et al., (1999) 
furthermore demonstrated that the ability to withhold responding during No-go trials remained 
relatively stable in sham operated animals over a 20 day period. In contrast, evidence of a 
gradual increase in accuracy during Go trials was observed. 
3.1.3. The Effects of Alterations in Primary Motivation on Disinhibition 
When investigating the effects of drugs of abuse in operant models that utilise food reinforcers, 
it is crucial to demonstrate that the observed alterations in behaviour are not governed simply by 
drug induced changes in the value of reward. This is of particular importance when 
investigating the stimulant nicotine. It is well established that nicotine suppresses appetite whilst 
cessation of smoking or nicotine treatment can lead to hyperphagia and weight gain (Grunberg 
1982; Grunberg, 1986; Grunberg, Bowen and Winders, 1986; Klesges et al., 1989; Miyata et al., 
1999; Pomerleau et al., 2000; Zhang et al., 2001). To aid interpretation of drug induced 
behavioural changes in animal models of disinhibition, previous research has investigated 
alterations in primary motivation on task performance in control animals. The value or 
motivation for food reward can be manipulated through varying levels of deprivation, either 
through prefeeding prior to the test session or maintaining animals at varying proportions of 
their adult body weights through restricting or increasing of daily food intake (e. g. Skinner, 
1938; Heyman and Monaghan, 1987; Rolls et al., 1995; Aoyama 2000). Utilising such 
methodology research has demonstrated that disinhibited responding, as assessed by the 
5CSRTT, is significantly reduced following the decrease in motivation for food reward (Carli 
and Samanin, 1992; Harrison et al., 1997; Grottick and Higgins, 2000; Grottick and Higgins, 
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2002; Bizarro and Stolerman, 2003). Conversely, increasing motivation for food reward has 
been reported to enhance levels of anticipatory responding in the 5CSRTT (Bizarro and 
Stolerman, 2003). These findings suggest that caution should be implemented when interpreting 
drug effects on measures of disinhibition in the 5CSRTT, as they may be indicative of changes 
in motivation rather than impulsivity. It is currently unknown whether measures of disinhibition 
in the go/no-go task are additionally sensitive to alterations in levels of primary motivation. 
3.1.4. Timing Behaviour 
A further factor that has hindered the interpretation of the effects of drugs of abuse in animal 
models of disinhibition, such as the DRL, is that performance in such tasks is highly dependent 
on timing ability (Paule et al., 1999; Wiley et al., 2000). As timing mechanisms are known to be 
sensitive to a number of drugs of abuse, including nicotine (e. g. Carrasco et al., 1998), it is 
essential that performance in the go/no-go task is not dependent on time perception. Harrison ct 
al., (1999) has previously argued that in contrast to other models of disinhibition, the need for 
timing behaviour is substantially reduced in the go/no-go paradigm, due to the presence of 
explicit extroceptive cues informing the animal when to and not to respond. This was not, 
however, explicitly investigated. 
3.1.5. Objectives of Experiment 1 
To determine the suitability of the symmetrically reinýorced go/no-go conditional visual 
discrimination task for the investigation of the relationship between nicotine dependence and 
disinhibition, a series of preliminary studies were therefore conducted to assess: 
i) The stability of performance in the go/no-go task (Experiment IA and IB). 
ii) The effects of acute alterations in primary motivation on task performance (Experiment 
IC). 
iii) Tle dependency of accuracy of performance on timing behaviour (Experiment I D). 
These objectives were achieved through conducting a series of preliminary studies in a control 
group of animals. The first objective was achieved through assessment of the stability of 
performance in the task across a three week period. As assessment of levels of inhibitory control 
during long term drug studies would, at stages, involve animals performing the task twice per 
test day, stability of task performance was also examined during a seven day period during 
which the number of daily test sessions was increased. The acute effects of alterations in 
primary motivation on task performance were then assessed by varying the level of motivation 
for food reward, through either prefeeding subjects immediately prior to the test session or 
acutely increasing levels of deprivation. Finally, to explore whether timing behaviour was 
necessary to accurately perform the task, the duration of stimulus presentation during no-go 
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trials was varied during a single test session. If the withholding of responding during no-go 
trials was not dependent on timing ability then such a manipulation would have no effect on 
levels of inhibitory control. 
3.2. EXPERIMENT l(A-D): VALIDATION OF THE SYMMETRICALLY 
REINFORCED GO/NO-GO CONDITIONAL VISUAL DISCRIMINATION TASK: 
PRELIMINARY CONTROL STUDIES 
3.2.1. METHOD 
3.2.1.1. Subjects 
Subjects were 8 adult male Lister hooded rats (Charles River, UK) weighing 300-320g at the 
start of training. On arrival to the laboratory animals were housed in pairs (cage size; 46 X 26.5 
X 26cm) and maintained under a 12 hour light/dark cycle (lights on at 0700h; lights off at 
1900h) at a controlled environmental temperature of 21.5 *C +2 *C and relative humidity of 
50% +5. Animals were maintained at 85% of their free feeding adult body weights throughout 
the testing period. Water was available ad libitum in home cages and feeding occurred at the 
end of each experimental day. The same subjects were utilised for Experiments 1 (A-D). During 
testing however two subjects were removed from study due to illness. One subject was removed 
during Experiment I A, a flirther subject during Experiment I B. Due to failure to reach criterion 
performance until the fourth month of testing, a third subject only performed Experiments I B- 
D. All animals were treated in accordance with the UK Animals (Scientific Procedures) Act 
1986. 
3.2.1.2. Apparatus 
Four identical operant chambers were used (30.5 X 24.1 X 29.2cm Med Associates Inc., USA). 
See general methodology of Chapter 2 section 2.5.1. for a more detailed description of 
apparatus. 
3.2.1.3. Behavioural Testing: Symmetrically Reinforced Go/No-go Conditional Visual 
Discrimination Task 
3.2.1.3.1. Pre-training 
Food deprived animals were initially magazine trained. During the first of these sessions 
animals were placed in an operant chamber with several sucrose pellets in an illuminated 
magazine. Continuous reinforcement (CRF) magazine training then followed. During a single 
training session the magazine light was illuminated, which signalled the availability of food 
reward. If the animal's head entered the illuminated magazine, a signal food pellet was 
delivered. Animals were then lever trained under CRF schedule. Only one lever was presented 
during these training sessions. The presentation of a right or left lever was counterbalanced 
across rats. A lever press resulted in the illumination of the magazine light which remained on 
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until the animal entered the magazine, following which a single sucrose pellet was delivered. 
The CRF schedule lever training continued until rats earned more than 50 pellets in 30 minutes 
on two consecutive sessions, usually requiring no more than 5 training sessions. 
3.2.1.3.2. Symmetrically Reinforced Go/No-go Conditional Visual Discrimination Task 
The task was based on Harrison et al. 's (1999) behavioural procedure and is summarised in Fig. 
3.1. The task consisted of a total of 80 trials, including 40 Go trials and an equal number of No- 
go trials presented randomly. Animals were required to discriminate between two visual stimuli 
of fast (0.1s pulses presented at 5Hz) and slow (0.4s pulses presented at 0.8311z) synchronised 
flashings of the stimulus lights located above the levers. For half the animals fast flashing 
stimuli indicated a Go trial, while the slow flashing stimuli indicated a No-go trial. For the 
remaining animals fast flashing lights signified a No-go trial and the slow a Go trial, thus 
allowing the stimulus-reward contingencies to be counterbalanced across the group. 
Each trial began with the illumination of the houselight and the initiation of a5 second inter- 
trial-interval (ITI) period, following which the discriminative visual stimuli were presented for a 
10 second duration. During the first 1.2 seconds of stimulus presentation (the pre-discrimination 
period) a response on the lever was recorded as an early response. In order to correctly identify 
the slow stimulus a complete cycle of the stimulus was required to be presented, which is 
completed only after this time point. Therefore early responses during this time had no further 
consequence as discrimination between the two stimulus frequencies was unlikely. The 
presentation of the stimuli continued for a maximum period of 10 seconds until either a 
response on the lever occurred or animals entered the food magazine. Regardless of trial type, if 
animals entered the magazine, a5 second time-out period followed and this response was 
recorded as an inappropriate magazine entry. During the time-out period the houselight was 
turned off and any further responses had no consequence on the trial. After the time out period 
the same trial was then restarted. 
If a response occurred on the lever during the stimulus presentation then one of two outcomes 
followed. If it was currently a Go trial, then a response on the lever resulted in the stimulus light 
being turned off, and the magazine light being turned on signalling the availability of a food 
reward. This response was recorded as a correct Go trial. The animal then had a period of 5 
seconds to enter the food magazine which would in turn deliver a single pellet and switch the 
magazine light off. If instead the animal was currently experiencing a No-go trial, a response on 
the lever resulted in the flashing of stimulus lights being terminated followed by a5 second time 
out period of darkness. In this case an incorrect No-go trial was recorded. 
If no lever response occurred during the stimulus presentation then again two outcomes 
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followed depending on whether animals were currently experiencing a Go or No-go trial. If no 
response occurred during a No-go trial then, at the end of the stimulus presentation the 
magazine light was switched on and animals had a5 second period in which to enter the 
magazine, thus inducing the delivery of a food reward. A correct No-go trial was recorded. If 
instead animals failed to make a response during a Go trial then a5 second time-out period of 
darkness followed and the trial was recorded as an incorrect Go trial. 
Response latencies and magazine entrance latencies were also recorded during both Go and No- 
go trials. Response latencies were measured from the end of the pre-discrimination period of the 
stimulus presentation until the lever was pressed. Response latencies were recorded as a correct 
and incorrect response latency during Go and No-go trials respectively. Both correct and 
incorrect response latencies were utilised to determine the ITI period prior to the following trial. 
This was achieved by subtracting the response latency from the total duration the stimulus could 
have been presented (10 seconds) if no lever response had occurred. This duration was then 
added to the 5 second ITI period. If no response occurred then the ITI duration was simply 5 
seconds as the stimulus had been presented for the total duration during the preceding trial. 
Therefore irrespective of the type of trial that preceded and how the animals responded, the 
duration between trials always remained constant. This prevented a Go response being favoured 
due to a possible increase in rate of delivery of reinforcement if a bias occurred. 
Magazine latencies were calculated from the time of the correct response; a lever response 
during Go trials or following the stimulus presentation during No-go trials, until the animal's 
entry into the food magazine. If animals failed to enter the magazine within 5 seconds, then this 
was recorded as a magazine omission and animals were not rewarded. All dependent variables 
recorded in the behavioural. procedure are summarised in Table 3.1. Training continued until 
animals reached a criterion of 85% total correct trials on two consecutive sessions. Animals 
typically acquired this level of performance following 8 weeks of training. Once this level of 
accuracy had been achieved, sessions continued for a one week period to ensure accuracy of 
performance had stabilised prior to testing. During training animals could conduct the 
behavioural task up to twice per day. 
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Fig. 3.1: Schematic diagram of the symmetrically reinforced go/no-go conditional visual discrimination task 
88 
Q4 
Chapter 3- Symmetrically Reinforced Go/No-go Paradigm 
Table 3.1: Behavioural measures recorded in the symmetrically reinforced go/no-go task 
Behavioural Dependent Variables 
Measure 
Accuracy of Total percentage correct trials 
Respo I nding (no. of correct Go trials + correct No-go trials/ 80 100) 
Percentage correct Go trials 
(no. of correct go trials/ 40 * 100) 
Percentage correct No-go trials 
(no. of correct no-go trials/ 40 * 100) 
Anticipatory No. of Go trials with early responses 
Responding 
No. of No-go trials with early responses 
No. of Go trials with inappropriate magazine entries 
No. of No-go trials with inappropriate magazine entries 
Speed of Correct response latency during Go trials (seconds) 
Responding 
Incorrect response latency during No-go trials (seconds) 
Magazine latency following correct Go trials (seconds) 
Magazine latency following correct No-go trials (seconds) 
Omissions No. of magazine omissions following correct Go trials 
No. of magazine omissions following correct No-go trials 
3.2.1.4. Design and Procedure 
0 
Each experiment followed standard operant testing procedures, outlined in detail previously in 
the general methodology of Chapter 2, section 2.5.2. Experiments I (A-D) employed a within 
subjects design. For Experiments I (B-D) task performance during all manipulations was 
compared to the stable averaged five day baseline obtained immediately prior to testing. Prior to 
all subsequent experimental manipulations it was ensured that animals had returned to BL 
performance before further testing. BL was defined as behaviour in the task deviating no greater 
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than 5% from the accuracy of performance reached by the subject during the assessment of 
stability during Experiment IA. All testing took place during the light phase of their LD cycle 
between 0800h and 1400h. Experimentation took place over a 12 week period. 
3.2.1.4.1. EXPERIMENT 1A: EXAMINATION OF THE STABILITY OF BEHAVIOUR IN THE 
SYMMETRICALLY REINFORCED Go/No-Go TASK 
Performance on the task was examined over a three week period, during which animals 
performed the task once daily. The duration was selected to reflect the duration of future chronic 
drug studies, where performance would be examined during seven days of baseline, chronic 
drug treatment and drug withdrawal. Time of operant testing remained constant for each subject 
during this experimental stage. 
3.2.1.4.2. EXPERIMENT 1B: EXAMINATION OF THE STABILITY OF BEHAVIOUR IN THE 
SYMMETRICALLY REINFORCED GO/NO-GO TASK WHEN PERFORMANCE IN THE TASK IS 
ASSESSED TWICE PER TEST DAY 
Stability of baseline performance was assessed across a seven day period during which animals 
performed two operant sessions per test day. Six hours separated daily test sessions during 
which time animals were returned to their holding room. 
3.2.1.4.3. EXPERIMENT 1C: EXAMINATION OF THE ACUTE EFFECTS OF ALTERATIONS IN 
PRIMARY MOTIVATION ON PERFORMANCE IN THE SYMMETRICALLY REINFORCED GOINO- 
GO TASK 
To provide comparator profiles for the effects of alterations in primary motivation, Experiment 
IC examined the effects of varying levels of deprivation on task performance. The effect of a 
decrease in motivation for food reward on behavioural parameters in the task was assessed twice 
using varying procedures. Under the first of these conditions suppression of motivation was 
achieved through allowing free access to a pre-weighed amount of normal rat chow for one hour 
immediately prior to testing in their home cage. Under the second condition motivation for 
sucrose reward delivered during the task was more specifically reduced through allowing 
animal's free access to a pre-weighed amount sucrose pellets for a 30 minute period prior to 
testing. A shorter time period of free feeding of sucrose pellets was selected based on 
preliminary observations indicating a much greater and more rapid consumption of sucrose 
pellets in comparison to normal rat chow. As with periods of normal feeding, paired housed 
animals were separated during prefeeding. In order to quantify the level of presatiation, each 
animal's BW was measured immediately prior and following feeding. The amount of food 
consumed during the prefeeding periods was also recorded. 
An increase in motivation for food reward was assessed during the third experimental condition. 
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This was achieved through the reduction of food allowance (normally 18.6g) the day prior to 
testing by 50%. The following test day animals were weighed immediately prior to operant 
testing to enable assessment of loss of BW. The sequence of manipulations was determined by a 
Latin square. Between each manipulation, an inter-test interval of at least six days elapsed 
during which subjects were maintained under their normal baseline operant testing and feeding 
regime. 
3.2.1.4.4. EXPERIMENT 11): EXAMINATION OF THE EFFECTS OF VARIABLE NO-GO STIMULUS 
DURATION ON PERFORMANCE IN THE SYMMETRICALLY REINFORCED GO/NO-GO TASK 
To determine whether inhibitory responding during No-go trials was dependent on timing 
behaviour, during a single test session the effects of varying the stimulus duration presented 
during No-go trials was assessed on performance. During the manipulation the No-go trials 
stimulus was presented for a duration of 5,10 or 20 seconds. The duration of stimulus 
presentation during Go trials remained unchanged from baseline test sessions and was presented 
for 10 seconds. An equal number of Go trials, and No-go trials of the three varying stimulus 
durations were randomly presented during 80 trials. Therefore each trial type was presented on 
twenty occasions during the test session. 
3.2.1.5. Statistical Analysis 
For all statistical procedures data were assessed for normality and transformed prior to analysis 
where necessary (see also section 2.7. ). Mauchley's test of sphericity was applied to all within 
subject variables, and when appropriate the degrees of freedom adjusted with the Greenhouse- 
Geisser correction. 
3.2.1.5.1. Training 
In order to compare the independent acquisition of Go and No-go trials the number of sessions 
required to reach above chance level of accuracy on each trial (65% total correct trials on two 
consecutive sessions) (Siegel, 1956) were analysed by a repeated measures west. 
3.2.1.5.2. EXPERIMENT 1A: EXAMINATION OF THE STABILITY OF BEHAVIOUR IN THE 
SYMMETRICALLY REINFORCED GONO-GO TASK 
Examination of the stability of performance across all behavioural parameters (accuracy of 
performance, anticipatory responding, speed of responding and omissions) was conducted by a 
one-way repeated measures ANOVA, with test day as the within subject factor. 
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3.2.1.5.3. EXPERIMENT 1B: EXAMINATION OF THE STABILITY OF BEHAVIOUR IN THE 
SYMMETRICALLY REINFORCED GO/NO-GO TASK WHEN PERFORMANCE IN THE TASK IS 
ASSESSED TWICE PER TEST DAY 
Behavioural measures across the seven day period during time one and time two performances, 
were independently compared to the prior five day average baseline performance: This was 
achieved by conducting a repeated measures one-way ANOVA on time one and time two 
behavioural measures, with test session as the within subject factor with 8 levels (average BL, 
plus seven test days). 
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3.2.1.5.4. EXPERIMENT M EXAMINATION OF THE ACUTE EFFECTS OF ALTERATIONS IN 
PRIMARY MOTIVATION ON BEHAVIOUR IN THE SYMMETRICALLY REINFORCED GO/NO-GO 
TASk 
For each experimental condition the five day average baseline performance prior to the 
manipulation was compared directly to the effects of alterations in primary motivation on 
behaviour. Comparisons across all parameters were conducted using repeated measures Wests. 
Comparison of differences in food intake and weight gained across manipulations were also 
conducted by a repeated measures West. Weight was assessed as both an absolute weight 
gain(g) (or loss) and percentage change from the weight recorded either immediately prior to the 
prefeeding period or the day prior to the feeding manipulation (in the case of assessment of 
acute-induced increase in motivation). 
3.2.1.5.5. EXPERIMENT 1D: EXAMINATION OF THE EFFECTS OF VARIABLE NO-GO STIMULUS 
DURATION ON PERFORMANCE IN THE SYMMETRICALLY REINFORCED GO/NO-GO TASK 
Variation in stimulus duration during No-go trials during a single test session was compared to 
average prior BL performance. Overall accuracy, anticipatory responding and speed of 
responding during Go trials were compared to BL performance using repeated measures Wests. 
Assessments of accuracy, anticipatory responding, speed of responding and omissions during 
No-go trials relative to BL performance were conducted instead by a series of one-way repeated 
measures ANOVAs, with stimulus duration as the within subject factor with 4 levels (No-go 
(13L 10secs duration), No-go (5secs duration), No-go (10secs duration), No-go(20secs 
duration)). Due to the reduction in the number of ! 3o and No-go trials during the manipulation, 
the frequency of trials with anticipatory responding and omissions was expressed as a 
proportion of trial number prior to analysis to enable valid comparison to BL. 
For Experiments I (A, B, D) all significant main effects were followed where appropriate by 
Bonferroni post hoc comparisons in order to identify the location of significant difference. If 
data could not be successfully transformed, then the non-parametric equivalent Friedman and 
Wilcoxon Signed Ranks tests were employed. In all cases of statistical analysis, a was set at 
p<0.05. 
3.3. RESULTS 
Magazine omissions (the failure to collect reward) following a correct response during Go trials 
rarely occurred throughout experimentation and therefore analysis of this behaviour was not 
conducted. 
3.3.1. Training 
Animals required 47.83 ± 3.74 (mean ± SEM) sessions to reach criterion performance of 85% 
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total percentage correct trials. Comparison of acquisition of Go and No-go trials indicated that 
animals reached above chance level of performance during Go trials following significantly 
fewer training sessions in comparison to the sessions required to reach this level of accuracy 
during No-go trials (t = -7.471, df = 6, p<0.001) (No. of training sessions to reach 65% correct 
Go Trials: 2.43 ± 0.20; No. of training sessions to reach 65% correct No-go Trials: 40.57 
5.25). 
3.3.2. EXPERIMENT IA: EXAMINATION OF THE STABILITV OF BEHAVIOUR IN THE 
SVMMETRICALLV REINFORCED GO/NO-GO TASK 
3.3.2.1. Accuracy of Responding 
Overall accuracy of perfon-nance in the go/no-go task remained stable across tile three week 
period varying between 84-90% total correct trials (F(3.542,17.712) = 0.827, N. S. ) (see Fig. 
3.2a). Stable furthennore, was the independent perforinance on Go and No-go trials, as 
supported by the absence of significant main effects of test day for both Go trials (F(2.845, 
14.225) = 1.063, N. S. ) and No-go trials (F(3.191,15.953) = 0.642 , 
N. S. ). As illustrated in Figs. 
3.2 (b-c), accuracy on Go trials was consistently greater than performance during No-go trials, 
with almost 100% accuracy of responding during these trials displayed. In contrast, performance 
during No-go trials ranged between 65-80% with considerably greater variability across animals 
in accuracy of responding on these trials. 
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Fie. 3.2 (c) 
Fig. 3.2 (a-c): Accuracy of responding: Stability of percentage correct Total trials (a), Go trials (b) and No-go 
trials (c) across the 21 day period. Each point represents the mean percentage ± SEM. 
3.3.2.2. Anticipatory Responding 
Analysis revealed no significant main effect of test day for frequency of early responding during 
Go (F(3.510,17.550) = 0.804, N. S. ) and No-go trials (F(2.518,12.591) =0.8434, N. S. ), 
indicating stability of performance across the three week period (see Figs. 3.3 (a-b)). 
Comparably, non-significant main effects of test day were indicated for inappropriate magazine 
entries during both Go (F(I. 720,8.599) = 0.843, N. S. ) and No-go trials (F(2.518,12.591) 
1.130, N. S. ) (Figs. 3.3 (c-d)). As clearly shown in Figs. 3.3 (a-d), the frequency of early 
responding was greatest during Go trials whilst inappropriate magazine entries were more often 
observed during No-go trials. 
95 
123456789 10 11 12 13 14 15 16 17 18 19 20 21 
Day 
123456789 10 11 12 13 14 15 16 17 18 19 20 21 
Day 
Chapter 3- Symmetrically Reinforced Go/No-go Paradigm 




















c w 5 
:E 
0 
Fi2.3.3 (a) Fh!. 3.3 (b) 








Fip-. 3.3 (c) Fi2.3.3 (d) 
Fig. 3.3 (a-d): Anticipatory responding: stability of early responses during Go trials (a) and No-go trials (b) 
across the 21 day period. Anticipatory Responding: stability of inappropriate magazine entries during Go 
trials (c) and No-go trials (d) across the 21 day period. Each point represents the mean number of trials 
SEM. 
3.3.2.3. Speed of Responding 
Figs. 3.4 (a-d) illustrate the stability of speed of responding measures within the go/no-go task 
during the three week period. No main effect of test day was observed for latency to correctly 
respond during Go trials (F(3.304,16.520) = 0.884, N. S. ) and incorrectly respond during No-go 
trials (F(3.830,19.150) = 1.211, N. S. ). 
Analysis of the speed at which animals collected reward furthermore indicated stability of 
performance. No significant main effect of test day was revealed for latency to collect reward 
following both correct Go and No-go trials (F (3.522,17.610) = 1.354, N. S.; F (3.493,17.464) 
1.339, N. S., respectively). 
3.3.2.4. Omissions 
Non-parametric analysis of the failure to collect reward during No-go trials indicated stability of 
this behavioural parameter across the assessed time period (X2 = 27.400, df = 20, N. S. ) (see Fig 
3.5). 
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Fig. 3.4 (a-d): Speed of responding: the stability of latency in seconds to respond correctly during Go trials (a) 
and incorrectly during No-go trials (b) across the 21 day period. Speed of Responding: the stability of latency 
in seconds to collect reward following correct Go trials (c) and No-go Trials (d) across the 21 day period. Each 
bar represents the mean latency in seconds ± SEM. 
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3.3.3. EXPERIMENT 1B: EXAMINATION OF THE STABILITY OF BEHAVIOUR IN THE 
SYMMETRICALLY REINFORCED GONO-GO TASK WHEN PERFORMANCE IN THE TASK IS 
ASSESSED TWICE PER TEST DAY 
3.3.3.1. Accuracy of Responding 
Figs. 3.6 (a-c) illustrate the stability of accuracy of performance in the go/no-go task when 
assessed twice per test day across a seven day period. Analysis of total percentage correct trials 
demonstrated no significant changes in overall accuracy in the task in comparison to baseline 
during time one (F(7,35) = 1.518, N. S. ) and time two (F(7,35) = 1.602, N. S. ) performance. 
Independent performance during both Go and No-go trials furthermore remained stable when 
animals performed the task twice per test day. No significant main effect of test day was 
indicated for Go trials (time one: F(7,35) = 0.715, N. S.; time two: F(7,35) = 1.520, N. S. ) and 
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Fii!. 3.6 (c) 
Fig. 3.6 (a-c): Accuracy of Responding: stability of percentage correct Total trials (a), Go trials (b) and No-go 
trials (c) across a seven day period during which animals performed the task twice per test day. Each point 
represents the mean percentage ± SEM. 
3.3.3.2. Anticipatory Responding 
Analysis of early responding during time one and time two revealed no significant main effect 
of test day for this anticipatory measure during both Go (time one: F(7,35) = 0.911, N. S.; time 
two: F(7,35) = 1.152, N. S. ) and No-go trials (time one: F(7,35) = 0.1.054, N. S.; time two: 
F(7,35) = 1.404, N. S. ). Performing the task twice per test day furthermore had no significant 
effect on the frequency of inappropriate magazine entries during Go (time one: F(7,35) = 0.689, 
N. S.; time two: F(7,35) = 1.133, N. S. ) and No-go trials (time one: F(7,35) = 1.061, N. S.; time 
two: F(7,35) = 1.176, N. S. ). Table 3.2 surnmarises the levels of anticipatory responding in the 
task displayed by animals during time one and time two in comparison to baseline performance. 
3.3.3.3. Speed of Responding 
Latency to respond correctly during Go trials and incorrectly during No-go trials did not differ 
significantly from baseline performance during time one and time two across the seven day 
period. No significant main effect of test day was indicated for correct (time one: F(7,35) = 
0.767, N. S.; time two: F(7,35) = 0.338, N. S. ) and incorrect response latency (time one: F(7,35) 
= 1,653, N. S.; time two: F(7,35) = 1.096, N. S. ). 
Analysis flirther revealed no significant main effect of test day for latency to collect reward 
during Go (time one: F(7,35) = 1.088, N. S.; time two: F(7,35) = 1.328, N. S. ), and No-go trials 
(time one: F(7,35) = 0.485, N. S.; time two: F(7,35) = 0.789, N. S. ) during task performance at 
both time periods. Table 3.3 summarises speed of responding measures in the task during time 
one and time two. 
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3.3.3.4. Omissions 
No significant main effect of test day was observed on failure to collect reward during no-go 
trials during performance in that task at time one (X2 = 4.555, df = 7, N. S. ) and time two (X2 = 
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3.3.4. EXPERIMENT 1c: EXAMINATION OF THE ACUTE EFFECTS OF ALTERATIONS IN 
PRIMARY MOTIVATION ON BEHAVIOUR IN THE SYMMETRICALLY REINFORCED GO/NO-GO 
TASK 
3.3.4.1. DECREASE IN PRIMARY MOTIVATION: Effects of 1h prefeeding of normal rat chow 
During lhr prefeeding of normal rat chow animals consumed an average of 12.58g ± 0.74. 
Following feeding, 15.85g ± 1.83 of BW was gained, increasing BW on average by 3.62 
0.28%. 
3.3.4.1.1. Accuracy of Responding 
Fig. 3.7 illustrates the effects of prefeeding of rat chow on accuracy of performance on the task. 
No significant effect on overall performance was observed following I hr pre-feeding (t =- 
0.575, df = 6, N. S. ). Analysis of the independent accuracy during Go and No-go trials further 
mirrored the lack of effect of accuracy of performance in the task (t = 0.796, df = 6, N. S; t 














Fig. 3.7: Accuracy of responding: The effects of prefeeding of normal rat chow on percentage correct Total 
trials, Go trials and No-go trials. Each bar represents the mean percentage ± SEM. 
3.3.4.1.2. Anticipatory Responding 
Prefeeding had no effect on early responding during both go (t = -0.678, df = 6, N. S. ) and no go 
trials (t = 0.977, df = 6, N. S. ). No significant effect of prefeeding was furthermore indicated for 
inappropriate magazine entries during both Go and No-go trials (t = 0.858, df = 6, N. S.; t= 
1.208, df = 6, N. S. ). Table 3.4 surnmarises the effects of alterations in primary motivation on 
anticipatory responding in the task. 
3.3.4.1.3. Speed of Responding 
Table 3.5 summarises the effects of alterations in primary motivation on speed of responding. 
Prefeeding of normal rat chow immediately prior to testing had no significant effect on the 
speed at which animals responded correctly during Go (t = -1.427, df = 6, N. S. ) or incorrectly 
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during No-go trials (t = 0.611, df = 6, N. S. ). 
Latency to collect food rewards during correctly performed Go and No-go trials in addition 
remained comparable to baseline (t 1.427, df = 6, N. S.; t= -0.932, df = 6, N. S., respectively). 
Although not significant, as shown in Table 3.5, a trend for magazine latencies to increase was 
observed following prefeeding. 
3.3.4.1.4. Omissions 
Failure to collect reward during No-go trials was increased significantly after prefeeding in 
animals (Z= -1.997, p=0.046). (see Table 3.5). 
3.3.4.2. DECREASE IN PRIMARY MOTIVATION: Effects of 30mins prefeeding of sucrose 
reward pellets 
During the 30 minutes of prefeeding an average of 12.10 ± 1.03g of sucrose pellets were 
consumed. In comparison to the BW immediately prior to feeding, 16.63 ± 2.81 g of weight was 
gained, increasing BW by 3.69 ± 0.60%. 
The amount of normal rat chow and sucrose pellets did not differ significantly across prefeeding 
manipulations (t = 0.405 df = 5, N. S). Furthermore, weight gained following each of the 
prefeeding sessions was comparable, as measured by actual weight gain and percentage increase 
in weight (all t: 5 -0.301, df = 5, N. S. ). 
3.3.4.2.1. Accuracy of Responding 
Reducing motivation for sucrose pellets had no significant effect on the overall accuracy of 
performance in the task in comparison to baseline (t = -1.525, df = 5, N. S). Independent 
assessment of Go and No-go trials supported further the lack of effect with no significant 
changes in performance during either Go (t = -1.470, df = 5, N. S. ) or No-go trials (t = -1.070, df 
= 5, N. S. ). Fig. 3.8 illustrates accuracy of responding in the task following prefeeding of 
sucrose pellets in comparison to baseline performance. 
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Fig. 3.8: Accuracy of responding: The effects of prefeeding of sucrose reward pellets on percentage correct 
Total trials, Go trials and No-go trials. Each bar represents the mean percentage ± SEM. 
3.3.4.2.2. Anticipatory Responding 
Following the specific decrease in motivation for sucrose reward, approaching significance was 
a decrease in early responding during both Go (t = 2.125, df = 5, p=0.087) and No-go trials (t = 
2.127, df = 5, p=0.087) (see Table 3.4). In comparison to baseline performance no significant 
changes in inappropriate magazine entries were observed during either type of trial (Go trials: t 
= 0.246, df = 5, N. S; No-go trials: t=2.004, df = 5, N. S. ) (see Table 3.4). 
3.3.4.2.3. Speed of Responding 
Prefeeding of sucrose pellets had no effect on latency to respond either correctly during Go 
trials or incorrectly during No-go trials (t = 0.524, df = 5, N. S.; t =0.242, df = 5, N. S. ) in 
comparison to BL latency. A non-significant trend for an increase in No-go trials magazine 
latency was however observed (t = -1.689, df = 5, p= 0.076), whilst no effect on the speed at 
which reward was collected during Go trials was evident (t = -0.964, df = 5, N. S. ) (see Table 
3.5). 
3.3.4.2.4. Omissions 
Analysis revealed that the frequency of omissions to collect reward during No-go trials 
significantly increased in comparison to BL following prefeeding of reward pellets (Z = -2.201, 
p=0.028) (see Table 3.5). 
3.3.4.3. INCREASE IN PRIMARY MOTIVATION: Effect of reducing allocated food 
consumption the day prior to testing 
Reducing food intake by 50% the day prior to testing, led to an average loss of 5.85 ± 1.03g of 
BW, and percentage decrease in weight of 1.30 ± 0.22%. 
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3.3.4.3.1. Accuracy of Responding 
Increasing the level of deprivation had no effect on the total percentage of correct trials 
performed on the task relative BL accuracy (t = -0.688, df = 6, N. S. ). Independent analysis of 
Go and No-go trials supported further the lack of influence of decreasing food intake the day 
prior to testing on task performance (t = -0.611, df = 6, N. S.; t= -0.894, df = 6, N. S., 












% Correct Trials 
Trial 
Fig. 3.9: Accuracy of responding: The effects of reducing food intake the day prior to testing on percentage 
correct Total trials, Go trials and No-go trials. Each bar represents the mean percentage: k SEM. 
3.3.4.3.2. Anticipatory Responding 
Early responding during both Go and No-go trials did not differ from baseline following an 
increase in motivation for food reward (t = 0.405, df = 6, N. S.; t=0.595, df = 6, N. S., 
respectively). The frequency of magazine entries during Go and No-go trials also remained 
unchanged (t = -0.930, df = 6, N. S.; t=1.066, df = 6, N. S., respectively) (see Table 3.4). 
3.3.4.3.3. Speed of Responding 
As shown in Table 3.5 increasing primary motivation decreased significantly the latency to 
incorrectly respond during No-go trials (t = 3.526, df = 6, p 0.012). In contrast correct 
response latency did not differ in comparison to baseline latency (t -0.380, df = 6, N. S. ). 
Furthermore, the speed with which reward was collected following either a correct Go or No-go 
trial remained unchanged from baseline (t = 0.516, df = 6, N. S.; t= -1.655, df = 6, N. S., 
respectively). 
3.3.4.3.4. Omissions 
Analysis indicated no effect of increasing deprivation on frequency of failure to collect reward 
during No-go trials (Z = -0.211, N. S. ) (see Table 3.5). 
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3.3.5. EXPERIMENT 11): EXAMINATION OF THE EFFECTS OF VARIABLE NO-GO STIMULUS 
DURATION ON PERFORMANCE IN THE SYMMETRICALLV REINFORCED GONO-GO TASK 
3.3.5.1. Accuracy of Responding 
Figure 3.10 (a-c) illustrate the effects of varying stimulus duration during no-go trials on 
accuracy of responding within the task in comparison to BL performance. Varying stimulus 
duration had no significant effect on overall accuracy of perforinance in the task in comparison 
to BL (t = 1.504, df = 5, N. S. ). Independent analysis of Go trials revealed a trend for an 
improvement in accuracy during the manipulation in comparison to BL. This observation 
however failed to reach significance (t = -2.456, df = 5, p=0.058). In contrast, although a trend 
for a decrease in accuracy during No-go trials was observed during the 20 second stimulus 
duration trials, analysis of perforinance revealed no indication of an effect of varying stimulus 
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Fip-. 3.10 (a-c): Accuracy of Responding: the effects of varying stimulus duration during No-go trials on 
percentage correct Total trials (a), Go trials (b) and No-go trials (c). Each bar represents the mean percentage 
± SEM. 
3.3.5.2. Anticipatory Responding 
Variable No-go trial stimulus duration produced no significant effect on frequency of early 
responding during either Go (t = -0.630, df = 5, N. S. ) or No-go trials (F(1,5) = 1.559, N. S. ) 
(Table 3.6). Furthermore, no differences were observed in the frequency of inappropriate 
magazine entries during Go trials (t = 0.473, df = 5, N. S. ). Conversely, a significant main effect 
of stimulus duration was observed on inappropriate magazine entries during No-go trials 
(F(3,15) =7.78, p=0.002). As tabulated in Table 3.6, the proportion of inappropriate magazine 
entries during stimulus presentation increased with increasing stimulus duration. Post hoc 
analysis however failed to locate significant differences between trials. 
3.3.5.3. Speed of Responding 
In comparison to BL perfon-nance correct response latency was significantly faster during the 
manipulation of the task (t = 3.389, df =5p=0.019). Analysis of incorrect response latency 
however revealed no significant main effect of stimulus duration (F(3,15) = 1.832, N. S. ) (see 
Table 3.7) 
Varying the stimulus duration during No-go trials led to a significant decrease in magazine 
latency during Go trials in comparison to BL (t = -3.548, df = 5, p=0.0 16). The latency with 
which reward during No-go trials was collected remained unchanged (F(3,15) = 0.936, N. S. ) 
(see Table 3.7). 
3.3.5.4. Omissions 
Varying stimulus duration had no significant effect on the frequency of omissions to collect 
reward during no-go trials (X2 = 1.909, df = 3, N. S. ) (see Table 3.7). 
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Table 3.6: Anticipatory responding in the symmetrically reinforced go/no-go task 














Go Trials With 0.34 ± 0.07 ------ 0.38 ± 0.33 ------ 
Early Responses 
No-go Trials With 0.12 ± 0.03 0.17 ± 0.05 0.11 ± 0.06 0.17 ± 0.06 
Early Responses 
Go Trials With 0.38 ± 0.01 ------ 0.03 ± 0.01 ------ 
Magazine Entries 
No-go Trials With 0.27 ± 0.06 0.18 ± 0.06 0.41 ± 0.10 0.51 0.09 
Magazine Entries I I I I 
Table 3.6: Each value represents the mean proportion: k hEM. w, p<U. U5,1w, P<U. Ul, www, p<U. UUI (Bonlerroni 
comparison) as compared to baseline. 
Table 3.7: Speed of responding and omissions in the symmetrically reinforced go/no-go 














Correct Response 1.17 ± 0.22 ------ 0.86 0.17* ...... . Latency 
Incorrect Response 2.03 ± 0.33 1.52 ± 0.21 1.90 0.42 2.42 ± 0.48 
Latency 
Go Magazine 0.28 ± 0.22 ------ 0.24 0.18* ------ 
Latency 
No-go Magazine 0.68 ± 0.05 0.90 ± 0.26 0.60 ± 0.16 0.78 ± 0.13 
Latency 
No-go Trial 0.02 ± 0.02 0.08 ± 0.04 0.05 ± 0.05 0.07 ± 0.03 
Magazine Omission I I I II 
Table 3.7: Each value represents the mean latency (seconds) :k SEM. *, P<0.05, **, p<0.01, 
p<0.001(Bonferroni comparison) as compared to baseline. 
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3.4. DISCUSSION 
The series of experiments reported in this chapter were designed to test the suitability of the 
symmetrically reinforced go/no-go paradigm for the exploration of the relationship between 
drug dependence and impulsivity in later experiments of this thesis. The results demonstrated 
that task performance is stable and insensitive to changes in primary motivatiorl. Furthermore, 
accuracy of responding in the task appears to be independent from timing behaviour. 
3.4.1. Training and Stability of Task Performance 
Animals successfully acquired the task, reaching an 85% overall accuracy of performance. In 
agreement with previous research, animals exhibited a substantially greater difficulty in leaming 
to inhibit responding during No-go trials (Ilarrison et al., 1999). Whilst accuracy of responding 
on Go trials reached above chance level in the first few training sessions, to reach comparable 
levels of accuracy on No-go trials required approximately 40 training sessions in the majority of 
subjects. This difference in acquisition across trials can be explained by the CRF lever training 
the animals received prior to being presented with the conditional stimulus reward 
contingencies. This training leads to an active response bias, which while favouring 
performance on Go trials, interferes strongly with learning of the No-go trials. In order to 
acquire the passive behavioural strategy to obtain reward on No-go trials, animals were first 
required to inhibit a previously learned response, which was likely to have impeded the learning 
process. 
Once criterion performance had been reached, assessment of performance over a three week 
period indicated that animals displayed stable overall accuracy of responding in the task, at a 
level of 85-90% accuracy. Independent performance during Go and No-go trials was 
furthermore stable across this duration. Other measurable behavioural parameters in the task, 
such as speed of responding, anticipatory behaviour, and frequency of omissions also displayed 
no evidence of significant changes across the three week period. Increasing the number of 
operant sessions to twice per test day had a minimal effect on all behavioural parameters in the 
task. These findings support, to some extent, previous observations of the stability of behaviour 
in sham operated control animals (Harrison et al., 1999). Comparable to the present research, 
accuracy during No-go trials displayed minimal variation over a 20 day period. In contrast to 
current data, however, is that Go trial accuracy displayed evidence of an improvement over test 
sessions. Assessment of stability in performance in Harrison et al., (1999) study was, however, 
conducted in trained animals after a two-week post-operative recovery period. The termination 
of testing in this study may have led to the lack of stability in performance on these trials. 
The establishment of the long-term stability of task performance in the present research is 
critical for the interpretation of later chronic drug studies of this thesis. Any changes that might 
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be observed during chronic nicotine administration and nicotine withdrawal can now be more 
confidently attributed to the effects of the experimental manipulation performed. It is important 
to highlight that, although stable, accuracy of responding differed across Go and No-go trials. 
Animals' ability to actively respond during Go trials was almost 100% accurate during task 
performance, a level of responding that varied minimally across animals. Conversely, the level 
of accuracy during No-go trials was considerably lower, reaching accuracy of no higher than 
80%. These data suggest that, despite extensive training and loss of reinforcement, animals 
continued to display difficulty in withholding inappropriate responding. The contrasting levels' 
of accuracy during Go and No-go trials is consistent with previous reports of baseline 
performance on comparable go/no-go tasks in both humans (de Wit et al., 2002) and animals 
(Fletcher, 1993; Harrison et al., 1999; Paine et al., 2003; Paine and Olmstead 2004). A critical 
advantage of employing a task where a response prepotency is created that is difficult to inhibit, 
is that it provides the opportunity to not only observe drug induced deficits in inhibitory control 
but also improvements in this behaviour (e. g. de Wit et al., 2002). 
In further contrast to Go trial performance, was the demonstrated greater variability across 
animals in the level'of performance during No-go trials (see Fig. 3.2(c)). Marked individual 
differences in levels of inhibitory control-have previously been reported in other paradigms of 
disinhibition, including the 5CSRTT (Dalley et al., 2007) and FCN schedule (Dellu-Ilagedom, 
2006). These spontaneous individual differences have led authors to argue that variability in 
performance across these paradigms may represent differences in 'trait' levels of impulsivity 
(Robbins, 2002; Dalley et al., 2007). 
3.4.2. The Effects of Alterations in Primary Motivation on Task Performance 
To ensure, in later studies of this thesis, that the observed effects of nicotine on performance 
were not governed by drug induced alterations in primary motivation, animals were tested under 
conditions of varying levels of deprivation. Prefeeding animals normal rat chow immediately 
prior to the test session had no significant effects on accuracy of responding in the task or on 
anticipatory behaviour. Whilst speed of responding did not differ significantly from BL, a 
significant increase in the failure to collect reward during No-go trials was observed. Although 
magazine latency has traditionally been used to index motivation (Robbins, 2002), task 
omissions and response latencies have recently been argued to more consistently reflect the 
level of motivation for reward in animals in paradigms such as the 5CSR'IT (Grottick and 
Higgins, 2002; Bizarro and Stolerman, 2003). It can therefore be argued that motivation for 
food reward was effectively decreased following prefeeding of normal chow. A comparable 
behavioural profile was observed following the reduction of specific satiety for sucrose reward. 
No significant changes were observed on accuracy of responding, anticipatory behaviour or 
latencies during performance. Once again, supporting the lack of motivation for food reward, a 
113 
Chapter 3- Symmetrically Reinforced Go/No-go Paradigm 
significant increase in omissions to collect reward during No-go trials was shown. These 
findings are inconsistent with the reported decrease in anticipatory responding reported in the 
5CSRTT following additional food prior to testing (Carli and Samanin, 1992; Harrison et al., 
1997; Grottick and Higgins, 2000; Grottick and Higgins, 2002; Bizarro and Stolerman, 2003). 
The possibility that the prefeeding manipulations of the present research did not reduce 
motivation to a great enough extent to observe alterations in performance, can not easily 
account for the discrepancy in findings. In the majority of previous research, animals consumed 
less food (4-5g) prior to testing than animals in the present study (12-12.6g), suggesting that 
motivation was reduced to a greater extent in the present research. Differences between the 
paradigms utilised to measure inhibitory control are more likely to explain the variation in 
findings. Unlike the go/no-go task, the 5CSRTT is primarily a model of sustained attention. It 
may be the case that the single parameter used to assess impulsive responding in this model is 
more sensitive to motivational changes than inhibitory measures in the go/no-go task. 
Acutely increasing the motivation for food reward also did not affect accuracy of responding or 
anticipatory behaviour on the task. Whilst the frequency of omissions remained unchanged from 
BL, evidence of an increase in motivation for food reward was demonstrated by the 
significantly faster speed with which incorrect responses were made during No-go trials. The 
suggestion that disinhibited responding, as assessed by the 5CSR17, is enhanced following an 
increase in motivation (Bizarro and Stolerman, -2003), is therefore largely unsupported by the 
present findings. The different paradigms utilised across studies, and the more severe level of 
deprivation induced in previous research may have accounted for the discrepancy in findings. 
Taken together, the lack of effect of both prefeeding and increasing deprivation on both 
accuracy of responding during No-go trials and anticipatory responding, suggest that measures 
of inhibitory control in this task are insensitive to changes in primary motivation. It can 
therefore be argued that it is unlikely that either the anorectic effects of nicotine or increased 
appetite associated with nicotine withdrawal will mediate any nicotine induced changes in 
inhibitory control that may be observed (Grunberg 1982; Grunberg et al., 1986; Klesges et al., 
1989; Miyata et al., 1999; Zhang et al., 2001). 
3.4.3. Timing Behaviour 
A factor that has hindered the interpretation of the effects of drugs of abuse in animal models of 
disinhibition, such as the DRL, is that performance in such tasks is highly dependent on timing 
ability (Paule et al., 1999; Wiley et al., 2000). As timing mechanisms are known to be sensitive 
to a number of drugs of abuse, including nicotine (Carrasco et al., 1998), it was essential to 
demonstrate that performance in go/no-go task was not heavily dependent on time perception. 
Findings revealed that varying the duration of stimulus presentation during No-go trials did not 
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affect overall accuracy, or independent performance during both Go and No-go trials in the task. 
Altering the duration of stimulus presentation did, however, led to alterations in frequency of 
inappropriate magazine entries during No-go trials. Inappropriate magazine entries were found 
to increase with longer stimulus duration. Post hoc analysis, however, failed to locate significant 
differences in comparison to the frequency of responding during BL. The time in which animals 
correctly responded and collected the reward during Go trials did, however, become 
significantly faster in comparison to BL performance. Conversely, varying the duration of 
stimulus presentation during No-go trials had no effect on the speed of responding during these 
trials. These findings suggest that the primary measures of disinhibition in the task (No-go trial 
performance); is not dependent on timing mechanisms, as supported by the comparable level of 
accuracy of responding during trials of varying stimulus duration. Accuracy of responding in the 
task therefore appears to be highly conditioned to extroceptive cues in the task, which 
minimises the need for timing behaviour. Animals appear to be utilising the differing visual 
cues to inform them when to respond and when not to respond (Harrison et al., 1999). The 
findings of the present study importantly indicate that nicotine induced changes on this measure 
of inhibitory control are unlikely to be related to alterations in timing processes. However, the 
evident increase in inappropriate magazine entries during No-go trials suggests that caution may 
need to be given when interpreting the effects of nicotine on this parameter. This behaviour 
appears to be more sensitive to drug induced effects on timing mechanisms, although it should 
be stressed that the alterations observed on this anticipatory measure did not differ significantly 
from BL. The decreased speed of responding during Go trials is difficult to interpret as these 
trials during the manipulation remained unchanged from the normal task procedure. The number 
of Go trials was however reduced to 10 trials during the manipulation. The observed faster 
speed of responding may have therefore reflected a heightened anticipation of eagerly awaited 
Go trials. 
3.4.4. Limitations 
Two potential limitations of the studies in this chapter should be noted. Firstly, due to illness, 
several animals had to be removed from study, reducing the N to 6 for the majority of 
experiments of this chapter. It is possible that the small subject number could have led to a 
decrease in power to detect an effect (type II error). However, with the exception of Experiment 
I D, no critical trends in the data were observed that failed to reach significance, suggesting that 
inclusion of a greater number of animals would have been unlikely to have changed 
dramatically the main conclusions of the present chapter. 
Secondly, whilst acute manipulations of primary motivation effectively compare to later, studies 
that investigate the acute administration of nicotine, longer term alterations in levels of 
motivation would have more effectively compared to future long term drug studies where 
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chronic nicotine administration and withdrawal will be investigated. Therefore, in subsequent 
studies of this thesis that assessed the appropriateness of the delayed reward task, investigation 
was also made of the prolonged effects of alterations in motivation for food reward on task 
performance. 
3.4.5. Conclusions 
In summary, the results of the present chapter have confirmed the suitability of the 
symmetrically reinforced go/no-go task as a paradigm that will enable the investigation of both 
acute and long term nicotine administration and nicotine withdrawal. Clear demonstration has 
been made of the long term stability of task performance and lack of sensitivity of behavioural 
disinhibition to changes in primary motivation. Finally, the presence of extroceptive cues in the 
task appears to minimise greatly the need for timing behaviour for accurate responding during 
No-go trials. Caution however, may need to be given when interpreting the effects of nicotine 
on inappropriate magazine entries. 
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CHAPTER 4 
Acute effects of nicotine on behavioural. 
disinhibition and the mediating role of the central 
nicotinic receptors 
4.1. INTRODUCTION 
4.1.1. General Introduction 
The loss of inhibitory control is believed to be a key component of drug addictive disorders that 
has been attributed primarily to dysfunction of the PFC (Jentsch and Taylor, 1999; Goldstein 
and Volkow, 2002; Lubman et al., 2004). The impaired behavioural disinhibition in drug 
dependent individuals has been proposed to underlie both the inability to regulate compulsive 
drug use and maintain successful abstinence despite the devastating health consequences 
(Goldstein et al., 2004; Lubman et al., 2004). 
Utilising behavioural measures of inhibitory control, past research has demonstrated extensive 
support for the heightened impulsive responding across different populations of drug abusers, 
including cigarette smokers (e. g. Fillmore and Rush, 2002; Spinella, 2002; Forman et al., 2004; 
Li et al., 2006). On tasks such as the CPT and the go/no-go paradigm, current heavy smokers 
have been shown to display a poorer ability to withhold inappropriate responding (Spinella, 
2002; Dinn et al., 2004; Yakir et al., 2007). Whilst such research strongly supports the 
association between smoking and disinhibition, the research does not address the key issue of 
whether disinhibition is a consequence of drug use or a risk factor in the development of 
nicotine dependence. As previously discussed, one way to further our understanding of the 
causal relationship between drug dependence and disinhibition is to assess the acute effects of 
nicotine on tasks designed to measure disinhibition. 
Although relatively few studies have attempted this, results to date have been inconsistent. No 
significant effects of acute nicotine on inhibitory control, as assessed by the CPT and SST, were 
reported in both non-smokers and overnight abstinent smokers (Levin ct al., 1998; Bekker et al., 
2005a). Conversely, amongst neuropsychiatric populations suffering from ADHD and 
schizophrenia, where baseline inhibitory control is abnormally low, acute nicotine increased 
inhibitory control (Levin et al., 1996b; Potter and Newhouse, 2004). It has been suggested that 
the positive effects of acute nicotine on behavioural inhibition may explain the high prevalence 
of smoking in these populations (de Leon et al., 1995; Pomerleau et al., 1995; Dervaux et al., 
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2004). If true, this theory would suggest that impairments in inhibitory control may perhaps 
predispose individuals to initiate smoking. 
In the animal literature experiments assessing the acute effects of nicotine have primarily 
focused on attentional tasks (Carli et al., 1983). Acute nicotine treatment increased anticipatory 
responding in the 5CSRTF, only at low doses (0.03-0.3mg/kg) and under task conditions of 
high attentional demand (e. g. Mirza and Stolerman, 1998; Blondel et al., 2000; Stolerman et al., 
2000; Mirza and Bright, 2001; Hahn, et al., 2002; Hahn et al., 2003; Bizarro, et al., 2004; Bruin 
et al., 2006; Day et al., 2007). An increase in inappropriate premature responding during a DRL 
schedule of reinforcement has also been reported following the acute administration of nicotine 
(Morrison, 1968; Bizot 1998; Popke, Mayorga, Fogle and Paule 2000a; 2000b). However, this 
effect may be related to nicotine's known effects on time perception (e. g. Hinton and Meck 
1996; Carrasco et al., 1998). 
Although behavioural studies have yielded inconsistent and unconvincing data, nicotine is 
known to alter the functioning of neurobiological mechanisms involved in the mediation of 
inhibitory control (Kirch et al., 1987; Vezina et al., 1992; Ramussen and Czachura, 1995; Nisell, 
1996; Balfour et al., 1998; Hildebrand et al., 1998; Harrison et al., 1999; Hildebrand, Panagis, 
Svensson and Nomikos, 1999; Olausson et al., 200 1; de Wit et al., 2002; Christakou et al., 2004; 
Rahman et al., 2004; Picton et al., 2007). Pharmacologically, nicotine initiates its agonistic 
actions by binding to the nicotinic acetylcholine receptors (nAChRs) that are located throughout 
the central (CNS) and peripheral nervous system. Most relevant to nicotine addiction are the 
neuronal nAChRs of which twelve subunits have been identified, a2-10 and 024 (Benowitz, 
1996; Role and Berg, 1996; Salamone and Zhou, 2000). The nAChRs are pentameric 
combinations of the a and P subunits, the most common formed in the brain being the 
heterometric a4P2 and the homomeric a7, accounting for 85% and 10% of the total nicotinic 
receptors respectively (Seguela et al., 1993; McGlee and Role, 1995; Zoli et al., 1998; Lukas et 
al., 1999). Nicotine receptors are present in several brain regions including the ventral tegmental 
area (VTA), striatum, NAc, PFC, amygdala and septal area (Clarke et al., 1985; Wada et al., 
1989; Marks et al., 1992; Nayak et al; 2000; Woolterton et al., 2003). In the CNS nicotine, via 
presynaptic and postsynaptic nAChRs, influences the release of various neurotransmitters 
including acetylcholine, noreadrenaline, DA, 5-11T, glutamate and GABA (Wonnacott et al., 
1990; Wonnacott, 1997; Li et al., 1998; Jones et al., 1999)., 
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4.1.2. Objectives of Experiment 2 (A-C) 
The primary objectives of Experiment 2 were therefore: 
i) To assess the acute effects of nicotine on disinhibition as measured by the 
symmetrically reinforced go/no-go visual discrimination task. 
ii) To determine whether the effects of acute nicotine on disinhibition are mediated 
through central nAChRs. 
To achieve these objectives a dose response function for nicotine was initially determined on 
behavioural disinhibition using the go/no-go task. To establish whether nicotine's effects on 
performance were mediated by central nicotinic receptors, a dose response function for 
mecamylamine (MEC) was also established. MEC is an effective non-specific antagonist of the 
central nicotinic receptors. The classic antagonist is generally believed to be non-competitive in 
its action although it has been proposed that MEC may also exhibit some competitive properties 
(Varanda et al., 1985; Martin, 1989; 1990; Francis and Papke, 1996). Finally, having 
determined effective doses of nicotine and 'silent' doses of MEC on task performance, 
combination drug treatments of nicotine and MEC were administered to assess whether MEC 
could antagonise the effects of nicotine in the go/no-go task. 
4.2. EXPERIMENT 2 (A-C): EXAMINATION OF THE ACUTE EFFECTS OF 
NICOTINE ON BEHAVIOURAL, DISINHIBITION AND THE MEDIATING ROLE OF 
THE CENTRAL NICOTINIC RECEPTORS 
4.2.1. METHOD 
4.2.1.1. Subjects 
Subjects were 12 adult male Lister Hooded rats (Charles River, UK). On arrival animals were 
housed in pairs and maintained under a 12 hour light/dark cycle (lights on at 0700h) in a 
controlled environmental temperature of 21 IC ± YC and relative humidity of 50% ± 10%. 
Animals weighed approximately 300-350g at the start of testing and were maintained at 85% of 
their free feeding adult body weights throughout the testing period. Water was available ad 
libitum in home cages and feeding occurred at the end of each experimental day. The same 
subjects were utilised for Experiments 2(A-C). However, following completion of Experiment 
2A one subject was removed from study due to illness. A total of II subjects were therefore 
used in experiments 2B and 2C. All animals were treated in accordance with the UK Animals 
(Scientific Procedures) Act 1996. 
4.2.1.2. Apparatus 
Four identical operant chambers were used (30.5 X 24.1 X 29.2cm Med Associates Inc., USA). 
See Chapter 2 section 2.5.1 for detailed description of apparatus. 
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4.2.1.3. Behavioural Testing 
Pre-training and the behavioural procedure of the symmetrically reinforced go/no-go conditional 
visual discrimination task have been outlined in detail previously in the methodology of Chapter 
3, section 3.2.1.3. Subjects were trained for approximately 8 weeks until performance had 
stabilised at 85% total correct trials or above. During training animals could conduct the 
behavioural task up to twice per day. 
4.2.1.4. Drugs 
Both nicotine hydrogen tartrate salt and mecamylamine hydrochloride (MEC) were dissolved in 
0.9% saline and administered s. c. in a volume of I mI/kg body weight. All doses were calculated 
as free base. The pH of all nicotine drug solutions was adjusted to approximately 6, using 0.1 M 
sodium hydroxide. Nicotine (0,0.125,0.25,0.5 and I. Omg/kg) was administered s. c. 10 minutes 
prior to testing. Mecamylamine hydrochloride (0,0.1,0.3 and I. Omg/kg) was administered s. c. 
20 minutes prior to operant testing. 
4.2.1.5. Design and Procedure - 
Experiments 2(A-C) employed a within-subjects design. The doses for each experiment were 
administered according to a Latin square design with a minimum of 72 hours between the 
administration of consecutive treatment doses. It was essential that animals had returned to 
baseline performance prior to the subsequent treatment condition being administered. Baseline 
performance was defffied as behaviour in the task deviating no greater than 5% from the 
accuracy of performance reached by the subject prior to initiating drug treatment. This drug 
regime was adhered to in all experiments. A minimum of a one week 'wash out' period was 
given between different drug experiments to minimise the possibility of drug carry over effects. 
During the seven day drug free period animals continued to perform the task daily. In the week 
prior to drug testing, animals were habituated to injection procedures, with subjects s. c. injected 
with Iml/kg saline 10 minutes prior to the operant session. Each experiment followed standard 
operant testing procedures, outlined in detail in general methodology of Chapter 2, section 2.5.2. 
Injection procedures, during all experiments, were conducted in a procedure room separate from 
both the holding room and operant test laboratory. All testing took place during the light phase 
of their LD cycle between 1500h and 1800h. Experimentation was conducted over an 8 week 
period. 
4.2.1.5.1. EXPERIMENT 2A: THE EFFECTS OF ACUTE ADMINISTRATION OF NICOTINE ON 
PERFORMANCE IN THE SYMMETRICALLY REINFORCED GONO-GO TASK 
Initially the dose-response function of nicotine (0,0.125,0.25,0.5 and I. Omg/kg, s. c. ) was first 
examined in the symmetrically reinforced go/no-go task. Following drug administration animals 
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were transferred immediately to the operant test room. 
4.2.1.5.2. EXPERIMENT 2B: THE EFFECTS OF ACUTE ADMINISTRATION OF MECAMYLAMINE 
ON PERFORMANCE IN THE SYMMETRICALLY REINFORCED GO/NO-GO TASK 
Following Experiment 2A the MEC dose-response (0,0.1,0.3 and 1.0mg/kg) on the 
symmetrically reinforced go/no-go paradigm was assessed. In contrast to experiment 2A, due to 
the longer inter-injection interval for the antagonist, animals were first returned to their holding 
rooms until 10 minutes prior to testing, at which point they were transferred directly to the 
operant testing laboratory. 
4.2.1.53. EXPERIMENT 2C: TiIE EFFECTS OF CO-ADMINISTRATION OF NICOTINE AND 
MECAMYLAMINE ON PERFORMANCE IN THE SYMMETRICALLY REINFORCED GO/NO-GO 
TASK 
Following Experiment 2B nicotine and MEC were co-administered to determine whether the 
nicotine induced disinhibition was in part mediated by central nicotinic receptors. The O. Smg/kg 
dose of nicotine was selected on the basis that this dose significantly increased behavioural 
disinhibition in the task during Experiment 2A. Mecamylamine dose-response data from 
experiment 2B indicated a lack of disruption of performance in the task across the dose range 
tested, enabling three 'silent' doses 0.1,0.3 and I. Omglkg of the antagonist to be co- 
administered with nicotine. Treatment conditions during the Experiment 2C were saline/saline, 
saline/NlC0.5. g/kg, 
MECo. l. g1kV 
NIC0.5mg/kgq MEC0.3mgIV NlCo. s., &g and MECI. OingAV NlCo. 5mg/kg. 
The saline/saline and saline/ NlC0. smg&g drug combinations both served as treatment controls. 
The first of these, saline/saline, controlled for the effects of combination injections on behaviour 
in the task, whilst the combined administration of saline/ NICO. 5, nAg, acted as a positive 
drug 
control. The first of all combination treatments was administered 20 minutes prior to the testing 
session, following which animals were returned to their holding room. Ten minutes prior to 
testing, animals were then returned to the preparation room where the second treatment was 
administered after which they were transferred directly to the operant testing room. 
4.2.1.6. Statistical Analysis 
For all drug experiments behaviouml measures, including accuracy of responding, anticipatory 
responding, speed of responding and omissions were analysed using a one-way repeated 
measures ANOVA, with treatment dose as the within subject factor. Significant main effects 
were investigated further by post hoc Bonferroni pairwise comparisons. 
Accuracy of responding on the task during non-drug test days was additionally compared across 
Experiments 2A-C. This comparison was conducted to determine whether changes in baseline 
accuracy of performance took place during the eight weeks of drug testing. Independently for 
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each experiment, the accuracy of performance displayed during the baseline sessions 
immediately prior to each treatment dose was averaged. The average baseline accuracy for 
Experiment 2A, 2B and 2C was then analysed by a one-way repeated measures ANOVA with 
Experiment as the within subject factor, followed where appropriate by Bonferroni 
comparisons. 
In cases where sphericity was violated the Greenhouse-Geisser correction was applied and the 
degrees of freedom adjusted accordingly to more conservative values. Data that violated 
normality was subjected to the appropriate transformations (see section 2.7). If data could not be 
successfully transformed, then the non-parametric Friedman test was employed, followed where 
appropriate by Wilcoxon Signed Ranks tests. In all cases of analysis a values of p<0.05 were 
deemed statistically significant. 
4.3. RESULTS 
Further supplementary statistical information (ANOVA tables) can be found in Appendix 1. 
Magazine omissions (the failure to collect reward) rarely occurred throughout drug 
experimentation and therefore analysis of this behaviour was not conducted. 
4.3.1. Baseline Performance 
Baseline accuracy of performance increased over sessions, leading to a significant difference in 
overall percentage correct trials across experiments (F(2,20) = 11.442, p<0.001) (Fig. 4.1). Post 
hoc analysis demonstrated that baseline accuracy increased significantly during Experiments 2B 
and 2C in comparison to performance during Experiment 2A (all p<0.05). Independent 
assessment of Go and No-go trials revealed that the increase in accuracy of performance across 
experiments was due to enhanced performance during No-go trials during experiments 2B and 
2C (F(2,20) = 12.403, p< 0.001). Baseline performance on Go trials in contrast did not differ 
across drug experiments (F(2,20)= 0.248, N. S). 
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% Correct Trials Across Experiments 
2A 2B 2C 
Experiment 
Total % Correct 0% Correct Go Trials 22 % Correct No-go Trials 
Fig 4.1: Comparison of baseline accuracy of performance of Experiments 2A-2C. Each bar represents the 
mean Percentage correct trials ± SEM. *, p<0.05, **, p<0.01, ***, p<0.001 (Bonferroni comparison) as 
compared to performance during Experiment 2A. 
4.3.2. EXPERIMENT 2A: THE EFFECTS OF ACUTE ADMINISTRATION OF NICOTINE ON 
PERFORMANCE IN THE SVMMETRICALLV REINFORCED C. o/NO-GO TASK 
4.3.2.1. Accuracy of Responding 
Acute administration of nicotine produced a significant deficit in overall perflon-nance in the task 
(F(4,44) = 5.769, p=0.001) (Fig. 4.2(a)). Bonferroni comparisons demonstrated a significant 
difference between saline control and the 0.5mg/kg (p<0.05) and highest I. Omg/kg (p<0.05) 
doses of nicotine. 
Independent assessment of accuracy of performance on Go and No-go trials revealed a 
significant reduction in accuracy during both trial types following nicotine treatment (F(4,44) 
=12.264, p< 0.001; F(4,44) = 2.802, p=0.037, respectively). As illustrated in Fig 4.2 (c), post 
hoc comparisons indicated an inability to withhold a response on No-go trials after 0.51ng/kg of 
nicotine (p<0.05). In contrast, performance during Go trials was reduced following a dose of 
I. Omg/kg of nicotine (Fig. 4.2 (b)). The highest dose differed not only from saline but also from 
the performance on Go trials following treatment with 0.125mg/kg and 0.25mg/kg of nicotine 
(all p<0.01). 
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Fig. 4.2 (a-c): Accuracy of Responding: the effects of acute nicotine administration on percentage correct Total 
trials (a), Go trials (b) and No-go trials (c). Each bar represents the mean percentage correct trials :L SEM. *, 
p<0.05, **, p<0.01, ***, p<0.001 (Bonferroni comparison) as compared to saline control. t, p<0.05, tt, p<0.01, 
tf f, p<0.001 (Bonferroni comparison) as compared to highest I. Omg/kg nicotine dose. 
124 
Total % Correct Trials 
0 0.125 0.25 0.5 
Nicotine Dose (mg/kg) 
%Correct Go Trials 
Chapter 4- Acute Effects of Nicotine on Behavioural Disinhibition 
4.3.2.2. Anticipatory Responding 
Figure 4.3 (a-d) illustrate the effects of acute nicotine treatment on anticipatory responding in 
the behavioural task. With the exception of the highest dose, nicotine treatment increased the 
frequency of early responses during trials. This trend reached significance during Go trials 
where a main effect of drug treatment was found (F(4,44) = 9.368, p<0.001) (Fig 4.3 (a)). Post 
hoc analysis revealed that following treatment with 0.1 25mg/kg the frequency of early 
responses significantly increased in comparison to the control and the highest dose of nicotine 
(all p<0.05). Furthermore, at the highest I. Omg/kg dose, the decrease in early responding during 
the pre-discrimination period reached significance in comparison to 0.5mg/kg nicotine (p<0.01). 
Analysis of this anticipatory response measure during No-go trials also confirmed a main effect 
of treatment (F(4,44) = 3.187, p=0.022). As shown in Fig 4.3 (b) early responses increased to 
the greatest extent at 0.25mg/kg, with the highest I. Omg/kg dose, in contrast, displaying a slight 
decrease in comparison to saline. Post hoc tests however revealed no significant differences 
between treatment conditions. 
Inappropriate magazine entries during the stimulus presentation increased significantly 
following nicotine treatment during Go trials (X2 = 15.159, df = 4, p=0.004). A dose-related 
trend for nicotine to increase magazine entries was shown (Fig. 4.3 (c)). The effect reached 
significance at 0.5mg/kg and the highest I. Omg/kg dose in comparison to saline (all p<0.05). 
Furthermore, the highest dose enhanced this anticipatory measure significantly compared to 
0.1 25mg/kg and 0.25mg/kg treatment conditions. Nicotine treatment had no significant effect on 
inappropriate magazine entries during No-go trials (F(4,44) = 1.427, N. S. ) (see Fig. 4.3 (d)). 
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Fig 4.3 (a-d): Anticipatory Responding: the effects of acute nicotine on early responses during Go trials (a) and 
No-go trials (b). Anticipator), Responding: the effects of acute nicotine on inappropriate magazine entries 
during Go trials (c) and No-go trials (d). Each bar represents the mean number of trials ± SEM. *, p<0.05, **, 
p<0.01, ***, p<0.001 (Bonferroni comparison) as compared to saline control. t, p<0.05, tt, p<0.01, tft, 
p<0.001 (Bonferroni comparison) as compared to highest I. Omg/kg nicotine dose. 
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4.3.2.3. Speed of Responding 
Table 4.1 sununarises the effects of nicotine treatment on all measures of speed of responding. 
Analysis revealed a significant main effect of nicotine treatment on the latency to respond 
correctly during Go trials (F(4,44) = 6.203, p<0.001). Further analysis of correct response 
latencies revealed that treatment with I. Omg/kg nicotine resulted in significantly slower lever 
responding in comparison to saline control and 0.125mg/kg nicotine (all p<0.05). However, the 
effect of treatment on incorrect response latencies during No-go 'trials failed to reach 
significance (F(4,44) = 0.774, N. S. ). 
Finally, nicotine had no significant effect on latencies to collect the reward during either Go or 
No-go trials (F(I. 831,20.14 1) = 2.8 82, p=N. S.; X2 = 9.067, df = 4, p=N. S., respectively). 
Table 4.1: The effect of acute nicotine on speed of responding in the symmetrically 
reinforced go/no-go task 
Behavioural Nicotine Dose (mg/kg) 
Measure Saline 0.125 0.25 0.5 1.0 
(control) 
Correct Response 
Latency 0.65 ± 0.08 0.60 ± 0.12tt 0.75 ± 0.09 0.82 ± 0.23 1.45 ± 0.3 1 
Incorrect Response 
latency 2.31 ± 0.31 2.04 ± 0.19 2.49 ± 0.25 2.65 ± 0.19 2.49 ± 0.44 
Go magazine 
Latency 0.36 ± 0.07 0.31 ± 0.05 0.30 ± 0.02 0.32± 0.02 0.39 ± 0.04 
No-go Magazine 
Latency 0.6010.11 0.49 ± 0.09 0.5410.08 0.54 ± 0.09 0.66 ± 0.06 
Table 4.1: Each value represents the mean latency (seconds) ± SEM. *, p<0.05, **, p<0.01, ***, p<0.001 
(Bonferroni comparison) as compared to saline control. t, p<0.05, tt, p<0.01, ttt, p<0.001 (Bonferroni 
comparison) as compared to highest I. OmgIkg nicotine dose. 
4.3.3. EXPERIMENT 2B: TjlE EFFECTS OF ACUTE ADMINISTRATION OF MECAMYLAMINE ON 
PERFORMANCE IN THE SYMMETRICALLY REINFORCED Go/NO-Go TASK 
4.3.3.1. Accuracy of Performance 
Administration of MEC had no significant effect on overall accuracy of performance (F(3,30) = 
1.571, N. S. ) - (Fig. 4.4(a)). Furthermore, independent analysis of Go and No-go trials also 
demonstrated a lack of effect of the nicotinic antagonist on accuracy of performance in the task 
(F(3,30) = 0.807, N. S.; F(3,30) = 1.463, N. S. respectively) (see Fig. 4.4(b) and (c)). 
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Fig 4.4 (a-c): Accuracy of Responding: the effects of acute mccamylamine administration on percentage 
correct Total trials (a), Go trials (b) and No-go trials (c). Each bar represents the mean percentage correct 
trials ± SEM. 
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433.2. Anticipatory Responding 
Table 4.2 summarises the effects of MEC on anticipatory responding. MEC failed to alter the 
frequency of early responding during Go trials ( F(3,30) = 0.117, N. S. ) and No-go trials (F(3,30) 
= 0.898, N. S. ). 
The frequency of magazine entries during Go trials also remained unchanged (F(3,30) = 0.240, 
N. S. ). While a significant effect was observed on this behaviour during No-go trials (F(3,30) = 
3.882, p=0.020), post hoe tests however did not identify any significant differences between 
drug treatments. 
Table 4.2: The effect of acute mecamylamine on anticipatory responding in the 
symmetrically reinforced go/no-go task 
Behavioural 
M 
Mecamylamine Dose (mg/kg) 
easure Saline 0.1 0.3 1.0 
(control) 
Go trials with Early 
Responses 15.91 ± 2.66 17.09 ± 1.94 16.55 ± 1.74 16.73 ± 2.31 
No-go trials with Early 
Responses 5.55 ± 1.57 4.82 ± 1.48 5.91 ± 1.34 6.45 ± 1.51 
Go trials with 
Magazine Entries 0.82 ± 0.46 0.64 ± 0.24 1.09 ± 0.44 0.91 ± 0.31 
No-Go trials with 
Magazine Entries 9.91 ± 2.32 6.18 ± 1.29 8.55+2.16 7.73 ± 1.55 
Table 4.2: Each value represents the mean frequency: i SENI. 
43.3.3. Speed of Responding 
The latency to correctly respond on the lever during Go trials did not differ following treatment 
(F(3,30) = 0.741, N. S. ), (see Table 4.3). In contrast, analysis of incorrect response latencies 
during No-go trials displayed a significant main effect of treatment (F (3,30) = 5.577, p= 
0.004). Post hoc comparisons revealed no significant differences between drug treatments and 
saline. The main effect instead reflected a significant decrease in latency to respond incorrectly 
at O. Img/kg in comparison to 0.3 and I. Omg/kg doses of mecamylamine (all p< 0.05) (Table 
4.3). 
Finally no significant treatment effects were observed on magazine latencies during both Go 
and No-go trials (F(l. 180,11.802) = 1.73 1, N. S.; F(I. 910,19.096) = 0.5 10, N. S., respectively). 
129 
Chapter 4- Acute Effects of Nicotine on Behavioural Disinhibition 
Table 4.3: The effect of acute mecamylamine on speed of responding in the symmetrically 
reinforced go/no-go task 
Behavioural 
M 
Mecamylamine Dose (mg/kg) 
easure Saline 0.1 0.3 1.0 
(control) 
Correct Response 
Latency 0.83 ± 0.13 0.87 0.12 0.75 ± 0.13 0.70+0.09 
Incorrect Response 
latency 2.02 ± 0.32 0.95 0.1 7§t 2.17 ± 0.40 1.71 ± 0.28 
Go magazine 
Latency 0.39 ± 0.09 0.32+0.05 0.33 ± 0.06 0.35 ± 0.05 
No-go Magazine 
Latency 0.70 ± 0.13 0.66±0.10 0.68 ± 0.14 0.66 ± 0.10 
Table 43: Each values represents the mean latency (seconds) :k SEM. §, p<0.05, §§, p<0.01, §§§, p<0.001 
(Bonferroni comparison) as compared to the 03mg/kg mccamylamine dose. f, p<0.05, tt, p<0.01, ttt, p<0.001 
(Bonferroni comparison) as compared to the highest I. Omg/kg mccamylamine dose. 
4.3.4. EXPERIMENT 2C: THE EFFECTS OF CO-ADMINISTRATION OF MECAMYLAMINE AND 
NICOTINE ON PERFORMANCE IN THE SYMMETRICALLY REINFORCED Go/No-Go TASK 
4.3.4.1. Accuracy of Performance 
A main effect of treatment was observed (F(4,40) = 18.761, p<0.001) (Fig. 4.5(a)). Pairwise 
comparisons demonstrated that nicotine alone significantly reduced the number of correct trials 
in comparison to the saline/saline control (p<0.01). Pre-treatment with MEC, across all doses, 
significantly antagonised the effects of nicotine on accuracy of overall performance, with co- 
administered doses of MEC/NIC failing to differ from the saline/saline control. Overall 
accuracy of performance on the task following all MECNIC combination treatments was 
significantly greater than performance following nicotine treatment alone (all p<0.01). 
Accuracy of performance on Go trials was not affected by nicotine or by its combination with 
the antagonist (F (4,40) = 2.945, N. S. ) (see Fig. 4.5 (b)). Analysis of the accuracy of 
performance on No-go trials in contrast revealed a significant main effect of treatment (F(4,40) 
= 20.512, p<0.001) (Fig. 4.5(c)). Nicotine, when administered alone significantly decreased the 
percentage of correct No-go trials relative to saline/saline control (p<0.01). Post hoc analysis 
revealed that pre-treatment with MEC across all doses blocked the effects of nicotine, as 
demonstrated by the lack of difference in comparison to the saline/saline dose. Furthermore, 
nicotine treatment alone differed significantly from all MECNIC combination treatments (all 
P<0.01). 
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Fig 4.15 (a-c): Accuracy of Responding: the effects of co-administration of nicotine and mecamylamine on 
percentage correct Total trials (a), Go trials (b) and No-go trials (c). Each bar represents the mean percentage 
correct trials ± SEM. *, p<0.05, **, p<0.01, ***, p<0.001 (Bonferroni comparison) as compared to saline/saline 
control. #, p<0.05, ##, p<0.01, ###, p<0.001 (Bonferroni comparison) as compared to nicotine treatment alone 
(0/0.5mg/kg dose). 
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4.3.4.2. Anticipatory Responding 
Despite the' marginal increase in anticipatory responding following the administration of 
nicotine alone, analysis demonstrated no significant main effect of treatment for the frequency 
of early responses or inappropriate magazine entries during both Go and No-go trials (all F 
(4,40): S 1.461, N. S. ) (see Table 4.4). 
Table 4.4: The effect of co-administration of nicotine and mecamylmaine on anticipatory 
responding in the symmetrically reinforced go/no-go task 
Behavioural Mecamylamine Dose (mg/kg) / Nicotine Dose (mg&g) 
Measure Saline/ Saline/ MECo. lmg/kg/ MECO. 3mgAg/ MECI. omsAg/ 
Saline NlCo. smAg NICo. smvkg 
NlCo. s. gAg 
NlCo. s. ekg 
(control) (control) 
Go trials with Early 
Responses 15.0 ± 1.96 15.46 ± 1.69 17.82 ± 1.99 18.18± 2.20 14.18: L 1.68 
No-go trials with Early 
Responses 5.45 ± 1.36 6.73 ± 1.20 5.82 ± 0.98 5.09 ± 1.30 5.45: k 1.43 
Go trials with 
Magazine Entries 0.73+0.24 1.27 ± 0.71 0.91 ± 0.39 1.18 ± 0.55 1.45 ± 0.37 
No-Go trials with 
Magazine Entries 8.18 ± 1.87 1 10.09 ± 1.44 1 8.91 ± 1.47 1 8.73± 1.56 1 8.27 ± 1.59 
Table 4.4: Each value represents the mean frequency * bL51. 
43.4.3. Speed of Responding 
In contrast to Experiment 2A, nicotine significantly increased the latency to incorrectly respond 
on the lever during No-go trials (F(4,40) = 5.694, p=0.001). This effect, which differed 
significantly from saline (p<0.05), was blocked by all pre-treatment doses of MEC (Table 4.5). 
Analysis of the speed at which animals responded on the lever during Go trials revealed no 
significant main effects of treatment (F(4,40) = 0.320, N. S. ). 
No significant effects were observed across drug treatments on the latencies to collect the 
reward following either a correct Go or No-go trial (F(I. 765,17.647) = 2.300, N. S.; F(2.196, 
21.917) = 1.781, N. S., respectively). Table 4.5 summarises the effects of combination treatment 
on speed of responding. 
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Table 4.5: The effect of co-administration of nicotine and mecamylmaine on speed of 
responding in the symmetrically reinforced go/no-go task 
Behavioural Mecamylamine Dose (mg/kg) / Nicotine Dose (mg/kg) 
Measure Saline/ Saline/ MECO. Imwlg/ MECO. 3mg/kg/ MECI. O. gAg/ 
Saline NICo. 5, Wkg NlCo. 5. wjg NICO. 5,,, Wkg NICo. 5mwlg 
(control) (control) 
Correct Response 
Latency 0.82 ± 0.10 0.82 ± 0.17 0.71 ± 0.11 0.78 ± 0.13 0.77 ± 0.11 
Incorrect Response 
latency 1.49 ± 0.10 3.19 ± 0.17* 1.78 ± 0.31 1.64 ± 0.34 1.53 ± 0.33 
Go magazine 
Latency 0.38 ± 0.11 0.32 ± 0.02 0.30 ± 0.04 0.33 ± 0.08 0.30: h 0.03 
No-go Magazine 
Latency 0.76 ± 0.09 0.61 ± 0.0 1 0.64 ± 0.11 0.74 ± 0.13 0.76: E 0.20 
Table 4.5: Each values represents the mean latency (seconds) :L SEM. *, p<0.05, **, p<0.01, ***, p<0.001 
(Bonferroni comparison) as compared to saline control. #, p<0.05, ##, p<0.01, ###q p<0.001 (Bonferroni 
comparison) as compared to nicotine treatment alone (0/0.5mg/kg dose). 
4.4. DISCUSSION 
The differences in levels of inhibitory control between smokers and non-smokers could be due 
to the direct effects of nicotine on impulsivity (Spinella 2002; Yakir ct al., 2007). To explore 
this theory Experiment 2(A-C), assessed, in drug naive rodents, the cffects of acute nicotine on 
behavioural disinhibition measured by the symmetrically reinforced go/no-go task. Furthermore, 
the role played by central nicotinic receptors in the mediation of nicotine's effects on 
behavioural disinhibition were also explored. The primary finding of the study was that 
nicotine induced disinhibition, an effect that was antagonised by doses of MEC that alone had 
no effects on performance in the task. Each of the findings of Experiment 2 A-C will be 
discussed in detail in the following section. 
Experiment 2A demonstrated that in animals without a history of nicotine exposure acute 
nicotine treatment at doses of 0.125 and 0.25mg/kg were without effect on overall accuracy in 
the task. However, a significant increase in premature early responding during Go trials was 
observed at the 0.125mg/kg dose, indicating evidence of perhaps enhanced impulsivity. Unlike 
accuracy of responding this behaviour has no consequence in the task and therefore may be 
more sensitive to the heightened impulsivity produced by low doses of nicotine. In contrast, 
overall performance in the task was significantly reduced at the two highest doses of nicotine, 
0.5mg/kg and I. Omg/kg. Nicotine however produced differing behavioural prof i1cs at each of 
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these doses. At the highest dose (1. Omg/kg) the reduction in accuracy can be attributed to the 
inability to actively respond during Go trials without affecting the ability to withhold 
responding during No-go trials. Although inappropriate magazine entries increased during Go 
trials following this dose, the significant slowing of correct lever responding and evidence of a 
reduction in early responding suggests an overall disruption in basic task performance at the 
highest 1. Omg/kg dose tested. Comparable deficits in general operant behaviour have been 
previously reported following this dose in the 5CSRTT procedure (e. g. Hoyle et al., 2006), and 
is most likely attributable to the often profound'locomotor depression observed at higher acute 
doses of the drug (Morrison and Stephenson, 1972; Stolerman, Fink and Jarvic, 1973; Clarke 
and Kumar, 1983; Gordan, Meehan and Schechter, 1993). 
Conversely, following treatment with the O. Smg/kg nicotine the reduction in overall accuracy is 
clearly related to a significant decrease in the ability to withhold responding on No-go trials 
whilst Go trial performance remained unaffected. This pattern of accuracy of responding 
reflects a clear manifestation of nicotine induced behavioural disinhibition (Fletcher, 1993). The 
increased impulsiveness at this dose was additionally supported by the coincident enhancement 
of anticipatory responding as measured by the increased frequency of inappropriate magazine 
entries during Go trials. The lack of effect on response and magazine latencies following this 
dose furthermore suggests that the drug-induced changes in impulsive responding reflect a 
genuine deficit in behavioural inhibitory control, rather than being a secondary effect to changes 
in locomotor activity (Clarke and Kumar, 1983). 
The ability of acute nicotine to augment disinhibited behaviour supports the theory that the 
heightened impulsivity in smokers (Spinella 2002; Yakir et al., 2006) may arise in part from the 
acute pharmacological effects of nicotine. These data are in agreement with previous preclinical 
research findings demonstrating enhanced premature responding in the SCSRTT and DRL in 
rodents following acute nicotine treatment (e. g. Morrison, 1968; Bizot 1998; Mirza and 
Stolerman, 1998; Blondel et al., 2000; Popke et al., 2000a; 2000b; Stolerman et al., 2000; 
Hahn, et al., 2002; Bizarro, et al., 2004; Bruin et al., 2006). However, the results contradict 
other laboratory studies adopting the 5CSRTT that have failed to observe an increase in 
anticipatory responding (Mirza and Bright, 2001; Hahn et al., 2003; Day et al., 2007). The 
inconsistent findings of the acute effects of nicotine on impulsive responding in the 5CSRTT 
may be accounted for by the generally lower dose range used in these studies in comparison to 
the present research (0.001-0.4mg/kg). Furthermore, unlike the go/no-go task the 5CSRTT is 
primarily a model of sustained attention which may explain the differing effects of nicotine on 
behavioural parameters of impulsivity in each of these paradigms. 
When comparing the findings to the human literature once again the present results appear to be 
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in opposition. Both a lack of effect and an increase in inhibitory control on the CPT and SST 
have been reported in human subjects following acute administration of nicotine (Levin Ct al., 
1996b; Levin et al., 1998; Potter and Newhouse, 2004; Bekker et al., 2005a). The differing 
paradigms utilised to assess inhibitory control is most likely to account for the discrepancy in 
findings. Firstly in past research utilising the CPT the additional positive effects of nicotine 
found on sustained attention may have masked nicotine's induced effects on behavioural 
disinhibition in this particular paradigm (Levin et al., 1996b; Levin et al., 1998; Bekker et al., 
2005a). Secondly, although the SST and go/no-go task are paradigms that both primarily assess 
inhibitory control, contrasting effects of drugs of abuse in each of these paradigms is not 
uncommon (e. g. Reynolds 2006b). The go/no-go task requires the ability to wait and withhold 
inappropriate responding while in contrast the SST requires the ability to stop an already 
initiated response and switch to an alternative behaviour. It may be that nicotine impairs only 
the former of these processes of inhibitory control, an argument further supported by that fact 
that evidence suggests that the two behaviours may be neurobiologically dissociated at the 
dopaminergic level (e. g. Liao and Cheng, 2000; Overtoom et al., 2003; Eagle et al., 2007). 
In contrast, across the dose range tested (0.1,0.3, I. Omg/kg) the nicotinic antagonist MEC in 
Experiment 2B displayed no effects on accuracy of responding in the task. Furthermore, 
anticipatory and speed of responding measures remained unchanged following its treatment in 
comparison to the saline control. The lack of effect of MEC on behavioural disinhibition 
extends previous research that reported no effects of the antagonist on impulsive responding in 
the 5CSRTT (Blondel et al., 2000). When co-administcrcd with nicotine all 'silent' doses of 
MEC antagonised the nicotine induced loss of inhibitory control at the 0.5mg/kg dose 
(Experiment 2C). Consistent with previous findings in the 5CSRTT (e. g. Blondel et al., 2000), 
this result suggests that the acute effects of nicotine on behavioural disinhibition are mediated 
by centrally located nicotinic receptors. The lack of selectivity of MEC however does not enable 
conclusions to be made regarding the specific nAhChR subtypes that may be involved in this 
particular behavioural effect of nicotine. There is some evidence from previous research to 
suggest that a4P2 and 0 receptors may play a fundamental role. For example, several studies 
have reported that administration of the competitive antagonist DIIPE, which has relative 
selectivity for the a4P2 and a4P4 receptors (Harvey and Luetje, 1996; Chavez-Nriega et al., 
1997), blocks the effects of nicotine on anticipatory responding in 5CSRTT (Blondel et al., 
2000; Grottick and Higgins, 2000). Combined with the finding that stimulation of a4P2 receptor 
by the agonist SIB 1765F is capable of increasing premature responding in the task (Grottick 
and Higgins, 2000), indicates strong evidence of the potential role of the a4P2 receptor in the 
modulation of nicotine induced disinhibition in the 5CSRTT. More recently, increased interest 
has also been focused upon the participation of the homomeric a7 receptor. In a7 nicotinic 
knockout mice anticipatory responding was found to be increased significantly relative to wild 
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type mice in models comparable to the 5CSRTT (Keller et al., 2005; Hoyle et al., 2006). At 
present, however, it is unknown whether the nicotinic receptors that govern anticipatory 
responding in the 5CSRTT also influence disinhibited behaviour in the go/no-go task. This 
question could be addressed by future studies examining the role of both the a4P2 and a7 
receptors in nicotine-induced impulsivity in the go/no-go paradigm. 
When considering the possible neural systems that may be mediating the nicotine induced 
effects on impulsivity, the mesocorticolimbic DA system is a likely candidate. When nicotine is 
administered acutely, as with other psychostimulants, striatal dopaminergic neurotransmission is 
enhanced (Di Chiara and Imperato, 1988). More specifically, stimulation of nAChRs receptors 
located within the VTA led to a dose-dependent increase in extracellular levels of DA in the 
shell of the NAc, believed to play a crucial role in nicotine's positive reinforcing properties 
(Benwell and Balfour, 1992; Nisell et al., 1994; Di Chiara and Imperato, 1988; Cadoni and Di 
Chiara, 2000). Interestingly both the P2 (Picciotto et al., 1998; Sharplcs et al., 2000; ) and 0 
(Schilstrom. et al., 1998) receptor subtypes have been implicated in acute nicotine induced DA 
release in the NAc and may be involved in the mediation of nicotine's effects on inhibitory 
control (Blondel et al., 2000; Grottick and Higgins, 2000; Hoyle et al., 2006; ). This suggests 
that nicotine-induced disinhibition may depend heavily on the stimulation of DA activity within 
the NAc via the a7, P2 nicotinic receptors. Lending support for this theory is the finding that 
blockade of the DA DI and D2 receptors significantly attenuated nicotine, cocaine and 
amphetamine induced impulsive responding in the 5CSRTT (van Gaalen ct al., 2006), 
indicating a crucial role of dopamine receptor activation in psychostimulant induced 
disinhibition. Implicating more directly the role DA activation in the NAc, a recent study by 
Pattij ct al (2007) demonstrated that enhanced impulsive responding following amphetamine in 
the 5CSRTT was blocked by administration of the D2 antagonist, eticlopride in the NAc. 
It is important to highlight that nicotine via presynaptic and postsynaptic nAChRs within the 
CNS influences the release of additional neurotransmitters that may have also played a role in 
the mediation of nicotine induced disinhibition in the present research. Administration of 
nicotine has been shown to lead to the release of acetylcholine, noradrcnaline, 5-11T, glutamate 
and GABA (Wonnacott et al., 1990; Wonnacott, 1997; Li et al., 1998; Jones et al., 1999). Of 
particular interest is 5-HT, which has been found to be elevated in the frontal cortex regions 
following systemic administration of nicotine (Ribciro et al., 1993; Nisell et al., 1996). As both 
the frontal cortex and 5-HT have been implicated in the neuronal processes related to inhibitory 
control (e. g. Harrison et al., 1999; Picton et al., 2007), the nicotine induced disruption of 5-11T 
and DA within the frontal cortex is therefore likely to have contributed to the deficits in 
inhibitory control observed following acute exposure. Since the neurobiological events 
downstream from nicotinic receptors were not explored in the present research, the proposed 
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mechanisms that may underlie nicotine induced disinhibition remain highly speculative and 
should be a focus of future research. 
The finding that acute nicotine reduced the ability to withhold inappropriate responding during 
No-go trials suggests that the stimulant increased disinhibition. The heightened impulsivity is 
consistent with the observed dysfunctional levels of inhibitory control observed in heavy 
smokers (Spinella, 2002; Yakir et al., 2007), and suggests that the association between 
impulsivity and nicotine dependence may, in part, be explained by nicotine induced effects on 
inhibitory control. However, several alternative explanations of the present findings need to be 
considered. Firstly nicotine's effects on impulsive responding may have been governed through 
the psychostimulants anorectic effects (McNair and Bryson, 1983; Prunberg et al., 1986; Levin 
et al., 1987; Blaha et al., 1998; Miyata et al., 1999; Zhang et al., 2001). This however is unlikely 
to be the case, the effects of reduction in motivation for reward through prc-feeding in 
Experiment 1C displayed no effects on performance in the task. Furthermore, no effect on 
latency to collect reward was observed following the acute administration of nicotine, providing 
strong evidence that findings were not indicative of changes in primary motivation. 
Secondly, the poorer performance in the task following nicotine treatment could reflect drug 
induced cognitive deficits that may impact upon accuracy during No-go trials. For example, 
impairment in conditional discrimination and breakdown in previously learned stimulus-rcward 
contingencies could lead to an active responding bias. It could also bc argued that both 
attentional and working memory processes are required for accurate performance in the go/no- 
go task, processes that may become disrupted following drug treatment. During the task animals 
are required to continually monitor the environment in order to be alerted when to, and when 
not to, respond and to recall the required responses associated with the discriminative stimulus. 
Previous research has however indicated that nicotine can improve conditional discrimination, 
attention and working memory, positive effects that have been established in both humans and 
animals (e. g. Terry et al., 1996; Levin et al., 1998; Mirza and Stolerman, 1998; Decamp and 
Schneider, 2006; Rusted and Trawley, 2006; Spinelli et al., 2006; Day ct al., 2007). Taken 
together, these findings suggest that observed loss of inhibitory control in the task is unlikely to 
be a consequence of a disruption in cognitive processes. 
Thirdly, based on evidence suggesting that nicotine increases intolerance to delayed 
gratification (Dallery and Locey, 2005); the poorer performance in the task could rcflect an 
inability to tolerate the delayed delivery of reward during No-go trials rather than disinhibited 
behaviour. As previously argued by Harrison et al. (1999), if reward in the go/no-go task 
decreased in value with delay then it would be expected that a reduction in latency to incorrectly 
respond during No-go trials would be demonstrated following nicotine treatment. No such effect 
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was observed following the acute administration of nicotine in the task. A related argument is 
that nicotine's known alterations in the perception of time (Pradhan and Dutta, 1970; Bizot, 
1997; Carrasco et al., 1998) could have affected performance, in that the length of time required 
to withhold responding during No-go trials appeared longer. This explanation however cannot 
account for performance in this particular paradigm of impulsivity. Exteroceptive visual cues 
are presented to inform the animal when to and when not to lever respond during trials therefore 
eliminating the need for timing behaviour. This argument is further supported by the findings in 
Experiment ID that demonstrated no effects on accuracy of responding in the paradigm during 
No-go trials when the duration of stimulus presentation was varied during the task, indicating 
that animals' responding was conditioned to the differing visual cues rather tile duration of 
stimulus presentation. 
It appears therefore that alternative explanations cannot easily account for the impaired 
performance during No-go trials, providing strong support that acute nicotine induces a genuine 
increase in impulsivity. Effectively establishing, in drug na1ve animals, that acute nicotine can 
induce impairments in inhibitory control, suggests that the ability to terminate drug taking 
behaviour could begin to be compromised following initial nicotine exposure. The drug induced 
loss of control could thus lead to continued drug taking and possibly facilitate or increase the 
possibility of making the transition to dependence. 
4.4.1. Conclusions 
The main findings of Chapter 4 demonstrate that acute nicotine can induce disinhibition in the 
go/no-go task, an effect that appears to be mediated by central nicotinic receptors. These 
findings suggest that nicotine induced behavioural disinhibition may therefore be an important 
process underlying the early stages of addiction, whereby initial smoking may lead to a loss of 
control over future drug seeking and taking behaviour thus increasing the likelihood of the 
transition to dependence. 
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CHAPTER 5 
The effects of chronic nicotine administration and 
nicotine withdrawal on behavioural disinhibition 
5.1. INTRODUCTION 
5.1.1. General Introduction 
In order to better understand the role played by impulsivity in both the maintenance and relapse 
of drug abuse, it is important to assess the effects of chronic nicotine administration, nicotine 
withdrawal and the residual sensitivity to nicotine following a sustained period of abstinence on 
disinhibition. Although Experiment 2 clearly demonstrated that acute nicotine administration 
leads to a loss of inhibitory 'control, chronic drug regimes model the pattern of drug use in 
dependent smokers more precisely. 
At present, the best evidence available to suggest that chronic drug use may increase 
disinhibition, is that heavier more dependent drug abusers display greater dysfunction in 
inhibitory control in comparison to less frequent, arguably non-dependent, drug users (Bolla et 
al., 2000; Spinella et al., 2002; Dinn et al., 2004; Yakir et al., 2007). Unfortunately, due to the 
cross sectional design of this research interpretation is hindered by the lack of information 
regarding pre-drug levels of impulsivity and therefore does not permit any valid conclusions to 
be made regarding the causality of the apparent dose-dependcnt-typc relationship between 
disinhibition and dependence. Once again, limited research has been conducted investigating the 
effects of chronic drug administration on disinhibition. Research that has explored the effects of 
chronic cocaine has yielded mixed results. Paine and colleagues (2003) failed to demonstrate 
any changes in performance on a go/no-go task during 14 days of cocaine administration, whilst 
Jentsh et al. (2002) reported an increase in perseverative responding on an object discrimination 
task using a comparable drug regime. Research investigating the effects of nicotine has 
indicated that repeated, intermittent dosing of nicotine progressively increased anticipatory 
responding in a SCSRTr, an attentional paradigm (1316ndel et al., 1999). 
Relapse into drugiaking behaviour following abstinence commonly occurs in the first few 
weeks of abstinence, (Gossop et al., 1989; Garvey et al., 1992; Hughes et al., 
i992; Kenford et 
al., 1994; Law and Tang, 1995). Therefore, Assessing the effects of nicotine withdrawal on 
inhibitory control may indicate the importance of disinhibition as a possible psychological 
mechanism underlying drug relapse in smokers. To date, evidence has been provided of a 
139 
Chapter 5- Nicotine Dependence and Behavioural Disinhibition 
persistent dysfunction in inhibitory control in both abstinent cocaine users and alcoholics 
relative, to control subjects at two weeks and three months following termination of drug 
consumption respectively (Gourdriaan et al., 2005; Verdejo-Garcia et al., 2007). In smoker's 
early nicotine withdrawal, 24hr abstinence, has been associated with an increase in anticipatory 
responding on the CPT (Hatsukami et al., 1989; Dawkins et al., 2007). However, following 
longer term nicotine abstinence, a minimum of six months, levels of disinhibition on the same 
task were found to be between that of non-smokers and smokers, but not significantly different 
from either group (Yakir et al., 2007). As discussed previously, the lack of longitudinal studies 
hinders the interpretation of these data. It is possible that early in drug withdrawal there is a loss 
of inhibitory control (Hatsukami et al., 1989; Dawkins et al., 2007), whereas later in drug 
abstinence this deficit recovers (Yakir et al., 2007). Conversely, the greater levels of inhibitory 
control over behaviour could have enabled these individuals to successfully abstain (Krishan- 
Sarin et al., 2007). 
Although early stages of abstinence are associated with high rates of relapse, longer term 
vulnerability after 'quitting' is well documented (Stephens and Cottrell, 1972; Robinson and 
Berridge, 2000; 2003; Hughes et al, 2004; ]Piasecki, 2006; Ilser, 2007). Current theories of drug 
addiction propose that impaired inhibitory control may increase the likelihood of drug relapse 
(Jentsh and Taylor, 1999; Goldstein and Volkow, 2002; Lubman et al., 2004). In support of this, 
long term drug taking leads to neuroadaptations; including alterations of the serotonergic and 
dopaminergic systems in areas associated with inhibitory control, including the VTA and its 
associated projections (Kirch et al., 1987; Vezina et al., 1992; Ramussen and Czachura, 1995; 
Nisell, 1996; Balfour et al., 1998; Hildebrand et al., 1998; Harrison et al., 1999; Hildebrand, 
Panagis, Svensson and Nomikos, 1999; Olausson et al., 2001; de Wit et al., 2002; Christakou et 
al., 2004; Rahman et al., 2004; Picton et al., 2007). Thus, neuroadaptations resulting from 
chronic drug taking may render the individual vulnerable to relapse in which a loss of inhibitory 
control may be a key aspect. In relation to this, one of the strongest predictors of smoking 
relapse is the initial lapse of smoking a single cigarette during abstinence (Brandon ct al., 1990; 
Nides et al., 1995; Shiffman et al., 1996). This in part may be mediated by neuroadaptations that 
leave the individual hypersensitive to the acute effects of nicotine on impulsivity leading to a 
loss of inhibitory control of future drug seeking and taking behaviour (relapse). 
5.1.2. Objectives of Experiment 3 and 4 
In an attempt to gain further understanding of the relationship between nicotine dependence and 
disinhibition the objectives of Experiments 3 and 4 were: 
i) To determine the effects of chronic nicotine exposure on disinhibition as assessed by 
the symmetrically reinforced go/no-go task (Experiment 3). 
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ii) To assess changes in levels of behavioural disinhibition during early stages of 
withdrawal when smokers are particularly vulnerable to relapse (Experiment 3). 
iii) To assess the stability of changes in disinhibition during longer term abstinence 
(Experiment 3). 
iv) To determine whether chronic drug exposure leads to long term alterations in 
responsivity to the acute effects of nicotine on disinhibition (Experiment 4). 
To achieve these objectives a longitudinal study was conducted in Experiment 3 during which 
the levels of inhibitory control of subjects was assessed in subjects prior to the initiation of drug 
treatment, during seven days of chronic. nicotine exposure, and during initial and long term 
nicotine withdrawal. Following this, the same subjects were tested by a series of acute nicotine 
challenges in Experiment 4. 
To verify that animals were experiencing nicotine withdrawal the nicotine abstinence syndrome 
was additionally assessed during Experiment 3 (Malin, ct al., 1992). In animals nicotine 
deprivation consists of observable, somatic (physical) symptoms that can be induced by 
precipitated or spontaneous nicotine withdrawal (Malin ct al., 1992; 1994; Hilderbrand et al., 
1997; Watkins et al., 2000). These symptoms can be quantified to determine the intensity of 
withdrawal (Malin et al., 1992). 
1 5.2. EXPERIMENT 3: ASSESSMENT OF THE EFFECTS OF CHRONIC NICOTINE 




Subjects were 19 adult male Lister Hooded rats (Charles River, UK). On arrival animals were 
pair-housed and maintained under a 12 hour light/dark cycle (lights on at 0700h) at controlled 
environmental temperature of 21 OC ± 50C and relative humidity of 50% ± 10%. During 
experimentation food was restricted in order to maintain animals at 85% of their free feeding 
body weights. Water was freely available in home cages and feeding occurred at the end of each 
experimental day. At the start of testing, animals weighed approximately 330-360g. All animals 
were treated in accordance with the UK Animals (Scientific Procedures) Act 1996. 
5.2.1.2. Apparatus 
Subjects performed the symmetrically reinforced go/no-go task in four operant chambers 
(dimensions 30.5 X 24.1 X 21cm Med Associates Inc., USA). During the observation of 
somatic withdrawal signs animals were placed in a glass observation tank (dimensions 40.5 X 
37 X 11 cm). Behaviours were recorded by a video camera (JVC TK-1280E) positioned 
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horizontally in front of the observation chamber. The camera was relayed to a monitor (TM- 
150OPS) in an adjacent laboratory. For a more detailed description of all apparatus refer to 
Chapter 2 section 2.5.1 and 2.6.1. 
5.2.1.3. Behavioural Testing 
The behavioural. procedure of the symmetrically reinforced go/no-go task, in addition to the pre- 
training required are outlined in detail within the general methodology of Chapter 3, section 
3.2.1.3. The behavioural measures assessed within the task are also detailed in this section. 
Subjects were trained for approximately 8 weeks until criterion performance of 85% total 
correct trials was reached on two consecutive sessions. Once this level of accuracy had been 
achieved, sessions continued for a one week period to ensure stability of performance prior to 
testing. 
5.2.1.4. Drugs 
Nicotine was dissolved in 0.9% saline and the pll adjusted to approximately 6. Nicotine was 
chronically administered through s. c. implanted osmotic mini pumps (Model 2MLI; Alzet, 
Charles River, UK) and the concentration calculated so that animals received 3.16mg/kg/day 
(free base) for a seven-day duration. The drug solution was released at a rate of I Ojd/hr (see also 
section 2.3.1. ). 
5.2.1.5. Design and Procedure 
A mixed design was employed to assess the chronic effects of chronic nicotine on behavioural 
disinhibition, with treatment group (chronic saline (n = 9) or nicotine treatment (n = 10)) as the 
between subject factor and test day as the within subject factor. Animals were separated into 
treatment group prior to the implantation of osmotic pumps. Groups were balanced according to 
their baseline accuracy of performance within the task. Experimentation followed standard 
operant testing procedures, detailed in the general methodology of Chapter 2, section 2.5.2. 
Operant testing took place duting the light phase of their LD cycle between 10001i and 1830h. 
5.2.1.5.1. THE EFFECTS OF CHRONIC NICOTINE ADMINISTRATION AND NICOTINE 
WITHDRAWAL ON PERFORMANCE IN THE SYMMETRICALLY REINFORCED GO/NO-Go TASK 
Once trained, animals were separated into two treatment groups and their baseline behaviour 
assessed in the operant task across a one week period, during which animals were tested once a 
day. Following the assessment of baseline behaviour osmotic pumps were surgically implanted. 
For a more detailed description of surgical procedures refer to the general thesis methodology of 
Chapter 2, section 2.4. Eighteen hours following the implantation of the osmotic pumps (or 
twelve hours following the initiation of drug release) animals were tested. During the eighteen 
hours post surgery animals recovered from surgery in their home cage prior to operant testing. 
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During the seven days of chronic nicotine administration, performance on the go/no-go task was 
assessed once each day. 
On the seventh day of drug administration pumps were surgically removed, initiating 
spontaneous withdrawal from nicotine. Performance on the task during withdrawal began 12 
hours following pump removal and continued for a three week period. In order to examine early 
effects of withdrawal on behavioural disinhibition, during the first two days of withdrawal 
animals conducted the task twice per day, at 12,18,36, and 42 hours post pump removal. Data 
from validation studies demonstrated that running animals twice per day on the task had little or 
no effect on performance (see Chapter 3). During the remaining withdrawal period animal's 
performance was then assessed once per day. 
5.2.1.5.2. ASSESSMENT OF THE NICOTINE ABSTINENCE SYNDROME 
The intensity of spontaneous withdrawal was assessed by observing the frequency of somatic 
signs. This was conducted using a nicotine abstinence scale developed by Malin et al., (1992). 
' body shakes, head shakes, chews, teeth Briefly the somatic signs, including gasps, writhes, 
chattering, cheek tremors, paw tremors, genital grooming, foot licks, yawns, ptosis and 
scratches were recorded. A detailed description of these behaviours in addition to the procedure 
adopted for their assessment have been outlined previously in the general methodology of 
Chapter 2, section 2.6 and Table 2.1. 
Prior to assessment all animals were habituated to both the test room and observation chamber 
on two consecutive days. Somatic signs were observed, the day before pump implantation 
(baseline assessment), the final day of chronic drug infusion, and during the first week 
following the termination of drug treatment. During withdrawal somatic signs were recorded for 
a ten minute period immediately following operant testing at 6,12.5,18.5,24,36.5,42.5,60.5, 
84.5,108.5, -132.5,156.5 and 180.5 hours following pump removal, with the exception of 
observations at 6 and 24 hours when no operant testing took place. The time points of 
observational sessions were selected on the basis of the previously reported elevation in somatic 
signs during withdrawal (Malin et al., 1992; 1994; Hilderbrand et al., 1997; Epping-Jordan et 
al., 1998; Harrison et al., 2001). 
5.2.1.6. Statistical Analysis - 
In the case of all statistical procedures data prior to analysis were assessed for normality and 
transformed where necessary (see also section 2.7). Mauchley's test of sphericity was applied to 
all within subject variables, and when appropriate the degrees of freedom adjusted with the 
Greenhouse-Geisser correction. The homogeneity of variance of between subject variables was 
assessed by Levine's test. In all cases, a values of p<0.05 were deemed statistically significant. 
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5.2.1.6.1. THE EFFECTS OF CHRONIC NICOTINE ADMINISTRATION AND NICOTINE 
WITHDRAWAL ON PERFORMANCE IN THE SYMMETRICALLY REINFORCED Go/NO-Go TASK 
Comparison of performance on the task by each treatment group was analysed across each stage 
of treatment; including baseline, chronic drug administration, withdrawal week one, withdrawal 
week two and withdrawal week three. Data from seven operant sessions were examined for each 
stage with the exception of withdrawal week one where nine test sessions were performed. 
Magazine omissions (the failure to collect reward) rarely occurred across all treatment stages 
and therefore analysis of this behaviour was not conducted. 
Assessment of differences in performance between treatment groups during baseline, involved a 
two-way mixed ANOVA conducted on all behavioural parameters (accuracy of performance, 
anticipatory responding and speed of responding), with treatment group (nicotine or saline) as 
the between subject factor and test session as the within subject factor. All significant main 
effects were analysed further by Bonferroni post hoc comparisons and interactions were 
followed where appropriate by simple effects analysis. A single one way ANOVA analysed the 
stability of behaviour across test days for each treatment group. Independent Wests analysed 
diffqrences between each group on behavioural measures at individual test sessions (Bonfeffoni 
correction of p< 0.007). 
Within and across treatment groups, animals demonstrated variability in baseline performance 
across parameters within the task. To control for the possibility that pre-drug differences in 
behaviour may influence the dependent variable being measured, all data from chronic drug 
and withdrawal treatment stages were subjected to a two- way mixed analysis of covariancc 
(ANCOVA) (Howell et al., 1992; Stevens 1992; Tabachnick and Fidcll 2007). At each of the 
treatment stages behavioural parameters were assessed with the average baseline performance 
over seven days acting as the covariate within the model. This analysis enabled pre-drug 
differences in baseline behaviour to be controlled for, thus reducing error variance and allowing 
a more accurate assessment of the effects of chronic drug treatment and withdrawal on 
behaviour. For all ANCOVAs, treatment group represented the between subject factor, whilst 
test session the within subject factor. Significant main effects were explored further by post hoc 
Bonferroni tests. Significant treatment group x test day interactions were examined by simple 
effects analysis; where individual means compared were adjusted to control for the effects of the 
covariate. One-way repeated measures ANCOVAs examined by group the stability of behaviour 
across test days, whilst a univariate ANCOVA compared groups at each individual test day 
(drug week, Bonferroni correction of p<0.007; withdrawal week 1, Bonferroni correction 
p<0.006; withdrawal week 2-3, Bonferroni correction of p< 0.007). 
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Prior to all ANCOVA a further assumption assessed was that of homogeneity of regression. 
This was assessed via the examination of interactions of the covariate with both the within and 
between subject variables. If homogeneity of regression was found to be violated (i. e. variables 
interacted significantly with the covariate) then the use of ANCOVA was no longer appropriate. 
Tbough rare, in such instances data was expressed instead as a percentage change from baseline 
and analysed by a two-way mixed ANOVA (Tabchnick and Fidell, 2007). 
5.2.1.6.2. ASSESSMENT OF THE NICOTINE ABSTINENCE SYNDROME 
Total somatic signs were analysed using a two-way mixed factors ANOVA, with treatment 
group as the between subject factor and observational session as the within subject factor. 
Bonferroni post hoc comparisons were applied to the data following significant main effects, 
whilst one-way ANOVA and independent Wests were used to examine further significant 
interactions. Individual categories of withdrawal symptomatology (see Table 2.1) were, in 
contrast, analysed non-parametrically due to violations of normality. Examination of somatic 
signs by treatment group across sessions were analysed by Freidman and Wilcoxon tests, while 
comparison between groups across sessions were performed by Mann Whitney procedural tests. 
5.2.2. RESULTS 
Figures 5.1 (a-c) illustrate the accuracy of performance within the task of each treatment group 
across all stages of study. All graphs represent actual mean values. The following sections in 
turn will investigate more closely differences in behaviour across treatment groups during each 
stage of study. 
For all reported ANCOVA the effect of the covariate (average baseline performance) remained 
highly significant across assessment of all parameters within the task (all F(1,16) 2: 6.908, p :5 
0.025). This indicated that performance during both chronic drug treatment and withdrawal was 
significantly influenced by pre-drug differences in baseline behaviour, therefore supporting the 
importance of its control within analysis. With the exception of performance on Go trials, 
homogeneity of regression was satisfactory for all behavioural measures. A lack of interaction 
was found between the covariate and the independent variables of both treatment group (all 
stages: all F(1,15) 0.001, N. S) and day (drug week: all F(6,90) 2: 0.481, N. S; withdrawal week 
one: all F(8,120) 0.123, N. S ; withdrawal week two: all F(6,90) ý: 0.225, N. S; withdrawal 
week three: all F(6,90) ý: 0.372, N. S. ). In the case of performance on Go trials, whilst the 
covariate was found not to interact with treatment group (all stages: all F(1,16) 2: 0.006, N. S), 
significant interactions were however consistently shown with the within subject factor of day 
(drug week: F (6,90) = 4.000, p 0.00 1; withdrawal week one, F (8,120) = 5.414, p<0.00 1; 
withdrawal week two: F (6,90) 3.734, p= 0.002; withdrawal week three: F (6,90) = 2.46 1, p= 
0.020). The violation of regression meant that this measure was therefore expressed as a 
145 
Chapter 5- Nicotine Dependence and Behavioural Disinhibition 
percentage change from baseline and analysed by a two-way mixed ANOVA. Unless otherwise 
stated, analysis of behavioural. parameters during both chronic drug administration and stages of 
withdrawal displayed no significant main effects of test day on measures of accuracy of 
perfonnance, anticipatory responding or speed of responding within the task. 
5.2.2.1. BASELINE 
5.2.2.1.1. Accuracy of Performance 
Prior to treatment overall performance, and independent performance during both Go and No-go 
trials was stable with no main effects of test day found (all F(6,102) < 2.047, N. S. ). Similar 
performance was observed across treatment groups as indicated by the absence of group main 
effects (all F(1,17): 5 0.320, N. S. ) and group x test day interactions found across all measures of 
accuracy during the seven day period (all F (6,102): 5 0.794, N. S. ) (see Fig. 5.1 (a-c)). 
5.2.2.1.2. Anticipatory Responding 
Analysis indicated no significant main effect of test day across all measures of anticipatory 
responding during baseline (all F(6,102): 5 1.162, N. S. ). Furthermore, no group differences were 
observed on the frequency of early responses or inappropriate magazine entries during both Go 
and No-go trials, with both non-significant between group main effects (all F(Ij 7) :51.749, 
N. S. ) or group x test day interactions found (all F(6,102) :50.792, N. S. ). See table 5.1 for 
summary of anticipatory responding across baseline week. 
5.2.2.1.3. Speed of Responding 
Table 5.2 summarises mean latency of speed of responding measures of both treatment groups 
across baseline week. Both correct and incorrect response latencies were stable during baseline 
with no main effect of test day observed (all F(6,102) :51.419, N. S. ). No differences were 
shown between treatment groups on the speed at which ]ever responses were made, either 
correctly during Go trials or incorTectly during No-go trials as shown by the non-significant 
main effects of group (all F(1,17): 5 3.507, N. S. ) and group x test day interactions (all (F (6,102) 
:50.918, N. S. ). 
Analysis of the speed with which animals collected reward demonstrated no significant main 
effect of test day for Go trial magazine latency (F(6,102) = 1.187, N. S. ). Treatment groups 
furthermore did not differ on this speed of responding measure as shown by the lack of 
significant between group main effect (F(1,17) = 0.302, N. S. ) and group x test day interaction 
(F(6,102) = 0.918, N. S. ) found. Conversely, a significant main effect of test day was indicated 
for No-go magazine latency (F(6,102) = 2.285, p=0.041), although post hoc analysis revealed 
no significant differences between baseline test days. Whilst a non-significant between group 
main effect was shown (F(1,17) = 0.234, N. S. ), the group x test day interaction reached 
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significance (F(6,102) = 4.059, p=0.001). Further statistical analysis revealed a significant 
difference between groups on baseline day 3, with faster latencies performed by the group to be 
treated with nicotine (t = 1.891, df = 17, p=0.040). Independent analysis of treatment group 
across baseline revealed a lack of significant main cffcct of test day for those animals that would 
be treated chronically with nicotine (F (6,54) = 2.110, N. S. ). In contrast, the saline treatment 
group displayed a significant main effect of day (F(6,48) = 3.993, p=0.003), although post hoc 
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5.2.2.2. CHRONIC ADMINISTRATION OF NICOTINE 
5.2.2.2.1. Accuracy of Performance 
As illustrated in Fig. 5.1 (a), the initiation of chronic nicotine treatment led to a significant 
reduction in a overall accuracy of performance on the task in comparison to the saline treatment 
group (F (1,16) = 6.076, p=0.020). Independent analysis of Go and No-go trials demonstrated 
that a greater inability to successfully withhold responding on No-go trials was displayed by the 
nicotine group as supported by the significant main effect of group on this measure of accuracy 
of responding (F (1,16) =5.961, p=0.027). In contrast no significant main effect of group was 
observed on performance during Go trials (F (1,17) = 0.132, N. S) (see Figs. 5.1 (b-c)). As shown 
in Fig. 5.1 (a and c) despite the demonstration of greatest deficits in performance by nicotine 
treated animals at the early stages of treatment, no significant group x test day interactions were 
indicated across all measures of accuracy within the task (Total trials, F(6,96) = 1.648, N. S.; Go 
trials, F(6,102) = 0.961; No-go trials F(6,96) = 0.737, N. S. ). 
5.2.2.2.2. Anticipatory Responding 
Analysis of anticipatory responding revealed that animals chronically treated with nicotine 
performed a significantly greater number of early responses during Go trials (F(1,16) = 9.033, 
p=0.008. ) (Fig. 5.2(a)). In contrast, no significant main cffects of treatment group were 
indicated for early responding during No-go trials or inappropriate magazine entries during Go 
and No-go trials (all F(1,16) :52.219, N. S. ). Analysis across all anticipatory measures during 
drug treatment furthermore demonstrated no significant group x test day interactions (all F(6,96) 
:51.386, N. S. ) (Fig. 5.2 (a-d)). 
5.2.2.2.3. Speed of Responding 
Nicotine treated animals latency to respond correctly during Go trials decreased in comparison 
to baseline latency (see Fig. 5.3 (a)). ANCOVA demonstmted a significant main effect of group 
(F(1,16) = 4.798, p =0.044), with nicotine animals responding significantly faster than saline 
treated animals. No significant group x test day interaction was found (F(6,96) = 0.386, N. S. ). 
In contrast incorrect response latencies during No-go trials did not differ between groups as 
shown by the non-significant main effect of group (F(l, 16) = 0.783, N. S. ) and group x test day 
interaction (F(6,96) = 0.241, N. S. ). 
Analysis of the latencies to collect the reward, demonstrated no differences between groups 
during both Go and No-go trials as indicated by the lack of significant main effects of group (all 
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Fi2.5.2 (a-d): Anticipatory Responding: effects of chronic nicotine administration on early responses during 
Go trial (a) and No-go trials (b). Anticipatory Responding: effects of chronic nicotine administration on 
inappropriate magazine entries during Go trials (c) and No-go trials (d). Each point represents the mean 
number of trials ± SEM. ** p<0.01 Main effect of group. 
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Fig. 53 (a-d): Speed of Responding: the effects of chronic nicotine administration on latency in seconds to 
respond correctly during Go trials (a) and incorrectly during No-go trials (b). Speed of Responding: the effects 
of chronic nicotine administration on latency in seconds to collect reward following correct Go trials (c) and 
No-go Trials (d). Each point represents the mean latency in seconds ± SEM. 
* 
p<0.05 Main effect of group 
5.2.2.3. NICOTINE WITHDRAWAL WEEK ONE 
5.2.2.3.1. Accuracy of Performance 
As clearly shown in Fig. 5.1 (a), total percentage of correct trials was consistently greater in 
animals experiencing nicotine withdrawal across sessions with the exception of 132 hours post 
termination of treatment. This observation was supported statistically by both a significant 
between group difference (F (1,16) = 9.572, p=0.007) and group x test day interaction 
(F(8,128) = 2.222, p=0.030). Simple effects analysis demonstrated that nicotine treated 
animals exhibited a significantly higher overall performance at 12 hours post pump removal 
compared to saline treated animals (F(1,16) = 0.967, p=0.005). Furthermore, the deficits in 
performance in animals experiencing nicotine withdrawal at 42 and 60 hours post termination of 
treatment just missed significance following Bonferroni adjustment (F(l, 16) = 4.852, p=0.043; 
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F(l, 16) = 7.642, p=0.0 14, respectively). One way ANCOVA by group revealed no significant 
main effect of test day for either the nicotine (F(8,64) = 0.548, N. S. ) or saline treatment group 
(F(8,56) = 0.513, N. S. ). 
As illustrated in Fig. 5.1 (c) the pattern of performance on No-go trials across groups mirrors 
that of overall accuracy (see Fig 5.1'(a)), with animals in nicotine withdrawal almost 
consistently demonstrating a greater percentage of correct No-go trials, with the greatest effect 
observed at 12 hours of withdrawal. Both a significant main effect of group (F(l, 16) = 9.225, p 
= 0.008) and group x test day interaction (F(8,128) = 2.911, p=0.005) was revealed. Further 
analysis demonstrated that the decrease in impulsive responding during nicotine withdrawal 
reached significance at 12 and 60 hours post pump removal relative to the control group (all F 
(1,16) 2: 9.113 p: 5 0.005). Differences between groups in addition almost reached significance at 
36,42 and 156 hours post pump removal (F(1,16) = 4.163, p=0.058; F(1,16) = 4.484, p= 
0.050; F(1,16) = 4.242, p=0.056, respectively). Further statistical exploration of the interaction 
revealed no significant main effect of test day for both treatment groups (saline, F(8,56) = 
0.489, N. S.; nicotine, F(8,64) = 8.10, N. S. ). 
Finally in contrast there was no difference in the accuracy of performance of Go trials between 
groups (see Fig. 5.1 (b)), with an absence of both significant between group (F (1,17) = 0.189, 
N. S. ) and group x test day interactions found (F(8,16) = 0.503, N. S. ). 
5.2.23.2. Anticipatory Responding 
As tabulated in Table 5.3 the frequency of early responses during both Go and No-go trials were 
lower in animals experiencing nicotine withdrawal. After controlling however for base line 
differences in early responding no significant between group (all F(1,16) :52.176, N. S. ) or 
group x test day interactions (all F (8,128) < 1.004, N. S. ) were found. 
Analysis of inappropriate magazine entries once again revealed, no differences between 
treatment groups during both types of trials, as indicated by the lack of main effects of group (d 
all F(1,16): S 0.559, N. S. ) and group x test day interactions (all F (8,128): 5 0.506, N. S. ) (see 
Table 5.3). 
5.2.233. Speed of Responding 
Table 5.4 summarises the effects of spontaneous withdrawal on speed of responding. Across 
week one of withdrawal the speed with which animals responded on the lever during both Go 
and No-go trials did not differ across groups, with non-significant group effects (all F(1,16): 5 
0.094, N. S ) and group x test day interactions found (all F(8,128) < 1.583, N. S. ). 
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Withdrawal did however differentially affect the latencies to collect the reward depending upon 
the type of trial being performed. During No-go trials there was no difference between groups in 
speed to collect the reward, supported statistically by the non-significant main effect of group 
(F(1,16) = 0.132, N. S. ) and group x day interaction observed (F(8,128) = 0.583, N. S. ). In 
contrast, whilst no main effect of group was shown for Go trial magazine latencies (F(1,16) = 
2.389, N. S. ), a significant group x test day interaction was displayed (F(8,128) = 3.230, p= 
0.002). Further analysis however demonstrated no significant differences between treatment 
groups on latency to collect reward during Go trials (all F(1,16) < 7.084, N. S. ). Independent 
examination of treatment groups furthermore revealed no significant main effects of test day for 
either nicotine (F(8,64) = 0.322, N. S. ) or saline treated animals (F(8,56) = 0.838, N. S. ). 
5.2.2.3.4. Somatic Withdrawal Signs 
As shown in Fig 5.4, animals experiencing nicotine withdrawal displayed a sharp elevation in 
the total frequency of somatic signs beginning at 6 hours post termination of drug treatment 
returning to baseline at 180.5 hours. Two-way ANOVA demonstrated both a significant main 
effect of treatment group (F (1,17) = 8.20 8, p=0.0 11) and group x time interaction (F(I 3,22 1) 
= 3.806, p<0.001). Further analysis demonstrated that the somatic signs exhibited by animals 
in nicotine withdrawal were significantly elevated in comparison to saline treated animals at 24, 
36.5,42.5,84.5 hours post pump removal (all t 2: 3.420, df = 17, p :50.003) . Furthermore, 
elevation of total somatic signs in animals experiencing nicotine withdrawal just missed 
significance at 12.5,18.5,60.5 and 156.5 hours post pump removal following Bonferroni 
correction (all t>2.127, df = 17, p: 5 0.030). 
Importantly no significant differences between treatment groups were displayed in the 
frequency of symptoms during baseline or chronic drug treatment (all t :50.260, df = 17, N. S. ). 
Further support of the existence of the spontaneous exhibition of the nicotine withdrawal 
syndrome is evident by the highly significant main effect of time shown in the nicotine treated 
animals (F(13,117) = 16.298, p<0.001) in contrast to the saline treated group (F(13,104) = 
2.345, N. S). The saline treated animals displayed no evidence of an increase in frequency of 
overall somatic signs during withdrawal in comparison to baseline. 
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Fig. 5.4: Total Somatic Withdrawal Signs: the frequency of overall somatic signs displayed during 
spontaneous withdrawal. Each point represents the mean number of trials ± SEM. *, p<0.05, **, p<0.01, ***, 
p<0.001 (Bonferroni comparison) indicate significant differences between nicotine and saline treatment 
groups. 
Table 5.5 displays the frequency of individual categories of somatic signs observed during 
spontaneous withdrawal. One of the most commonly exhibited category of symptoms in animals 
experiencing nicotine withdrawal were teeth chattering and chews. The increase in frequency 
reached significance in comparison to saline treated animals as early as 6 hours post pump 
removal and continued for a time course of 132.5 hours (all U> 13.50, N= 19, p<0.022). In 
terms of gasps and writhes, animals experiencing nicotine withdrawal more frequently displayed 
these somatic signs in comparison to saline treated animals at 18.5 and 42.5 hours post 
termination of treatment (all U> 27.50, N= 19, p<0.039). Shakes and tremors furthermore 
showed a significant increase in nicotine treated animals at 18.5 and 36.5 hours ofspontaneous 
withdrawal (all U> 21.00, N= 19, p<0.047). Finally, the miscellaneous observational 
category, including signs for example of scratching and foot licks, elevated significantly in 
nicotine treated animals at 18.5,24,36.5,42.5,84.5 and 156.5 hours post pump removal (all U 
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Chapter 5 Nicotine Dependence and Behavioural Disinhibition 
5.2.2.4. NICOTINE WITHDRAWAL WEEK Two 
5.2.2.4.1. Accuracy of Performance 
As shown in Fig. 5.1 (a) overall performance in the task during the second week of withdrawal 
did not differ across groups, as demonstrated by the lack of significant group effect (F(1,16) 
1.756, N. S. ) and group x test day interaction found (F(6,96) = 1.183, N. S. ). Analysis of the 
accuracy of performance during go and no-go trials produced similar results, with main effects 
of treatment group (Go trials, F(1,17) = 1.933, N. S.; No-go trials, F(1,16) 0.176, N. S. ) and 
group x test day interactions failing to reach significance (Go trials, F(6,102) 0.819, N. S.; No- 
Go trials, F(6,96) = 1.745, N. S. ) (see Fig. 5.1 (b-c)). Although no statistically significant 
differences were found between groups during performance on No-go trials, as clearly 
illustrated in Fig. 5.1 (c) from the 91h day of withdrawal there was a steady decrease in accuracy 
of performance of No-go trials displayed by the chronically treated nicotine group. 
5.2.2.4.2. Anticipatory Responding 
Minimal difference across groups was observed in the frequency of early responses performed 
during both Go and No-go trials. No significant between group (all F(1,16) < 0.337, N. S. ) or 
group x test day interactions (all F(6,96) 5 1.816, N. S ) were demonstrated on this anticipatory 
measure (see Fig. 5.5 (a-b)). 
In contrast nicotine treated animals consistently displayed a greater number of magazine entries 
compared to the saline treated animals during Go trials (F(1,16) = 5.210, p=0.036) (Fig. 
5.5 (c)). The difference observed did not interact with test day (F(6,96) = 0.199, N. S. ). Analysis 
of magazine entries during No-go trials did not demonstrate a main effect of group (F(1,16) = 
0.027, N. S. ), although a significant group x test day interaction was however shown (F(6,96) = 
2.305, p=0.04). Despite a tendency for this anticipatory behaviour to be more frequent in 
animals treated previously with nicotine, simple effects analysis failed to demonstrate any 
significant differences between groups across test days (all F(l, 16) :52.412, N. S) (see Fig. 5.5 
(d)). Furthermore no significant main effect of test day was shown for either the previously 
treated nicotine (F(6,48) = 0.365, N. S. ) or saline animals (F(6,42) = 0.669, N. S. ). 
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Fia. 5.5 (a-d): Anticipatory Responding: effects of nicotine withdrawal during the second week post 
termination of treatment on early responses during Go trials (a) and No-go trials (b). Anticipatory 
Responding: effects of nicotine withdrawal during the second week post termination of treatment on 
inappropriate magazine entries during Go trials (c) and No-go trials (d). Each point represents the mean 
number of trials ± SEM. 
* 
p<0.05' Main effect of group 
5.2.2.4.3. Speed of Responding 
Both correct and incorrect response latencies did not differ across groups as demonstrated by the 
non-significant between group effects (all F(1,16) < 0.035, N. S. ) and group x test day 
interactions (all F(6,96) < 1.726, N. S. ). 
During the second week of withdrawal latency to collect the reward following both correct Go 
and No-go trials was similar across groups. ANCOVA revealed a non-significant effect of group 
(all F(l, l 6) < 0.117, N. S. ) and group x day interaction (all F(6,96) < 0.444, N. S. ) on both 
measures. Analysis of Go magazine latencies did however demonstrate a significant main effect 
of test day irrespective of treatment group (F(6,96) = 3.130, p=0.038). Post hoc comparisons 
however revealed no significant differences between tests sessions. Table 5.6 summaries speed 
responding measures across withdrawal week two. 
5.2.2.5. NICOTINE WITHDRAWAL WEEK THREE 
5.2.2.5.1. Accuracy of Performance 
No group differences were observed on overall accuracy of perforinance during the third week 
of testing following the termination of chronic drug treatment, as indicated by the lack of 
significant between group (F(1,16) = 2.326, N. S. ) and group x test day interaction (F(6,96) = 
1.979, N. S. ) (see Fig. 5.1 (a)). Independent analysis of Go trials demonstrated parallel findings 
with an absence of group differences, evident by a non-significant group effect (F(1,17) = 
0.617, N. S. ), and group x test day interaction (F(2.447,41.601) = 1.618, N. S. ) (see Fig. 5.1 (b)). 
However, as illustrated in Fig. 5.1 (c) performance on No-go trials in animals previously treated 
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with nicotine displayed a gradual decline in accuracy of performance from the 90' day post 
termination of treatment. This deficit in performance continued during the early stages of the 
third week of nicotine withdrawal, as supported by the significant group x test day interaction 
(F(6,96) = 2.924, p=0.012). Further analysis revealed that the increase in behavioural 
disinhibition expressed by the nicotine treated group reached significance on day 17" day post 
chronic drug treatment (F(1,16) = 13.271, p=0.002), whilst day 15 just failed to reach 
significance following Bonferroni correction (F(1,16) = 4.829, p=0.043). A one way 
ANCOVA of test day revealed no significant main effects for both the saline (F(6,42) = 0.503, 
N. S. ) and nicotine treated rats (F(6,48) = 1.504, N. S. ) across this seven day period. 
5.2.2.5.2. Anticipatory Responding 
Table 5.7 summarises anticipatory responding measures across treatment groups in the third 
week of withdrawal. No difference in responding within the task was shown between treatment 
groups across all measures of anticipatory responding. A lack of both significant group effects 
(all F(l, l 6) :50.575, N. S. ) and group x test day interactions (all F(6,96) :51.292, N. S. ) were 
displayed following ANCOVA of early responding and magazine entries during both Go and 
No-go trials. 
5.2.2.5.3. Speed of Responding 
Analysis of both incorrect and correct response latencies and the speed at which reward was 
collected during both Go and No-go trials demonstrated no significant differences between 
groups (all F(1,16) :53.021, N. S. ) or interactions of group perfonnce across test sessions (all 
F(6,96) :51.643, N. S. ). Speed of responding measures across treatment groups are summarised 
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Chapter 5- Nicotine Dependence and Behavioural Disinhibition 
53: EXPERIMENT 4: EXAMINATION OF THE EFFECTS OF ACUTE NICOTINE 
CHALLENGES ON BEHAVIOURAL DISINHIBITION FOLLOWING PREVIOUS 
EXPOSURE TO NICOTINE 
53.1. METHOD 
5.3.1.1. Subjects 
Subjects were 19 adult male Lister Hooded rats (Charles River, UK). All animals had completed 
Experiment 3 and had been previously chronically treated with either nicotine (n = 10) or saline 
(n = 9). Subject details have been previously outlined in the methodology of Experiment 3, 
section 5.5.1.1. At the start of testing, animals weighed approximately 370400g. 
5.3.1.2. Apparatus 
See section 5.2.1.2. 
53.13. Behavioural Testing 
The behavioural procedure of the symmetrically reinforced go/no-go conditional visual 
discrimination task has been described previously in the general methodology of Chapter 3, 
section 3.2.1.3. The behavioural measures assessed in the paradigm are in addition detailed in 
Chapter 2. Details of subject training have been outlined previously in Experiment 3, section 
5.2.1.3. 
53.1.4. Drugs 
Nicotine hydrogen tartrate salt, was dissolved in 0.9% saline and the p1l adjusted to 
approximately 6, using O. IM sodium hydroxide. Nicotine (0,0.125,0.25 and 0.5mg/kg) was 
administered s. c. in a volume of Iml/kg to assess the effects of acute nicotine challenges on 
behavioural disinhibition following the chronic administration of drug treatment. All doses were 
calculated as free base and prepared freshly on each test day. Nicotine was administered 10 
minutes prior to the operant test session. 
5.3.1.5. Design and Procedure 
Assessment began three weeks following the initiation of spontaneous withdrawal. All animals 
had returned to baseline levels of accuracy of performance observed prior to the initiation of 
chronic drug treatment. Furthermore no differences between groups in terms of their accuracy 
on the task were present. 
The cffects of acute nicotine challenges were examined using a mixed design, with treatment 
group (either previously chronically treated with saline or nicotine) as the between subject 
factor and acute drug treatment condition as the within subject factor. Treatment conditions 
were administered according to a Latin square design with a minimum of 72 hours between 
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drug administrations. It was essential that animals had returned to baseline performance prior to 
the subsequent treatment condition being administered. Baseline performance was defined as 
behaviour in the task deviating no greater than 5% from the accuracy of performance reached by 
the subject prior to the initiation of acute drug challenge regime. In the week prior to the 
commencement of acute nicotine testing, animals were habituated to injection procedures on 
two occasions, with subjects s. c. injected with Iml/kg saline. Experimentation followed 
standard operant testing procedures, which have been outlined previously in the general 
methodology of Chapter 2, section 2.5.2. All operant testing took place during the light phase of 
their LD cycle between 1000h and 1400h. 
5.3.1.6. Statistical Analysis 
To ensure animals had both returned to baseline levels of performance and that no differences 
were present between treatment groups, accuracy of performance during the first three days 
following the third week of withdrawal were compared to the average baseline accuracy 
observed in the week prior to the initiation of chronic drug treatment. Data was analysed by a 
two-way mixed ANOVA with test session as the within subject factor and treatment group as 
the between subject factor. 
Across all behavioural parameters assessment of the effects of acute nicotine following chronic 
nicotine exposure was conducted by a two-way mixed ANOVA, with treatment dose as the 
within subject factor and treatment group as the between subject factor. Significant main effects 
were assessed further by Bonferroni post hoc comparisons. Significant treatment dose x group 
interactions were explored further by one-way repeated measures ANOVAs examining the 
nicotine dose-response by group, in addition to independent Wests comparing groups at 
individual treatment doses (Bonferroni correction of p<0.0125). Mauchley's test of sphericity 
was applied to all within subject variables, and when appropriate the degrees of freedom 
adjusted with the Greenhouse-Geisser correction. The homogeneity of variance of between 
subject variables was assessed by Levine's test. All data prior to analysis was assessed for 
normality and transformed where necessary (see also section 2.7). If data could not be 
successfully transformed, then the non-parametric Friedman test was employed to examine, by 
treatment group, the dose-response to nicotine, followed where appropriate by Wilcoxon 
procedures. Mann Whitney U tests were applied to the data to allow group comparisons at each 
treatment dose. In all cases of analysis a values of p<0.05 were deemed statistically significant. 
5.3.2. RESULTS 
Magazine omissions (the failure to collect reward) rarely occurred throughout drug 
experimentation and therefore analysis of this behaviour was not conducted. 
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53.2.1. Return to Baseline 
Statistical comparisons of accuracy of responding in the task to that of performance prior to the 
initiation of chronic drug treatment revealed that overall accuracy and independent performance 
during Go and No-go trials had returned to baseline levels, as indicated by the lack of 
significant main effects of test session (df = 3,51, all F ý: 0.105, N. S. ). Furthermore, treatment 
groups did not differ in their accuracy across measure as shown by the non-significant main 
effects of group (df = 1,17, all F 2: 0.001, N. S. ) and group x test session interaction found (df 
3,5 1, all F 2: 1.3 77, N. S. ). 
53.2.2. Accuracy of Performance 
Acute nicotine reduced the total percentage of correct trials performed on the task in a dose 
related manner (F(3,51) =28.174, p< 0.001). Post hoc analysis revealed that all doses of 
nicotine significantly reduced accuracy of overall performance in comparison to saline control 
treatment, with the greatest effect shown at the highest 0.5mg/kg dose (all p<0.001). 
Furthermore, the highest dose significantly reduced accuracy in comparison to the lower 
0.125mg/kg and 0.25mg/kg nicotine doses (all p<0.05) (see Fig. 5.6 (a)). Although no main 
effect of group was found (F(1,17) = 2.944, p=0.104) a significant dose x treatment group 
interaction was revealed (F(3,5 1) = 3.5 92, p =0.020). Further analysis demonstrated that whilst 
acute nicotine treatment significantly affected both previously treated saline (F(3,24) = 7.125, p 
= 0.001) and nicotine treated animals (F(3,27) = 29.213, p<0.001), those pre-exposed to 
chronic nicotine were more sensitive to the effects, with a significant reduction in accuracy 
shown across all doses tested in comparison to the control dose (all p<0.05) (see Fig. 5.6 (a)). 
Furthermore, following the highest treatment dose overall accuracy was significantly reduced in 
comparison to the 0.125mg/kg nicotine dose (p<0.05). In contrast, in nicotine naYve animals 
nicotine reduced the total percentage of correct trials only at the highest dose in comparison to 
control (p<0.05). Between group comparisons at each dose demonstrated that animals 
previously treated with nicotine performed significantly poorer than animals previously treated 
with saline following the 0.25mg/kg nicotine (t = 1.104, df = 17, p=0.0 12). 
Analysis of performance during Go trials revealed a significant main effect of nicotine on the 
ability to correctly respond during these trials (F(3,51) = 3.281, p=0.028). Post hoc analysis 
however failed to locate significant differences between treatment doses tested (all p>0.05). No 
significant between group effect was found (F(l, 17) = 1.503, N. S. ), however a significant dose 
x treatment group interaction was indicated (F(3,51) = 3.418, p=0.024). Individual one way 
ANOVA of treatment groups revealed no significant main effect of treatment dose on the 
accuracy of performance during Go trials, for either previously treated saline (F(3,27) = 1.379, 
N. S. ) or nicotine animals (F(I. 789,14.313) = 3.804, N. S) (see Fig. 5.6 (b)). Furthermore no 
significant differences between treatment groups were located across individual test doses (all t 
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3.99, df = 17, N. S. ). 
Analysis of No-go trials revealed a highly significant main effect of acute treatment found 
(F(3,51) = 31.395, p<0.001). Post hoc analysis demonstrated that all doses of nicotine reduced 
accuracy of performance during No-go trials in comparison to saline control (all p<0.001). The 
effect at the highest dose differed significantly from perforinance after the 0.125mg/kg 
treatment dose (p<0.05). Although no significant main effect of treatment group was observed 
(F(1,17) = 3.949, N. S. ), a significant group x treatment dose interaction demonstrated group 
differences in response to acute nicotine treatment (F(3,51) = 4.369, p=0.008). One way 
ANOVA demonstrated a significant main effect of treatment dose for both the saline (F (3,24) = 
7.141, p=0.001) and nicotine (F(3,27) = 28.173, p<0.001) treatment groups. For the saline 
treatment group, performance was significantly reduced in comparison to saline control at the 
0.5mg/kg (p<0.01) dose. Conversely, a dose related reduction in accuracy of responding during 
No-go trials was observed in the nicotine treatment group. Performance during No-go trials was 
significantly impaired by all doses tested relative to saline control (all p<0.05). Furthermore, the 
perfon-nance of animals in the nicotine treatment group was significantly worse following 
treatment of both 0.25mg/kg and 0.5mg/kg in comparison to the lowest, 0.125mg/kg, nicotine 
dose tested (all p<0.05). Comparisons between groups across doses moreover revealed that 
nicotine group animals perforined No-go trials significantly poorer than the saline treatment 
group at 0.25mg/kg dose (t = 6.754, df = 17, p=0.010), whilst differences in perfon-nance at the 
0.5mg/kg doses just missed significance (t = 1.740, df = 17, p=0.049). 
Total % Correct Trials 
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Fig. 5.6 (b) 













Fii!. 5.6 (c) 
Fh!. 5.6 (a-0: Accuracy of Responding: the effects of acute nicotine administration on percentage correct Total 
trials (a), Go trials (b) and No-go trials (c). Each bar represents the mean percentage correct trials ± SEM. *, 
p<0.05, **, p<0.01, ***, p<O. 001 (Bonferroni comparison) as compared to saline control. f, p<0.05, tt, p<0.01, 
ttt, p<0.001 (Bonferroni comparison) as compared to highest 0.5 mg/kg §, p<0.05, §§, p<0.01, §§§, p<0.001 
(Bonferroni comparison) as compared to 0.25 mg/kg nicotine dose. 
5.3.2.3. Anticipatory Responding 
Figs 5.7 (a-d) illustrate the frequency of anticipatory responding across the dose range tested. 
Assessment of early responses demonstrated a significant main effect of dose for this 
anticipatory measure during both Go and No-go trials (all F(3,51) >- 2.704, p<0.05). During Go 
trials early responses increased significantly at the 0.125mg/kg dose in comparison to saline 
treatment (p<0.05). Post hoc analysis of early responses during No-go trials however, indicated 
no significant differences between doses. No significant main effect of treatment group was 
observed on early responses during both Go and No-go trials (all F(1,17) < 1.687, N. S. ), 
although dose x treatment group interactions just failed to reach significance (all F(3,51) < 
2.464, p>0.052. ). As shown in Fig. 5.7 (a-b), in contrast to nicotine nafve animals those 
previously treated with nicotine displayed a trend of a greater increase in the frequency of early 
responding following acute treatment. 
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Acute nicotine failed to affect the frequency of inappropriate magazine entries during the 
stimulus presentation of both Go and No-go trials (all F(3,51) < 1.104, N. S. ). This lack of effect 
was furthermore consistent across treatment groups, with both between group (all F(1,17) <_ 
0.935, N. S. ) and dose x group interactions failing to reach significance (all F(3,51) < 0.669, 
N. S. ) (see Fig. 5.7 (c-d)). 
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Fie. 5.7 (d) 
Fi2.5.7 (a-d): Anticipatory Responding: the effects of acute nicotine on early responses during Go trials (a) 
and No-go trials (b). Anticipatory Responding: the effects of acute nicotine on inappropriate magazine entries 
during Go trials (c) and No-go trials (d). Each bar represents the mean number of trials :b SE. * p<0.015, 
(Bonferroni comparison) main effect of treatment dose, its compared to saline control. 
5.3.2.4. Speed of Responding 
Figs. 5.8 (a-d) illustrate the effect of acute nicotine challenges on measures of speed of 
responding. No significant main effect of dose was observed on correct or incorrect response 
latency (all F(3,51) < 2.333, N. S. ). Response latency during both trials was furthermore similar 
across groups with a lack significant main effect of group (all F(l, 17) <- 0.369, N. S. ) and dose x 
group interactions found (all F(3,5 1) < 0.317, N. S. ). 
Acute nicotine significantly increased Go trial magazine latencies in a dose related manner 
(F(3,51) = 16.110, p<0.001), reaching significance at 0.25 and 0.5mg/kg doses in comparison 
to the control treatment (all p<0.05). The slower latencies to collect reward at these doses 
differed significantly from the lowest 0.125mg/kg nicotine dose (all p<0.001). However, no 
evidence of differences between treatment groups in response to acute nicotine on this measure 
were demonstrated, with a non-significant between group and dose x group interaction 
displayed (F(1,17) = 0.001, N. S.; F(3,51) = 1.114, N. S., respectively). Analysis of latencies to 
collect the reward during No-go trials additionally revealed a significant main effect of 
treatment dose (F(3,51) = 4.806, p=0.005), although post hoc analysis revealed no significant 
differences between nicotine doses and saline treatment. Instead the main effect highlighted the 
significantly slower latency to collect reward during No-go trials at the highest 0.5mg/kg dose 
in comparison to the lowest 0.125mg/kg treatment dose (p <0.05). Once more a lack of 
difference between treatment groups was shown in response to nicotine, as evident by the non- 
significant between group and dose x group interaction found (F(l, 17) = 2.119, N. S.; F(3,5 I) 
1.583, N. S., respectively). 
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H2.5.8 (d) 
Fig. 5.8 (a-d): Speed of Responding: the effects of acute nicotine administration on latency in seconds to 
respond correctly during Go trials (a) and incorrectly during No-go trials (b). Speed of Responding: the effects 
of acute nicotine administration on latency in seconds to collect reward following correct Go trials (c) and No- 
go Trials (d). Each point represents the mean latency in seconds ± SE. p<0.05, **, p<0.01, ***, p<0.001 
(Bonferroni comparison) main effect of treatment dose, as compared to saline control. t, p<0.05, tt, p<0.01, 
ttt, p<0.001 (Bonferroni comparison) main effect of treatment dose, as compared to highest 0.5 mg/kg §, 
p<0.05, §§, p<0.01, §§§, p<0.001 (Bonferroni comparison) main effect of treatment dose, as compared to 0.25 
mg/kg nicotine dose. 
5.4. DISCUSSION 
A strong association between nicotine dependence and behavioural disinhibition has been 
demonstrated in the literature (Spinella, 2002; Yakir et al., 2007); the causality of this 
relationship however remains to be fully determined. The studies of this chapter were the first of 
preclinical research to longitudinally examine the relationship between nicotine and behavioural 
disinhibition in a paradigm primarily adopted to assess inhibitory control, the symmetrically 
reinforced go/no-go task. The main findings were: (1) chronic nicotine treatment was associated 
with a substantial loss of inhibitory control, (2) cessation of chronic nicotine treatment led to a 
spontaneous nicotine abstinence syndrome during which a short lived rebound increase in 
inhibitory control was observed, (3) long term withdrawal was associated with heightened 
behavioural disinhibition and (4) despite nicotine induced effects on inhibitory control 
diminishing 21 days following termination of treatment, subjects remained hypersensitive to 
nicotine's effects on impulsivity. Each of these findings will be discussed in detail in the 
following sections. 
5.4.1. Chronic Effects of Nicotine on Behavioural Disinhibition 
Investigation of the effects of chronic nicotine treatment in Experiment 3 demonstrated marked 
deficits in overall performance on the go/no-go task in comparison to saline treated animals. 
The impairments in accuracy were restricted to performance on No-go trials providing strong 
support that chronic exposure to nicotine led to a dysfunction in inhibitory control. The 
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behavioural profile of nicotine treated animals further differed from the control group in that an 
enhanced frequency of early responding during Go trials was additionally observed. Nicotine 
treated animals also responded correctly during Go trials significantly faster than control 
subjects. Taken together, the observed behavioural changes during the chronic exposure to 
nicotine are indicative of reduced inhibitory control (Fletcher, 1993; Harrison et al., 1999). 
The impulsive profile observed is not only in agreement with the effects of repeated nicotine 
treatment on premature responding and response latencies in the 5CSRTT (Blondel et al., 2000), 
but also supports the increase in behavioural disinhibition following chronic treatment of other 
psychostimulants such as cocaine (Jentsh et al., 2002). 1 lowever, in contradiction to the findings 
of Blondel and colleagues, the effects of repeated nicotine treatment on inhibitory control did 
not increase with repeated administration. Conversely, the greatest impact of treatment was 
demonstrated during the first three days of chronic nicotine treatment (see Fig. 5.1 (a) and (c)). 
Although a significant treatment x day interaction was not observed, clearly present was a 
transient strengthening of inhibitory control during No-go trials during the final days of 
treatment, suggesting that the initial effect of nicotine on impulsivity recovered over testing. 
This pattern of effect is most likely due to the development of tolerance to nicotine. If tolerance 
does explain the observed transient effect of nicotine on impulsivity then animals only 
examined at the end of a comparable drug regime should display no differences in impulsive 
responding. Indeed adopting the precise nicotine dosing regime as in the present study, Shoaib 
and Bizarro, (2005) reported no differences in anticipatory responding in the 5CSRTT between 
saline and nicotine treated animals on the final V' day of osmotic pump implantation. 
The elicitation of tolerance to nicotine actions during chronic or repeated drug exposure is not 
an uncommon finding, and has been observed across a range of behaviours in both laboratory 
animals (Stolerman, 1999; DiChiara, 2000) and human smokers (Perkins, 2002). These can 
include tolerance to nicotine's effects on nausea (e. g. Pomerlau 1995), locomotor depression 
(Clarke and Kumar, 1983), analgesia (Mousa, Aloyo, and Van Loon, 1988; Cepeda-Benito et 
al., 2006), brain reward threshold (e. g. Harrison et al., 2001) and drug discrimination (e. g. 
James et al., 1994; Robinson et al., 2007). Nicotine tolerance has been attributed to the nAChR 
desensitisation or inactivation observed during chronic exposure to the drug (Wonnacott, 1990; 
Marks et al., 1992; Littleton, 2001). Initially nicotine stimulates the nAChR leading to its 
activation but it is then followed by a rapid desensitisation during which the inactivated receptor 
fails to respond nicotine (Corringer et al., 1998; Quick and Lester, 2002). The period of 
inactivation becomes greater with longer term drug exposure (Mansvelder, Keath and McGhee, 
2002) leading to the up-regulation of nAChRs and basis for nicotine tolerance (Collins et al., 
1990; Wonnacott, 1990; Littleton, 2001). Interestingly, the subunits that have been found to 
desensitise most rapidly are the a402 and a7 receptors, subunits, which also display the longest 
176 
Chapter 5- Nicotine Dependence and Behavioural Disinhibition 
duration of inactivation and greatest up-regulation during chronic nicotine exposure (Olale et 
al., 1997; Quick and Lester, 2002; Nguyen, Ramussen and Perry, 2003). As discussed in 
Chapter 4, both these nicotinic receptor subunits have been implicated in the mediation of 
nicotine-induced disinhibition, as measured by the 5CSRTT (Blondel et al., 2000; Grottick and 
Higgins, 2000; Keller et al., 2005; Hoyle et al., 2006). As clear demonstration has been made 
that nicotine mediates its effects on disinhibition in the go/no-go task via central nAChR (see 
Chapter 4), it is therefore possible that the up-regulation of these receptors may underlie the 
developed tolerance to nicotine's initial impact on impulsivity in the present study. 
Why therefore did Blondel and et al. (2000) demonstrate a contrasting sensitisation to the 
effects of nicotine on impulsive responding? The most likely explanation for the discrepancy 
lies in the varying patterns of nicotine dosing adopted across studies. Tolerance to nicotine's 
effects is most readily observed when the drug is administered repeatedly in close succession, a 
drug regime that was conducted in the present study and that is more comparable to the pattern 
of drug use shown by dependent smokers (e. g. Post, 1980; Benwell, Balfour and Birrek, 1995). 
In contrast, sensitisation to nicotine is more likely to manifest following intermittent dosing 
(DiFranza and Wellman, 2007), a pattern of nicotine dosing adopted by Blondel et al., (2000). 
As discussed previously in Chapter 4 (section 4.4), nicotine induced disinhibition cannot be 
easily accounted for by alternative explanations such as impairments in conditional 
discrimination, working memory, attention and timing ability (e. g. Terry et al., 1996; Levin et 
al., 1998; Mirza and Stolerman, 1998; Decamp and Schneider, 2006; Rusted and Trawley, 2006; 
Spinelli et al., 2006; Day et al., 2007). Furthermore, increased intolerance to delayed reward is 
unlikely to account for the observed inability to withhold responding during No-go trials, as a 
reduction in incorrect response latency was not shown during the chronic treatment of nicotine 
(Harrison et al., 1999). 
As with the effects of acute nicotine on performance in the task, the impulsive responding 
observed is also unlikely to have been mediated by nicotine's anorectic effects (McNair and 
Bryson, 1983; Grunberg et al., 1986; Levin et al., 1987; Blaha et al., 1998; Miyata et al., 1999; 
Zhang et al., 2001). Firstly, if nicotine's anorectic effects affected performance in the task then 
it would be expected that latency to collect reward in the task would increase (Bolles, 1965), 
this was not the case. Secondly, reducing motivation for reward in the preliminary research of 
Chapter 3 had no effects on task behaviour. 
The loss of inhibitory control during chronic drug treatment could have arisen as a secondary 
effect of nicotine's ability to induce hyperactivity following repeated drug exposure (e. g. Clarke 
and Kumar, 1983). Although the decrease in response latency that was observed during 
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treatment could be indicative of hyperactivity, the effect was restricted to Go trial response 
latencies. If indeed the observed loss of inhibitory control was a consequence of nicotine 
increased motor activity, then rather than being explicitly associated to the correct responding 
during Go trials it would be expected that a reduction in latency would extend to all speed of 
responding parameters in the task. 
It therefore appears, that most likely, chronic nicotine led to a genuine impairment in inhibitory 
control and suggests that the heightened impulsivity observed in smokers is a consequence of 
chronic nicotine use (Spinella, 2002; Yakir et al., 2007). Based on the present findings smokers 
may however become rapidly tolerant to the nicotine-induced effects on impulsivity, possibly 
accounting for the lack of reported effects of acute nicotine on behaviouml disinhibition in 
current smokers (Bekker et al., 2005a). As the greatest effects of nicotine on disinhibition 
appear to be during the initial period of drug treatment it may be the case that a loss of 
inhibitory control may be a key component during the early stages of addiction (Jentsch and 
Taylor, 1999; Goldstein and Volkow, 2002; Lubman et al., 2004). Nicotine intake during this 
stage may lead to the loss of control over drug seeking and taking behaviour leading to the 
continued maintenance of drug use. 
The potential neurobiological mechanisms that may be mediating the effects of nicotine on 
impulsivity have been proposed in detail previously in Chapter 4. Most likely to be involved is 
the stimulated release of DA and 5-11T in regions associated with inhibitory control, including 
the VTA and its associated projections (Di Chiara and Imperato, 1988; Benwell and Balfour, 
1992; Ribeiro et al., 1993; Nisell et al., 1996; Harrison et al., 1999; van Gaalen et al., 2006; 
Pattij et al., 2007; Picton et al., 2007). However, it is important to consider that chronic nicotine 
exposure has been associated with a decline of DA release within the regions of the VTA and 
the NAc shell (Ramussen and Czachura, 1995; Cardoni and Di Chiara, 2000), believed in part to 
be mediated by the inactivation and up-regulation of nicotinic receptors (Watkins, Koob and 
Markou, 2000a). Evidence suggests that DA receptor stimulation is crucial for the effects of 
nicotine induced disihibition (van Gaalen et al., 2006); therefore it is possible that the observed 
tolerance to nicotine's effects may have been the result of the desensitisation of receptors at the 
molecular level and resultant decline in synaptic DA release. 
5.4.2. Effects of Initial Nicotine Withdrawal on Behavioural Disinhibition 
The cessation of chronic nicotine treatment gave rise to spontaneous nicotine withdrawal, 
supported by the significant elevation of somatic signs. Overall somatic symptoms peaked at 24 
hours post pump removal and remained significantly elevated (with the exception of 60.5), for 
84.5 hours following termination of treatment (see Fig. 5.4). Teeth chattering and chews were 
the earliest symptom to manifest, arising significantly in comparison to the control group as 
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early as 6 hours following cessation of treatment. 'Me most frequently observed signs were 
scratches and foot licks, incorporated here within the miscellaneous category. During this period 
chronically saline treated animals, in contrast, demonstrated no evidence of an elevation of 
somatic signs. Consistent with previous research, the results therefore confirm that a nicotine 
abstinence syndrome is precipitated following the termination of chronic nicotine treatment 
(Malin et al., 1992; Hildebrand et al., 1997; 1999; Epping-Jordan et al, 1998; Watkins et al., 
2000a; Harrison et al., 2001). Based upon aggregated behavioural signs the time course of the 
withdrawal syndrome was comparable to that of Harrison et al. (200 1), however was longer than 
that reported by other previous research despite comparable nicotine regimen across studies 
(Malin et al., 1992; Hildebrand et al., 1997; 1999; Epping-Jordan et al, 1998). Furthermore, 
whilst the withdrawal syndrome in the current study was characterised most greatly by a 
significant increase in scratches and foot licks, the prominent somatic symptoms reported 
previously were conversely gasps, writhes and ptosis (Hildebrand et al., 1997; 1999; Epping- 
Jordan et al, 1998; Malin et al., 1992). This discrepancy could possibly be due to differences in 
rat strain adopted across studies, which may give rise to varying somatic symptomatology. 
During the early stages of nicotine deprivation overall performance in the task was significantly 
higher than that of the saline treatment group. This was attributed to a greater ability to withhold 
responding during No-go trials whilst active responding during Go trials remained comparable 
to control subjects. These findings indicate that in direct contrast to chronic drug effects, early 
stages of nicotine withdrawal is associated with an increase in inhibitory control, an effect 
which is at its maximum at 12 and 60 hours post cessation of drug administration. Nicotine 
withdrawal had no significant effect on anticipatory measures or speed of responding in the 
task. Although evidence of an increase in the latency to collect the reward during Go trials was 
observed, statistical analysis failed to locate significant differences between groups across test 
sessions. These findings are in agreement with recent reports of the effects of both spontaneous 
and DHPE precipitated nicotine withdrawal in nicotine dependent animals in the 5CSRTT 
(Shoiab and Bizarro, 2005). Adopting a comparable drug regime as in the present study, 
spontaneous and precipitated nicotine withdrawal led to a significant reduction in anticipatory 
impulsive responding in comparison to saline treated animals, the effect however was more 
pronounced following DHPE precipitated withdrawal (Shoiab and Bizarro, 2005). 
The findings of the present research however appear to be in direct opposition to the reported 
heightened impulsive responding on the CPT in smokers following both 24 hour (Ilatsukami et 
al., 1989) and overnight abstinence (Dawkins et al., 2007) relative to when nicotine satiated. 
The version of the CPT adopted in this research could however be argued to be a more 
cognitively demanding paradigm than the present go/no-go task, possibly accounting for the 
discrepancy in findings. For example the CPT adopted by Dawkins et al., (2007) depended 
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heavily on attention and working memory, requiring participants to attend to the presentation of 
a series of five-digit sequences and to respond when a sequence was identical to the former. 
Smoking abstinence is associated with deficits in cognitive processing including both attention 
and working memory (e. g. Al-Adawi and Powell, 1997; Morris 1999; Mendrek et al., 2006). 
Impairments can arise as early 4h following cessation and peak at 12-48 hours of withdrawal 
(Snyder et al., 1989), making it possible that the impaired inhibitory control on the CPT may 
have been a secondary effect of nicotine deprivation on cognitive processing within the task. 
The contrasting increase in inhibitory control relative to the reduced levels observed during 
chronic nicotine treatment is however consistent with the rebound syndrome of nicotine 
withdrawal, which is characterised by both behavioural and affective symptoms that are often in 
direct contrast to the effects of chronic exposure (Watkins et al., 2000b; Koob and Le Moal, 
2001; Hughes, 2007a). For example nicotine produces pleasurable reinforcing effects, a 
reduction in anxiety, decrease in appetite and positive effects on cognition (e. g. Pomerlau and 
Pomerlau, 1992; Stolerman and Jarvis, 1995; Heishman, 2002) Nicotine withdrawal in contrast 
can be associated with depressed mood, anxiety, increased appetite and deficits in cognition 
(Hughes et al., 1991; Heishman, 2002; Hughes, 2007b). The present research findings suggest 
that the characteristic rebound syndrome of nicotine withdrawal may also extend to incorporate 
nicotine's effects on inhibitory control. When considering the possible processes that may 
govern this short lived decrease in impulsivity, it is'unlikely that an increase in appetite 
following termination of nicotine is mediating the effect (Grunberg et al., 1986; 1987; Miyata et 
al., 1999). Experiment IC revealed no effects on accuracy of responding in the task following 
an increase in primary motivation (Bizarro and Stolerman, 2003). Furthermore, no evidence of a 
decrease in response latency or latency to collect food was observed; conversely indication of a 
slowing in collection of reward was shown during Go trials. 
It is further unlikely that deficits in attention during nicotine withdrawal, an effect replicated in 
the animal literature, can account for the findings (Shoiab and Bizarro, 2005). If indeed 
attentional processes do play an important role in accuracy of performance in the go/no-go task 
then it would be predicted that a decrease in accuracy in the model should be displayed during 
drug deprivation. Animals experiencing nicotine withdrawal in the present research in contrast 
displayed an increase in accuracy of responding in the task. 
An alternative process that may be mediating the increase in inhibitory control is related to the 
affective symptoms of nicotine withdrawal, in particular depression (Gilbert 1998; Baker et al., 
2004). One of the key symptoms of depression is anhedonia, or "diminished sensitivity to 
reward" (DSM IV; Markou et al., 1998). Following the ten-nination of identical chronic drug 
regimes that were adopted in the present research, changes in affective state have been reliably 
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shown in an animal model of withdrawal utilising intracranial self stimulation methodology 
(Epping-Jordan et al., 1998; Watkins et al., 2000b; Harrsion et al., 2001; Cryan et al., 2003). 
The manifestation of this symptom during withdrawal could have led to a reduction of the value 
of the food reward. This effect could have, in turn, decreased the motivation to earn the reward, 
thus increasing passivity in the task. Such passiveness in the current paradigm would favour 
performance during No-go trials, which requires animals to withhold responding. Based on the 
theory, it would also be predicted that diminished motivation for reward would additionally 
reduce active responding during Go trials and slow the speed of responding in the task. No 
differences in performance between treatment groups were however observed during Go trials, 
although it could be argued that with extensive testing active responding during these trials may 
have become a highly conditioned possibly habitual response and therefore less sensitive to 
changes in affective state. With the exception of latency to collect reward during Go trials, no 
evidence of alterations in speed of responding in the task were observed during nicotine 
deprivation. The increase magazine latency demonstrated during Go trials is an arguable 
indication of a reduction in motivation, however statistically the difference between treatment 
groups failed to reach significance. Although at this stage it cannot be dismissed that alterations 
in sensitivity to reward may play a role in mediating the improved accuracy during No-go trials, 
the lack of significant evidence of the influence of anhedonia on other variables within the task 
provides a strong argument against this possibility. Thus, it is highly likely that an improvement 
in inhibitory control, rather than diminished sensitivity to reward, is responsible for the greater 
ability to withhold responding on No-go trials during initial nicotine withdrawal. 
Indication that early stages of nicotine deprivation are associated with a rebound increase in 
inhibitory control suggests that this subcomponent of impulsivity may not be involved in 
smoking relapse during the initial few days of nicotine withdrawal. Instead relief from aversive 
symptoms of withdrawal, which are at their greatest during the first week post termination of 
nicotine abuse, may play more of a crucial role in predicting relapse at this stage (Koob and 
LeMoal, 2001; Hughes 2007b). 
Although the present study is unable to distinguish the neurobiological processes underlying the 
increase in inhibitory control during early withdrawal, understanding of the neurobiological 
theories of nicotine withdrawal may provide insight into the possible mechanisms involved. As 
previously discussed, at the molecular level one of the neural adaptations that take place during 
chronic nicotine exposure is the up-regulation of nicotinic receptors (Littleton et al., 2000; 
Kenny and Markou, 2001). When nicotine exposure ceases however these excess receptors 
remain unopposed and begin to recover from descnsitisation; a process argued to perhaps 
mediate the symptoms of withdrawal (Watkins et al., 2000a; Kenny and Markou, 2001). The 
precise 
biological 
mechanisms of how this would occur still remain unclear, however strong 
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evidence has suggested that the downstream effect of nicotine abstinence is reduced DA release. 
Cessation of both the chronic treatment and self administration of nicotine in rodent models of 
withdrawal have been associated with a decrease in DA release in both the mesolimbic system 
and NAc, believed to mediate somatic and affective symptornatology respectively (Fung et al., 
1996; Hildebrand et al., 1999; Watkins et al., 2000; Koob and Le Moal, 2001; Rahman et al., 
2004). The findings that blockade of DI and D2 receptors is capable of decreasing premature 
disinibited responding in both the 5CSRTT (Harrison et al., 1997; Koskinen and Sirvio, 2000; 
Hahn et al., 2002; Shoaib and Bizarro, 2005; van Gaalen et al., 2006) and FCN (Liao and 
Cheng, 2000) provides potential evidence that alterations in this particular neurochemical 
system during withdrawal may modulate the increase in inhibitory control. This is further 
supported by the fact that the NAc has been implicated as an important brain structure that may 
modulate impulsive control (Reading and Dunnett, 1995; Christakou et al., 2004; Pothuizen et 
al., 2005). Interestingly, the most substantial decrease in DA neuronal firing in the VTA (which 
projects to the NAc) is suggested to appear in the first 2 days following cessation of nicotine 
treatment (Liu and Jin, 2004), a time period during which inhibitory control was at its greatest in 
the present research. 
Whilst a reduction in DA release is one of the most dominant neurobiological theories of 
nicotine withdrawal, alterations in other systems may additionally play a role in the mediation 
of a decrease in impulsivity. For example, decreased serotonergic and glutamate functioning 
have additionally been implicated in nicotine withdrawal (Watkins et al. 2000a; Harrison et al, 
2001; Kenny and Markou, 2004). Although it is currently unknown what role glutamate may 
play in modulating inhibitory control, as previously discussed extensive evidence has implicated 
serotonergic systems in the neurobiology of impulsive behaviour (Linnola, 1983; Soubrie, 1986; 
Harrison et al., 2001), suggesting strongly the potential involvement of this system in the 
observed alterations in impulsivity during the initial stages of drug deprivation. 
5.4.3. Effects of Long Term Nicotine Withdrawal on Behavioural Disinhibition 
By the second week of nicotine withdrawal the observed enhancement in inhibitory control had 
diminished and overall accuracy had returned to levels of that performed by the saline treatment 
group. Examination of independent performance during Go and No-go trials finilicrinore 
supported a lack of significant difference between treatment groups during this stage. However, 
as clearly shown in Fig. 5.1 (c) from day 9 post termination of treatment, animals chronically 
treated with nicotine demonstrated an increasing deficit in accuracy of performance ' 
during no- 
Go trials. Whilst premature early responding did not differ between groups, inappropriate 
magazine entries were significantly enhanced during both Go and No-go trials in animals 
experiencing withdrawal. No group differences were indicated on speed of responding 
parameters during this stage of nicotine withdrawal. 
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During the third week of withdrawal overall accuracy of performance remained comparable 
across groups. This lack of difference between groups was mirrored by the performance during 
Go trials. In contrast however, the increasing deficit in performance during No-go trials that 
began in week two of withdrawal continued and reached statistical significance on day 17, 
whilst just missing significance on day 15 of withdrawal (see Fig. 5.1 (c)). As clearly shown in 
Fig. 5.1 (a-c), this deficit in inhibitory control recovered and the accuracy of responding in 
chronically nicotine treated animals were indistinguishable from the saline group by the 18'h day 
post termination of treatment. No group differences were indicated during this stage on 
anticipatory or speed of responding measures in the task. 
Taken together these findings indicate that longer term nicotine withdrawal is associated with an 
increasing deficit in inhibitory control, supported firstly by the enhanced anticipatory 
responding in week two of nicotine withdrawal and the inability to withhold responding during 
No-go trials at the early stages of week three of nicotine abstinence. Based on these findings it 
may be predicated that smoking relapse after cessation may be most prevalent during this time 
due to an enhanced inability to control drug seeking and taking behaviour. Interestingly, 
smoking relapse is often rapid with estimates suggesting that 75% of smokers relapse within the 
first two weeks of abstinence, a time period that according to the present research is associated 
with impairments in inhibitory control (Garvey et al., 1992; Hughes et al., 1992; Kenford et al., 
1994; Law and Tang, 1995). With recent evidence additionally suggesting that greater levels of 
impulsivity can significantly predict relapse to smoking, these findings provide strong support 
that the heightened disinhibition observed may play a key role in mediating drug relapse during 
this stage of withdrawal (Doran et al., 2004; Krishnan-Sarin et al., 2007). Pharmacological and 
behavioural treatment interventions that target strengthening inhibitory control during this stage 
of abstinence may therefore prove to be an effective future intervention to aid smoking 
cessation. 
Due to minimal research assessing the time course of chronic nicotine induced neuroadaptations 
during long term withdrawal, it is difficult to determine at this stage the ncurobiological 
processes that may be modulating this heightened impulsivity. It has been demonstrated that' 
following 12 days of repeated nicotine treatment VTA dopamine neuronal activity, although 
depressed during initial withdrawal, return to baseline levels by 10 days post termination of 
treatment suggesting that this particular neurobiological system may be playing a minimal role 
(Ramussen and Czachura, 1986; Liu and Yin, 2004). The continued dopaminergic activation of 
prefrontal pathways by chronic stimulants has however been argued to lead to longer lasting 
abnormalities in areas of the PFC, a brain region believed critically involved in the functioning 
of inhibitory control (e. g. Volkow et al., 1996; Goldstein and Volkow, 2002; Aron et al., 2004). 
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In human smokers recent research has demonstrated that chronic smoking, as with other drugs 
of abuse such as cocaine and methamphetamine, is associated with reduced gray matter volumes 
and densities in frontal brain areas including the ACC and occipital cortex relative to non- 
smokers (Brody et al., 2004). Long term abstinence is furthermore associated with significant 
hypoactivation, in the PFC in particular the orbitofrontal cortical areas (Neuhaus et al., 2006). If 
the neuroanatomical abnormalities within these regions do indeed reflect damage owing to long 
term exposure to nicotine, rather than some pre-existing condition, then this may indicate 
potential dysfunctional systems that may be modulating the heightened impulsivity during 
longer term withdrawal. In support of this theory only a brief exposure to nicotine has been 
shown to elicit neuritic damage in rodents (e. g. Xu et al., 2001; Abreu-Villaca et al., 2003). 
Alterations in serotonergic activity associated with chronic nicotine exposure must also be 
considered as a possibly neurochernical modulator involved in the expression of disinhibited 
behaviour at this stage of withdrawal. Attenuated 5-HT levels have been demonstrated in 
regions of the limbic system (Olausson et al., 2001), hippocampus (Benwell and Balfour, 1982) 
and frontal cortex (Kirch et al., 1987) following repeated treatment with nicotine. The 
relationship between serotonergic functioning and impulsivity is complex. However, the inverse 
relationship between serotonergic functioning and impulsive behaviour is a neurobiological 
theory that has received support in models of inhibitory control, including the go/no-go task, 
thus making it a prime neurobiological candidate that may be mediating the relationship 
between long term nicotine withdrawal and impulsivity (Fletcher, 1993; Harrison et al., 1999). 
As neurobiological processes were not assessed in the present research, the proposed neural 
adaptations that may underlie the observed disinhibited behaviour remain highly speculative. 
What the present research can elucidate however is that regardless of the neuroadaptations 
involved they appear to be a temporary effect, at least in terms of level of impulsivity expressed 
at baseline (see below). As clearly demonstrated performance across all parameters in the go/no- 
go task by 18 days post termination of treatment had returned to comparable levels of control 
group. Until now research has been unable to determine the relative permanence of any drug 
induced changes in impulsivity. Yakir et al. (2007) for example demonstrated that ex-smokers 
who had remained abstinent for a six month period displayed a level of inhibitory control on the 
CPT that was intermediate between current and never smokers. Ilese findings could firstly 
suggest that the intermediary levels of inhibitory control in ex-smokers is a result of reversible 
nicotine induced changes on impulsive behaviour. At six months following termination of 
smoking however self control has yet to return fully to levels of never smokers. Conversely, the 
greater control over behaviour observed in ex-smokers could have been a trait that has enabled 
these individuals to successfully abstain. The present findings provide support for the former of 
these interpretations, with clear demonstration that nicotine induced increases in impulsivity 
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observed at baseline is a temporary cffect. 
5.4.4. Effects of Acute Nicotine Challenges on Behavioural Disinhibition in Animals 
Previously Exposed to Chronic Nicotine 
Twenty one days following the termination of drug treatment the dose response to acute nicotine 
was compared across groups in order to determine whether changes in responsivity to nicotine's 
effects on impulsivity had developed following chronic treatment of the stimulant. Animals 
previously exposed to chronic nicotine displayed a significantly more profound impairment in 
overall accuracy of responding following acute nicotine administration in comparison to 
nicotine naive animals. Animals chronically treated with nicotine demonstrated a significant 
reduction in accuracy of performance across all doses tested relative to the control dose. 
Conversely, nicotine naive animals displayed a significant reduction only at the highest 
0.5mg/kg dose tested in comparison to saline control. Furthermore, the chronic nicotine 
treatment group performed significantly poorer than the saline treatment group following acute 
treatment of the 0.25mglkg dose. Independent analysis of Go trials revealed that performance 
during these trials remained unchanged following treatment. Although a significant group x 
dose interaction was indicated on this measure, further statistical analysis revealed that no 
significant differences between treatment groups were observed on accuracy of Go trial 
performance following acute drug treatment. Ile impaired overall accuracy of performance in 
the golno-go task displayed by both treatment groups was instead clearly as a result of the 
inability to correctly withhold responding during No-go trials. Once again, the effect was more 
substantial in animals previously treated with nicotine. Acute nicotine dose dependently reduced 
accuracy during No-go trials in this group of animals. In nicotine naive animals impaired 
performance was in contrast only observed at the highest 0.5mg/kg dose tested. Comparison of 
group performance at individual doses ftirthermore indicated that animals previously exposed to 
nicotine exhibited a greater inability to withhold responding following the 0.25mg/kg dose in 
comparison to nicotine naive animals whilst differences in responding following the 0.5mg/kg 
dose just missed significance. 
Previous nicotine exposure did not however differentially affect the response to acute nicotine 
on anticipatory responding measures in the task. The effect of acute nicotine challenges was 
similar in both groups. Early responding during Go trials was found to be significantly enhanced 
following acute treatment of 0.125mg/kg nicotine dose. Early responding during No-go trials 
and inappropriate magazine entries did not differ from that of anticipatory responding following 
control treatment. The cffect of acute nicotine on speed responding was furthermore comparable 
across treatment groups. Both correct and incorrect response latencies remained unchanged 
following acute trcatment. Conversely, latencies to collect the reward following Go trials 
significantly increased following treatment of 0.25 and 0.5mg/kg doses of nicotine. Although a 
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slowing in latency to collect reward was additionally observed during No-go trials, differences 
across doses only reached significance between the highest 0.5mg/kg dose and lowest 
0.1 25mg/kg dose tested. 
Taken together these findings demonstrate that both treatment groups demonstrated evidence of 
acute nicotine induced disinhibition. In nicotine naTive animals the effect on accuracy of 
responding was flirthermore in a manner that directly replicated the findings of Experiment 2A. 
In contrast, in animals with previous nicotine exposure the observed nicotine induced loss of 
inhibitory control was a substantially more profound effect, providing strong evidence that 
chronic nicotine treatment can induce sensitisation to the effects of nicotine on behavioural 
disinhibition, an effect still present three weeks following the termination of drug treatment. 
Tle present research is the first to establish that chronic nicotine can render subjects 
hypersensitive to nicotine's effects on bchavioural disinhibition after period of sustained 
abstinence in a validated model of impulsivity. Research has previously demonstrated potential 
evidence of the sensitisation of the effects of nicotine on anticipatory responding in the 
5CSRTT, with repeated nicotine administration leading to an increasing effect on impulsive 
responding (Grottick and Higgins, 2001; 2000; Day et al., 2007). A decrease in reaction time 
was however additionally observed in the majority of past research (e. g. Grottick and Higgins, 
2000; 2001), making it difficult to dissociate the observed effects from that of nicotine induced 
hyperactivity that is additionally associated with repeated intermittent nicotine exposure (e. g. 
Clarke and Kumar, 1983). 
Although behavioural sensitisation to nicotine can manifest as an increase in locomotor activity 
(Clarke and Kumar, 1983; Chaudhry, Turanis and Karler, 1988; Pierce and Kalivas, 1997), it is 
highly unlikely that the enhanced nicotine induced deficits in inhibitory control following 
chronic nicotine treatment in the present research are secondary to locomotor effects. A vital 
argument against this explanation is that acute nicotine in the task did not influence response 
latencies during both Go and No-go trials in either treatment group. Furthermore, the speed at 
which food rewards were collected displayed evidence of a sloning in latency, providing strong 
support for the notion that in the current study a dissociation can be made between nicotine 
sensitised disinhibition and psychostimulant induced hyperactivity. 
Demonstration that latencies to collect reward daring Go trials were significantly increased at 
the highest doses may be indicative of nicotine's established anorectic effects (McNair and 
Bryson, 1983; Grunberg et al., 1986; Levin et al., 1987; Blaha et al., 1998; Miyata et al., 1999; 
Zhangetal., 2001). It is unlikely however that alteration in primary motivation can account for 
the more substantial loss of inhibitory control displayed by animals with previous nicotine 
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exposure. Firstly, the increase in latency to collect reward following nicotine was an effect 
observed in both treatment groups. Furthermore, in Chapter 3 of this thesis decreasing 
motivation for reward through prefeeding was demonstrated to have minimal impact on 
inhibitory control in the go/no-go tasL Although previous research has indicated potential 
evidence of an impact of pre-feeding on impulsive responding in paradigms such as the 
5CSRTr, findings have demonstrated an effect opposite to that observed in the present study, 
where a decrease in impulsive responding was observed (Carli and Samanin, 1992; Harrison et 
al., 1997; Grottick and Higgins, 2000; Grottick and Higgins, 2002; Bizarro and Stolerman, 
2003). 
The increased magnitude of the effect of nicotine in animals with previous nicotine exposure 
appears therefore to reflect evidence of a genuine sensitisation to nicotine's effects on 
behavioural disinhibition. Behavioural sensitisation to drugs of abuse has long been argued by 
researchers to be greatly involved in drug seeking and taking behaviour (Robinson and 
Berridge, 1993). More specifically, the process is hypothesised to mediate the transformation 
for wanting the drug into craving for the drug. Traditionally behavioural sensitisation in animals 
has been argued to manifest as an increase in locomotor activity (Clarke and Kumar, 1983; 
Chaudhry, Turanis and Karler, 1988; Pierce and Kalivas, 1997). The present findings have 
however indicated that behavioural sensitisation to nicotine can additionaHy be reflected as 
enhanced behavioural disinhibition, supporting further the importance of a loss of control over 
behaviour as a key component of addiction (Jentsh and Taylor, 1999; Goldstein and Volkow, 
2002; Luban et al., 2004). 
According to the current study sensitisation to the effects of nicotine on inhibitory control were 
still present at 5 weeks following termination of treatment, a period likely to be equivalent to 
many years in a human smoker's lifespan. Whether effects can persist for a greater period is an 
avenue for future research, however it has been demonstrated that nicotine sensitised locomotor 
effects can persist unchanged for up to a month following termination of drug exposure (Miller 
et al., 2001; 2003), with one study reporting observed effects at 75 days post termination of 
treatment (Villegier et al., 2003). 'ne persistence of the increased rcsponsivity to nicotine's 
effects on disinhibition provides strong support that a loss of inhibitory control may be a key 
mechanism underlying smoking relapse (Robinson and Berridge, 2000; DeFranza and Wellman, 
2005). Ile findings suggest that an abstaining smoker that is exposed to even low levels of 
nicotine is at a substantial risk of relapsing due to the profound effect of nicotine on the loss of 
inhibitory control over future drug seeking and taking behaviour. In support for this theory one 
of the strongest predictors of smoking relapse is the initial lapse of smoking one cigarette 
following quitting (Brandon et al., 1990; Nides et al., 1995; Shiffman et al., 1996), findings 
which can now possibly be attributed to the induced profound loss of control over behaviour 
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following the acute exposure to nicotine. 
The neurobiological processes believed to be involved in nicotine sensation may potentially be 
mediating the enhanced drug induced disinhibition. Chronic stimulation of the 
mesocorticolimbic DA system is believed to lead to neural adaptations pre and postsynaptically 
rendering the system hypersensitive to the effects of nicotine (Robinson and Berrdige, 1993). 
These alterations led to the augmented release of DA in the NAc (Cadoni and Di Chiar-a. 2000; 
Olausson et aL, 2001a; Rahm Zhang and Corrigall, 2003) and PFC (Vezina et al., 1992; 
Niscll et al., 1996) following subsequent exposure nicotine. As discussed previously, a crucial 
role for DA receptor activation in stimulant drug induced disinhibition has been provided by 
recent research (Van Gaalen et al., 2006; Pattij et al., 2007). Research conducted by Olausson 
and colleagues has furthermore demonstrated that sensitisation to nicotine may depend on a 
complex interaction between dopaminergic and serotonergic systems. Adopting the elevated 
plus ma e, authors demonstrated that rats repeatedly treated with nicotine spent an increasingly 
greater amount of time on the open arms and made more entries to the open arms of the maze 
(Olausson et al., 1999; Olausson et al, 2001b). Although traditionally an ethological model of 
anxiety, the researchers tentatively argued that the disinhibited behaviour in the maze could also 
be a reflection of an increased sensitisation to nicotine's effects on impulsive control (Olausson 
et al., 1999; Olausson et al, 2001b; Olausson, Engel and Soderpalm, 2002). Interestingly, 
subchronic treatment with both the SSRI citalopram, and the S-HTIA agonist 8-OH-DPAT 
blocked the sensitised expression of disinhibited behaviour in the maze. These findings suggest 
that enhanced disinhibition following chronic nicotine treatment may depend on nicotine 
induced reduction in 5-HT neurotransmission (Olausson et al., 1999; Olausson et al., 2001b). 
Although it is important that these findings are replicated in a validated model of impulsivity 
such as go/no-go task, the findings importantly indicate the potential of serotonergic enhancing 
drugs as future pharmacological agents that may aid smoking cessation. Indeed, it has 
previously been shown in rodents that comparable 5-HT enhancing drugs are capable of 
attenuating the self administration of psychostimulants including nicotine (Optiz and Weisher, 
1988), cocaine (e. g. Carroll et al., 1990; Glatz et al., 2002) and amphetamine (Lyness, 1983), 
possibly by means of strengthening inhibitory control. Furthermore, in human research the SSRI 
paroxetine when administered in combination with transdermal nicotine patches increased 
abstinence rates significantly (Killen et al., 2000). These findings taken together with the 
presented evidence of the crucial role disinhibition may have in smoking relapse, wan-ants 
greatly further investigation of the cffectiveness of 5-HT enhancing agents as treatment for 
nicotine dependence. 
5.4.5. Conclusion 
To conclude, the series of studies within this chapter has yielded extensive evidence to suggest 
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that the association between smoking and disinhibition is partly attributed to nicotine induced 
effects on inhibitory control. Chronic nicotine administration led to a specific reduction in 
inhibitory control in the go/no-go paradigm; an effect that was not sustained over the seven days 
of treatment, suggesting that tolerance to the effects of nicotine had developed. Termination of 
nicotine treatment caused a spontaneous nicotine abstinence syndrome, during which inhibitory 
control over behaviour appeared to be enhanced. This improvement in impulsive control was 
however short lived with a contrasting deficit in inhibitory control observed during longer term 
withdrawal. Three weeks following termination of treatment baseline levels of inhibitory control 
returned to pre-treatment levels of impulsivity, confirming that chronic nicotine induced effects 
on inhibitory control is a reversible effect. Ile neural adaptations associated with chronic 
exposure however rendered animals sensitised to the effects of acute nicotine on inhibitory 
control, highlighting the potential relevance of disinhibition in smoking relapse. Taken together, 
these findings suggest that a loss of inhibitory control induced by nicotine may be critically 
involved in both the initial and end stages of nicotine addiction. More specifically, exposure to 
nicotine in the early stages of abuse may lead to a loss of control over future drug seeking and 
taking behaviour increasing the likelihood of the transition to addiction and maintenance of the 
disorder. With increasing drug exposure however, tolerance to nicotine's influence on inhibitory 
control is likely to develop. The neural adaptations that then develop as a consequence of 
chronic exposure may become unmasked during long term abstinence giving rise to 
dysfunctional inhibitory systems leading to a loss of control over behaviour and subsequent 
relapse at the end stages of addiction. Whilst discussion has been made of the potential 
neurobiological events that may have mediated the behavioural cffects observed, it is important 
that future research begins to determine conclusively the processes involved. Such research will 
hopefully in turn enable progression of the development of future pharmacological treatments 
that may aid smoking cessation. 
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CHAPTER 6 
Validation of the delayed reward paradigm 
6.1. INTRODUCTION 
6.1.1. General Introduction 
Impulsivity has been equated with the preference of immediate over delayed gratification 
(Rachlin and Green, 1972; 'Ainslie, 1974). This particular subcomponent of impulsivity 
contrasts to that of behavioural disinhibition in that impulsive choice reflects more a cognitive, 
decision-making process rather than motor inhibition (Brunner and Hen, 1997; Evenden, 1999). 
One of the most common and effective behavioural assessments of impulsive choice is delay 
discounting, which is based upon the function by which the subjective value of a reward is 
depreciated by a delay to its delivery (Green et al., 1994; Bickel and Marsh, 2001). Research has 
revealed that both humans and'non-humans discount the value of rewards as the delay to its 
receipt increases, with the loss of value of delayed reward being faster in more impulsive 
subjects (Mazur, 1987; Rachlin et al., 1991; Green ct al., 1994; Richards et al., 1997). Both 
exponential, and to a greater extent hyperbolic, functions have accounted for the trend of 
discounting of delayed reward across humans and animals (e. g. Kirby, 1997; Richards et al., 
1997; 1999a; Mazur, 2001; Kirby and Santiesteban, 2003; Frederick et al., 2003). The similarity 
in discounting processes across species is of importance as it potentially allows researchers to 
extrapolate findings from non-human models to humans. 
The various paradigms utilised to measure delay discounting in both humans and animals have 
been detailed previously (section 1.3.2.2. ). Rat models of impulsive choice can be divided into 
"systematic" and "adjusting" delayed reward tasks. The present thesi§ adopted the former of 
these procedures, which requires food-restricted animals to choose between one of two levers; 
one delivering a single food pellet immediately, the other delivering several pellets after a 
programmed delay. Choices are made during discrete trials and the delay to the delivery of the 
larger reinforcer is increased (or decreased) systematically as the session progresses, normally 
from 0 to 60 seconds (e. g. Evenden and Ryan, 1996; Cardinal et al., 2000). Percent choice of 
delayed reward is taken as an index of impulsive choice, with more impulsive animals choosing 
the delayed reward to a lesser extent. Research has reliably demonstrated that, at baseline, 
animals' choice behaviour in the task is highly sensitive to delay; and task manipulations that 
reduce or omit standard delays to the delivery of the larger reward result in an increased 
preference of the delayed, larger reward (Evenden and Ryan 1996; Cardinal et al., 2000; Isles et 
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al., 2003). 
6.1.2. Stability of Impulsive Choice 
Despite the extensive use of the delayed reward task in preclinical research (e. g. Evenden and 
Ryan 1996; 1999; Cardinal et al., 2000; Paine et al., 2003; Winstanley et al., 2005), surprisingly 
limited investigation has been made regarding the stability of choice behaviour in the task. In 
order to assess the long-term effects of chronic nicotine administration and subsequent nicotine 
withdrawal on impulsive choice, it is essential that the stability of baseline impulsivity in the 
task is established in the absence of drug treatment and withdrawal. Previous research has 
provided evidence that animals' choice behaviour remained delay-sensitive across many months 
of study; however no indication was given of whether levels of impulsive choice changed over 
time (Evenden and Ryan, 1996). More recently, research has indicated extensive individual 
variation in levels of impulsive choice in rodents, as measured by systematic delayed reward 
paradigms (Cardinal et al., 2000; Winstanley et al., 2003a; Dellu-Ilagedorn, 2006). Only 
Winstanley et al., (2003), however, demonstrated evidence of stability of choice behaviour prior 
to pharmacological manipulations. Choice behaviour of individual animals was reported to be 
stable across a 10 day period, irrespective of the level of impulsivity. 
6.1.3. The Effects of Alterations in Primary Motivation on Impulsive Choice 
As previously discussed in Chapter 3, as many drugs of abuse such as nicotine, have appetitive 
effects (e. g. Grunberg, 1986; Miyata et al., 1999; Zhang et al., 2001), it is essential to 
demonstrate that delay discounting is not altered by changes in primary motivation. As food 
rewards are utilised in the delayed reward task, nicotine-induced changes on performance could 
arguably be due to alterations in primary motivation rather than sensitivity to delayed 
gratification. To date, research has yielded inconsistent effects of varying levels of motivation 
on delay discounting in animals. Both an increase in choice of delayed reward (Bradshaw and 
Szabadi, 1992; Wogar 1992; Ho et al., 1997) and lack of effect have been reported following the 
increase in primary motivation (Logue and Pena-Corrcal 1985; Logue et al., 1988; Richards et 
al., 1997; Cardinal et al., 2000; Wade et al., 2000). In contrast to this, no effects on preference 
for delayed reward have been reported following a reduction in deprivation state (Logue and 
Pena-Correal, 1985; Logue et 
ý1., 1988; Richards et al., 1997; Cardinal et al., 2000; Wade et al., 
2000). 
6.1.4. Objectives of Experiment 5 
The studies presented in this chapter were designed to assess the suitability of the delayed 
reward task for later experiment& investigating acute and long-term nicotine administration and 
nicotine withdrawal. To achieve this, a series of experiments were conducted in a control group 
of animals to assess: 
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i) The stability of performance in the delayed reward task (Experiment 5A). 
ii) The effects of acute alterations in primary motivation on task performance (Experiment 
5B). 
iii) The effects of prolonged alterations in primary motivation on task performance 
(Experiment 5C). 
iv) The sensitivity of choice behaviour to alterations in the 
delay to, the delivery of reward 
(Experiment 5D). 
These objectives were achieved through a series of preliminary control studies. In the first of 
these studies, the stability of task performance of a control group of animals was assessed across 
a three week period. Individual differences in levels of impulsive choice were also determined 
through the application of the exponential delay discounting function to choice data. The acute 
effects of alterations in primary motivation on task performance were then assessed by altering 
the level of motivation for food reward through either prefeeding subjects immediately prior to 
the session or acutely increasing levels deprivation - manipulations known to effectively vary 
the value/motivation for food reward (Heyman and Monaghan, 1987). Based on the limitations 
of Chapter 3, examination was also made of the effects of prolonged changes in deprivation 
level on performance in order to more effectively compare this study with long-tenn drug 
studies. Finally, to examine the sensitivity of choice behaviour to delay exploration was made of 
the effects of a reduction in duration of normal task delays on task performance during a single 
test session. 
6.2. EXPERIMENT 5 (A-D): VALIDATION OF THE DELAYED REWARD TASK: 
PRELIMINARY CONTROL STUDIES 
6.2.1. METHOD 
6.2.1.1. Subjects 
Subjects were 10 adult male Lister-hooded rats (Charles River, UK) weighing 360-390g at the 
start of training. On arrival to the laboratory animals were housed in pairs (cage size; 46 X 26.5 
X 26cm) and maintained under a 12 hour light/dark cycle (lights on at 0700h; lights off at 
1900h) at a controlled environmental temperature of, 21.5*C ±2*C and relative humidity of 
55% +5. Animals were maintained at 85% of their free feeding adult body weights throughout 
the testing period. Water was available ad libitum in home cages and feeding occurred at the 
end of each experimental day. The same subjects were utilised for Experiments 5(A-D). All 
animals were treated in accordance with the UK Animals (Scientific Procedures) Act 1986. 
6.2.1.2. Apparatus 
Four identical operant chambers were used (dimensions 30.5 X 24.1 X 21cm and 30.5 X 24.1 X 
29.2cm; Med Associates Inc., USA). Refer to General Methodology of Chapter 2, section 2.5.1, 
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for a detailed description of apparatus. 
6.2.1.3. Behavioural Testing: Delayed Reward Task 
6.2.1.3.1. Pre-training 
Animals were initially magazine trained by placing sucrose pellets in the illuminated magazine 
and allowing free access to them for two consecutive sessions. CRF lever training then 
commenced, during which, animals were trained to lever press the right and left lever on 
alternate training sessions. Responding on a lever resulted in the illumination of the magazine 
light and the delivery of a single sucrose pellet. CRF training, on each lever, continued until 100 
pellets were earned within a 20-minute period on two consecutive sessions. This normally 
required no more than five training sessions. 
Animals were then trained on a simplified version of the full delayed reward task. Each trial was 
40 seconds in duration and commenced with the illumination of the house and magazine light 
and retraction of both levers. Animals were required to enter the magazine within 10 seconds in 
order for a single lever to be presented and the magazine light to be turned off. If the animal 
failed to nose poke the magazine then the trial was aborted and the chamber returned to 
darkness for the remainder of the current trial. When presented with a lever, a response was 
required within 10 seconds or the chamber returned to darkness and the lever retracted until the 
following trial was initiated. If the animal did respond on the lever, a single pellet was delivered 
and the magazine light was turned on until either the pellet was collected or six seconds had 
passed. Trials were presented in pairs so that the lcft lever was presented once and the right 
lever presented once. The order of presentation during each pair of trials was randomised. This 
stage of training continued until 60 trials had been successfully completed within one hour for 
two consecutive sessions. Animals were then transferred to the full task where delays and small 
verses larger rewards were introduced. 
6.2.1.3.2. Delayed Reward Task 
The delayed reinforcement task was based on Evenden and Ryan (1996) and Cardinal et al. 
(2000) behavioural procedures and is illustrated in Fig 6.1. The task consisted of a total of 60 
trials, each of 100 seconds duration. The initiation of each trial was signalled by the illumination 
of the house light and magazine light. Animals were required to nose poke the magazine within 
10 seconds, which resulted in the magazine light being extinguished and both levers being 
presented. This ensured that the animal was centrally located between both levers prior to 
making a response choice. The latency to enter the magazine was recorded as the trial initiation 
latency. If the animal failed to make a nose poke response during this time period the trial was 
recorded as a "trial" omission and the chamber returned to darkness. The chamber remained in 
this ITI period for the remainder of the trial duration. 
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On successful presentation of the levers, animals were required to respond on either ]ever within 
a 10 second period. If no lever response occurred, the levers were retracted, the houselight 
extinguished and the chamber returned to the ITI for the remaining duration of the trial. This 
behaviour was then recorded as a "choice" omission. One lever was designated the 'immediate' 
lever the other the 'delayed' lever for each animal. Assignment of 'immediate' and 'delayed' 
levers was counterbalanced left or right across animals. When a response on the lever was 
made both levers were withdrawn and the houselight turned off. A response on the 'immediate' 
lever resulted in the immediate delivery of a single food pellet. A response on the 'delayed' 
lever resulted in the delivery of five food pellets, delivered one second apart, following a 
programmed delay (of either 0,10,20,40,60 seconds). The latency to choose a lever was 
recorded as the response latency and was measured from the point of initiating the trial, by nose 
poking the magazine, to pressing the lever. During the delivery of sucrose pellets the magazine 
light was illuminated until either the animal entered the magazine to collect the reward or six 
seconds had passed. The chamber then entered the ITI period for the remainder of the 100 
seconds until the initiation of the following trial. Initiation and response latencies were used to 
calculate the length 6f the ITI period to ensure that, regardless of behaviour in each trial, the 
duration of all 60 trials remained constant. If collection of the pellets occurred prior to the 
initiation of the next trial then magazine latency was calculated from the time of delivery of the 
first pellet until point of entrance into the magazine to collect the reward. Failure to collect 
pellets prior to the next trial was recorded as a "magazine" omission. 
Each session comprised of a total of 60 trials consisting of five blocks of 12 trials. Delays varied 
across blocks so for each block delays were 0,10,20 40 and 60 seconds. The direction of delays 
was counterbalanced across animals, so that for half the animals delays ascended in a step-wise 
manner across the session, and for the remaining, descended. Each block of trials began with 
two forced trials followed by 10 free-choice trials. During forced trials only one lever was 
presented, therefore no choice was available. Each lever w4s presented once in a randomised 
order during one of the forced trials. Implementing forced trials ensured that the animal had 
been exposed to the delay and that they also experienced both the large and small rewards prior 
to making a choice in the following free choice trials. During free choice trials both levers were 
presented. Each session length was 100 minutes and animals received one session per day. 
Immediate and delayed lever choices were recorded during free choice trials - allowing percent 
choice of delayed lever to be calculated across delay (no. of delayed lever responses/total 
number of response's). Impulsive choice can be measured as a decrease in choice of the delayed 
lever. Omissions were excluded from choice calculations. Table 6.1 summarises all dependent 
measures recorded in the procedure. Training continued until animals displayed stable, delay- 
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FW. 6.1: Schematic diagram of the Delayed Reward Task (adapted from Cardinal et al., 2000) 
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Table 6,1: Behavioural measures recorded in the delayed reward task 
Behavioural Dependent Variables 
Measure 
Choice Overall percent choice of delayed lever 
Behaviour (No. of delayed reward 
lever responses/ (50-no. of omissions)* 100). 
Percent choice of delayed lever by delay (0,10,20,40 & 60) 
o. of delayed reward lever responses/ (I 0-no. of omissions)* 100). 
Speed of Trial initiation latency (seconds) 
Responding 
'Delayed' reward lever response latency (seconds) 
'Immediate' lever response latency (seconds) 
Magazine latency following delayed reward choice (seconds) 
Magazine latency following immediate reward choice (seconds) 
Omissions No. of trial omissions 
No. of choice omissions 
No. of magazine omission following delayed choice 
No. of magazine omission following immediate choice 
6.2.1.4. Design and Procedure 
All experiments followed standard operant testing procedures, previously outlined in detail in 
the general methodology of Chapter 2, section 2.5.2. Experimentation took place over a 16 week 
period. Experiments 5 (A-D) employed a within-subjccts design. Prior to all subsequent 
experimental manipulations it was ensured that animals had returned to Bl, performance prior to 
further testing. Bl, was defined in the task as impulsive choice deviating no greater than 10% 
from the level of overall choice of delayed reward demonstrated by the subject during the 
assessment of stability in Experiment 5A. All testing took place during the light phase of their 
LD cycle between 0800h and 1730h. Time of operant testing remained constant for each subject 
across experiments. 
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6.2.1.4.1. EXPERIMENT 5A: EXAMINATION OF THE STABILITY OF BEHAVIOUR 
IN THE DELAYED REWARD TASK 
Once trained, the stability of choice behaviour, speed of responding and frequency of omissions 
in the task were examined across a three week period. The duration of assessment was chosen to 
reflect the time period of future chronic drug studies, where performance would be examined 
during seven days of baseline, chronic drug treatment and drug withdrawal. 
6.2.1.4.2. EXPERIMENT 511: EXAMINATION OF THE ACUTE EFFECTS OF 
ALTERATIONS IN PRIMARY MOTIVATION ON PERFORMANCE IN THE 
DELAYED REWARD TASK 
Following Experiment 5A, the acute effects of varying levels of deprivation on task 
performance was assessed. The effect of a decrease in motivation for food reward on 
behavioural parameters in the task was assessed twice using different procedures. The 
experimental conditions differed in terms of whether subjects were fcd normal rat chow or 
sucrose rewardpellets prior to the session. Under the first of these conditions motivation for 
reward was suppressed through allowing free access to a pre-weighed amount of normal rat 
chow for one hour immediately prior to operant testing in the subject's home cage. Under the 
second condition, motivation for sucrose reward was reduced through allowing animals' free 
. 
access to a pre-weighed amount of sucrose pellets for a 30 minute period prior to testing. The 
latter of these conditions enabled the reduction of specific satiety for the sucrose reward that 
would be earned during the test session. A shorter duration of free access to sucrose pellets was 
selected based on preliminary observations that indicated a much greater and rapid consumption 
of sucrose pellets in comparison to normal rat chow. For both experimental manipulations, 
animals were individually housed. In order to quantify the level of presatiation, each animal's 
BW was measured prior to and after feeding. The amount of food consumed during the 
prefeeding periods was also recorded. 
The third manipulation explored the effects of increasing motivation for food reward on 
performance in the task. This was achieved through the 50% reduction of allocated food 
allowance (normally 18.6g) the day prior to testing. The following test day animals were 
weighed immediately prior to operant testing to confirm loss of BW. The sequence of 
manipulations for each subject was determined by a Latin square. Between each manipulation, 
an inter-test interval of at least six days elapsed, during which, animals were maintained under 
their normal Bl, testing and feeding conditions. 
197 
Chapter 6- Validation of the Delayed Reward Paradigm 
6.2.1.4.3. EXPERIMENT 5C: EXAMINATION OF THE EFFECTS OF CHRONIC 
ALTERATION IN PRIMARY MOTIVATION ON PERFORMANCE IN THE 
DELAYED REWARD TASK 
Following Experiment 5B, assessment was made of chronic alterations in primary motivation on 
task performance. This was achieved through altering daily food ration (normally 18.6g, ' 
inclusive of food reward consumed in the task). To assess a longer term decrease in motivation, 
the daily food ration was increased by 20% over a seven day period. To assess a longer term 
increase in motivation, the daily food ration was decreased by 20% over a seven day period. 
This duration of assessment was chosen to reflect the time period over which chronic nicotine 
and nicotine withdrawal would be assessed in the task. Between each manipulation, an inter-test 
interval of at least six days elapsed, during which, animals were maintained under their normal 
BL testing and feeding conditions. 
6.2.1.4.4. EXPERIMENT 51): EXAMINATION OF THE REDUCTION OF DELAYS TO 
THE DELIVERY OF REWARD ON PERFORMANCE IN THE DELAYED REWARD 
TASK 
To provide further support that choice behaviour in the task was delay sensitive, within a single 
test session, normal delays (0,10,20,40 and 60 seconds) were replaced with reduced delays of 
0,1,2,5 and 15 seconds. All other aspects of the task remained identical, with animals 
completing 12 trials during each delay condition, the first two of which were forced choice 
trials. This enabled the direct comparison of choice behaviour during delay conditions with 
normal and reduced delays. 
6.2.1.5. Statistical Analysis 
6.2.1.5.1. Training 
To determine that animals' choice behaviour in the task was both sensitive to delay and stable 
prior to the initiation of testing, data from three consecutive test sessions was analysed using a 
two-way repeated measures ANOVA, with both day and delay (0,10,20,40 and 60s) as the 
within-subject factors. A significant main effect of delay would indicate sensitivity of choice 
behaviour across delays, while a non-signif icant main effect of day would demonstrate evidence 
of stability of this choice. 
6.2.1.5.2. EXPERIMENT 5A: EXAMINATION OF THE STABILITY OF BEHAVIOUR IN THE 
DELAYED REWARD TASK 
To assess the stability of behaviour in the task, overall choice of delayed reward, speed of 
responding and omissions were analysed using a one-way repeated measures ANOVA, with test 
day as the within-subject factor. Analysis of the choice of reward by delay, was conducted using 
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a two-way repeated measures ANOVA, with both test day and delay (0,10,20,40 and 60s) as 
the within-subject variables. 
Extensive variability in the sensitivity of delayed reward was identified within the group of 
animals tested. In order to further explore the individual variation in choice behaviour within the 
task, based on Winstanley et al. (2005; 2003a), the level of impulsive choice for each animal 
was determined through the application of the exponential curve to the averaged data obtained 
during assessmcnt of stability, in the form: 
C-(kd) 
Where: 
y= the frequency of choice of the delayed larger reward. 
d= delay in delivery of the large reward. 
k= rate of exponential decrease of choice of the larger reward with increasing delay. 
The larger the k value, the steeper the exponential curve, indicating that animals with increasing 
delay chose the smaller immediate reward to a greater extent. Highly impulsive animals would 
therefore display greater k values in comparison to less impulsive. RI was utilised as an index of 
the exponential equation's goodness of fit of the animal's choice data. The application of 
exponential curves was conducted using Microsoft Excel Curve fitting programme. 
6.2.1.5.3. EXPERIMENT 5B: EXAMINATION OF THE ACUTE EFFECTS OF ALTERATIONS IN 
PRIMARY MOTIVATION ON PERFORMANCE IN THE DELAYED REWARD TASK 
For each motivational manipulation, all behavioural measures in the task were compared to the 
prior averaged five day baseline performance. With the exception of choice by delay, analysis of 
all parameters within the task was conducted using a repeated measures West. Analysis of the 
choice of reward by delay, in contrast, was analysed by a two-way repeated measures ANOVA, 
with delay and motivational level as the within-subject factors. Comparisons of differences in 
food intake and weight gained across the prcfeeding manipulations were also conducted by a 
repeated measures West. Weight was assessed as both an absolute weight gain or loss (g) and as 
percentage change from the weight recorded immediately prior to the free feeding period. 
6.2.1.5.4. EXPERIMENT 5C: EXAMINATION OF THE EFFECTS OF CHRONIC ALTERATION IN 
PRIMARY MOTIVATION ON PERFORMANCE IN THE DELAYED RENVARD TASK 
Performance on the task during prolonged alterations in motivation for food reward were 
compared to BL behaviour averaged across the five days immediately prior to initiation of the 
manipulation. Overall choice of delayed reward, speed of responding and omissions were 
199 
Chapter 6- Validation of the Delayed Reward Paradigm 
analysed by a one-way repeated measures ANOVA, with day as the within-subject factor with 
eight levels (BL, plus seven test days). Choice by delay was analysed by a two-way repeated 
measures ANOVA, with day and delay as the within-subject factors. Changes in BW during 
chronic alterations in motivation were expressed as both absolute weight gain or loss (g) and 
percentage change in BW from the day prior to testing. These data were compared to changes in 
BW during the BL week, prior to the initiation of testing by repeated measures Wests. 
6.2.1.5.5. EXPERIMENT 5D: EXAMINATION OF TIIE REDUCTION OF DELAYS TO THE 
DELIVERY OF REWARD ON PERFORMANCE IN TIIE DELAYED REWARD TASK 
Task performance during this manipulation was compared to BL. BL behaviour was defined as 
average task performance across the five days prior to testing. Overall choice of delayed reward, 
speed of responding and omissions were analysed by repeated measures Wests. Due to differing 
task delays, statistical comparison of choice by delay was no longer appropriate between BL 
and the task manipulation. Delay dependency was therefore analysed independently for BL and 
the delay manipulation. This was achieved by a one-way repeated measures ANOVA, with 
delay as the within-subject factor. 
For Experiments 5 (A-D), all significant main effects were followed, where appropriate, by 
Bonferroni post hoc comparisons. Significant interactions observed following the analysis of 
choice by delay were examined further by simple effects analysis. Repeated measures one-way 
ANOVAs (Experiments 5A and 5C) or Wests (Experiments 5B) were used to examine 
differences in choice behaviour at each delay (Bonferroni correction of p<0.01). Inie 
interactions were also examined by a one-way ANOVA assessing the main effect of delay under 
each level of the variable being tested. 
For all statistical procedures, data prior to analysis were assessed for nonnality and transfonned 
where necessary (see also section 2.7). Mauchley's test of sphericity was applied to all within 
subject variables, and when appropriate the degrees of freedom were adjusted with the 
Greenhouse-Geisser correction. If data could not be successfully transformed, then the non- 
parametric equivalent - Friedman and Wilcoxon Signed Ranks tests - were employed. In all 
cases of statistical analysis, a was set at p<0.05. 
6.3. RESULTS 
Across Experiments 5 (A-D) omissions of both lever selection, and collection of reward 
following an immediate choice, were not analysed due to both behaviours rarely occurring. 
6.3.1. Training 
Animals' choice behaviour in the task became sensitive to delay following an average of 42.5 ± 
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2.06 training sessions. Choice behaviour was both delay sensitive (F(4,36) = 33.106, p<0.001) 
and stable (F(2,18)= 2.372, N. S. ) prior to testing. Post hoc analysis revealed that the greatest 
sensitivity to delay was observed at 20,40 and 60 second delay conditions, during which 
preference for the delayed reward was significantly reduced in comparison to 0 delay choice 
trials (all p<0.05). Analysis demonstrated no significant delay x day interaction (F(8,72) = 
1.17 3, N. S. ) 
6.3.2. EXPERIMENT 5A: EXAMINATION OF THE STABILITV OF BEHAVIOUR IN 
THE DELAYED REWARD TASK 
6.3.2.1. Choice Behaviour 
Figure 6.2 illustrates the overall percentage choice of the delayed larger reward across tile 21 
day period. Analysis demonstrated that overall choice behaviour was stable across this time 
period with no significant main effect of test day (F(20,180) = 1.374, N. S. ). Analysis of choice 
behaviour by delay supported further the stability of performance with no significant main 
effect of test day (F(5.528,49.751) = 1.349, N. S. ). A significant main effect of delay was 
however found, demonstrating that choice behaviour was highly sensitive to delay (F(I. 977, 
17.795) = 47.164, p<0.001). As clearly shown in Fig. 6.3, preference of tile delayed reward 
decreased with increasing delays. The delay-dependent effect was supported by post hoc 
analysis that revealed choice behaviour differed significantly between all delay conditions (all 
p<0.05). An exception to this effect was the reduction in choice during the 10 second delay 
trials which failed to reach significance in comparison to the 0 second delay condition during 
the task (p>0.05). Analysis further revealed no significant test day x delay interaction during the 
21 days (F(8.092,72.824) = 1.507, N. S. ). 










Fii!. 6.2: Choice Behaviour: stability of overall percentage choice of delayed reward across the 21 day period. 
Each point represents the mean percentage ± SEM. 
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Fig. 6.3: Choice Behaviour: stability of percentage choice of delayed reward during each delay across the 21 
day period. Each point represents the mean percentage ± SEM. 
6.3.2.2. Speed of Responding 
Figure 6.4 (a-e) illustrates the stability of speed of responding measures in the delayed reward 
task across the 21 day period. Analysis revealed no significant main effect of test day on the 
latency to initiate trials (F(3.617,32.549) = 1.047, N. S. ) and the speed with which the delayed 
and immediate reward were chosen (F(3.374,30.366) = 2.580, N. S.; F(4.028,36.248) = 2.570, 
N. S., respectively). 
The speed with which reward was collected following an immediate choice was also stable 
across testing (F(I. 105,9.946) = 1.579, N. S. ). As shown in Fig. 6.4 (e), the latency to collect 
reward following a delayed reward choice was both greater and more variable across animals 
than immediate reward magazine latency. However, there was no significant main effect of test 
day on this measure (F(4.613,41.513) = 0.479, N. S. ). 
6.3.2.3. Omissions 
Failure to both initiate trials and collect food reward following a delayed reward choice 
remained stable across the 21 day period (X2 = 21.559, df = 20, N. S.; X2 = 11.838, df = 20, 
N. S., respectively) (see Fig. 6.5). 
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Fig. 6.4 (a-e): Speed of Responding: the stability of latency in seconds to initiate trials (a), select an immediate 
reward (b) and select a delayed reward (c). Speed of Responding: the stability of latency in seconds to collect 
reward following an immediate reward choice (d) and a delayed reward choice (e) across the 21 day period. 
Each point represents the mean latency in seconds ± SEM. 
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Fig 6.5: Omissions: stability of frequency trial omissions (a) and magazine omission following a delayed choice 
(b) across the 21 day period. Each point represents the mean frequency ± SEM. 
6.3.2.4. Individual Variation in Levels of Impulsive Choice 
Despite animals receiving identical training in the task, as illustrated in Fig. 6.6, marked 
individual differences were observed in the rate of discounting of delayed reward. The rate of 
exponential decay of choice of the larger delayed reward was determined for each animal. The k 
coefficient obtained for each subject was plotted and is summarised in Table 6.2, in addition to 
the R2 values. Subjects 3 (k = 0.864) and 8 (k = 1.309) were identified as extreme outliers as 
they displayed significantly greater k values in comparison to the rest of the group (mean k= 
0.198 ± 0.031). The R2 values displayed in Table 6.2 indicate that the exponential discounting 
function provided a good characterisation of the individual animal data. 
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Fip-. 6.6: Choice Behaviour: individual variability in the average rate of discounting of delayed reward during 
the 21 day stability test period. Each point represents the mean percentage choice. 
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Table 6.2: Individual rat data, indicating steepness of discounting (k) and goodness of fit 
(w ) 
Subject k value W value 
1 0.13 0.78 
2 0.07 0.88 
3 0.86 0.89 
4 0.15 0.76 
5 0.34 0.86 
6 0.24 0.69 
7 0.11 0.99 
8 1.31 0.98 
9 0.28 0.66 
10 0.28 0.86 
Mean SEM 0.38 0.84 
0.13 0.04 
6.3.3. EXPERIMENT 511: EXAMINATION OF THE ACUTE EFFECTS OF 
ALTERATIONS IN PRIMARY MOTIVATION ON PERFORMANCE IN THE 
DELAYED REWARD TASK 
633.1. DECREASE IN PRIMARY MOTIVATION: Effects of I li Prefeeding of Normal 
Rat Chow 
During I hr prefeeding of normal rat chow animals consumed an average of 11.72 ± 0.50g. 
Following feeding, an average of 12.88 ± 0.71g of BW was gained, increasing BW on average 
by 2.54 ± 0.14 %. 
6.3.3.1.1. Choice Behaviour 
Prefeeding for aI hr period prior to operant testing had no significant effect on overall 
percentage choice of delayed reward in the task in comparison to baseline (t = 1.527, df = 91 
N. S. ) (Overall choice of delayed reward: BL- 69.96 ± 6.34%; following prefeeding -65.04 ± 
6.42%). Analysis of choice by delay furthermore revealed no significant main effect of level of 
motivation on choice of delayed reward (F(1,9) = 0.577, N. S. ). A highly significant main effect 
of delay was indicated (F(4,36) = 41.652, p<0.001), with post hoc analysis demonstrating a 
reduction in choice of delayed reward at 20,40 and 60 seconds in comparison to choice 
behaviour during 0 delay trials (all p<0.01). No significant motivation x delay interaction was 
observed (F(4,36) = 0.661, N. S. ) (see Fig. 6.7). 
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H2.6.7: The effects prefeeding of normal rat chow on choice of delayed reward across delay condition. Each 
point represents the mean percentage ± SEM. 
6.3.3.1.2. Speed of Responding 
Table 6.3 summarises the effects of alterations in primary motivation on speed ot'responding 
measures in the task, relative to prior average BL performance. Reducing motivation through 
prefeeding with normal rat chow significantly increased the latency to initiate trials in the task 
(t = -4.471, df = 9, p=0.001). The speed with which the immediate reward was selected was 
slower in comparison to BL (t =-2.326, df = 9, p=0.045). However, the latency to select the 
delayed larger reward was not altered by prefeeding (t = -1.892, df = 9, N. S. ). 
Following prefeeding, the speed with which the reward was collected following both an 
immediate and delayed reward choice was found not to differ from BL latency (t =-1.170, df = 
9, N. S.; t=1.325, df = 9, N. S. ) (see Table 6.3). 
6.3.3.1.3. Omissions 
Reducing motivation had no significant effect on the frequency of trial omissions (Z =-1.389, N 
= 10; N. S. ) or failure to collect the reward following a delayed reward choice (Z =-1.122, N 
=10; N. S. ). Table 6.4 displays the effects of alterations in motivation on frequency of omissions 
in the task, in comparison to BL frequency. 
6.3.3.2. DECREASE IN PRIMARY MOTIVATION: Effects of 30 Mins Prefeeding of 
Sucrose Reward Pellets 
Animals consumed an average of 12.49 ± 0.84g during the 30 minutes of free access to sucrose 
reward pellets, increasing BW immediately prior to feeding by 12.32 ± 1.03g -a percentage 
increase of 2.38 ± 0.21 %. 
The amount of non-nal rat chow and sucrose pellets did not differ significantly across prefeeding 
manipulations (t = -1-100 df = 9, N. S). No differences were observed between the 
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manipulations in the BW gained following each of the feeding sessions, as measured by actual 
weight gain and percentage increase in weight (t = 0.550, df = 9, N. S.; t=0.766, df = 9, N. S., 
respectively). 
6.3.3.2.1. Choice Behaviour 
Despite an observed trend for a decrease in overall choice of delayed reward following 
prefeeding with sucrose pellets, this effect failed to reach significance (t = 2.231, df 9, N. S. ) 
(Overall choice of delayed reward: BL- 73.30 ± 6.18%; following prefeeding-68.01 6.66%). 
Choice of behaviour by delay indicated no significant main effect of level of motivation (F(1,9) 
= 2.849, N. S. ), although choice behaviour was delay-dependent (F(4,36) = 35.766, p<0.001). 
Post hoc comparisons indicated that the choice of the delayed reward was significantly lower at 
40 and 60 seconds relative to the choice during the 0 second delay condition (all p<0.01). Level 
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Fig. 6.8: The effects prefeeding of sucrose reward pellets on choice of delayed reward across delay condition. 
Each point represents the mean percentage ± SEM. 
6.3.3.2.2. Speed of Responding 
Latency to initiate trials became significantly slower following prefeeding with sucrose reward 
pellets (t = -2.998, df = 9, p=0.0 15) (see Table 6.3). The speed with which both the immediate 
and delayed reward were selected did not differ from BL latency (t =-1.589, df= 9, N. S.; t 
1.476, df = 9, N. S., respectively). 
After prefeeding with sucrose reward pellets, the magazine latencies for the immediate reward 
choice remained comparable to BL (t = 0.565, df = 9, N. S. ); however, there was a slowing in the 
speed with which the delayed reward was collected (t = -3.229, df = 9, p =0.009) (Table 6.3). 
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6.3.3.2.3. Omissions 
Prefeeding with sucrose reward pellets prior to operant testing had no significant effect on the 
failure to initiate trials or collect the reward following a delayed reward choice (Z = -1.219, N= 
10; N. S.; Z= -1.130, N= 10; N. S. ) (see Table 6.4). 
6.3.3.3. INCREASE IN PRIMARY MOTIVATION: Effect of Reducing Food 
Consumption the Day Prior to Testing 
The reduction of food allowance by 50% on the day prior to testing led to a loss of an average of 
4.52 ± 0.72g of BW and percentage decrease in weight of 1.01 ± 0.002%. 
6.3.3.3.1. Choice Behaviour 
Increasing motivation for food reward led to a significant increase in overall percentage choice 
of the delayed larger reward (t = -2.507, df = 9, p=0.033) (Overall choice of delayed reward: 
BL- 70.06 ± 7.18%; following reduction of daily food intake 73.06 ± 8.07%). Analysis of 
choice by delay further supported the increased preference for the delayed reward (F(4,36) = 
8.253, p=0.018). A main effect of delay was also revealed (F(4,36) = 32.826, p<0.001), 
indicating that the choice of the delayed larger reward decreased with increasing delays, 
reaching significance at the 40 and 60 second delay conditions in comparison to choice during 0 
second delay trials (all p<0.001). The effect of increasing motivation on choice behaviour was 
delay dependent, as indicated by the significant motivation x delay interaction (F(4,36) = 5.688, 
p=0.001). To examine this interaction further, a series of repeated measures Wests compared 
choice behaviour at each delay (see Fig. 6.9). Following the increase in motivation, the choice 
of the delayed reward was significantly increased during the 10 second delay condition in 
comparison to choice at this delay under BL conditions (t = -5.577, df = 9, p<0.001). Choice of 
delayed reward across all remaining delay conditions remained comparable to BL choice (all t 2: 
0.210, df = 9, N. S. ). 
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ids E Delay 10 Seconds II Delay 20 Seconds ý Delay 40 Seconds 0 Delay 60 Seconds 
Fig. 6.9: Simple effects analysis of motivation *delay interaction: The effect of reducing food intake the day 
prior to testing on percentage choice of delayed reward across delay condition. Comparison of choice at each 
delay. Each bar represents the mean percentage 4: SEM. *, p<0.05, **, p<0.01, ***, p<0.001 (Bonferroni 
comparison) as compared to baseline. 
Independent analysis of the main effect of delay during BI. and following all increase in 
motivation for food reward, indicated choice behaviour was delay-sensitive during both 
conditions (F(4,36) =40.115, p<0.001; F(4,36) = 23.608, p<0.001). As illustrated in lig. 
6.10, during 131, choice of delayed reward was significantly lower at 10,40 and 60 seconds 
delay in comparison to choice behaviour when no delays were present during trials (all p <0.01 ). 
However, after one day of reduced daily food allowance, choice ofdelayed reward wits only 
significantly reduced at the highest 60 second delay condition relative to choice during the 0 
second delay condition (p < 0.00 1). 












I--#-- AVERAGE BASELINE 0 REDUCTION OF DAILY FOOD INTAKE I 
Fig. 6.10: Simple effects analysis of motivation*dclay interaction: The effect of reducing food intake the day 
prior to testing on rate of discounting of delayed reward under each condition. Each point represents the mean 
percentage ± SEM. *, p<0.05. **, p<0.01, ***, p<0.001 (Bonferroni comparison) as compared to choice of 
delayed reward at 0 seconds delay condition. 
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6333.2. Speed of Responding 
Increasing levels of food deprivation prior to testing had no significant effect on the latency to 
initiate trials (t = -1.327, df = 9, N. S. ), or the speed with which animals selected an immediate 
or delayed reward (t = -0.260, df = 9, N. S., t= -0.740, df = 9, N. S., respectively) (see Table 6.3). 
Magazine latency following an immediate reward choice furthermore did not differ from Bl, (t 
= -1.189, df = 9, N. S. ). In contrast, the speed with which animals collected reward following a 
delayed reward choice became significantly faster (t = 1.905, df = 9, p=0.045) (see Table 6.3). 
6.3.3.2.3. Omissions 
Increasing levels of food deprivation significantly decreased the frequency of failures to initiate 
trials during task performance (Z = -2.060, N= 10, p= 0.039). Magazine omissions following a 
delayed reward choice did not differ significantly from Bl, (Z = 0.001, N= 10, N. S. ) (see Table 
6.4). 
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63.4. EXPERIMENT 5C: EXAMINATION OF THE EFFECTS OF CHRONIC 
ALTERATION IN PRIMARY MOTIVATION ON PERFORMANCE IN THE DELAYED 
REWARD TASK 
Maintaining animals on a 20% greater daily food allowance for a one week period resulted in a 
significant greater BW gain in comparison to the prior BL week under the normal feeding 
regime (absolute BW gain, t=- 11.65 8, df = 9, p<0.00 1; percentage increase in BW, Z 
2.803, p=0.005, respectively) (See Table 6.5). 
Table 6.5: Long-term decrease in primary motivation on BW change 
Body Weight Change Scven Day 
Basclinc 
Long Term Dccrease in 
Motivation 
I 
Absolute BW gain (g) 
Percentage Change in BW 
+1.16 ± 0.83 
+0.22 ± 0.15 
+16.36 ± 1.07*** 
+3.07 ± 0.18** 
Table 6.5: Each value represents the mean ± SEM. *, p<0.05, **, p<0.01, ***, p<0.001 (Bonrerroni 
comparison) as compared to baseline. 
II 
63.4.1. EFFECTS OF A PROLONGED DECREASE IN PRIMARY MOTIVATION 
6.3.4.1.1. Choice Behaviour 
Increasing the daily food allowance by 20% had no effect on overall choice of delayed reward 
in the task (F(7,63) = 2.462, N. S. ) (see Fig. 6.11). Analysis of the choice of reward by delay 
revealed no significant main effect of level of motivation (F(7,63) = 1.816, N. S. ). Evidence that 
choice behaviour was sensitive to delay was however shown, indicated by a main effect of delay 
(F(4,36) = 41.903, p<0.001). Further analysis revealed that choice of delayed reward was 
significantly reduced at 40 and 60 seconds relative to choice during 0 second delay trials (all 
p<0.001). No significant delay x day interaction on choice behaviour was observed (F(28,252) 
= 0.858, N. S. ) (see Fig. 6.12). 
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Fig. 6.11: The effect of prolonged reduction in primary motivation on overall percentage choice of delayed 
reward. Each point represents the mean percentage ± SEM. 












Fig. 6.12: The effect of prolonged reduction in primary motivation on percentage choice of delayed reward 
across delay condition. Each point represents the mean percentage ± SEM. 
6.3.4.1.2. Speed of Responding 
No main effect of day was revealed on the latency to initiate trials (l, (7,63) = 0.698, N. S. ). 
Increasing daily food allowance across seven days moreover had no significant cfl'cct oil speed 
with which animals selected the delayed and immediate reward (F(I. 507,13.559) = 1.097, N. S.; 
F(2.359,21.223) = 0.403, N. S., respectively), or the latency at which the reward was collected 
(F(2.100,18.903) = 0.188, N. S.; F(I. 927,17.342) = 0.374, N. S., respectively). Table 6.7 
summarises the effects of long term alterations of primary motivation for lood reward on speed 
of responding parameters in the task. 
6.3.4.1.3. Omissions 
No significant main effect of day was observed on tile failure to initiate trials or to collect 
reward following a delayed reward choice (X2 = 10.637, df ý 7, N. S.; X2= 2.059, df= 7, N. S., 
respectively) (see Table 6.8). 
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6.3.4.2. EFFECTS OF A PROLONGED INCREASE IN PRIMARY MOTIVATION 
Reducing daily food intake by 20% for a one week period resulted in significant loss of BW in 
comparison to BL week, prior to the manipulation under the normal feeding regime (absolute 
BW gain, t= -8.130, df = 9, p<0.001; percentage increase in BW, Z= -2.803, p=0.005, 
respectively) (See Table 6.6). 
Table 6.6: Long-term increase in primary motivation on BW change 
Body Weight Change Seven Day Long Tenn Increase in 
Baseline Motivation 
Absolute BW gain (g) +1.22 ± 0.93 -11.50 0.88** 
Percentage Change in BW 
1 




Table 6.6: Each value represents the mean :E SEAL *, p<0.05, **, p<0.01, ***, p<0.001 (Bonferroni 
comparison) as compared to baseline. 
6.3.4.2.1. Choice Behaviour 
Figure 6.13 illustrates the overall choice of delayed reward during the seven days where 
motivation for food reward was increased. Analysis demonstrated a significant main effect of 
day during this period (F(7,63) = 6.210, p<0.001). Post hoc comparisons revealed that the 
choice of the delayed reward was significantly increased on the final 70' day of reduced food 
intake in comparison to choice preference during BL. Analysis of choice by delay also revealed 
a significant'main effect of day (F(4,36) = 7.179, p<0.001), indicating once again the 
significant increased preference of delayed reward on the final day of the motivational 
manipulation. A significant main effect of delay was also revealed (F(4,36) = 27.312, p 
<0.001), with selection of the larger, delayed reward being significantly decreased at 40 and 60 
second delay conditions in comparison to 0 second delay trials (all p<0.05). The effect of a 
prolonged increase in deprivation on decreasing choice of delayed reward was not however 
delay dependent, as indicated by the non-significant motivation x delay interaction (F(28,252) 
=1.019, N. S. ). 
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Fig. 6.13: The effect of prolonged increase in primary motivation on overall percentage choice of delayed 
reward. Each point represents the mean percentage ± SEM. *, p<0.05, **, p<0.01, ***, p<0.001 (Bonferroni 
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Fig. 6.14: The effect of prolonged increase in primary motivation on percentage choice of delaved reward 
across delay condition. Each point represents the mean percentage ± SEM. 
6.3.4.2.2. Speed of Responding 
The prolonged decrease in daily food allowance had no significant main effect on tile latency to 
initiate trials (F(7,63) = 1.075, N. S. ), or the speed with which both the immediate and delayed 
reward were selected in the task (F(I. 897,17.077) = 0.686, N. S.; F(1.994,17.943)= 0.935, 
N. S., respectively). Latencies to collect reward following both a delayed and immediate reward 
choice also remained unchanged from baseline (F(7,63) = 1.882, N. S.; F(I. 602,14.419) = 
0.223, N. S. ) (see Table 6.9). 
6.3.4.2.3. Omissions 
The frequency of initiation of trial omissions and failure to collect delayed reward did not differ 
from baseline performance (X2 = 1.928, df = 7, N. S.; X2 = 10.742, df = 7, N. S., respectively) 
(see Table 6.10). 
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6.3.5. EXPERIMENT 51): EXAMINATION OF THE REDUCTION OF DELAYS TO 
THE DELIVERY OF REWARD ON PERFORMANCE IN THE DELAYED REWARD 
TASK 
6.3.5.1. Choice Behaviour 
Reduction of delays during the task had a profound effect on choice behaviour, increasing 
significantly overall choice of the delayed larger reward in the task (t = -6.880, df = 9, p= 0.001) 
(Overall choice of delayed reward: BL- 71.53 ± 6.76%; Following reduction of delays- 83.30 
6.86%). 
Assessment of choice behaviour by delay, revealed that choice behaviour was delay-dependent 
during both BL and the delay manipulation, as indicated by the significant main effects of delay 
(F(4,36) = 34.582, p<0.001; F(4,36) = 5.849, p=0.010, respectively). Post hoc analysis 
revealed that, whilst during BL choice of the delayed reward differed significantly from 0 delay 
trials at 40 and 60 delay conditions (all p<0.001), following the reduction of delay to the 
delivery of the larger reward no significant differences were observed between choice behaviour 
across delays ( all p>0.05) (see Fig 6.15). 












NORMAL DELAYS -ýW- SHORTER 
Fig. 6.15: Simple effects analysis of delay length*dclay interaction: The effect of reduced task delays on rate of 
discounting of delayed reward under each condition. Each point represents the mean percentage ± SEM. *, 
p<0.05. **, p<0.01, ***, P<0-001 (Bonferonni comparison) as compared to choice of delayed reward at 0 
seconds delay condition. 
6.3.5.2. Speed of Responding 
Reducing delays in the task had no significant effect on the latency to initiate trials (t 1.592, df 
= 9, N. S), or the speed with which animals selected a delayed and immediate choice t=0.592, 
df = 9, N. S.; t=1.333, df = 9, N. S., respectively). 
No differences in comparison to BL were indicated on the speed with which reward was 
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collected following either a delayed or immediate reward choice in the task (t = 0.097, df = 9, 
N. S.; t= -1.711, df = 9, N. S., respectively). See table 6.11 for speed of responding parameters 
during the delay manipulation. 
63.5.3. Omissions 
The frequency of failures to initiate trials did not differ significantly from Bl, performance (Z = 
-0.316, N= 10, N. S. ). However, the number of magazine omissions following the selection of 
the delayed reward increased significantly when the shorter delays were tested (Z = -2.103, N 
10, p=0.035) (see Table 6.12). 
Table 6.11: Speed of responding in the delayed reinforcement task following reduction In 
task delays 
Behavioural Measure Average BL 
Normal Task Delays 
Shorter Task 
Delays 
Initiation Latency 1.21 :b0.05 1.06 ± 0.13 
Immediate Response Latency 0.67 ± 0.04 0.69 ± 0.05 
Delayed Response Latency 0.72 ± 0.05 0.68 ± 0.04 
Immediate Magazine Latency 0.22 ± 0.03 0.24 ± 0.03 
Delayed Magazine Latency 1.60 ± 0.73 2.76 ± 1.07 
Table 6.11: Each value represents the mean latency (seconds) * SLM. 
Table 6.12: Omissions in the delayed reinforcement task following reduction In task 
delays. 
Behavioural Measure Average BL Shorter Task I 1ý 




Following Delayed Choice 
0.24 ± 0.16 
1.70 ± 0.97 
0.20 ± 0.13 
4.10 ± 1.67* 
Table 6.12: Each value represents the mean frequency :k SEM. *, p<0.05, **, p<0.01, ***, p<0.001 
(Bonferonni comparison) as compared to baseline. 
6.4. DISCUSSION 
The delayed reward task is a paradigm utilised extensively in preclinical research to assess 
levels of impulsive choice in rodents (e. g. Evenden and Ryan, 1996; Cardinal et al., 2000; Isles 
et al., 2003; Paine et al., 2003; Winstanley et al., 2003a; Uslaner and Robinson, 2006). The 
studies reported in the present chapter were conducted to assess the appropriateness of the task 
for longer term drug studies and to assess the effects of manipulations of primary motivation 
which are expected to occur following nicotine administration. 
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The present study replicated findings reported in previous research using this behavioural 
paradigm (Evenden and Ryan, 1996; Cardinal et al., 2000). As training progressed, animals' 
choice behaviour became contingent upon the delay to the delivery of the larger reward. Rats 
displayed a systematic shift in response from a choice of the larger delayed reward at short 
delays, to choice of the smaller immediate reward when the delay to the delivery of the larger 
reward was increased. A significant reduction in preference of the delayed reward was observed 
at the higher 20,40 and 60 second delay conditions in comparison to choice trials when no 
delays were present. The delay discounting indicated is comparable to the pattern of choice 
observed previously in mice (Isles et al., 2003) pigeons (Mazur, 1987; Green et al., 2004) and 
humans (Rachlin et al., 1991; Green et al., 1994). 
6.4.1. Stability of Task Performance 
Results of Experiment 5A indicated that levels of impulsive choice remained stable across a 
three week period. These findings confirm and extend the findings of Ev enden and Ryan (1996) 
and Cardinal et al. (2000) concerning long-term sensitivity to delayed reward in the paradigm. 
Moreover, the findings are consistent with more recent research in the human literature that has 
provided evidence of the stability of delay discounting over a three month period in a control 
student population (Ohmura et al., 2006). The speed of responding and frequency of omissions 
during task performance also displayed no evidence of significant variation during the 21 day 
period. The latency to initiate trials, make a reward choice and collect a reward were extremely 
rapid (all <2 seconds), indicating that behavioural performance was under a high degree of 
stimulus control. In further support of this, omissions to initiate trials and to select and collect 
the rewards were minimal during performance of the task. The demonstration of stability of 
both choice behaviour and other task parameters in a control group of animals is crucial for later 
experiments of this thesis; this will enable any changes observed during chronic drug exposure, 
and initial and long-term drug withdrawal to be more confidentially attributed to the drug 
manipulations rather than changes in baseline performance. 
A further important observation during the experimentation of this chapter was that, despite 
identical training on the task, extensive individual variability in impulsive choice was 
demonstrated at baseline (see Fig 6.6). The presence of individual differences in levels of 
impulsivity have been reported previously by authors adopting this particular delayed reward 
task (e. g. Cardinal et al., 2000; Winstanley et al., 2003a; Dellu-11agedorn, 2006) and also'other 
variant models, including adjusting amount, and delay procedures (Richards et al., 1997; Perry 
et al., 2005) and the T-maze delay discounting paradigm (Poulos et al., 1995). Based on the 
exponential model of decay, k estimates in animals in the present study ranged from, 0.066 to 
0.864, allowing a- group of high (k range: 0.864 to 1.309) and low impulsive (k range: 0.066 to 
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0.280) animals to be identified. Supporting earlier research, the differences in learning ability 
were incapable of explaining the variation in rates of delay discounting, With both high and low 
impulsive animals requiring a comparable average of 41.5 ± 0.67 and 42.75 ± 2.31 training 
sessions respectively prior to the display of delay sensitive, stable choice behaviour in the task 
(Poulos et al., 1995; Dellu-Hagedorn, 2006). Taken together, these finding strongly suggest that 
the variability in performance at baseline may reflect differences in "trait" level of 
impulsiveness in rodents (Poulos et al., 1995; Perry et al., 2005). 
These observed levels of "trait" discounting of de , 
layed reward, as indicated by k, appear 
however to be considerably greater than that reported previously utilising a comparable model 
of delayed reward in rodents (k range: 0.011-0.140) (Winstanley et al., 2003). This suggests that 
the animals in the present research are substantially more impulsive. As both studies utilised 
Lister-hooded rodents, strain differences can not account for differences in the levels of 
discounting observed (e. g. Adriani et al., 2003). A difference across studies, however, was the 
level of food restriction adopted; animals in the study of Winstanley et al. were maintained on 
14g of food per day in contrast to the 18.6g utilised in the present study. Previous research 
(Bradshaw 
, 
and Szabadi, 1992; Wogar 1992; Ho et al., 1997), and data from the present study 
(see below), suggest that more severe, prolonged deprivation can lead to an increase in choice of 
delayed reward which may account for the reported lower levels of impulsive choice at baseline 
in previous research (Winstanley et al., 2003). 
It is important to emphasise that the primary index of impulsivity in the paradigm is that of the 
percentage choice of delayed reward and the present research was not designed to compare 
competing models of delay discounting functions. Although the discounting of the delayed 
reward displayed by animals in the present research were well-described by the exponential 
model (see Table 6.2), it is highly plausible that other competing models such as the hyperbolic 
function may have additionally accounted for the data effectively (Richards et al., 1997; 1999a; 
Mazur, 2001). Comparison of decay functions that can account for choice behaviour within this 
model is an avenue for future research. 
6.4.2. The Effects of Alterations in Primary Motivation on Task Performance 
Nicotine is known to have effects on appetite (Grunberg, 1986; Grunberg et al., 1986; Miyata et 
al., 1999; Zhang et al., 2001). Given that later studies of this thesis assess the effects of acute 
and chronic nicotine administration and nicotine withdrawal on task performance, it was 
important to determine the effects of both increases and decreases in motivation for reward on 
performance in the delayed reward task. In agreement with previous research, acute prefeeding 
of normal rat chow and sucrose pellets had no significant effect on preference for delayed 
reward in the task (Logue and Pena-Correal, 1985; Logue et al., 1988; Richards et al., 1997; 
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Cardinal et al., 2000; Wade et al., 2000). Speed of responding parameters were however 
increased following prefeeding, indicating evidence of changes in motivation for reward. 
Consumption prior to testing of both normal rat chow and sucrose pellets, significantly 
increased the latency to initiate trials and respectively slowed the speed with which the 
immediate reward was chosen and the delayed reward was collected. These findings suggest 
that speed of responding measures and choice behaviour in the task can change independently. 
The lack of effect of a decrease in motivation on choice behaviour was also replicated following 
the prolonged increase in food intake. This was despite the 16 times greater increase in absolute 
BW across the seven day period relative to BL weight gain. In contrast to the acute feeding 
manipulations, longer term reduction in daily food intake was not associated with changes in the 
speed of responding in the task. These findings suggest that acute prefeeding displayed a greater 
magnitude of effect on speed of responding in comparison to prolonged reduction in 
deprivation level. 
Conversely, acutely increasing the deprivation state of animals, significantly increased the 
overall choice of delayed reward in comparison to baseline choice behaviour. The enhanced 
preference of the delayed larger reward was delay-dependent, increasing choice significantly 
during the 10 second duration trials. The discounting of delayed reward was clearly less 
pronounced following the decrease in daily food intake, with only choice at the highest delay 
differing significantly from choice at the 0 second delay condition. Evidence of increased 
motivation for food reward was indicated by the significant reduction in the speed with which 
the delayed reward was collected and the reduction in failures to initiate trials. A comparable 
increase in the overall choice of delayed reward was observed following the prolonged increase 
in motivation for food reward, an effect that only reached significance during the final test 
session on the seventh day of the manipulation. The effect was not delay-dependent, although 
trends of an increase in preference of delayed reward in comparison to baseline were observed 
at the. highest 40 and 60 second delay conditions. No other behavioural parameters in the task 
were affected by the increase in deprivation state, although the restricted daily feeding regime 
led to a significant (I 1.5g) loss in BW. Once again, in comparison to the acute-induced increase 
in motivation for reward, longer term increases in level of deprivation on task performance 
appear to be having less of an effect on performance. The increased preference for delayed 
reward observed following the acute and long-term increase in deprivation is in agreement with 
some (Bradshaw and Szabadi, 1992; Wogar 1992; Ho et al., 1997) but not all previous reports 
examining the effects of deprivation level on choice behaviour (Logue and Pena-Correal 1985; 
Logue et al., 1988; Cardinal et al., 2000; Wade et al., 2000). The variant delayed reward 
paradigms and contrasting food and water rewards utilised across research is likely to account 
for the discrepancy in findings. 
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Taken together, these findings have provided valuable comparator data of the effects of 
alterations in motivation for food reward which will facilitate interpretation of the effects of 
nicotine on performance of this task. The demonstration that choice behaviour was insensitive to 
decreases in motivation for the food reward, suggests that the anorectic effects of nicotine 
(Grunberg, 1986; Miyata et al., 1999; Zhang et al., 2001) are likely to play a minimal role in the 
drug-induced behavioural changes in the task. In contrast, the present findings suggest the need 
for caution when interpreting the effects of nicotine withdrawal on impulsive choice, during 
which, an associated increase in appetite and weight gain has been reported (Grunberg et al, 
1986; Miyata et al., 1999). The present findings demonstrate that increasing motivation for the 
food reward leads to increases in the choice of the larger delayed reward and may be incorrectly 
inferred as being less impulsive. It is therefore crucial that the effects of increased "motivation 
for food reward on task performance are considered during the interpretation of nicotine 
withdrawal on impulsive choice. 
6.4.3. Delay Sensitivity 
To determine the sensitivity of animals' choice behaviour to variations in the delay of 
reinforcement, a final manipulation involved the assessment of the effects of reducing the 
standard task delays on choice behaviour to 0,1,2,5, and 15 seconds. This led to the substantial 
increase in overall choice of delayed reward (>80%). Under the delay manipulation, choice 
behaviour displayed minimal evidence of delay dependency, with choice of delayed reward 
failing to differ across delay conditions (see Fig. 6.15). The substantial changes in choice 
behaviour confirm that performance in the delayed reward task is highly controlled by changes 
in delay. The fact that heightened sensitivity to delay was demonstrated even after a six month 
period of extensive training and testing indicates strong evidence that the pattern of choice 
behaviour within the task does not become a habitual response with longer term testing. Still 
evident during the delay manipulation however, was the characteristic within session shift in 
choice from the delayed to the immediate reward. This suggests that the passage of time, or 
progression of the session, may be a factor that, in addition to delay, may be affecting choice 
behaviour in the task. A limitation of the present research is that it does not effectively examine 
this theory. In order to explore this factor, complete omission of delays on choice behaviour 
could have been investigated or the effects of reversal of the normal sequence of delay 
conditions assessed. Research that has indeed investigated these manipulations in comparable 
paradigms reported that reversal of delay conditions leads to the alteration of choice of delayed 
reward in the opposite direction (Cardinal et al., 2000; Isles et al., 2003). The complete removal 
of delays profoundly increases the choice of delayed reward, although the shift from delayed to 
immediate reward remained, suggesting that to some extent the progression of the session may 
come to control rodent choice behaviour in the task with extensive testing (Evenden and Ryan, 
1996; Cardinal et al., 2000). 
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6.4.4. Conclusions 
In conclusion, the present studies demonstrated the long-term stability of choice behaviour and 
its sensitivity to delay, the lack of effect of decreases in primary motivation on impulsive 
choice, and the sensitivity of choice behaviour to increases in motivation for food reward. These 
data indicate the utility of the delayed reward task as an effective paradigm for the future 
investigation of effects of nicotine on impulsivity. Furthermore, the findings suggest caution 
must be given when interpreting the effects of nicotine withdrawal on task performance. 
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CHAPTER 7 
Acute effects of nicotine on impulsive. - choice and 
the mediating role of the central nicotinic receptors 
7.1. INTRODUCTION 
7.1.1. General Introduction 
Impulsive choice is considered a central mechanism in the acquisition, maintenance and relapse 
of drug addictive disorders. Drug dependent individuals frequently select the relatively brief but 
immediate reinforcing effects, or relief of withdrawal symptoms achieved from drug 
intoxication, over the longer term social and health benefits associated with a drug free life style 
(Madden et al., 1997). 
Research using the DD task has shown that drug users discount the value of delayed rewards at 
a steeper rate than non-drug abusing controls. This has been reported for abusers of cocaine 
(Moeller et al., 2002; Coffey et al., 2003; Kirby and Petry, 2004), opioids (Madden et al., 1997; 
1999; Kirby et al., 1999; Kirby and Petry, 2004) and alcohol (Vuchinich and Simpson, 1998; 
Petry, 2001). Demonstration has also been made of the pervasiveness of heightened impulsive 
choice in heavy smokers (Bickel et al., 1999; Mitchell, 1999; Reynolds et al., 2004; Reynolds, 
2006a; Johnson et al., 2007). Greater sensitivity to delayed gratification in smokers in 
comparison to non-smokers has been demonstrated across differing magnitudes of reward, when 
considering both losses and gains (Baker et al., 2003), and when making choices regarding a 
range of commodities (Odum. et al., 2005). Consistent with other drug dependent populations, 
smokers furthermore display more pronounced delay discounting of their drug of abuse (i. e. 
cigarettes) in comparison to other reward commodities. This finding suggests that the delayed 
drug of abuse loses its subjective value to a greater extent than other delayed rewards (Bickel et 
al., 1999; Baker et al., 2003; Johnson et al., 2007). 
Whilst past research has left no doubt regarding the association between nicotine dependent 
individuals and impulsive choice, what remains unclear is to what extent the heightened 
sensitivity to delayed gratification leads to the initiation of smoking, or to what extent the 
heightened sensitivity to delayed gratification is a consequence of nicotine exposure. The 
demonstrated dose-dependent type relationship that has been shown between cigarette smoking 
and DD, suggests that the relationship is of a causal nature (Reynolds et al., 2004; Ohmura et 
al., 2005; Reynolds, 2006a; Johnson et al., 2007). One study that has attempted to explore the 
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direction of causality between impulsive choice and nicotine dependence by comparing 
adolescent smokers (smoked on average for 2.23 years), adult smokers (smoked on average for 
5.00 years) and non-smokers (Reynolds, 2004). Reynolds argued that if impulsivity was a 
determining factor in the onset of nicotine addiction then both smoking groups should not differ 
in terms of impulsivity choice. Conversely, if long term cigarette consumption induces 
heightened impulsivity then adult smokers should display significantly greater rates of 
discounting in comparison to adolescent smokers. The results demonstrated that adult smokers 
discounted delayed monetary rewards to a greater degree than both non-smokers and young 
adolescent smokers. Adolescent smokers did not differ significantly from the control group, 
supporting the hypothesis that heightened impulsivity may be a consequence of long term 
nicotine exposure. For this interpretation to hold true however it must be assumed that all the 
adolescent smokers will continue smoking until adulthood. 
In order to assess the theory that differences in impulsive choice between smokers and non- 
smokers arises due to the exposure of nicotine, research is necessary that explores directly the 
effects of the stimulant on DD. Despite the extensive research examining the effects of acute 
administration of stimulants such as cocaine and amphetamine (e. g. Cardinal et al., 2000; Paine 
et al., 2003; Helms et al., 2006), only one study has been conducted to assess the cffects of 
nicotine on impulsive choice. Following the acute administration, of nicotine (0.03-1. Omg/kg), 
Dallery and Locey (2005) reported a dose dependent increase in choice of the immediate 
smaller reward in a rodent adjusting delay paradigm. Caution, however, needs to be given when 
interpreting these findings, because the study consisted only of 5 subjects and the researchers 
failed to counterbalance the order of treatment doses across animals. 
Although currently there is limited evidence to support the hypothesis that heightened 
impulsivity is a consequence of nicotine exposure, it is highly likely that nicotine impacts levels 
of impulsive choice due to the stimulants known ability via the nAChRs to alter the functioning 
of neurobiological systems believed to be involved in the mediation of the sensitivity to delayed 
reward (Di Chiara and Imperato, 1988; Nisell et al., 1996; Summer et al., 1996; Balfour et al., 
1998; Mobini et al., 2000a; Cardinal et al., 2000; 2001; Adriani et al., 2004; Kheramin et al., 
2004). 
7.1.2. Objectives of Experiment 6 (A-C) 
The primary objectives of Experiment 6 were therefore: 
i) To assess the acute effects of nicotine on impulsive choice as measured by the 
systematic delayed reward paradigm. 
ii) To determine whether the effects of acute nicotine on impulsive choice are, mediated 
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through central nAChRs. 
As in the experiments of Chapter 4, to achieve these objectives a dose response function for 
nicotine was initially determined on impulsive choice. As detailed previously (section 4.1. ), 
nicotine acts via stimulating the nAChRs located throughout the CNS and peripheral nervous 
system. To establish whether nicotine's effects on impulsive choice were also mediated by 
central nicotinic receptors, the dose response function for the centrally acting nicotinic 
antagonist MEC was also examined. Finally, combination drug treatments of nicotine and 
'silent' MEC were administered to assess whether MEC could antagonise the effects of nicotine 
in the delayed reward task. 
7.2. EXPERIMENT 6 (A-C): EXAMINATION OF THE EFFECTS OF ACUTE 
ADMINISTRATION OF NICOTINE ON IMPULSIVE CHOICE AND 
CHARACTERISATION OF THE RECEPTORS MEDIATING THESE EFFECTS 
7.2.1. METHOD 
7.2.1.1. Subjects 
Subjects were 11 adult male Lister Hooded rats (Charles River, UK). Animals were housed in 
pairs on arrival at the laboratory and maintained under a 12 hour light/dark cycle (lights on at 
0700h) at controlled environmental temperature of 21 *C ± 41C and relative humidity of 50% ± 
10%. Across experiments food was restricted in order to maintain animals at 85% of their free 
feeding body weights. Water was available freely in home cages and feeding occurred at the end 
of each experimental day. At the start of testing, animals weighed approximately 350-380g. The 
same subjects were utilised for Experiments 6(A-C). Following the assessment of acute nicotine 
in Experiment 6A one subject failed to return to a stable baseline and was therefore removed 
form study. Only 10 subjects therefore completed Experiments 6B and 6C. All animals were 
treated in accordance with the UK Animals (Scientific Procedures) Act 1986. 
7.2.1.2. Apparatus 
Subjects conducted the task in two sets of four operant chambers (dimensions 30.5 X 24.1 X 
21cm and 30.5 X 24.1 X 29.2cm, Med Associates Inc., USA). Refer to Chapter 2 section 2.5.1 
for a detailed description of apparatus. 
7.2.1.3. Behavioural Testing 
The behavioural. procedure of the delayed reinforcement task, in addition to the pre-training 
required has been described previously in the general methodology of Chapter 6, section 6.2.1.3. 
In this section also is the outline of behavioural measures assessed in the paradigm. Training 
continued on the task until subjects displayed choice behaviour that was delay sensitive and 
stable across a ten day period. Training was completed within approximately 10 weeks, during 
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which animals completed one session of the task per day. 
7.2.1.4. Drugs 
Both nicotine hydrogen tartratc salt and mccamylamine hydrochloride (MEC) were dissolved in 
0.9% saline and administered s. c. in a volume of I mL'kg body weight. All doses were calculated 
as free base and prepared freshly on each test day. The p1l of all NIC drug solutions was 
adjusted to approximately 6, using O. lM sodium hydroxide. Nicotine (0,0.125,0.25 and 
0.5mg/kg) was administered s. c. 10 minutes prior to operant testing. The decision not to 
examine the effects of the higher 1. Omg/kg dose of nicotine was based upon the sedation and 
non-specific disruption of behaviour that was observed following its treatment in the go/no-go 
task (see Chapter 4, section 4.4). MEC (0,0.1,0.3 and I. Omg/kg) was administered s. c. 20 
minutes was prior to testing. 
7.2.1.5. Design and Procedure 
A within-subjects design was employed for experiments 6 (A-C). Treatment conditions were 
administered according to a Latin square design with a minimum of 72 hours separating 
consecutive drug treatments., It was ensured that animals had returned to BL performance prior 
to subsequent treatment doses being administered. Baseline was defined as impulsive choice 
deviating no more than 10% from the level of overall choice of delayed reward demonstrated by 
the sub ect prior to the initiation of Experiment 6A. Between experiments a one week 'wash j 
out' period was given to minimise the possibility of drug carry over effects. During this period 
animals continued to perform the operant task once per day. 
In the week prior to the initiation of drug testing, animals were habituated to injection 
procedures on two occasions, with subjects injected with I ml/kg s. c. saline 10 minutes prior to 
the operant session. All experimentation followed standard operant testing procedures, outlined 
in detail in the general methodology of Chapter 2, section 2.5.2. All injection procedures were 
conducted in a procedure room separate from both the holding room and operant test laboratory. 
Testing, took place during the light phase of their LD cycle between 0830h and 1400h. 
Experimentation was conducted over a 16 week period. 
7.2.1.5.1. EXPERIMENT 6A: THE EFFECTS OF ACUTE ADMINISTRATION OF NICOTINE ON 
PERFORMANCE IN THE DELAYED REWARD TASK 
The dose-response of nicotine on impulsive choice was first examined. Each of the four 
treatment conditions (0,0.125,0.25, and 0.5mg/kg s. c. ) were administered 10 minutes prior to 
the test sessions following which they were transferred immediately to the operant test room. 
The sequence of nicotine doses was administered twice to each animal. Examination of each 
drug dose during two test sessions enabled a more accurate determination of the drug effects on 
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impulsive choice, through increasing the number of choice trials at each delay to twenty. 
7.2.1.5.2. EXPERIMENT 6B: Ti[E EFFECTS OF ACUTE ADMINISTRATION OF 1%1ECAMYLAMINE 
ON PERFORMANCE IN THE DELAYED REWARD TASK 
Following Experiment 6A, a MEC dose response function (0,0.1,0.3 and l. 0mg/kg) was 
examined. As no difference in performance during time one and time two treatment of nicotine 
was observed on task performance each treatment of MEC was administered only once (see 
results section 7.3.3.2). The longer inter-injection interval for the antagonist meant that animals 
were first returned to their holding rooms until 10 minutes prior to testing, at which point they 
were transferred directly to the operant testing laboratory. 
7.2.1.5.3. EXPERIMENT 6C: THE EFFECTS OF CO-ADMINISTRATION OF NICOTINE AND 
MECAMYLAMINE ON PERFORMANCE IN THE DELAYED REWARD TASK 
Following Experiment 6B, nicotine and MEC were co-administcred to determine whether the 
nicotinic antagonist was capable of blocking the effects of nicotine on the delayed 
reinforcement task observed in Experiment 6A. The O. Smg/kg dose of nicotine was selected on 
the basis that this dose increased sensitivity to delay to the greatest extent across the nicotine 
dose range tested during Experiment 6A. Furthermore, this dose affected a range of bchavioural 
parameters in the task, indicative of an increase in impulsive behaviour. MEC dose-rcsponse 
data from Experiment 6B demonstrated a lack of effect of the antagonist on impulsive choice 
across the dose range examined, enabling three 'silent' doses of the drug to be co-administered 
with nicotine. Treatment conditions during the co-administration experiment were saline/saline, 
saline/NIC0.5. g/kg, MECo. jmg/kg/NICO. 5mg/kgt MECO. 3mg/kg/NlCO. 5mg/kg and MECI. O. IAV NICO. 5'mg/kg- 
Saline/saline and saline/ NIC0.5. Wkg drug combinations served as treatment controls. 
Saline/saline, controlled for the effects of combination injections on behaviour, whilst the 
combined administration of saline/ NICO. 5. gAg, acted as a positive drug control. The first of all 
combination treatments was administered 20 minutes prior to testing, following which animals 
were returned to their holding room. Ten minutes prior to the testing session, animals were then 
returned to the preparation room where the second treatment was administered after which they 
were transferred directly to the operant testing room. All drug combinations were administered 
once. 
7.2.1.6. Statistical Analysis 
To assess the sensitivity to delay and stability of baseline behaviour prior to drug testing, data 
from ten consecutive test sessions was analysed using a two-way repeated measures ANOVA, 
with both day and delay as the within subject factors. A significant main effect of delay would 
indicate sensitivity of choice behaviour across delays, while a non-significant main effect of day 
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would demonstrate evidence of stability of this choice. 
For all drug experiments behavioural parameters, including overall choice of delayed reward 
(CDR), speed of responding and omissions were analysed using a one-way repeated measures 
ANOVA. Analysis of the choice of reward by delay, was conducted using a two-way repeated 
measures ANOVA, with both treatment condition and delay (0,10,20,40 and 60s) as the 
within subject variables. During experiment 6A, each dose of nicotine was administered twice; 
data therefore from both test sessions was averaged for each treatment dose prior to analysis. 
Due to the repeated administration of nicotine during experiment 6A, dose response data on 
choice behaviour was compared from time one administration to time two. This analysis was 
conducted to assess whether prior nicotine exposure altered subsequent response to nicotine. A 
threc-way ANOVA was applied to the data with treatment, delay and time as the within subject 
factors. 
Choice behaviour on the task during non-drug baseline days was compared across Experiments 
6A-C. This analysis was conducted to determine the stability of BL impulsive choice across the 
16 weeks of testing. Independently for each experiment, choice behaviour across delays during 
the BL test session immediately prior to each treatment dose was averaged. The average 
baseline for Experiment 6A, 6B and 6C was then analysed by a two-way repeated measures 
ANOVA with Experiment and delay as the within subject factors. 
All significant main effects of analysis were assessed further by Bonferroni post hoc 
comparisons. Significant interactions were examined further by simple effects analysis. In the 
case of significant treatment x delay interactions, simple one-way ANOVAs were used to 
examine both the main effects of treatment dose across each of the five delay conditions and the 
main effects of delay at individual treatment doses. Mauchley's test of sphericity was applied to 
all within subject variables, and when appropriate the degrees of freedom adjusted with the 
Greenhouse-Geisser correction. All data prior to analysis was assessed for normality and 
transformed where necessary (see also section 2.7). If data could not be successfully 
transformed, then the non-parametric Friedman test was employed, followed where appropriate 
by Wilcoxon Signed Ranks tests. In all cases of analysis a values of p<0.05 were deemed 
statistically significant. 
7.3. RESULTS 
Further supplementary statistical information (ANOVA tables) can be found in Appendix 2. 
Across experiments 6(A-C) omissions of both lever selection and collection of reward following 
an immediate choice were not analysed due to both behaviours rarely occurring. 
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7.3.1. Baseline Performance: Pre-drug Testing 
Prior to the initiation of drug testing analysis of choice behaviour across ten consecutive 
sessions demonstrated that behaviour was both stable (F(9,90) = 0.337. N. S) and delay sensitive 
across animals (F(4,40) = 52.301. p< 0.001). Post hoc analysis revealed that tile greatest 
sensitivity to delay was during 40 and 60 second delays. During these trials choice for tile 
immediate reward was significantly greater in comparison to when no delays were present 
during choice (all p<0.01). No significant delay x day interaction was 116und (F(36,360) - 
1.429, N. S). 
7.3.2. Baseline Performance: During Drug Testing 
Baseline choice behaviour across delay remained consistent across Iýxpcriments with no main 
effect of Experiment (F(2,18) = 0.519, N. S) or experiment x delay interaction observed (1-'(8,72) 
= 0.409, N. S). Baseline choice behaviour furthermore rernamed highly sensitive to delay 
(F(2.251,20.259) = 66.041, p< 0.001), with significant reductions in choice of tile larger 
delayed reward remaining at 40 and 60 seconds delay in comparison to when no delays were 
present (all p<0.01) (see Fig. 7.1). 
Average Baseline Choice Behaviour Across Experimental Stages: 












Fig. 7.1: Comparison of baseline choice behaviour across delay of Experiments 6 A-C 
7.3.3. EXPERIMENT 6A: THE EFFECTS OF ACUTE ADMINISTRATION OF NICOTINE ON 
PERFORMANCE IN THE DELAVED REWARD TASK 
7.3.3.1. Choice Behaviour 
A marked dose-dependent decrease in the choice ofthe delayed reward was lound l'ollowing tile 
acute administration of nicotine (F(3,30) = 30.478, p<0.001). As illustrated in Fig. 7.2, all 
doses administered significantly decreased overall choice ol'delayed reward in comparison to 
the saline control, with the greatest reduction in choice ofdclayed reward being observed at the 
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highest 0.5t-ng/kg dose (all p< 0.01). Furthennore, the choice ot'delayed reward at tile 0.5mg/kg 
dose was significantly lower than the 0.1 25mg/kg and 0.25mg/kg treatment doses (all p<0.01). 
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Fig. 7.2: The effects of acute nicotine on overall percentage choice of dcla)cd rc%ard. Each bar represent% the 
mean percentage ± SEM. *, p<0.05, **, p<0.01, ***, p<O. IH)l (Ronferroni comparl%on) as compared to saline 
control. t, p<0.05, tt, p<0.01, ttt. p<0.001 (Bonferroni comparlson) a% compared to highem I. Omg/kg nicotine 
dose. 
Analysis of' choice by delay once again denionstratcd it highly significant inain el'I'ect of 
treatment dose (1-'(3,30) = 25.610, p-0.001). A main clTect ol'dclay was Ibrilicrinore flound 
(F(I. 653,16.528) = 74.188, p -- 0.001), indicating that pi-O'crence for the delayed larger reward 
was significantly lower at the 20,40 and 60 second delay conditions in comparison to the 0 
second delay condition (all p--0.01). Analysis revealed a significant treatinciit (lose x delay 
interaction, suggesting that treatment doses differentially allected choice ofthe larger reward by 
delay (1-(12,120) = 5.016, p -- 0.001). To examine the interaction hirther a series one-way 
ANOVAs assessing the main effect of* treatment at each delay were conducted (see Fig. 7.3). No 
significant main effect of treatment was observed at the 0 second delay condition with tile 
predominate choice being that of'the larger reward across drug treatments at this delay (1, '(3.30) 
=0.897, N. S. ). Conversely, significant main effects of'nicotine treatment it the 10,20,40 and 60 
second delay conditions were found (all F(3,30) > 6.550. p-0.002). Post hoc comparisons 
revealed that following the lowest 0.125mg/kg dose. choice ot'delayed reward was significantly 
lower only during 40 second delay trials in comparison to choice behaviour at this dclay 
following saline control (p<0.05). Following treatment of' the 0.251ng/kg dose. choice of' tile 
delayed reward in comparison to saline control was significantly lower at both tile 40 and 60 
second delay conditions (all p<0.0 I ). At the highest 0.5mg/kg dose choice was decreased at 10. 
20,40 and 60 second delay conditions in comparison to choice at these dclays following saline 
(all p<0.01). Fut-thermore, the reduction in choice at 10 seconds following 0.5mg/kg dose 
reached significance in comparison to the lowest 0.125nig/kg dose (p- 0.05). Decreased choice 
during the 20 second delay trials additionally reached significance in comparison to tile 
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0.1 25mg/kg and 0.25mg/kg doses (all p<0.05). 
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Fie. 7.3: Simple effects analysis of treatment*dclay interaction: The effects of acute nicotine on percentage 
choice of delayed reward across delay condition. Treatment effects across each delay. Each bar represents the 
mean percentage ± SEM. *, p<0.05, **, p<0.01, ***, p<0.001 (Bonferroni comparison) as compared to saline 
control. t, p<0.05, tt, p<0.01, ttt, p<0.001 (Bonferroni comparison) as compared to highest 0.5mg/kg nicotine 
dose. 
The significant dose x delay interaction was further analysed by examining the main effect of 
delay at individual test doses. As illustrated in Fig. 7.4, all doses displayed a significant main 
effect of delay (all F(4,36) > 34.477, p<0.00 1), with a dose related reduction in choice of 
delayed reward across 10,20,40 and 60 second delay conditions following nicotine treatment. 
Analysis of choice behaviour across delay during saline treatment displayed a significant 
reduction of choice of delayed reward at 40 and 60 seconds delay in comparison to when there 
was no delay following the selection of the larger reward (all p<0.01). A similar behavioural 
pattern of choice of delayed reward was shown at the lowest 0.1 25mg/kg treatment of' nicotine 
where the greatest intolerance to delay was also seen at 40 and 60 second delay conditions (all 
p<0.01). Following 0.25mg/kg choice of delayed reward was significantly lower at 20,40 and 
60 delay conditions in comparison to the 0 second delay condition (all p<0.05). Under tile 
influenced of the highest 0.5mg/kg nicotine dose, post hoc analysis indicated that choice of the 
delayed reward was significantly lower across all delays in comparison to the 0 second delay 
condition (all p<0.01). 
233 
Omg/kg 0.125mg/kg 0.25mg/kg 0.5mglkg 
Nicoltne Dose (mg/kg) 
Chapter 7- Acute Effects of Nicotine on Impulsive Choice 













Fig. 7.4: Simple effects analysis of treatment*delay interaction: The effects of acute nicotine on rate of 
discounting of delayed reward under each treatment dose. Each point represents the mean. Each point 
represents the mean. *, p<0.05. **, p<0.01, ***, p<0.001 (Bonferroni comparison) as compared to choice of 
delayed reward at 0 seconds delay condition. 
7.3.3.2. Comparison of Administration of Nicotine at Time One and Time Two 
No differences in response to nicotine were observed on choice of delayed reward across delay 
at time one and time two administration of treatment. This was supported by the non significant 
main effect of time (F(l, 10) = 0.187, N. S. ) and the lack of signi f icant time x treatment (F(3,30) 
= 1.129, N. S. ), time x delay (F(4,40) = 0.845, N. S. ) and time x treatment x delay (F(12,120) 
0.624, N. S. ) interactions. 
7.3.3.3. Speed of Responding 
Nicotine treatment was found to decrease the latency to initiate trials in tile task (F(3,30) 
8.101, p<0.001). This effect reached significance at the 0.25mg/kg (p<0.05) and 0.5mg/kg 
(p<0.01) doses of nicotine in comparison to the control treatment condition (see Fig. 7.5). Tile 
speed with which animals made a choice between rewards, however, was not affected following 
nicotine treatment. This lack of effect was evident for both the latency to choose the immediate 
(F(3,30) = 1.631, N. S. ) and delayed reward ( F(I. 535,15.351) = 1.875, N. S. ). 
The speed with which animals collected food reward following an immediate choice was not 
affected by the acute administration of nicotine (F(3,30) = 0.118, N. S. ). In contrast, following a 
delayed reward choice 0.5mg/kg nicotine significantly reduced the latency to collect the reward 
(X2 = 11.182, df = 3, p= 0.0 11 ). As well as differing from control (p< 0.0 1 ), the 0.5mg/kg dose 
in addition reduced significantly delayed magazine latency relative to 0.25mg/kg nicotine dose 
(p< 0.05). Table 7.1 summarises the effects of the acute administration of nicotine on speed of 
responding in the delayed reward task. 
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FiL,. 7.5: The effects of acute nicotine on trial Initiation latvnc. %. Fach har rcprv%vn1% 1he nican Im1vnc. % 
*, p-0.05, **, p-0.01, ***, p<0.001 (Bonfvrroni comparkon) *% compared to %aline confrol. 
7.3.3.4. Omissions 
No siginflicaill cfl'cct oftrealinent was observe(1 on omissiolls to lllitliltc 111. Ils (X*' 5.1)47, (11' 
3, N. S). At (lie lugliest 0.5nig/kg (lose however a significant decrease in magazine omissions lo 
collect delayed reward was shown (X" 9.720, (it' 3,1) 0.021 ). Table 7.2 summanses the 
effects ofnicotinc trcatment on omissions. 
Table 7.1: The effect of acule nicotine on speed of respondhig in the dclaý ed rcý% ard tjt%k 
lichavioural 
m - 
Nicolinc Dow (ing ký-) 
casill C 
S. 11111C 0.125 0.25 
(control) 
I 
Inilliedialc Rc. spolisc I alclic. " 0.61 f 0.03 0.63 1 0.03 0.62 1 0.02 0.00 1 0.0 1 
Dclaycd Rcsponsc I. amicy 0.73 1 0.03 0.67 1 0.03 0,73 1 0.04 is 1 00 
1111111c(lialc magallfic I'atclicy 0.29 1 0.05 0.27 1 0.04 0.26 f 0.03 .1, I (). I 
Dclayed magazilic I "ItclICN, 1.09 f 0.21 (), 93 1 0.20 0.90 1 (). 2()1- 0,04 f 0.20 
Fable 7.1: Each value reprewnis the Incan lulenc) (%Ccond%) I IsiFNI. p- 0.05, p- 0.01, "', p- 11.0111 
(Bonferroni comparison) a% compared to %aline confrol. 1. p- 1). (15. p- (). ()I. p. (I. IHII (IjonIVI-onj 
comparison) as compared to highem 0.5mg/kg nicollne dow. 
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Magazine Omissions Following 
Delayed Choice 
Nicotinc Dosc (nig/kg) 
Saline 0.125 0.25 0.5 
(control) 
0.27 ± 0.18 1 0.32 ± 0.15 1 0.14 ± 0.10 1 0.59 ± 0.24 
1.23 ± 0.49 1 1.09 ± 0.48 1 0.73 ± 0.50 1 0.45 -t 0.31 * 
Table 7.2: Each value represents the mean frequency ± SENI. *, P<0-05, **, p<0.01, ***, p<0.001 (Ronferroni 
comparison) as compared to saline control. 
7.3.4. EXPERIMENT 6B: THE EFFECTS OF ACUTE ADMINISTRATION OF MECAMVLAMINE ON 
PERFORMANCE IN THE DELAYED REWARD TASK 
7.3.4.1. Choice Behaviour 
A significant main effect of treatment was observed on overall choice of delayed lever 
following treatment with MEC (F(3,27) = 30.478, p=0.01 1). Post hoc analysis however revealed 
that no drug treatments differed significantly from control. ]'he main eflect instead reflected 
evidence of a marginal, though significant, difference between the highest, l. Onig/kg dose, 
where an decrease in choice of delayed reward was shown, in comparison to 0.1 mg/kg treatment 
(p<0.05) (see Fig 7.6). 















Fig. 7.6: The effects of acute mecamylamine on overall percentage choice of delayed reward. Each bar 
represents the mean percentage ± SEM. t, p<0.05, tt, P<0-01, tft, p<0.001 (Bonferroni comparison) as 
compared to highest I. Omg/kg nicotine dose. 
Analysis of choice by delay again demonstrated a main effect oftreatment (f, (3,27) = 3.246, p- 
0.037). Post hoc comparisons however displayed no significant differences between drug 
treatments. A highly significant main effect of delay was additionally revealed (F(2.05,18.493) 
t 
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=31.10 1, p<0.00 1), indicating that choice of the delayed reward was significantly lower at 40 
and 60 second delay conditions in comparison to the 0 delay condition (all p<0.05). A 
significant dose x delay interaction was also found (F (12,108) = 2.098, p= 0.028). As shown in 
Fig. 7.7, further analysis of the interaction examining the main effect of treatment at each delay, 
indicated that choice of delayed reward did not differ following treatment at 0,10,40 and 60 
second delays (all F(3,27) < 2.665, N. S). A significant main effect oftreatinent however was 
shown at the 20 second delay (F(3,27) = 4.063, p= 0.017). Post hoc analysis at this delay 
revealed that choice behaviour following treatment did not differ From saline, but instead the 
highest dose of MEC decreased preference for the delayed reward in comparison to the 
0.3mg/kg treatment dose (p = 0.05). 












0 0.1 0.3 1 
Mecamylmalne Dose (mg/kg) 
13 Delay 0 seconds M Delay 10 seconds I ; Delay 20 seconds II Delav40 seconds MD@alv SO seconds 
Fig. 7.7: Simple effects analysis of treat ment*dclay interaction: The effects of acute mccamylarnine on 
percentage choice of delayed reward across delay condition. Treatment effects across each delay. Each bar 
represents the mean percentage ± SEM. t, p<0.05, tt, p<0.01, tit, p<0.001 (Bonferroni comparison) as 
compared to highest I. Omg/kg nicotine dose. 
Exploration of interaction through assessment ofthe main effect ofdclay across individual test 
doses revealed that choice across all treatments of the antagonist were sensitive to delay (all 
F(4,36) > 16.24, p<0.001). Saline treatment, 0.1 and 0.3mg/kg MEC significantly decreased 
choice of the delayed reward at 40 and 60 seconds in comparison to the zero delay condition (all 
p<0.05) (see Fig. 7.8). Choice of the delayed reward Following I. Oing/kg MEC significantly 
decreased choice at 20,40 and 60 seconds delay in comparison to the 0 second delay condition 
(all p<0.05) (see Fig. 7.8). 
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Choice of Delayed Reward Across Delay 
SALINE--O-Moc 
Fig. 7.8: Simple effects analysis of treatment*delay interaction: The effects of acute mecamylamine on rate of 
discounting of delayed reward under each treatment dose. Each point represents the mean. *, p<0.05, **, 
p<0.01, ***, p<0.001 (Bonferroni comparison) as compared to choice of delayed reward at 0 seconds delay 
condition. 
7.3.4.2. Speed of Responding 
Table 7.3 summarises the effect of the nicotinic antagonist on speed ofresponding in the task. 
MEC did not affect the latency to initiate trials (F(3,26) = 0.487, N. S. ), the latency with which 
animals chose either the delayed or immediate reward (all F(3,27) < 1.381, N. S. ) or the speed 
with which animals collected reward following either an immediate ot'delayed reward choice 
(F(I. 722,15.497)= 1.381, N. S; F(3,27) = 0.286, N. S., respectively). 
7.3.4.3. Omissions 
Administration of MEC did not affect the frequency of trial omissions or failure to collect 
reward following a delayed reward choice (all X2< 1.737, df = 9, N. S) (see table 7.4). 
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Mecamylamine Dose (mg/kg) 
easure Saline 0.1 0.3 1.0 
(control) 
Trial Initiation Latency 1.43 ± 0.14 1.66±0.20 1.53 ± 0.15 1.55 ± 0.15 
Immediate Response Latency 0.68 ± 0.06 0.71 0.04 0.66 ± 0.04 0.68 ± 0.04 
Delayed Response Latency 0.73 ± 0.03 0.75 0.05 0.72 ± 0.04 0.72 ± 0.03 
Immediate Magazine Latency 0.30 ± 0.08 0.28 0.05 0.29. +0.05 0.31 ± 0.07 
Delayed Magazine Latency 0.92 ± 0.20 1 0.94 0.22 1 1.15: h 0.33 0.96±- 0.23 
Table 73: Each value represents the mean latency :E SENI. 





Magazine Omissions Following 
Delayed Choice 
Mecamylamine Dose (mg/kg) 
Saline 0.1 0.3 1.0 
(control) 
III 
0.80 ± 0.33 1 1.10 ± 0.60 10.90 J: 0.41 10.70 ± 0.30 
1.30 ± 0.62 1 1.50 ± 0.70 12.00 ± 1.02 1 0.90: L 0.41 
Table 7.4: Each value represents the mean frequency: E SENI. 
7.3.5. EXPERIMENT 6C: TnE EFFECTS OF CO-ADMINISTRATION OF NICOTINE AND 
MECAMYLAMINE ON PERFORMANCE IN THE DELAYED RENVARD TASK 
7.3.5.1. Choice Behaviour 
Analysis of overall choice of delayed reward demonstrated a significant main effect of treatment 
(F(4,26) = 17.487, p<0.001) (see Fig. 7.9). Nicotine treatment alone significantly reduced 
choice of the delayed reward in comparison to saline control (p<0.01). Co-administration of 
nicotine with O. lmg/kg MEC, furthermore, significantly reduced overall choice of the delayed 
reward in comparison to control treatment (p<0.05). Following co-administration of nicotine 
and 0.3mg/kg MEC, however, the choice of the delayed reward did not differ from saline 
treatment and was furthermore significantly greater than choice of delayed reward following 
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nicotine treatment alone (p<0.01). Finally, the co-administration of nicotine and I. Omg/kg MEC 
dose significantly decreased choice of the delayed reward in comparison to saline treatment. 
Following the co-administration of nicotine with both 0.1 and I. Orng/kg MFC, overal I choice of' 
delayed reward was furthermore significantly lower than choice of the delayed reward following 
pre-treatment with 0.3mg/kg MEC (all p<0.05) (see Fig. 7.9). 













He. 7.9: The effects of co-administration of nicotine and mccamyiamine on overall percentage choice of 
delayed reward. Each bar represents the mean percentage I SEM. *, p<0.05, **, p<O. ()I, ***, p<0.0()l 
(Bonferroni comparison) as compared to saline control (O/Omg/kg dose). #, p<0.05, ##, p<0.01, ###, p<0.001 
(Bonferroni comparison) as compared to nicotine treatment alone (0/0.5mg/kg dose). ^, p<0.05, ^^, p<0.01, 
AAA, p<0.001 (Bonferroni comparison) as compared to combined treatment of 0.3mg/kg meca myla mine and 
nicotine (0.3/0.5mg/kg dose). 
The effects observed following co-adininistration ofnicotine and MIT are further supported by 
the significant main effect of treatment following analysis of choice by delay (F(4,36) = 20.248, 
p< 0.001). A significant main effect of delay was also observed (l, (2.315,20.839) = 59.861, p< 
0.001), indicating that choice of delayed reward was significantly reduced during tile 20,40 and 
60 second delay trials in comparison to the 0 second delay condition (all p<0.05). Analysis 
additionally revealed a dose x delay interaction (F(12,120) = 2.317, p= 0.005) (see Fig. 7.10). 
Further assessment revealed that the main effects of treatment across delay conditions reached 
significance at all delays with exception of the 0 second delay condition (all F(4,36) > 4.742, p 
< 0.004). Post hoc analyses revealed that nicotine treatment alone sigilificalitly reduced choice 
of the delayed larger reward at 20 and 40 second delays in comparison to salme (all p<0.05). In 
contrast, examination of pre-treatment with 0.1 and I. Omg/kg MFC decreased choice of' the 
delayed reward significantly at the 20 seconds delay only in comparison to saline control (all 
p<0.05). However, choice of reward across all delays following the co-administratioll of 
nicotine and both O. Img/kg and I. Omg/kg did not differ from that of' choice following tile 
administration of nicotine alone. In contrast, following co-administration of nicotine and 
0.3mg/kg MEC, choice of delayed reward across all delays did not dit'fer from saline control (all 
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p>0.05). Choice of delayed reward, however, at 20,40 and 60 seconds delays was significantly 
greater than choice at these delays following nicotine treatment alone. Pairwise comparisons 
also highlighted that following pre-treatment with 0.3mg/kg MEC, choice of delayed reward 
during the 10 seconds delay condition was significantly greater than choice at this delay 
following pre-treatment with the lowest 0.1 mg/kg M EC dose. 












MDelav 10 Seconds DDelav20 Seconds []Delav40 Seconds MDelav 60 Seconds 
Fig. 7.10: Simple effects anah, sis of treatment*dclay interaction: The effects of acute nicotine on percentage 
choice of delayed reward across delay condition. Treatment effects across each delay (a) and rate of 
discounting at individual doses (b). Each bar represents the mean percentage ± SEM. p<0.05, p<0.01, 
p<0.001 (Bonferroni comparison) as compared to saline control (O/Omg/kg dose). p<0.05, p<0.01, 
p<0.001 (Bonferroni comparison) as compared to nicotine treatment alone (0/0.5mg/kg dose). 
A, 
p<0.05, 
AA, p<0.01, AAA, p<0.001 (Bonferroni comparison) as compared to combined treatment of 0.3mg/kg 
mecamylamine and nicotine (0.3/0.5mg/kg dose). 
Analysis of the dose x delay interaction was further explored through a series of one-way 
ANOVAs assessing the main effects of delay across single combination doses. All treatment 
conditions resulted in choice behaviour that was sensitive to increasing delays (all F(4,36) > 
23.101, p<0.001) (see Fig. 7.11). Post hoc analysis of choice behaviour under saline treatment 
revealed that choice of delayed reward was significantly reduced at 40 and 60 second delays in 
comparison to choice behaviour during the 0 delay condition (all p<0.05). When, nicotine was 
administered alone, choice of the delayed reward was significantly lower across all delays in 
comparison to choice of reward when no delays were present (all p<0.05). Following pre- 
treatment with 0.1 mg/kg MEC, choice behaviour was similar to that of nicotine treatment alone, 
with choice of the delayed reward being significantly reduced at 20,40 and 60 second delay 
conditions in comparison to choice at the 0 delay (all p<0.01). However, following the co- 
administration of nicotine and 0.3mg/kg MEC choice across delays was most similar to saline 
treatment, with choice of delayed reward only reaching significance at 40 and 60 seconds in 
comparison to the 0 delay condition (all p<0.01) (see Fig. 7.11). Intermediate between saline 
control and nicotine treatment alone was the choice across delays following pre-treatment with 
the highest I. Omg/kg MEC. Choice of the delayed reward was decreased at 40 and 60 second 
delay conditions in comparison to choice at the zero delay condition (all p< 0.01). 
241 
0/0 0/0.5 0.1/0.5 0.3/0.5 1.0/0.5 
Mecarnylarnine / Nicotine Dose (mg/kg) 












0 10 20 40 60 
Delay (Seconds) 
Saline/SmOn. a Saline/0.5mg/kg Nicotine 
O. Imglkg Mecantylarnine/0.5m9ft Nicotine 0.3mg/kg M&c&myIamin*IO. 5mgIkq Nicotine 
I. Omg/kg M*camyImmin*/0.5mgIkg Nicotine 
Fig. 7.11: Simple effects analysis of treatment*delay interaction: The effects of acute nicotine on rate of 
discounting of delayed reward under each treatment dose. Each point represents the mean. *, p<0.05, 
p<0.01, ***, p<0.001 (Bonferroni comparison) as compared to choice of delayed at 0 seconds delay. 
7.3.5.2. Speed of Responding 
As in Experiment 6A, nicotine treatment alone significantly decreased latency to initiate trials in 
the task in comparison to control (p<0.05) (F(4,36) = 4.788, p=0.003). All combination nicotine 
and MEC treatment doses conversely failed to reach significance in comparison to saline (all p> 
0.05) (see Fig. 7.12). As shown in Table 7.5 neither nicotine treatment alone or in combination 
with MEC altered the speed with which animals responded on the lever to select their reward, or 
the latency with which they collected their reward (all F(4,36):! ý 2.127, N. S). 











0 -- ----- 
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Fie. 7.12: The effects of co-administration of nicotine and mccamylamine on trial initiation latency. Each bar 
represents the mean percentage ± SEM. *, p<0.05, **, P<0-01, ***, P<0-001 (Bonferroni comparison) as 
compared to saline control (O/Omg/kg dose). 
7.3.5.3. Omissions 
No main effect of treatment was observed on the frequency of trial omissions or failure to 
collect reward following a delayed reward choice (all X2 < 7.800, df = 4, N. S) (see Table 7.6). 
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Table 7.5: The effect of co-administration of nicotine and mccamylamine on speed of 
responding in the delayed reinforcement task 
Behavioural Mecamylamine Dose (mg/kg) / Nicotine Dose (mg/kg) 
Measure Saline/ Saline/ MECO. I. glkV 
MECO. 3mglkV MECI. omglkV 
Saline NICo. 5mg/kg NICO. 5mg/kg NICo. 5 gAs 
NICo. 5. g/kg 
(control) (control) 
Immediate Response 0.64 0.03 0.73 ± 0.04 0.63 ± 0.03 0.63 ± 0.04 0.63 ± 0.05 
Latency 
Delayed 0.71 0.02 0.87 ± 0.11 0.72 ± 0.02 0.72 ± 0.03 0.75 ± 0.05 
Response Latency 
Immediate Magazine 0.30 0.05 0.27 ± 0.03 0.32 ± 0.06 0.27 ± 0.05 0.26 ± 0.04 
Latency 
Delayed 1.07 0.35 0.75 ± 0.19 0.75 ± 0.16 1.26 ± 0.47 1.45 ± 0.62 
Magaz ne Latency I I I I II 
Table 7.5: Each value represents the mean latency :L SEAL 
Table 7.6: The effect of co-administration of nicotine and mccamylamine on omissions In 
the delayed reinforcement task 
Behavioural Mecamylamine Dose (mg/kg) / Nicotine Dose (mg/kg) 
Measure Saline/ Saline/ MECo.,. VkV MECo,,. WIV MECI. o. WkV 
Saline - NICo. 5. g/kg NlCo. 5, ng/kg NlC0.5. sAjj NICo. 5mg/kg 
(control) (control) 
Trial Omissions 0.20 ± 0.13 0.00 ± 0.00 0.30 ± 0.21 0.00 ± 0.00 0.30 ± 0.13 
Magazine Omissions 1.80 ± 1.13 0.9 ± 0.64 0.610.34 2.7 ± 1.72 1.50 ± 0.87 
Following 
Delayed Choice 
Table 7.6: Each value represents the mean frequency: h SEM. 
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7.4. DISCUSSION 
The experiments in the present chapter were designed to examine the effects of acute nicotine 
on impulsive choice and to determine whether these effects were mediated by the central 
nicotinic receptors. Such research was primarily conducted to elucidate whether the heightened 
impulsive choice in smokers may in part be a consequence of nicotine exposure, a theory which 
to date had not been rigorously tested (Bickel et al., 1999; Mitchell, 1999; Baker et al., 2003; 
Mitchell, 2004; Reynolds et al., 2004a; Reynolds, 2006). 
Consistent with the findings of the previous chapter, prior to drug testing animals choice 
behaviour became contingent on the delay to the delivery of the larger reward. The sensitivity of 
choice behaviour furthermore remained stable across the 16 weeks of drug testing. The acute 
administration of nicotine led to a proibund dose related decrease in overall choice of the 
delayed, larger reward. The reduction in choice was also delay dependent. Closer examination 
of choice behaviour revealed that the effects of nicotine were not due to an alteration in 
preference of reward during 0 second delay trials. Instead the reductions in choice of delayed 
reward were indicated at the 10,20,40 and 60 second delay trials. With increasing dose of 
nicotine, the reduction in choice of delayed reward was observed at a greater number of delay 
trial blocks, supporting further the dose dependent effect of nicotine on choice behaviour (see 
Figs. 7.3 and 7.4). At the highest 0.5mg/kg dose, selection of the delayed reward was found to 
be decreased across 10,20,40 and 60 second delay trials. Taken together, this pattern of choice 
behaviour suggests acute nicotine rendered animals substantially more impulsive in their 
choices (Evenden and Ryan, 1996; Cardinal et al., 2000). 
Further support that animals performed more impulsively in the task following nicotine was 
provided by the more rapid speed at which trials were initiated at the 0.25mg/kg and O. Smglkg 
nicotine doses. Whilst the latency at which the choice between rcwards remained unchanged, 
the speed with which the delayed reward was collected also became significantly faster at the 
highest dose tested (0.5mg/kg). At this dose, furthermore, a reduction in frequency of omissions 
to collect the delayed reward was observed. 
These findings are consistent with the heightened impulsive choice that has been observed in 
heavy smokers (Bickel et al., 1999; Mitchell, 1999; Baker et al., 2003; Mitchell, 2004; Reynolds 
, et al., 2004; Reynolds, 2006a), and confirms previous preclinical reports of nicotine induced 
intolerance to delayed reward in a rodent adjusting delay procedure (Dallery and Locey, 2005). 
The present results moreover, are in agreement with the increased impulsive choice observed 
following the acute administration of other drugs of abuse including cocaine, amphetamine and 
alcohol in comparable delayed reward tasks in both humans and animals (e. g. Logue et al, 1992; 
Evenden and Ryan, 1996; Cardinal et al., 2000; Hellmans et al., 2005; Helms et al., 2006; 
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Reynolds et al., 2006). 
The notion that nicotine promotes impulsive choice supports the theory that heightened 
sensitivity to delayed gratification in smokers is in part a consequence of the direct exposure to 
nicotine. However, other plausible interpretations of the present findings deserve consideration. 
Firstly, the delayed reward task involves rodents making choices between rewards of both 
different magnitudes and delay. The increase in choice of the delayed reward following nicotine 
could therefore be due to either changes in the sensitivity to delay or reward magnitude, or both 
(Ho et al., 1999). Nicotine treated animals may have selected the immediate reward to a greater 
degree due to the larger reward not being perceived as valuable as when under control 
treatment. It is well established in the human literature that when the delayed reward is 
perceived as less valuable, it is discounted to a greater extent (Green et al., 1997; 1999; Johnson 
and Bickel, 2002). Going against this argument, however, is that nicotine is known to increase 
the value of sucrose reinforcement Qias and Ellison, 1990). Furthermore, the majority of 
research in animals has demonstrated that choice behaviour is less sensitive to changes in 
reward magnitude than humans (Richards ct al., 1997; Grace et al., 1999; Farrar et al., 2003; 
Green et al., 2004). Finally, nicotine treated animals continued to select the delayed larger 
reward on almost a 100% of trials during the 0 second delay condition. This suggests that 
animals were still sensitive to the difference in magnitude of both rewards and able to 
discriminate effectively between them. Taken together, evidence suggests that the increase 
preference for the immediate reward is more likely due to nicotine induced hypersensitivity to 
delay. 
An alternative explanation for the observed increase in impulsive choice, is that under drug 
treatment a response bias or response perseveration on the lever delivering the smaller reward 
was formed. Once again, the persistent choice of the larger reward during 0 delay trials provides 
strong evidence against this explanation of the present findings (Mitchell, 2004). 
The change in choice behaviour may have instead been governed by nicotine's anorcctic effects 
(McNair and Bryson, 1983; Grunberg et al., 1986; Levin et al., 1987; Blaha ct al., 1998; Miyata 
et al., 1999; Zhang et al., 2001). There is little evidence, however, to support this interpretation. 
Firstly, in agreement with previous research, the results of the present thesis suggest that 
decreasing motivation for food reward has no significant effect on levels of impulsive choice in 
the delayed reward task (Logue and Pena-Correal, 1985; Logue et al., 1988; Cardinal et al., 
2000; Wade et al., 2000; Richards et al., 1997). Secondly, if motivation for the reward was 
reduced it would be predicted that latencies to collect reward in the task would increase. This 
was not the case; latency to collect delayed reward actually became faster following drug 
treatment. 
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Nicotine could instead be affecting cognitive processes argued to a play role in delay 
discounting tasks, such as working memory. Hinson and colleagues (2003) demonstrated that 
college students discounted delayed reward more steeply when working memory was impaired 
by increasing working memory load. Working memory is likely to be a cognitive process 
involved during the comparison of alternative rewards in the task. As previously discussed, 
however, nicotine has led to improvements working memory in both humans and animals 
(Rusted and Trawley, 2006; Spinelli et al., 2006). Therefore, it is highly unlikely that the 
observed greater levels of delay discounting can be attributed to disruption in this cognitive 
processes. 
The increased choice of the immediate reward may in part be explained by the known effects of 
nicotine on time perception (Pradhan and Dutta, 1970; Bizot, 1997; - Carrasco et al., 1998). 
Nicotine is known to increase 'internal clock' speed, i. e. over estimate the passage of time. 
Under the influence of nicotine, the delay to the delivery of the larger reward is therefore likely 
to have been perceived as more delayed. As delayed reward is discounted to a greater extent 
with increasing delay (Green ct al., 1994; Bickel and Marsh, 2001), the observed increased 
preference for the immediate reward may have been mediated by nicotine's induced alterations 
in timing mechanisms. Providing indirect support for this theory, is the finding that at the 
highest nicotine dose (0.5mg/kg), latency to collect delayed reward was significantly reduced, 
as was the frequency of failures to collect delayed reward. These data could indicate that the 
animal had over estimated the passage of time during the delay to the delivery of reward, and 
therefore approached the magazine to await reward delivery at an earlier time period. Being at a 
closer proximity to the magazine when the reward was delivered would have consequently led 
to faster magazine latencies and decreased likelihood of magazine omissions. This theory is 
however tentative. In order to have supported more accurately the disruption in timing ability in 
the task, a measure of magazine entries during the period of delay would have been more 
indicative of this effect. Unfortunately, this measure was not taken. Despite the present research 
being unable to conclusively determine whether an overestimation of the passage of time 
mediated the increase in preference for immediate reward, from the reviewed evidence it 
appears highly likely that there is a close association between time perception and delay 
discounting. 
Taken together, the increased preference of the immediate reward appears most likely to have 
been mediated by the nicotine induced hypersensitivity to delay, leading to a genuine increase in 
impulsivity. It appears however, that time perception may be a closely related process to delay 
discounting. Nicotine, therefore, may in part have increased delay sensitivity via its influence on 
timing mechanisms. 
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Experiment 6B investigated the effects of the centrally acting nicotinic antagonist, MEC, on 
levels of impulsive choice. The antagonist alone displayed no effect on overall percentage 
choice of delayed reward in comparison to control treatment. Evidence of greater delay 
dependency of choice behaviour was however indicated following the highest MEC dose 
(l. 0mg/kg). At this dose choice of delayed reward was significantly reduced across a greater 
number of delay trial blocks (20,40 and 60seconds) in comparison to choice behaviour at the 
zero delay condition. This was in contrast to control treatment where choice behaviour only 
differed at 40 and 60 second delay conditions. It is important to consider, however, that 
preference for the larger reward did not differ significantly between the highest MEC dose and 
saline treatment across all delay conditions. Other parameters in the task, including speed of 
responding and frequency of omissions also remained unchanged following MEC 
administration. 
When co-administered with 0.5mg/kg nicotine, 0.3mg/kg MEC antagonised the nicotine 
induced hypersensitivity to delay. At the MECo. 31nW1gNlCO. 5. g/kg dose, overall choice of delayed 
reward, and choice by delay did not differ from saline treatment, supporting the complete 
reversal of nicotine's effects on impulsive choice. Conversely, co-administration of nicotine 
with 0.1 and I. Omg/kg MEC failed to block nicotine's cffects on choice behaviour, with both 
combination doses reducing choice of delayed reward significantly in comparison to control. 
Furthermore, analysis of choice by delay revealed that preference of delayed reward was 
specifically reduced at 20 second delay trials in comparison to saline treatment at both the 
MECo. jmg/kg/NICO. 5mg/kg and MECj. o. g/kgNICo. s. g/kg doses. Replicating the effects on task 
performance in Experiment 6A, nicotine alone once again significantly decreased latency to 
initiate trials. In contrast to impulsive choice this effect was reversed by co-administration of all 
MEC pre-trcatment doses. 
These findings suggest that an optimal dose of MEC is required to block nicotine's effects on 
choice behaviour; indicating perhaps evidence of competitive antagonism of the effects of 
nicotine on impulsive choice, via blockade of the centrally located nicotinic receptors. Although 
the classic antagonist is generally believed to be non-competitive in its action, it has reported 
previously that MEC may also exhibit some competitive properties, for example on behaviours 
such as locomotor activity (Varanda ct al., 1985; Martin, 1989; 1990; Francis and Papke, 1996). 
The studies of the present chapter are the first of preclinical research to demonstrate that 
nicotine's effect on impulsive choice are mediated by the central nAChRs. I lowever, the lack of 
selectivity of MEC does not enable elucidation of the specific nAhChR subtypes that may be 
involved in this effect of nicotine (Chavez-Nriega et al., 1997). As previously discussed in 
Chapter 4, research has implicated the cOP2 and a7 receptors in the mediation of nicotine 
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induced disinhibition (Blondel et al., 2000; Grottick and Higgins, 2000; Keller et al., 2005; 
Hoyle et al., 2006). Whether these receptor subtypes are additionally involved in the modulation 
of impulsive choice is unknown. Extensive research is available to suggest, however, that the 
subcomponents of the impulsivity are often dissociated at the receptor subtype level, as is the 
case with both serotonergic and dopaminergic systmes (Wade et al., 2000; Talpos et al., 2006; 
van Gaalen et al., 2006). Through the use of more selective nicotinic antagonists, such as 
DHOE, future research should focus upon dissociating the role of speciric nicotinic subtypes in 
mediation of impulsive choice. 
The neurochemical events beyond the nicotinic receptor were not investigated in the present 
research. However, taking together the present findings of the nicotine induced impulsivity with 
previous observations of the increase in impulsive choice following both cocaine and 
amphetamine, suggests that a common neurobiological mechanism is likely to be involved 
(Logue et al, 1992; Evenden and Ryan, 1996; Cardinal et al., 2000; Helms et al., 2006). One 
possible candidate is therefore the increase in dopamincrgic ricurotransmission resulting from 
nicotine administration (Di Chiara and Imperato, 1988). Nicotine, via stimulation of the 
nAChRs located within the VTA, leads to the enhancement of extracellular levels of DA in the 
NAc and areas of PFC cortex (Oades and Halliday, 1987; Di Chiara and Imperato, 1988; 
BenwclI and Balfour, 1992; Nisell et al., 1994; 1996; Cadoni and Di Chiara, 2000). As both the 
NAc and orbitofrontal region of PFC have long been implicated in the neuronal processes 
underlying impulsive choice, it is reasonable to argue that the alteration in DA 
neurotransmission in these regions are likely to play role in the nicotine induced intolerance to 
delayed reward (Cardinal et al., 2001; Kheramin et al., 2002; 2004 Mobini ct al., 2002; 
Winstanely et al., 2004; Pothuizen et al., 2005). 
This is not to ignore the fact that nicotine is also known to stimulate the release of several other 
neurotransmitters, including noreadrenaline, 5-11T, glutamate and GABA (Wonnacott ct al., 
1990; Wonnacott, 1997; Li et al., 1998; Jones et al., 1999), that may also be involved in the 
acute pharmacological effects of nicotine on discounting of delayed reward. Whilst there is 
extensive support for the role of 5-11T in the neurobiology of impulsive choice, there currently 
is limited evidence available of the potential involvement of other neurotransmitter systems (e. g. 
Wogar et al., 1993; Ho et al., 1998; Mobini et al., 2000a; 2000b). Future studies should identify 
conclusively the neuronal processes involved in the association between nicotine and 
intolerance to delayed reward. Such data will prove crucial if impulsive choice is to become a 
target for future pharmacological treatment strategies for nicotine addiction. 
7.4.1. Conclusions 
In summary, the findings of the present chapter have demonstrated that acute nicotine induces a 
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profound reduction in choice of delayed that is most likely governed by the increased sensitivity 
to delay. This effect moreover appears to be mediated by the central nicotinic receptors. These 
findings suggest that the initial exposure to nicotine in drug naYve individuals may render them 
hypersensitive to delay. This may result in the longer term social and health benefits, associated 
with a continued drug free lifestyle,, to be highly discounted at this stage. As a Consequence, 
individuals may more likely select the immediate reinforcing properties of nicotine, thereby 
leading to continued smoking and likelihood of the development of dependence. 
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CHAPTER 8 
The effects of chronic nicotine administration and 
nicotine withdrawal on impulsive choice 
8.1. INTRODUCTION 
8.1.1. General Introduction 
Experiment 7 demonstrated that when administered acutely, nicotine leads to a profound 
increase in impulsive choice, as supported by the delay dependent reduction in choice of the 
delayed larger reward. In Chapter 5 it was proposed that in order to gain a more in depth 
understanding of the role played by impulsivity in the maintenance and relapse of drug addictive 
disorders, it is important that the effects of chronic nicotine, nicotine withdrawal, and the 
alterations in responsivity to nicotine following a period of abstinence, are additionally explored 
on aspects of impulsivity. 
To date, only one study has explored the effects of chronic nicotine treatment on the sensitivity 
of delayed gratification. A comparison was made of the effects of acute nicotine challenges 
administered prior to and during the final stages of 65 days of chronic nicotine treatment. 
During the 65 day period, rats were treated daily with a single 0.3mg/kg injection of nicotine. 
Findings demonstrated that greater levels of discounting of delayed reward were exhibited 
following the chronic exposure to nicotine, including treatment of the saline dosc (Dallery and 
Loccy, 2005). However, as previously discussed, the methodological limitations of Dallery and 
Locey (2005) study, such as the considerably low subject number (N=5), raises issues regarding 
the validity of findings. The reported heightened impulsive choice following chronic nicotine 
exposure is nevertheless consistent with the increase in impulsivity observed during the repeated 
administration of methamphetamine (Richards et al., 1999a) and cocaine (Logue et al. 1992; 
Paine at al., 2003) in comparable rodent models of delayed reward. 
To determine the contribution of impulsive choice to the risk of relapse in smokers, it is 
important to assess the levels of sensitivity to delayed gratification during the first two weeks of 
withdrawal when smokers are known to be at the greatest risk of relapse (Gossop et al., 1989; 
Garvey et al., 1992; Hughes et al., 1992; Kenford et al., 1994; Law and Tang, 1995). Indeed, 
smokers when nicotine deprived have been found to discount both hypothetical monetary 
rewards (Field et al., 2006) and cigarettes (Mitchell ef al., 2004; Field et al., 2006) to a 
significantly greater extent in comparison to when nicotine sated. Longer term abstinence from 
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nicotine, has in contrast, been associated with a reduction in levels of delay discounting that a 
more comparable to the rates of non-smokers (Bickel et al., 1999). Taken together, these 
findings suggest perhaps a biphasic relationship between abstinence and impulsive choice may 
exist. However, the lack of information regarding pre-smoking levels of impulsive choice in 
these individuals hinders interpretation of the relationship between abstinence and levels of 
delay discounting. It is possible, that initially drug deprivation leads to an increased rate of 
discounting of delayed reward, but is then followed with a decrease in impulsive choice with 
continued abstinence. Conversely, the reductions in delay discounting with longer term 
abstinence could suggest that lower levels of impulsivity may have enabled these individuals to 
successfully abstain from smoking (Bickel et al., 1999). In support of the latter theory, more 
recent research had demonstrated that higher levels of impulsive choice on behavioural delayed 
reward tasks significantly predicted smoking relapse (Krishan-Sarin ct al., 2007; Yoon et al., 
2007). Only longitudinal research that assesses the level of discounting at the point of cessation 
through to longer term abstinence will enable the establishment of the relationship between 
impulsive choice and smoking abstinence. 
Smokers, as with other drug abusers are known to relapse long after drug withdrawal (Stephens 
and Cottrell, 1972; Robinson and Berridge, 2000; 2003; Hughes et al, 2004; Piasecki, 2006; 
Hser, 2007). The mechanisms involved in long term drug relapse, are currently not well 
understood. Whilst theories have implicated a loss of inhibitory as a key component in drug 
relapse (Jentsh and Taylor, 1999; Goldstein and Volkow, 2002; Lubman et al., 2004), the roles 
of other aspects of impulsivity, such as impulsive choice, have not been thoroughly investigated. 
Chapter 5 of this thesis demonstrated that chronic drug exposure can render animals 
hypersensitive to the effects of nicotine on disinhibition. These effects were observed long aftcr 
cessation of drug treatment and when levels of inhibition had returned to BL. These findings 
present strong evidence of the key role of this aspect of impulsivity in drug relapse, and may in 
part explain why a single lapse in smoking is one of strongest predictors of relapse (Brandon et 
al., 1990; Nides et al., 1995; Shiffman et al., 1996). Whether a comparable increase in 
responsivity to the effects of nicotine on impulsive choice is evident is currently unknown. 
Prolonged exposure to nicotine, however, is known to lead to alterations in scrotonergic and 
doparninergic systems in regions implicated in impulsive choice, including the VTA and its 
associated projections the NAc and OPFC (e. g. Kirch et al., 1987; Vezina et al., 1992; 
Ramussen and Czachura, 1995; Ramussen and Czachura, 1995; Nisell, 1996; Balfour et al., 
1998; Hildebrand et al; 1998; 1999; Mobini et al., 2000a; Wade et al., 2000; Olausson et al., 
2001; Rahman et al., 2004; Winstanley et al., 2004; Pothuizen et al., 2005). These neural 
adaptations may also increase the sensitivity to the effects of nicotine on impulsive choice. If 
this is the case, smoking during cessation may lead to the delayed rewards associated with 
continued abstinence to be discounted to a greater degree. This in turn may lead to individuals 
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selecting once again the more immediate rewarding effects of nicotine (relapse). 
8.1.2. Objectives of Experiment 7 and 8 
In an attempt to gain further understanding of the complex association between nicotine 
dependence and impulsive choice the objectives of Experiments 7 and 8 were therefore: 
i 
i) To determine the effects of chronic nicotine exposure on impulsive choice as measured 
by the delayed reward task (Experiment 7). 
ii) To assess changes in levels of impulsive choice during the early stages of withdrawal 
when smokers are particularly vulnerable to relapse (Experiment 7). 
iii) To assess the stability of changes in impulsive choice during longer term abstinence 
(Experiment 7). 
iv) To establish whether chronic drug exposure and withdrawal leads to long tenn 
alterations in responsivity to the effects of acute nicotine administration on impulsive 
choice (Experiment 8). 
v) To preliminarily explore differences in response of high and low "trait" impulsive 
animals to the effects of chronic nicotine treatment, nicotine withdrawal and acute 
nicotine following longer term abstinence (Experiment 7 and 8). 
To achieve these objectives a longitudinal study was conducted in Experiment 7 during which 
the levels of impulsive choice of subjects was assessed prior to the initiation of drug treatment, 
during seven days of chronic nicotine administration, and during initial and long term nicotine 
withdrawal. The same subjects were then tested by a series of acute nicotine challenges in 
Experiment 8. Comparable to Chapter 5, in order to ensure that animals were experiencing 
nicotine withdrawal, assessment was additionally made of the nicotine abstinence syndrome 
(Malin ct al., 1992). 
The findings of Chapter 6 indicated that marked individual differences in sensitivity to delayed 
gratification at baseline were observed, possibly reflecting differences in "trait" level of 
impulsiveness (Winstanley et al., 2003; Dellu-Ilagedorn 2006). Whilst research has 
demonstrated that high levels of impulsive choice can lead to greater self administration of 
cocaine (Perry et al., 2005) and consumption of alcohol (Poulos et al., 1995), it has yet to be 
determined whether high and low impulsive animals respond differcntially to the effects of 
nicotine on impulsive choice. To therefore achieve the final objective of this chapter, individual 
differences in levels of impulsive choice were determined through the application of the 
exponential delay discounting function to BL choice data. The differences in response of high 
and low impulsive animals to the effects of chronic nicotine, nicotine withdrawal and residual 
sensitivity to nicotine following a period of abstinence were then explored. As this was only a 
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preliminary investigation with a small number of subjects, the effects were only assessed on the 
primary measure of impulsive choice. 
8.2: EXPERIMENT 7: ASSESSMENT OF THE EFFECTS OF CHRONIC NICOTINE 
ADMINISTRATION AND NICOTINE WITHDRAWAL ON IMPULSIVE CHOICE 
8.2.1. METHOD 
8.2.1.1. Subjects 
Subjects were 24 adult male Lister Hooded rats (Charles River, UK). Animals were housed in 
pairs on arrival at the laboratory and maintained under a 12 hour light/dark cycle (lights on at 
0700h) at controlled environmental temperature of 21 *C ± 4T and relative humidity of 50% 
10%. During experimentation food was restricted in order to maintain animals at 85% of their 
free feeding body weights. Water was available ad libitum in home cages and feeding occurred 
at the end of each experimental day. At the start of testing, animals weighed approximately 360- 
380g. All animals were treated in accordance with the UK Animals (Scientific Procedures) Act 
1986. 
8.2.1.2. Apparatus 
Subjects conducted the delayed reinforcement task in two sets of four operant chambers 
(dimensions 30.5 X 24.1 X 21cm and 30.5 X 24.1 X 29.2cm Mcd Associates Inc., USA). 
During the observation of somatic withdrawal signs animals were placed in a glass observation 
tank (dimensions 40.5 X 37 XII cm). Behaviours were recorded by a vidco camera (JVC TK- 
1280E) positioned horizontally in front of the observation chamber. The camera was relayed to 
a monitor (TM-150OPS) in an adjacent laboratory. For a more detailed description of all 
apparatus refer to Chapter 2 section 2.5.1 and 2.6.1. 
8.2.1.3. Behavioural Testing 
The behavioural procedure of the delayed reward task, in addition to the prc-training required 
has been described previously in detail in Chapter 6, section 6.2.1.3. The behavioural measures 
assessed in the paradigm arc also addition detailed in this section. Training continued on the 
task until subjects displayed choice behaviour that was delay sensitive and stable across a ten 
day period. Animals completed one session of the task per day and training was completed 
within approximately 10 weeks. 
8.2.1.4. Drugs 
Nicotine hydrogen tartrate salt was dissolved in 0.9% saline and the p1l adjusted to 
approximately 6, using OAM and LOM sodium hydroxide. The drug solution was chronically 
administered through s. c. osmotic mini pumps (Model 2MLI; Alzet, Charles River, UK) and the 
concentration calculated so that animals received 3.16mg/kg/day for a seven-day duration. 
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Nicotine was released at a rate of I Old/hr (see also section 2.3.1). 
8.2.1.5. Experimental Design and Procedure 
A mixed design was employed to examine the chronic effects of nicotine on impulsive choice, 
with treatment group (chronic saline (n = 11) or nicotine treatment (n = 13)) as the between 
subject factor and test day as the within subject factor. Animals were separated into treatment 
group prior to the implantation of osmotic pumps, matched for baseline levels of impulsive 
choice. All experimentation followed standard operant testing procedures, outlined in detail in 
the general methodology of Chapter 2, section 2.5.2. All operant testing took place during the 
light phase of their LD cycle between 0830h and 1730h. 
8.2.1.5.1. The Effects of Chronic Nicotine Administration and Nicotine Withdrawal on 
Impulsive Choice in the Delayed Reward Task 
Once trained, animals were separated into two treatment gioups and their base line behaviour 
assessed in the operant task across a seven day period. Following the examination of BL 
behaviour, osmotic pumps were then surgically implanted under isofluranc/oxygcn anacsthesia, 
and dependent on which group the animals were allocated to, filled with either saline or 
nicotine. For a more detailed description of surgical procedures refer to the general thesis 
methodology of Chapter 2, section 2.4. Forty two hours following the implantation of the 
osmotic pumps (or thirty six hours following the initiation of drug release) the effects of the 
chronic administration of nicotine on impulsive choice were measured. For the duration of the 
forty two hours post surgery animals remained in their home cage to allow them to rccovcr from 
surgery'prior to operant testing. During the seven days of drug administration, behaviour in the 
delayed discounting task was examined during six sessions, with animals conducting the task 
once per day. 
The initiation of spontaneous nicotine withdrawal was then achieved through the removal of the 
pumps on the seventh day following pump implantation. Examination of performance in the 
delayed discounting task began 12 hours following pump removal and continued for a three 
week period. During this time animals conducted one operant test session per day. 
8.2.1.5.2. Assessment of the Nicotine Abstinence Syndrome 
The intensity of spontaneous withdrawal was assessed by observing the frequency of somatic 
signs. This was conducted using a nicotine abstinence scale developed by Malin et al., (1992). 
Briefly the number of somatic signs, including gasps, writhes, body shakes, head shakes, chews, 
teeth chattering, cheek tremors, paw tremors, genital grooming, foot licks, yawns, ptosis and 
scratches were recorded. A detailed description of these behaviours are summarised in the 
general methodology of Chapter 2, section 2.6.2 and Table 2.1. 
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Prior to assessment, all animals were habituated to both the test room and observation chamber 
on two consecutive days. Somatic signs were observed, the day before pump implantation 
(baseline assessment), the final day of chronic drug'infusion, and during the first week 
following the termination of drug treatment. During withdrawal somatic signs were recorded at 
6,13.5,18,24,37.5,61.5,85.5,109.5,133.5,157.5 and 181.5 hours following pump removal. 
The majority of somatic signs were assessed by the experimenter immediately following operant 
behavioural testing for a period of ten minutes. The exception to this was during the early onset 
of withdrawal, when somatic signs were also observed at 6,18 and 24 hours when operant 
testing did not take place. The time points of observational sessions were selected on the basis 
previously reported elevation in somatic signs during nicotine withdrawal (Malin et al., 1992; 
Malin et al., 1994; Ifilderbrand et al., 1997; Epping-Jordan et al., 1998; Harrison et al., 2001). 
8.2.1.6. Statistical Analysis 
In the case of all statistical procedures data prior to analysis were assessed for nonnality and 
transformed where necessary (see also section 2.7). Mauchley's test of sphericity was applied to 
all within subject variables, and when appropriate the degrees of freedom adjusted with the 
Grccnhouse-Gcisscr correction. The homogeneity of variance of between subject variables was 
assessed by Levines test. In all cases of analysis a values of p<0.05 were deemed statistically 
significant. 
8.2.1.6.1. The Effects of Chronic Nicotine Administration and Nicotine Withdrawal on 
Impulsive Choice in the Delayed Reward Task 
Comparison of performance on the task by each treatment group was analysed across each stage 
of treatment; including baseline, chronic drug administration, withdrawal week one, withdrawal 
week two and withdrawal week three. Data from seven operant sessions were examined for each 
stage with the exception of chronic drug treatment where only six test sessions were conducted. 
To assess differences in performance between treatment groups during baseline, a two-way 
mixed ANOVA was conducted on all behavioural parameters (CDR and speed of responding), 
with treatment group (nicotine or saline) as the between subject factor and test day as the within 
subject factor. Comparison of choice of reward by delay, involved a thrce-way mixed ANOVA 
being applied to the data, with treatment group as the between subject factor and both test day 
and delay (0,10,20,40 and 60s) as the within subject variables. All significant main effects 
were analysed further by Bonferroni post hoc comparisons and interactions were followed 
where appropriate by simple effects analysis. Single repeated measures ANOVA analysed the 
stability of behaviour across test days for each treatment group. Independent t-tcsts analysed 
differences between each group on measures at individual test days (BonfcrToni correction of p< 
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0.007). 
The data gathered during BL week was, furthermore, assessed to determine the classification of 
animals as either a high or low impulsive subject. This was achieved by applying an exponential 
curve to the data for each subject to determine the degree of discounting of delayed rcward (see 
Chapter 6, section 6.2.1.5.2. for more detail on statistical procedure). 
Both within and across treatment groups, animals demonstrated extensive variability in BL 
performance across parameters within the task. To control therefore for the possibility that pre- 
drug differences in behaviour may influence the dependent variable being measured during both 
chronic and withdrawal treatment stages, all data was subjected to a two-way mixed 
ANCOVA (Howell ct al., 1992; Stevens 1992; Tabachnick and Fidell 2007). At each treatment 
stage behavioural parameters were assessed with the average performance under baseline 
conditions acting as the covariate within the model. This analysis enabled pre-drug differences 
in baseline behaviour to be controlled for, thus reducing error variance and allowing a more 
accurate assessment of the effects of chronic drug treatment and withdrawal on behaviour. 
ANCOVA was applied to variables measuring overall CDR and speed of responding. Due to the 
complex design, choice of the larger reward across delays was independently assessed at each of 
the five delays. Analysing choice data in such a manner enabled baseline choice of delayed 
reward to be controlled for within the ANCOVA at each delay. For all conducted ANCOVAs, 
treatment group represented the between subject factor, whilst test day the within subject factor. 
Significant main effects were explored further by post lioc Bonferroni tests. Significant 
treatment group x, test day interactions were examined further by simple effects analysis; where 
individual means compared were adjusted to control for the effects of the covariate. One-way 
repeated measures ANCOVAs examined by group the stability of behaviour across test days, 
whilst a univariate ANCOVA compared groups at each individual test day (drug week, 
Bonferroni correction of p<0.008; withdrawal week 1-3, Bonferroni correction of p< 0.007). 
Prior to all ANCOVA a furthcr assumption asscssed was that of homogcncity of rcgrcssion. 
This was assessed via the examination of interactions of the covariatc with both the within and 
between subject variables. If homogeneity of regression was found to be violated (i. e. 
interactions were found to be significant), then the use of ANCOVA was no longer appropriate. 
Though rare, in such instances data was expressed instead as a percentage change from baseline 
and analysed by a two-way mixed ANOVA (Tabchnick and Fidell, 2007). 
To assess finally whether baseline differences in impulsive choice affected animals response to 
the chronic administration and withdrawal from nicotine, data from high and low impulsive 
animals were analysed independently and compared. The application of exponential curves to 
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baseline data identified a group of low impulsive subjects allocated across treatment groups 
(nicotine group (n = 9); saline group (n = 6)). A smaller group of highly impulsive animals were 
in addition present within each treatment condition (nicotine group (n = 4); saline group (n = 5) 
see result section 8.5.2.6). The examination of treatment stage on impulsive choice in low 
impulsive animals was assessed as above. Due to the low sample size of highly impulsive 
animals, data was not subjected to statistical analysis; descriptives of choice behaviour were 
instead plotted and explored. 
8.2.1.6.1. Assessment of Somatic Withdrawal Signs 
Total somatic signs were analysed using a two-way mixed factors ANOVA, with treatment 
group as the between subject factor and observational session as the within subject factor. 
Bonerrfoni post hoc comparisons were applied to the data following significant main effects, 
whilst one-way ANOVA and independent Wests were used to examine further significant 
interactions. As normality was violated, individual categories of withdrawal symptomology 
were, in contrast, analysed non-parametrically (see Table 2.1). Examination of somatic signs by 
treatment group across sessions were analysed by Freidman and Wilcoxon tests, while 
comparison between groups across sessions were performed by Mann Whitney procedural tests. 
8.2.2. RESULTS 
Figure 8.1 illustrates and compares the overall percentage choice of delayed reward across all 
stages of study. Fig. 8.2 (a-e) illustrate choice behaviour by delay. The following results 
sections of this chapter will explore in sequence the differences in performance on the delayed 
reward task between treatment groups across stages of baseline, chronic drug treatment and 
withdrawal weeks one, two and three. All graphs and tabulated data represent actual mean 
values. 
Across all ANCOVA of performance during both drug treatment and withdrawal the effect of 
the covariate (average baseline performance) remained highly significant for all parameters 
measured within the task (all F(1,21) ý: 20.409, p :50.001). 71iis indicated the importance of 
controlling for BL differences in behaviour within analysis. With the exception of the magazine 
latency, following an immediate reward choice, homogeneity of regression was satisfactory for 
all measures within the task including both choice and speed of responding parameters. Across 
behaviours, within the task no significant interactions were displayed between the covariatc and 
the between subject factor of treatment group (all F(1,20): 5 0.001, N. S) or within subject factor 
of test day (drug week: all F(5,100) : 50.185, N, S ; withdrawal week one: all F(6,120): 5 0.222, 
N. S ; withdrawal week two: all F(6,120): 5 0.290, N. S; withdrawal week three: (all F(6,120): 5 
0.443, N. S. ). Homogeneity of regression was however violated for immediate magazine latency 
across stages of study, with a significant interaction shown between the covariate and within 
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subject factor of test day (drug week: F (5,100) = 6.541, p<0.001 ; withdrawal week one :F 
(6,120) = 6.697, p<0.001; withdrawal week two :F (6,120) = 11.770, p<0.001; withdrawal 
week three: F (6,120) = 5.547, p=0.003). The covariate displayed no interaction however with 
the between subject factor of treatment group on this measure (all F(1,20) :50.039, N. S) This 
speed of responding measure was therefore expressed as a percentage change from BL and 
analysed by a two-way mixed ANOVA. 
Analysis of behaviour during both BL, chronic drug administration and withdrawal, unless 
otherwise stated, displayed no significant main effects of test day on measures of choice 
behaviour or speed of responding within the delayed reinforcement task. The failure to initiate 
trials, choose a reward and to collect the reward following both immediate and delayed reward 
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8.2.2.1. Baseline 
8.2.2.1.1. Choice Behaviour 
Prior to chronic drug treatment overall choice of delayed reward was stable, as indicated by the 
non-significant main effect of test day (F(6,132) = 0.723, N. S. ). Choice behaviour was 
comparable across treatment groups as shown by the non-significant main effect of group 
(F(1,22) = 0.095, N. S. ) and group x test day interaction found (F (6,132) = 1.886, N. S. ) (see 
Fig. 8.1). 
Analysis of choice behaviour by delay indicated no main effect of test day (F(6,132) = 0.921, 
N. S. ) and furthermore demonstrated that animal's choice was highly sensitive to delay (F(4,88) 
= 107.441, p <0.001). Post hoc analysis revealed that selection of the larger delayed reward 
:T TITT T T 
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decreased significantly with increasing delays (all p< 0.001), with choice across all delays 
differing significantly from other delay trials. Further supporting the stability of choice across 
delay, was the non-significant day x delay interaction shown (F(24,528) = 0.569, N. S. ). 
Analysis revealed no group differences in choice behaviour across delay conditions during BL. 
This was supported statistically by the non significant between group effect and group x delay 
interaction found (F(1,22) = 0.118, N. S.; F(4, &8) = 0.192, N. S., respectively). Furthermore, 
analysis indicated a lack of significant group x day and group x delay x day interaction on 
choice data (F(6,132) = 1.647, N. S.; F(24,528) = 1.256, N. S., respectively) (see also Fig. 8.2(a. 
e)). 
8.2.2.1.2. Speed of Responding 
Table 8.1 summarises speed of responding measures in the delayed reinforcement task during 
baseline. Prior to chronic drug treatment latency to initiate trials was both stable (F(6,132) = 
1.337, N. S. ) and comparable across treatment groups (F(1,22) =. 0.334, N. S. ). Furthermore, the 
speed at which the delayed and immediate reward were chosen and the latency at which the 
reward was collected was also stable across baseline (df = 1,22; all F 2: 0.48 1, N. S. ) and did not 
differ between groups (df = 1,22; all F ý: 0.268, N. S. ). No significant group x delay interactions 
were shown across analyses of speed of responding measures during this stage (df = 6,132; all F 
2: 0.268, N. S. ). 
8.2.2.2. Chronic Administration of Nicotine 
8.2.2.2.1. Choice Behaviour 
Chronic nicotine treatment resulted in a decrease in overall choice of delayed reward from BL. 
As shown in Fig. 8.1 nicotine treated animals demonstrated a lower percentage choice of 
delayed reward in comparison to saline treated animals that was supported statistically by the 
significant main effect of group (F(1,21) = 6.267, p= 0.021). Group differences however were 
not found to interact with test day (F(5,105) = 0.393, N. S. ). Although not supported 
statistically, as shown in Fig. 8.1, the decrease in choice of delayed reward was at its greatest at 
the early stages of drug treatment following which a gradual return to baseline levels of choice 
was observed. 
Choice behaviour across delays during individual test sessions is shown in Fig. 8.2 (a-e). A 
clear trend was shown in nicotine animals for choice of the larger reward across 10,20,40 and 
60 second delays to decrease in relation to average BL choice, whilst choice performed by 
saline animals remained relatively unchanged. These trends however failed to reach significance 
with a lack of between group effect and group x day interactions found across analyses of all 
delays (df = 1,21; all F 2ý 2.211, N. S; df = 5,105; all F 2: 0.393, N. S., respectively). Changes in 
patterns of choice however were not displayed in the zero delay condition, with animals across 
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treatment groups continuing to select the larger reward to the greatest extent at this delay. 
Analysis of choice behaviour at this delay revealed no significant main effect of group or group 
x test day interaction (F(1,21) = 0.175, N. S.; F(3.498,73.458) = 0.497, N. S. ). 
8.2.2.2.2. Speed of Responding 
Table 8.2 summaries the speed of responding during the chronic administration of drug 
treatment. Despite a demonstrated Irend for nicotine treated animals to more rapidly initiate 
trials in comparison to baseline performance, no significant treatment group differences were 
however found, with an absence of both significant between group (F(1,21) = 1.016, N. S. ) and 
group x day interaction shown (F(I. 825,38.329) = 1.236, N. S. ). Treatment groups furthermore 
were found not to differ on the speed at which animal's lever responded when selecting the 
delivery of either the immediate or delayed reward (all F(1,21): 5 2.113, N. S). Group differences 
on response latencies in addition were found not to interact with test day (all F(5,105): 5 1.236, 
N. S). 
Analysis of the speed at which animals collected reward following both an immediate and 
delayed reward choice demonstrated no significant main effect of treatment group (F(1,22) = 
0.099,, N. S; (F(1,21) = 0.511, N. S., respectively). Furthennore, no significant group x test day 
interaction were displayed on magazine latency following an immediate choice (F(5,110) 
1.079, N. S. ), or delayed reward choice (F(5,105) = 1.757, N. S. ) (see Table 8.2). 
8.2.23. Nicotine Withdrawal Week One 
8.2.2.3.1. Choice Behaviour 
Following the initiation of spontaneous withdrawal no signiricant differences were observed on 
overall choice of delayed reward during the first week of drug withdrawal. No significant 
between group or group x test day interaction were found (F(1,21) = 2.584, N. S.; F(3.846, 
80.756) = 1.120, N. S. ). As shown in Fig. 8.1, the percentage choice of delayed reward of 
animals experiencing nicotine withdrawal was comparable to that of saline treated animals up 
until 84 hours post termination of treatment. Following this time point however a clear trend 
was shown for the preference of delayed reward to decrease in nicotine treated animals. 
Choice of reward by delay demonstrated no significant differences across delays between 
treatment groups, with a lack of both group main effects and group x test day interactions shown 
(F(1,21) :53.142., N. S.; F(36,126) :53.117, N. S., respectively). During early onset of 
withdrawal, at 10,20 and 40 seconds delay, the reduction in choice of larger reward that was 
evident during chronic nicotine treatment, had returned to levels similar to that of saline treated 
animals and BL (Fig. 8.2 (a-e)). Evident also from Fig. 8.2 (a-e) was a trend shown for saline 
treated animals to decrease discounting of delayed reward in comparison to BL choice 
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behaviour. 
8.2.2.3.2. Speed of Responding 
Latency to initiate trials during withdrawal week one did not differ between treatment groups, 
with analysis demonstrating a non-significant main effect of group and group x test day 
interaction (F(1,21) = 29.895, N. S; F(4.036,84.748) = 0.973, N. S. ). ANCOVA of the speed at 
which rewards were selected revealed that whilst no significant between group difference was 
observed on immediate reward response latency, nicotine animals responded significantly faster 
in comparison to saline animals when selecting the delayed reward (F(1,21) = 1.182, N. S.; 
F(1,21) = 4.720, p=0.041, respectively). Inspection of means summarised in Table 8.3 
demonstrate, however, that this effect was aided by the observed slower latency relative to BL 
performed by saline treated animals. The speed at which the delayed reward was chogen by 
animals experiencing nicotine withdrawal varied only minimally from average BL performance. 
Analysis of both measures of responses revealed no significant group x test day interaction 
(F(3.423,71.890) = 1,814, N. S.; F(3.625,76.128) = 1.462, N. S., respectively). 
No significant differences were demonstrated on latency to collect reward following either an 
immediate (F(1,22) = 0.568, N. S. ) or delayed reward choice (F(1,21) = 0.023, N. S. ). Magazine 
latency by group, furthermore, was not found to interact with test day, for either the collection 
of immediate or delayed reward (F(6,132) = 0.725, N. S.; F(3.348,70.317) = 1.850, N. S., 
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8.2.2.3.3 Somatic Withdrawal Signs 
Animals experiencing nicotine withdrawal displayed a rapid sharp elevation in the total 
frequency of somatic signs beginning at 6 hours post termination of treatment, reaching peak 
frequency at 18 hours of nicotine withdrawal (see Fig. 8.3). Analysis demonstrated a significant 
main effect of both time and treatment group (F(12,264) = 13.973, p<0.001; F (1,22) - 
15.967, p<0.001, respectively) in addition to a group x time interaction (F(12,264) = 5.845, p 
< 0.001). Further analysis revealed whilst no significant differences between treatment groups 
were displayed during BL and chronic drug treatment (all t<1.065, df = 22, N. S. ), animals in 
nicotine withdrawal however exhibited a significantly greater frequency ofsomatic signs from 6 
hours until 109.5 hours post tennination of chronic drug treatment (all t>3.400, df = 22, p< 
0.003). 
Examination by treatment group displayed no evidence of an increase in frequency of overall 
somatic signs in saline treated animals, with a lack of significant main effect of test session 
found (F (5.962,56.993) = 2.2215, N. S). This was in contrast to the highly significant effect 
shown in the nicotine treated animals, supporting further the presence of' a somatic nicotine 
withdrawal syndrome in this treatment group (F(5.333,63.992) = 20.155, p<0.001). Post hoc 
analysis revealed significantly elevated somatic signs at 6,13.5,18,24,37.5,61.5,85.5,133.5 
hours post pump removal in comparison to B1. frequency ( all p <0.01). 














Fig. 8.3: Total Somatic Withdrawal Signs: the frequency of overall somatic signs displayed during 
spontaneous withdrawal. Each point represents the mean number of trials ± SEM. *, p<0.05, **, p<0.01, ***, 
p<0.001 indicate significant differences between nicotine and saline treatment groups. 
Table 8.4 displays the frequency of individual categories of somatic signs observed during 
spontaneous withdrawal. Animals experiencing nicotine withdrawal exhibited more frequently 
gasps and writhes in comparison to saline treated from as early as 6 hours post pump removal 
and continued for a time course of 84.5 hours (all U> 22.00, N= 24, p<0.50). Teeth chattering 
and chews were furthermore a more commonly observed symptom in animals in nicotine in 
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Chapter 8- Nicotine Dependence and Impulsive Choice 
withdrawal, reaching significance at 6,18,24,37.5,61.5,85.5,133.5 hours post termination of 
treatment in comparison to saline treated animals (all U ý: 7.00, N= 24, p: 5 0.049). Shakes and 
tremors were only significantly elevated in previously treated nicotine animals at 18 and 24 
hours of withdrawal (all U ?: 28.00, N= 24, p50.01). Finally, the most commonly exhibited 
symptoms in animals experiencing nicotine withdrawal were those of scratches and footlicks. 
Both somatic signs, in cooperated in the miscellaneous observational category, reached 
significance in comparison to saline treated animals at 6,18,24,37.5,61.5 post termination of 
treatment (all U ?: 20.50, N= 24, p: 5 0.020). 
8.2.2.4. Nicotine Withdrawal Week Two 
8.2.2.4.1. Choice Behaviour 
During the second week of withdrawal nicotine treated animals consistently chose the delayed 
larger reward to a lesser extent than saline treated animals (F(1,21) = 6.001, p=0.023). Group 
differences in choice behaviour were not found to interact with test day (F(3.554,74.627) 
0.829, N. S. ) (see Fig. 8.1). 
The effect of nicotine withdrawal on choice behaviour was furthermore delay dependent. 
Analysis of choice behaviour across delays demonstrated a significantly lower choice of the 
larger delayed reward made by animals experiencing nicotine withdrawal at the 40 second delay 
condition (F(1,21) = 4.160, p=0.05). As shown in Figs. 8.2 (d), the significant difference 
observed between treatment groups was aided by the coincided slight increase in choice of 
delayed reward by the saline treatment group. No significant group x test day interaction was 
observed at this delay (F(3.752,78.799) = 0.645, p=0.694). Despite the additional observed 
lower choice of delayed reward across 10,20,60 delay conditions in animals experiencing 
nicotine withdrawal (see Fig. 8.2 (a-e)), differences in choice across all other delay trial blocks 
failed to reached significance, as indicated by the non-significant between group main effects 
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Chapter 8- Nicotine Dependence and Impulsive Choice 
8.2.2.4.2 Speed of Responding 
Table 8.5 summarises speed of responding measures across groups during withdrawal week 
two. No significant main effects of treatment group were displayed on the speed at which trials 
were initiated or latency at which immediate or delayed reward choices were made (F(1,21): s 
1.915, N. S. ). Furthermore, across measures of initiation latency and immediate and delayed 
response latency no significant group x test interactions were displayed (F(3.492,73.228) = 
1.131, N. S; F(3.890,81.6830) = 0.822, N. S.; F(3.211,67.434) = 0.135, N. S., respectively). 
Latency to collect both immediate and delayed rewards was similar across treatment groups 
with a lack of both significant main effects of group (F(1,22) = 0.499, N. S.; F(1,21) = 0.001, 
N. S., respectively) and group x test interactions shown on both measures (F(6,132) = 0.702, 
N. S; F(6,126) = 0.966, N. S., respectively). 
8.2.2.5. Nicotine Withdrawal Week Three 
8.2.2.5.1. Choice Behaviour 
By the third week post termination of treatment, choice behaviour of animals treated chronically 
with nicotine had returned to BL levels and was similar to the overall choice of the delayed 
larger reward displayed by the saline treatment group (see Fig. 8.1). Analysis revealed no 
significant between group or group x test day interaction on overall choice of delayed reward 
(F(1,21) = 0.599, N. S.; F(6,126) = 0.616, N. S., respectively). 
Similar choice behaviour across treatment groups was also evident in, the choice of delayed 
reward across delays (see Figs. 8.2 (a-d)). An absence of both main effects of group and group x 
test day interactions were shown across all delay conditions within the task (F(1,21) :51.606, 
N. S.; F(36,126): 5 1.689, N. S., respectively). As clearly illustrated in both Figs 8.2 (a-e) across 
delay conditions nicotine treated animal's choice of the larger reward had returned to levels 
parallel to that observed prior to the initiation of chronic drug treatment. 
8.2.2.5.2. Speed of Responding 
Speed of responding within the delayed reinforcement task, tabulated in Table 8.6, was similar 
across treatment groups during the third week post termination of treatment. No significant main 
effects of group (F(1,21): 5 0.991, N. S. ) or group x test day interactions (F(6,126): S 0.933, N. S. ) 
on the speed at which animals initiated trials and selected immediate and delayed rewards were 
found. Immediate and delayed reward magazine latencies were in addition found not differ 
across treatment groups, with an absence of both significant between group (F(1,22) = 3.915, 
N. S.; F(1,21) = 3.151, N. S., respectively) and &oup x test day interactions shown (F(6,132) 
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Chapter 8- Nicotine Dependence and Impulsive Choice 
8.2.2.6. High vs. Low "Trait" Impulsivity 
The rate of exponential decay was determined for each animal during baseline week. This 
analysis identified a group of highly impulsive animals (N = 9) whose rate of discounting of the 
delayed reward, as represented by k, was significantly greater than the remaining group (N = 
15) (t = 5.255, df = 22, p<0.001). A mean k value of 0.5420 ± 0.07 was represented by the high 
impulsive animals in comparison to a mean k value of 0.2130 ± 0.03 displayed by tile low 
impulsive group. Individual animal k values in addition to R2 values are summarised in Table 
3.1. Appendix 3. Indication that the exponential function provided a good fit of the data, was 
demonstrated by the average R2 values of 0.87 ± 0.03 and 0.82 ± 0.04 for the choice data for 
high and low impulsive animals respectively. 
Fig. 8.4 illustrates the average discounting of delayed reward performed by both the high and 
low impulsive groups during baseline BL. To assess differences in response of high and low 
impulsive animals to chronic nicotine and withdrawal on choice behaviour, analysis was 
conducted independently for each of the groups. Across both saline and nicotine treatment 
groups, N=6, and N= 9, low impulsive animals were identified respectively. In terms of high 
impulsive animals, N= 4 were present in the nicotine group compared to N=5 in the saline 
treatment group. Fig. 8.5 illustrates and compares overall choice of delayed reward across 













Comparison of Delayed Discounting Function of High and 
Low Impulsive Animals 
0 10 20 40 
Delay (seconds) 
HIGH IMPULSIVE LOW IMPULSIVE 
H2.8.4. Choice Behaviour: the average rate of discounting of delayed reward during baseline of high and low 
"trait" impulsive animals. Each point represents the mean percentage choice ± SEM. 
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8.2.2.6.1. Baseline 
8.2.2.6.1.1. Choice Behaviour 
During baseline performance low impulsive animal's overall choice of delayed reward was both 
stable (F(4.107,49.280) = 1.108, N. S. ) and similar across treatment groups, supported 
statistically by the lack of significant main effect of treatment group (F(l, 12) = 0.276, N. S. ) (see 
Fig. 8.5). Significant, however, was the day x group interaction (F(4.107,49.280) = 2.932, p= 
0.029). Further analysis however revealed no significant group differences in choice across 
individual test days (all t : 5-0.062, df =13, N. S. ). Analysis by treatment group furthen-nore 
demonstrated no significant main effect of test day for either saline or nicotine treatment groups 
(F(2.433,7.300) = 0.400, N. S; F(6,42) = 0.577, N. S., respectively). 
Analysis of choice by'delay demonstrated no significant main effect of test day (F(6,78) = 
0.089, N. S. ). Choice of delayed reward by low impulsive animals was highly sensitive to delay, 
supported by the main effect of delay (F(4,52) = 65.155, p<0.001). Choice of the larger 
reward decreased with increasing delays, with choice at all delays differing sipificantly from 
the 0 second delay condition (all p<0.05). Further support for the stability of delay dependency 
in low impulsive animals, was indicated by the non-significant day x delay interaction (F(24, 
312) = 0.505, N. S. ). Delay dependency did not differ across treatment groups with absence of a 
main effect of group (F(1,12) = 0.001, N. S. ), group x delay and group x delay x day interactions 
found (F(4,52) = 0.077, N. S.; F(24,312) = 1.088, N. S., respectively) (see Fig. 8.6 (a-e)). 
The overall choice of delayed reward displayed by high impulsive animals during BL was also 
both relatively stable and similar across treatment groups. An exception to this stability was BL 
day 6 (see Fig. 8.5). During this test session, the saline treatment group displayed a greater 
percentage choice of the delayed larger reward. Further'examination of choice behaviour by 
delay, also revealed similar levels of preference of the larger reward across treatment groups 
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H2.8.6 (a-e): Choice Behaviour: the effects of chronic nicotine administration and withdrawal on percentage 
choice of delayed reward during each delay in high and low impulsive animals. Each point represents the 
mean percentage choice. *p< 0.05 Main effect of group 
8.2.2.6.2. Chronic Administration of Nicotine 
8.2.2.6.2.1. Choice Behaviour 
When treated chronically with nicotine low impulsive animals demonstrated a substantial 
reduction in overall choice of delayed reward in comparison to saline treated animals (F(1,12) 
=10.763 ,p=0.007), an effect that was consistent over the treatment period and was at its 
maximum during the first test session (see Fig. 8.5). Overall choice of delayed reward by 
treatment group was however found not to interact with test day (F(5,60) = 0.147, N. S. ). The 
increase in impulsive choice was furthermore delay dependent in nicotine treated animals. As 
illustrated in Fig. 8.6 (a-e) choice of delayed reward was found to be significantly lower at 10, 
20 and 60 second delay conditions in comparison to choice behaviour displayed by the saline 
control group (all F(1,12) ý: 5.228, p<0.041). In contrast, choice behaviour during drug 
278 
1234567123456 12 36 60 84 108132156 89 10 11 12 13 14 15 16 17 18 19 20 21 
%Choice of Delayed Reward 60 Seconds Delay 
Chapter 8- Nicotine Dependence and Impulsive Choice 
treatment was similar across treatment groups at 0 and 40 second delays (all F(1,12) :52.599, 
N. S. ). Analyscs indicatcd no significant intcractions bctwccn group and tcst day across all dclay 
conditions (all F: 5 1.345; df ý: 2.169,26.943, N. S. ) (see Fig. 8.6 (a-e)). 
The chronic administration of nicotine in contrast had minimal affect on impulsive choice in 
high impulsive animals. As clearly illustrated in Fig. 8.5, overall percentage choice of delayed 
reward in nicotine treated animals failed to change dramatically from BL, with choice behaviour 
being comparable to that of saline treated animals during drug treatment. Examination of 
choice of reward by delay further supports the lack of response to chromic nicotine. Across 
delays discounting of delayed reward in nicotine treated animals remained similar to both BL 
and choice behaviour displayed by saline treated animals (see also 8.6 (a-e)). 
8.2.2.6.3. Nicotine Withdrawal Week One 
8.2.2.6.3.1. Choice Behaviour 
In comparison to BL, the reduction in overall choice of delayed reward by low impulsive 
nicotine treated animals continued following the termination of drug treatment (see Fig. 8.5). 
Analysis revealed a significant main effect of treatment group aided by the slight increase in 
overall percentage choice of delayed reward displayed by the saline treated animals (F(1,12) = 
6.904, p 0.020). The treatment group effect was found not interact with test day (F(2.81 1, 
34.566) 0.393, N. S. ). As demonstrated in Figs. 8.6 a-e, animals experiencing nicotine 
withdrawal displayed a greater reduction in choice of the delayed larger reward across delays in 
comparison to control animals, with the exception of 0 second delay trials. In contrast, saline 
treated animals appeared to increase their choice of the delayed reward at 40 and 60 second 
delay trials relative to baseline. Analysis of choice by delay however revealed that impulsive 
choice between treatment groups only differed significantly at 60 seconds delay (F(1,12) = 
6.904, p=0.022). An absence of significant between group effects were indicated across all 
remaining delays (all F(1,21): 5 2.460, N. S. ). Finally no significant group x test day interactions 
were found across all delay conditions (all F: 5 1.817, df ?: 2.198,26.3 75, N. S. ). 
The termination of nicotine treatment in contrast in high impulsive animals led to a decrease in 
impulsive choice in comparison to baseline and saline control animals, peaking at 36 hours post 
pump removal (see Fig. 8.5). Overall choice of delayed reward remained greater in nicotine 
treated animals from 36 until 84 hours of drug withdrawal. As illustrated in Fig. 8.6(a-c) this 
was as a result of the greater choice of delayed reward at 20,40 and 60 second delay conditions 
in comparison to both BL and choice displayed by the saline treatment group. 
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8.2.2.6.4. Nicotine Withdrawal Week Two 
8.2.2.6.4.1. Choice Behaviour 
Low impulsive animals experiencing the second week of withdrawal continued to display 
reduced choice of the delayed, larger reward in comparison to the saline treated animals (see 
Fig. 8.5). Analysis of overall percentage choice of delayed reward revealed a significant main 
effect of treatment group that did not interact with test day (F(l, 12) = 8.5 89, p=0.0 13; F(6,72) 
= 0.440, N. S., respectively). Choice of delayed reward was significantly reduced at the higher 
40 and 60 second delay conditions in comparison to saline control animals (all F(l, 12) 2: 6.202, 
p: 5 0.026) (see Figs. 8.6 (a-e)). Group differences however were not found to interact with test 
day (all F(6,72): 5 0.5 10, N. S. ). Similar choice behaviour was displayed across treatment groups 
during 0,10 and 20 second delays, indicated by the absence of both significant between group 
(all F(l, 12) :51.899, N. S. ) and group x test day interactions shown (all F :50.599, df 2: 2.198, 
26.375,, N. S. ). 
During the second week post termination of nicotine treatment, high impulsive animals 
displayed no evidence of differences in overall choice of delayed reward in comparison to the 
saline treatment group (see Fig. 8.5). The lack of difference in choice behaviour was indicated 
furthermore across delay conditions as illustrated in Fig. 8.6(a-c). Saline treated animals 
displayed in contrast a slight increase in choice of the delayed, larger reward. 
8.2.2.6.5. Nicotine Withdrawal Week Three 
8.2.2.6.5.1. Choice Behaviour 
By the third week post termination of treatment overall choice of delayed reward by low 
impulsive nicotine treated animals had returned to BL. A lack of difference between treatment 
groups on overall percentage choice of delayed reward was displayed, with no significant main 
effect treatment group or group x test day interaction found (F(1,12) = 0.095, N. S.; F(6,72) = 
0.936, N. S., respectively) (see Fig. 8.5). Analysis of choice across delays demonstrated 
furthermore comparable reward selection between treatment groups with both main effects of 
group and group x test day interactions failing to reach significance (all F(l, 12) :52.02 1, N. S.; 
all F(6,72) < 1.212, N. S., respectively) (see Figs. 8.6 (a-c)) 
In contrast, high impulsive animals displayed the greatest reduction of delayed reward in 
comparison to the saline treatment during the third week of withdrawal (Fig. 8-6). Nicotine 
treated animals displayed a decreased pattern of overall choice of delayed reward in comparison 
to baseline performance from day 18 to 20 post termination of treatment. During these test 
sessions was the coincided increase in choice of delayed reward by the saline treatment group, 
which aided and led to the display of higher levels of impulsive choice in nicotine treated 
animals until day 21. Examination of choice by delay revealed that this was due to the reduction 
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in choice of delayed reward by nicotine treated animals during the 10 and 20 second delays, 
where in contrast an increase in choice was shown by saline treated animals (see Fig. 8.6(a-e)). 
In comparison to BL, however, nicotine treated animals appeared to differ minimally in choice. 
Saline treated animals however displayed evidence OF an increase in choice of the delayed 
reward. 
8.3: EXPERIMENT 8 EXAMINATION OF THE EFFECTS OF ACUTE NICOTINE 




Subjects were 24 adult male Lister Hooded rats (Charles River, UK). All animals had completed 
Experiment 7 and had been previously chronically treated with either nicotine (n = 13) or saline 
(n = 11). Subject details have been previously outlined in methodology of Experiment 7, section 
8.2.1.1. At the start of testing, animals weighed approximately 400440g. 
8.3.1.2. Apparatus 
Subjects conducted the delayed reinforcement task in two sets of four operant chambers 
(dimensions 30.5 X 24.1 X 21cm 30.5 X 24.1 X 29.2cm Med Associates Inc., USA). For a more 
detailed description of all apparatus refer to Chapter 2 section 2.5.1. 
8.3.1.3. Behavioural Testing 
The behavioural procedure of the delayed reinforcement task has been described previously in 
the general methodology of Chapter 6, section 6.2.1.3. The bchavioural measures assessed in the 
paradigm are in addition detailed in Chapter 6. Details of subject training have been outlined 
previously in Experiment 7, section 8.2.1.3. 
8.3.1.4. Drugs 
Nicotine hydrogen tartrate salt was dissolved in 0.9% saline and the p1l adjusted to 
approximately 6, using O. lM sodium hydroxide. Nicotine (0,0.125,0.25 and 0.5mg/kg) was 
administered s. c. in a volume of I ml/kg bodyweight. All doses were calculated as free base and 
prepared freshly on each test day. Nicotine was administered 10 minutes prior to the operant test 
session. 
8.3.1.4. Design and Procedure 
Assessment began three weeks following the initiation of spontaneous withdrawal. All animals 
had returned to BL level of impulsive choice and no significant -differences were observed in 
comparison to choice behaviour recorded prior to the initiation of chronic drug treatment. 
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Furthermore, no differences between groups in terms of their choice behaviour were present. 
The effects of acute nicotine challenges were assessed using a mixed design, with treatment 
group (either previously chronically treated with saline or nicotine) as the between subject 
factor and acute drug treatment condition as the within subject factor. Treatments were 
administered according to a randomised Latin square design with a minimum of 72 hours 
separating consecutive drug treatments. It was ensured that animals had returned to BL 
performance prior to subsequent treatment doses being administered. Baseline was defined as 
overall choice of the delayed reward deviating no greater than 10% from the level of impulsive 
choice of delayed reward demonstrated by demonstrated by the subject prior to the initiation of 
the acute drug challenge regime. During the three days prior to the initiation of acute nicotine 
challenge, animals were habituated to injection procedures on two occasions, with subjects s. c. 
injected with lml/kg saline 10 minutes prior to the operant session. Experimentation followed 
standard operant testing procedures, outlined in detail in the general methodology of Chapter 2, 
section 2.5.2. All operant testing took place during the light phase of their LD cycle between 
0830h and 1730h. 
Each of the four treatment challenges (0,0.125,0.25, and 0.5mg/kg s. c. ) were administered 10 
minutes prior to the test session following which they were transferred immediately to the 
operant test room. All injection procedures were conducted in a procedure room separate from 
both the holding room and operant test laboratory. Comparison of the acute cffccts of nicotine 
across treatment groups was conducted over a three week pcriod. 
8.3.1.5. Statistical Analysis 
To ensure animals had returned to BL levels of performance prior to treatment and no 
differences were present across treatment groups, choice of delayed rcward across delay during 
the first three days following the third week of withdrawal were compared to the average choice 
behaviour observed during baseline week prior to chronic drug treatment. Data was then 
analysed by a three-way mixed measures ANOVA with test session and delay as the within 
subject factors and treatment group as the between subject factor. 
For the examination of differences between treatment groups in response to acute nicotine 
challenges, results for each behavioural parameter were analysed by a two-way mixed ANOVA, 
with treatment condition as the between subject factor and treatment dose condition as the 
within subject factor. Choice of reward by delay, involved a three-way ANOVA being applied 
to the data, with both treatment condition and delay (0,10,20,40 and 60s) as the within subject 
variables and treatment group as the between subject factor. 
To assess whether BL differences in impulsive choice affected animals response to acute 
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nicotine on discounting of delayed reward, data from high and low impulsive animals were 
analysed independently and compared. The examination of acute nicotine challenges on choice 
behaviour in low impulsive animals was assessed as above. Due to the low sample size of 
highly impulsive animals, data was not subjected to statistical analysis; descriptive of choice 
behaviour were instead plotted and explored. 
All main effects of analysis were assessed further where appropriate by Bonferroni post hoc 
comparisons. To examine significant treatment dose x group interactions, one way repeated 
measures ANOVA examined by group the response across acute drug treatments, whilst a series 
of independent Wests compared groups at each treatment dose (Bonferroni correction of 
p<0.0125). To explore further treatment dose x delay interactions, simple one-way ANOVAs 
were used to both examine the main effects of treatment across each delay conditions and the 
main effect of delay at individual treatment doses. Mauchley's test of sphericity was applied to 
all within subject variables, and when appropriate the degrees of freedom adjusted with the 
Greenhouse-Geisser correction. The homogeneity of variance of between subject variables was 
assessed by Levine's test. All data prior to analysis was assessed for normality and transformed 
where necessary (see also section 2.7). If data could not be successfully transformed, then the 
non-parametric Friedman test was employed to examine the dose-rcsponsc to nicotine by 
treatment group followed where appropriate by Wilcoxon procedures. Mann Whitney U tests 
were applied to the data to allow comparison of responses by group at each treatment dose. In 
all cases of analysis a values of p<0.05 were deemed statistically significant. 
8.3.2. RESULTS 
Failure to initiate trials, make a reward choice and to collect reward following selection, rarely 
occurred across all treatment doses. Analysis of these parameters was therefore not conducted. 
8.3.2.1. Return to Baseline 
Comparison of choice behaviour to that of performance prior to the initiation of chronic drug 
treatment, revealed that choice of delayed reward had returned to BL levels. This was supported 
by the non-significant main effect of test session (F(3,66) = 1.780, N. S. ). Choice behaviour was 
highly sensitive to delay (F(2.572,56.592) = 124.612, p<0.001), with choice of delayed reward 
being significantly reduced across all delays in comparison to the 0 second delay condition (all 
p<0.001). Further support that choice behaviour had returned BL was indicated by the non- 
significant day x delay interaction (F(12,264) = 1.863, N. S. ). Analysis also revealed that choice 
behaviour did not differ between treatment groups, ai shown by non-significant main cffect of 
group (F (1,22) = 0.001, N. S. ). Furthermore support for the similarity of choice at this stage 
was indicated by the non-significant group x day, group x delay and group x day x delay 
interactions observed (F(3,66) = 0.716, N. S.; F(4,88) = 1.627, N. S.; F(12,264) = 1.279, N. S. ). 
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8.3.2.2. Choice Behaviour 
Acute administration of nicotine, as shown in Fig. 8.7, significantly decreased prel'ercncc for thc 
delayed larger reward in a dose related manner (F(I. 972,43.389) = 21.214, p<0.001). Post hoc 
analysis revealed a significant increase in rate of discounting of delay across all doses tested in 
comparison to saline control (all p<0.001). Furthermore, the highest 0.5mg/kg dose decreased 
significantly choice of delayed reward in comaprison to the 0.125mg/kg treatinent dose. Both 
treatment groups responded similarly to the acute nicotine challenges with no significant main 
effect group or group x dose interaction found (F(1,22) = 0.082, N. S, F(1,972,43.389) = 11.04, 
N. S., respectively). As illustrated in Fig. 8.7 almost identical reductions in overall choice of' 
delayed reward in both treatment groups were observed following 0.25mg/kg and 0.5nig/kg 
doses of nicotine. Conversely, following the lowest 0.125mg/kg dose, nicotine naYve animals 













He. 8.7: The effects of acute nicotine on overall percentage choice of delayed reward. Each bar represents the 
mean percentage ± SEM. *, p<0.05, **, p<0.01, ***, p<0.001 (Bonferroni comparison) as compared to saline 
control. t, p<0.05, tt, p<0.01, ttt, p<0.001 (Bonferroni comparison) as compared to highest 0.5mg/kg nicotine 
dose. 
Analysis of choice by delay once again demonstrated a highly significant reduction ofchoice of' 
delayed reward (F(2.078,45.726) = 20.949, p<0.001), Furthermore demonstration of delay 
dependency was shown, supported by a highly significant main effect of delay (F(2.206, 
48.539) = 154.241, p<0.001). Choice of delayed reward decreased significantly with 
increasing delays, with choice of the delayed reward across all delay conditions differing 
significantly from choice at other delay trials (all p<0.001). A significant treatment dose x delay 
interaction was also found, suggesting that the effects of acute nicotine were delay dependent (F 
(5.955,131.016) = 3.171, p=0.006). Further analysis ofthe main effects of treatment at each 
delay demonstrated, with the exception of 0 seconds, that nicotine promoted choice of' the 
immediate reward (all F(3,66) ? 5.228, p -< 
0.002) (see Fig. 8-8). Post hoc comparisons revealed 
that the lowest 0.125mg/kg dose, decreased choice of delayed reward during 20 and 40 second 
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delay trials in comparison to choice during control treatment (all p<0.01). Following 0.25mg/kg, 
choice of delayed reward was decreased at 10,20 and 40 second delays in comparison to 
control. At the highest, 0.5mg/kg dose choice was decreased across the greatest number ofdelay 
conditions, reducing significantly choice of delayed reward at 10,20,40 and 60 seconds in 
comparison to saline (all p< 0.05) (see Fig. 8.8). 
Individual analysis of the main effects of delay across individual nicotine doses revealed that 
choice was delay sensitive following all treatments (all F> 34.477, df > 2.490,54.785, p< 
0.001). The delay dependency became greater with increasing doses of nicotine (see Fig. 8.9). 
Post hoc analysis revealed choice ot'delayed reward was significantly greater at 10,20 40 and 
60 seconds delays in comparison to the 0 delay condition all doses tested (al I p<0.0 I 
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Fig. 8.8: Simple effects analysis of treat ment*dclay interaction: The effects of acute nicotine 01, percentage 
choice of delayed reward across each delay condition. Each har represents the mean percentage ± SE. *, 
p<0.05, **, p<0.01, ***, p<0.001 (Bonferronni comparison) as compared to saline control. t, p<0.05, tt, 
p<0.01, ttt, p<0.001 (Bonferronni comparison) as compared to highest 0.5mg/kg nicotine dose. 
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Fig. 8.9: Simple effects analysis of treat men Odelay interaction: The effects of acute nicotine on rate of 
discounting of delayed reward under each treatment dose. Each point represents the mean. *. p<0.05, **, 
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Fig. 8.10(a-d) compare the choice of delayed reward across delays of treatment groups 
following each dose tested. Almost identical delay dependent choice behaviour was shown 
following saline treatment, 0.25mg/kg and 0.5mg/kg nicotine doses. Once again, following the 
0.125mg/kg dose, evidence of a greater decrease in choice of delayed reward across 10,20,40 
and 60 second delays was displayed by nicotine naYve animals. Statistically however, no 
significant differences were demonstrated between treatment groups in response to nicotine. 
Analysis revealed no significant main effect of group (F(1,22) = 0.182, N. S. ), group x dose, 
group x delay or group x dose x delay interaction (F(2.206,48.539) = 0.151, N. S.; 1--(2.078, 
45.726) = 1.245, N. S.; F(5.955,131.016) = 0.736, N. S., respectively). 
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Fig. 8.10(a-d): Choice Behaviour: The effects of acute nicotine on rate of discounting of delayed reward under 
each treatment dose. Each point represents the mean. *, P<0-05, **, P<0.01, ***, p<0.001 (Bonferroni 
comparison) as compared to choice of delayed reward at 0 seconds delay condition. 
8.3.2.3. Speed of Responding 
Table 8.7 summaries speed of responding measures in the task following the administration of 
acute nicotine challenges. Nicotine treatment did not significantly affect the latency to initiate 
trials or to choose between the delayed and immediate reward, with an absence of significant 
main effect of treatment shown across parameters (all F(3,66) <- 2.030, N. S). Furtherniore, 
speed of responding on these measures were comparable across treatment groups with no 
significant group main effects (all F(1,22) -< 
0.352, N. S) or group x treatment dose interactions 
displayed (all F(3,66) < 2.415, N. S). 
Nicotine differentially affected the latency to collect reward dependent upon the reward choice 
made. No significant effects treatment were shown on latency to collect reward following an 
immediate reward choice (F(2.008,44.176) = 1.378, N. S. ). In contrast, acute nicotine decreased 
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the latency to collect the reward following a delayed reward choice in a dose dependent manner 
(F(3,66) = 0.444, p=0.020). Post hoc analysis however failed to demonstrate significant 
differences between treatment conditions. Comparison of treatment groups once again 
demonstrated a lack difference in response to nicotine on latency to collect reward, with no 
significant between group effects (all F(1,22): S 0.560, N. S) or group x dose interactions shown 
6n both immediate and delayed reward magazine latency (F(2.008,44.1760 = 0.576, N. S; 
F(3,66) = 0.444, N. S., respectively). 
Table 8.7: The effect of acute nicotine on speed of responding In the delayed reinforcement 
task. 
Behavioural Measure Nicotine Dose (mg/kg) 
Saline 0.125 0.25 0.5 
(control) 
Initiation Latency N 1.04 ± 0.07 0.96 ± 0.06 0.97 0.10 0.91 ± 0.07 
S 0.92 ± 0.09 0.87 ± 0.05 0.87 0.06 1.01 ± 0.09 
Immediate response N 0.66 ± 0.04 0.77 ± 0.05 0.74 0.04 0.77 ± 0.04 
latency S 0.72 ± 0.04 0.70 ± 0.04 0.72 0.05 0.73 ± 0.05 
Delayed response N 0.88 ± 0.11 0.87 ± 0.08 0.85 0.06 0.84 ± 0.06 
latency S 0.97 ± 0.11 0.85 ± 0.06 0.83 ± 0.06 0.90 ± 0.09 
Immediate magazine N 0.20 ± 0.03 0.21 ± 0.02 0.23 ± 0.03 0.22 ± 0.03 
latency S 0.23 4- 0.03 0.24 ± 0.03 0.22 ± 0.02 0.27 d: 0.03 
Delayed magazine N 1.55 ± 0.47 0.92 ± 0.19 0.89 ± 0.20 0.78 ± 0.12 
latency S1 1.60 ± 0.41 1.30 ± 0.31 1.08 ± 0.22 1 1.04 ± 0.29 
Table 8.7: Each value represents the mean latency (seconds) : l: SEM. 
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8.3.2.4. High vs. Low "Trait" Impulsivity 
In order to assess differences in responses to acute nicotine challenges based upon baseline 
levels of "trait" impulsive choice, independent examination of high and low impulsive animals 
on choice behaviour was in addition conducted. 
8.3.2.4.1. Choice Behaviour 
Acute administration of nicotine in low impulsive animals reduced the overall percentage choice 
of the delayed reward (F (3,39) = 16.906, p<0.00 1) (Fig. 8.1 I (a)). The significant increase in 
sensitivity to delay was observed across all doses tested in comparison to saline control 
treatment (all p<0.01). Previous nicotine exposure in low impulsive animals had no effect on 
response to acute nicotine with a lack of both significant between treatment group and group x 
test day interactions shown (F(1,13)= 0.006, N. S.; F(3,39) = 0.625, N. S., respectively). Analysis 
of choice by delay revealed once again a significant main effect of treatment dose (F(3,39) 
16.969, p<0.001). Choice behaviour was furthermore delay dependent (F(4,52) = 77.336, p< 
0.001), with selection of the larger delayed reward decreasing significantly with increasing 
delay (all p<0.01). 
The ability of acute nicotine to decrease choice of the lager delayed reward was furthermore 
dependent on delay, as indicated by the significant dose x delay interaction (F(12,156) = 2.747, 
p=0.002). Further analysis of treatment at each delay condition revealed that alteration in 
choice was not made following treatment during the 0 second delay condition (F(3.39) = 1.906, 
N. S. ). Nicotine increased the choice of the immediate smaller reward during the 10,20,40 and 
60 delay conditions (all F(3,39) ?: 5.751, p: 5 0.002) (see Fig. 8.12(a)). In comparison to saline 
treatment, the lowest 0.125mg/kg dose decreased choice of the delayed reward during the 40 
second delay condition only (p<0.05). Following 0.25mg/kg nicotine treatment preference for 
the delayed reward was significantly reduced at both 10 and 40 second delays (all p <0.05). The 
most profound decrease in choice of delayed reward was observed following the highest 
0.5mg/kg dose, where a decreased in choice in comparison to control was indicated during 10, 
20,40 and 60 second delay conditions (all p<0.01). 
Analysis of the main effect of delay at each dose further supported the dose dependent increase 
in impulsive choice. As illustrated in Fig. 8.13(a) under the influence of each treatment dose a 
main effect of delay was displayed (all F(4,52) > 23.444, p<0.001). Delay dependency 
became greater with increasing dose of nicotine. Following the administration of saline and the 
lowest 0.125mg/kg dose, choice of delayed reward only decreasea significantly in comparison 
to 0 delay condition during 40 and 60 second delay trials (all p<0.000). In contrast, at the higher 
0.25 and 0.5mg/kg doses, nicotine choice ratios became significantly reduced across all delays 
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relative to the 0 delay condition (all p<0.05). 
Once again, analysis of choice by delay revealed that previous chronic nicotine exposure had no 
significant effect on the response to acute nicotine challenges in low Impulsive aninials. Choice 
behaviour across delays was almost identical in both groups following nicotine treatment (see 
Fig. 8.14(a-d)). Analysis indicated no significant main effect ofgroup, group x delay, group x 
dose or group x dose x delay interactions (F(l, 13) = 0.008, N. S.; F(4,52) = 0.152, N. S., 1, (3,38) 
= 0.808, N. S.; F(12,156) = 0.621, N. S., respectively). 
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Rz. 8.1 I(b) 
H2.8.11 (a-b): The effects of acute nicotine on overall percentage choice of delayed reward in low (a) and high 
impulsive (b) animals. Each bar represents the mean percentage ± SEM. *, p<0.05, **, p<0.01, ***, p<0.001 
(Bonferroni comparison) as compared to saline control. t, p<0.05, tt, p<0.01, i-IJ, p<0.001 (Bonferroni 
comparison) as compared to highest 0.5mg/kg nicotine dose. 
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Fip-. 8.12(a-b): Treatment*dclay interaction: The effects of acute nicotine on percentage choice of delayed 
reward across each delay condition in low (b) and high (b) impulsive animals. Each bar represents the mean 
percentage ± SE. *, p<0.05, **, p<0.01, ***, p<0.001 (Bonferroni comparison) as compared to saline control. 
t, p<0.05, tt, p<0.01, ttt, p<0.001 (Bonferroni comparison) as compared to highest 0.5mlp/kg nicotine dose. 
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H2.8.13(b) 
Fig. 8.13 (a-b): Treatment*delay interaction: The effects of acute nicotine on rate of discounting of delayed 
reward under each treatment dose. Each point represents the mean. *, p<0.05, **, p<0.01, ***, p<0.001 
(Bonferroni comparison) as compared to choice of delayed reward at 0 seconds delay condition. 
Exploration of the effects of acute nicotine in high impulsive animals demonstrated a decreased 
choice of delayed reward relative to saline treatment (see Fig. 8.11 (b)) Irrespective of treatment 
group, the effect of acute nicotine on overall choice behaviour was however considerably less 
dramatic than that observed in the low "trait" impulsive animals. Due to the low sample size of 
highly impulsive animals, statistical analysis could not be conducted on the data. Comparison of 
treatment groups revealed that animals with previous nicotine exposure demonstrated a lesser 
reduction in overall choice of delayed reward following acute nicotine. This differentiation in 
response is clearly shown at the lowest 0.125mg/kg dose (see Fig. 8.11 (b)). 
Fig. 8.12(b) examines choice behaviour across delay in high impulsive animals irrespective of 
treatment group. Clearly evident is the decrease in choice of delayed reward with increasing 
doses of nicotine across the 10,20,40 and 60 seconds delay conditions in comparison to choice 
behaviour during saline drug treatment. Alteration in choice behaviour was importantly not 
shown during the 0 seconds delay, where choice of the larger reward was at its greatest. Further 
evidence of the delay dependent reduction of the delayed larger reward is demonstrated in Fig. 
8.13(b). Illustrated is a clear shift leftwards of the delay discounting function, with increasing 
doses of nicotine. Comparison of the delay dependent choice behaviour of treatment groups is 
illustrated in Fig. 8.14 (a-d). Mean data once again suggests evidence of a decreased sensitivity 
to acute nicotine's ability to decrease choice of delayed reward in animals previously exposed to 
nicotine. With exception of the 0 delay condition, across treatment doses nicotine na*fve animals 
displayed a greater reduction in choice of the delayed reward across delays following nicotine. 
The variation across treatment groups in response to acute nicotine is most evident following the 
treatment of 0.1 25mg/kg treatment dose. 
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8.4. DISCUSSION 
Despite there being no doubt of the association between heavy smokers and heightened 
impulsive choice, an understanding of the complex nature of this relationship remains to be 
fully determined (Bickel et al., 1999; Mitchell, 1999; Reynolds et al., 2004; Reynolds, 2006a; 
2006b; Johnson et al., 2007). The experiments of the present chapter were therefore designed to 
begin to elucidate more precisely the association between impulsive choice and nicotine 
dependence. Through use of a longitudinal'design, the effects of chronic nicotine, nicotine 
withdrawal and the residual sensitivity to nicotine following a sustained period of abstinence 
were assessed on levels of impulsive choice. The data suggested six general conclusions: (1) 
chronic nicotine exposure is associated with increased impulsive choice, (2) initial nicotine 
deprivation was without effect on impulsive choice, (3) longer term withdrawal was associated 
with a substantial increase of impulsive choice, (4) chronic nicotine induced effects on 
impulsive choice are temporarily transient, (5) previous nicotine exposure appears to have a 
minimal effect on subsequent response to acute nicotine following a period of sustained 
abstinence, and (6) high and low "trait" impulsive animals appear to respond differentially to 
the effects of chronic nicotine and nicotine withdrawal. Each of these key findings will be 
discussed in detail in the following sections. 
8.4.1. Chronic Effects of Nicotine on Impulsive Choice 
The chronic administration of nicotine led to a significant reduction in overall choice of delayed 
reward in comparison to saline treated animals, an effect that was at its greatest druing the early 
stages of drug treatment. Although the effect on choice behaviour was not statistically delay 
dependent, a clear trend for a decrease in choice of delayed reward was observed across the 
higher 40 and 60 second delay conditions whilst choice at the 0 second delay condition 
remained unchanged (see 'Fig. 8.3(a-d)). Chronic nicotine treatment displayed no other 
significant effects on performance measures in the task. 
These findings suggest that nicotine increased levels of impulsive choice during chronic 
exposure. The data appear to be consistent with previous research examining the chronic effects 
of not only nicotine, but also amphetamine and cocaine on levels of impulsive choice in animal 
models of delayed reward (Richards et al., 1999; Paine et al., 2003; Dalley and Locey, 2005). 
The present results provide further evidence that the dysfunctional decision making in heavy 
smokers arises as consequence of nicotine exposure (Bickel et al., 1999; Mitchell, 1999; 
Reynolds et al., 2004; Reynolds, 2006a; 2006b; Johnson et al., 2007). There are, however, 
alternative interpretations of these results. The decrease in choice of delayed reward could have 
been mediated instead by changes in perceived magnitude of reward, or a response bias on the 
lever delivering the immediate reward (Ho et al., 1999). However, these interpretations of the 
present effects of nicotine are unlikely for reasons previously detailed in Chapter 7 (section 7.4). 
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These include the lack sensitivity of animal's choice behaviour to changes in magnitude of 
reward and more crucially the continued choice of the larger reward during the zero delay 
condition on almost 100% of trials (Richards et al., 1997; Grace et al., 1999; Farrar et al., 2003; 
Green et al., 2004). The latter of these reasons support not only animals continued ability to 
effectively discriminate between different magnitudes of reward, but also provides evidence of a 
lack of response bias on the immediate lever during chronic treatment. 
Alternatively, it could be that the increased choice of immediate reward could have instead been 
governed by nicotine induced changes in appetite (McNair and Bryson, 1983; Grunberg ct al., 
1986; Levin et al., 1987; Blaha et al., 1998; Miyata et al., 1999; Zhang et al., 2001). However, 
this explanation cannot easily account for the present data. Consistent with previous reports, the 
findings of Chapter 6 indicated that decreasing motivation for food reward over a seven day 
period did not affect choice in the delayed reward task (see also Cardinal et al., 2000). 
Furthermore, latency to collect reward, which can arguably be taken as an index of motivation, 
remained unchanged during chronic drug treatment. 
As discussed in the previous chapter two processes that may influence choice behaviour in the 
delayed reward task are working memory and time perception (Hinson ct al., 2003; Mitchell, 
2004). Due to the reported positive effects of nicotine on working memory it is unlikely that the 
increase in preference for the immediate reward was mediated by drug induced impainncnts in 
this cognitive process (Rusted and Trawley, 2006; Spinelli ct al., 2006). Howcvcr, as with the 
acute effects of nicotine on impulsive choice, the ability to overestimate the passage of time is 
likely to have played a role in the observed alterations in choice behaviour (Pradhan and Dutta, 
1970; Bizot, 1997; Carrasco et al., 1998). Nicotine may have led to tile delay to the delivery of 
the larger reward being perceived as longer than the saline treatment group, causing the delayed 
reward to be discounted to a greater degree. This interpretation does not suggest that the 
observed alterations in choice behaviour are not indicative of an incrcasc in sensitivity to 
delayed gratification, but rather that a mechanism by which this may be increased is via a 
disruption in timing ability. 
From reviewing the available evidence, it appears most likely, that chronic nicotine led to an 
increased sensitivity to delayed reward, rendering animals more impulsive in their decision 
making. Although nicotine treated animals' choice of delayed reward was consistently lower 
than that of the control group during treatment, it is important to highlight that the greatest 
deficit was indicated during the first test session. Following this time point, a gradual increase in 
self control was observed during the following days of drug treatment (see Fig. 8.1). Although 
this was not supported statistically by a significant day x group interaction, the observation that 
nicotine's initial effects were not sustained across the testing period suggest that tolerance to the 
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effects of nicotine on impulsive choice may have been shown. These findings are comparable to 
data reported by Paine et al. (2003) who demonstrated induced tolerance the effects of cocaine 
on delay gratification during a two week drug regime. As discussed previously in Chapter 5 
(section 5.5.1), it is well established that tolerance to nicotine's actions develops on a range of 
behaviours in both human smokers and animals; an effect argued to be mediated by the 
deactivation and upregulation of central nicotinic receptors (Collins et al., 1990; Wonnacott, 
1990; Stolerman, 1999; DiChiara, 2000; Littleton, 2001; Perkins, 2002; Cepeda-Benito et al., 
2006; Robinson et al., 2007). As clear demonstration has been made that nicotine mediates its 
effects on impulsive choice via central nAChRs (see Chapter 7), it is possible that the neural 
adaptations observed at these receptors could mediate the development of tolerance to nicotine's 
initial deficit on self control in the delayed reward task. 
The neurobiological systems downstream from the nAChRs, that may have been involved in the 
nicotine induced changes in choice behaviour, have been touched upon in the previous chapter. 
It is likely that the decrease in choice of the delayed reward is attributable to the enhancement of 
DA and 5-HT in regions of the NAc and OPFC, as both these neurochemical systems and 
anatomical regions have been implicated in impulsive choice (Oades and Halliday, 1987; Di 
Chiara and Imperato, 1988; Benwell and Balfour, 1992; Ribeiro et al., 1993; Nisell ct al., 1996, 
Cardinal ct al., 2001; Kheramin et al., 2002; 2004 Mobini et al., 2002; Winstanely et al., 2004; 
Pothuizen et al., 2005; van den Bergh et al., 2006). Interestingly, with repeated nicotine 
exposure, the increase in synaptic DA in regions of the VTA and its associated projections 
begins to decline (Ramusscn and Czachura, 1995; Cardoni and Di Chiara, 2000). This effect, 
which is believed to be in part mediated by the up-rcgulation of nAChRs, may have therefore 
played a role in the observed tolerance to the effect of nicotine on impulsive choice (Watkins ct 
al., 2000a). However, as the present behavioural study did not evaluate the neuronal processes 
involved in the observed effects, the proposed mechanisms remain highly speculative. 
8.4.2. Effects of Initial Nicotine Withdrawal on Impulsive Choice 
The termination of nicotine treatment caused a spontaneous nicotine abstinence syndrome. This 
was supported by the marked elevation of somatic sypmtomatology, beginning at 6 hours post 
pump removal and remaining elevated for a time period of 133.5 hours (see Fig. 8.7). Consistent 
with previous research the profile of abstinence signs predominately included, gasps, writes, 
teeth chattering, chews, shakes, tremors, scratches and foot licks (Malin et al., 1992; Hildebrand 
et al., 1997; 1999; Epping-Jordan et al, 1998; Watkins et al., 2000a; llarrison et al., 2001; Malin 
et al., 2006). The most frequently observed sign was that of scratches and foot licks, 
incorporated here within the miscellaneous category. Despite comparable drug treatment 
regimes, the abstinence syndrome observed in the present research, once again, appears to be of 
a longer duration than that reported in previous studies. As discussed previously, the most likely 
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explanation of the inconsistency is the differences in rat strains utilised across studies (Malin et 
al., 1992; Epping-Jordan et al, 1998; Hildebrand et al., 1999; 1997). 
Initial drug withdrawal was associated with no differences in overall choice of delayed reward 
in comparison to saline treatment group. Choice of the larger reward across delays was also 
similar across groups. As shown in Fig. 8.1 however, from 108 hours post cessation of treatment 
a clear trend of a gradual decrease in percentage choice of delayed reward was observed. During 
this stage animals experiencing nicotine withdrawal were significantly faster at sclccting the 
delayed reward in comparison to saline treatment group. Caution should however be given when 
interpreting this cffect, due to the coincident slowing of response latency relative to BL 
displayed in saline treated animals. 
In comparison to human research the lack of effect displayed during initial withdrawal is 
consistent with Mitchell (2004) who reported no effects of 24 hours nicotine deprivation on 
monetary delayed reward tasks in smokers. Although subjects discounted cigarettes to a greater 
degree during drug withdrawal, authors concluded that this was attributed to an increase in 
preference for cigarettes rather than enhanced sensitivity to delay. The current data are, 
however, in opposition to a more recent study reporting greater levels of discounting of delayed 
reward in smokers who had abstained for a minimum of 13 hours (Field et al., 2006). The most 
likely explanation for differences in findings across studies is the use of real verses hypothetical 
rewards. More comparable to the present research, the subjects in Mitchell (2004) made choice 
regarding real rewards and experienced the delay to their delivery. In contrast, in the study 
conducted by Field et al., hypothetical rewards were instead utiliscd during the task. 
If the lack of effect of early nicotine withdrawal observed in both the present research and 
Mitchell (2004) are valid results, the implications of these findings is that impulsive choice may 
not be crucially involved in relapse to smoking during early abstinence. Instead the avcrsive 
symptoms of withdrawal, or intense craving, may be key factors involved in the failure to 
remain abstinent during this stage (e. g. Koob and LeMoal, 2001; Shiffman et al., 2003; Bagot, 
Heishinan and Moolchan, 2007; Hughes 2007b). 
It is important to consider when interpreting these findings that withdrawal from chronic 
nicotine has been associated with an increase in appetite and weight gain (Grunberg et al., 1986; 
1987; Miyata et al., 1999). Consistent with previous research, studies in Chapter 6 demonstrated 
that increasing motivation for food reward both acutely and for a duration of 7 days, led to a 
marginal increase in the overall choice of delayed reward in the paradigm (Bradshaw and 
Szabadi, 1992; Wogar 1992; Ilo et al., 1997). It is possible that the changes in the value of the 
reward may have maskcd nicotine's effects on increasing impulsivity. Indeed, nicotine 
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deprivation is associated with deficits in DA functioning in both the mesolimbic system and 
NAc (Fung et al., 1996; Hildebrand et al., 1998; Watkins et al., 2000; Koob and Le Moal, 2001; 
Rahman et al., 2004). As inhibiting DA neurotransmission in the NAc and related regions of 
BLA, has been associated with the heightening of impulsive choice (Cardinal et al., 2001; 
Winstanley et al., 2004a; Denk et al., 2005), the lack of difference between groups on levels of 
impulsive choice during nicotine withdrawal appear somewhat inconsistent with 
neurobiological data. However, the effects of nicotine on motivation for food reward in the 
task is likely to have been minimal, as no evidence of alterations in latency to collect reward 
were demonstrated. As will later be discussed, differences in high and low trait impulsivity in 
response to nicotine withdrawal are likely to have masked the effects of nicotine deprivation on 
impulsive choice at this stage. 
8.4.3. Effects of Long Term Nicotine Withdrawal on Impulsive Choice 
The gradual decrease in the overall choice of the delayed reward that began at 108 hours post 
termination of treatment, continued and reached significance during the second week of nicotine 
withdrawal. During this stage of abstinence, animals experiencing nicotine withdrawal 
consistently selected the delayed larger reward to a lesser extent than the saline treated animals. 
The effect was furthermore delay related, with preference of the delayed reward being 
significantly lower during the 40 second delay trials. By the third week of nicotine withdrawal 
the nicotine withdrawal induced impulsivity had recovered, and choice behaviour in chronically 
nicotine treated animals was indistinguishable from that of the saline group. During withdrawal 
week two and week three, both treatment groups performed comparably on speed of responding 
measures in the delayed reward task. 
These findings suggest that week two of withdrawal is associated with an incrcasc in levels of 
impulsive choice. Based on the present findings, it can be predicted that smokers may be more 
likely select the immediate rewarding effects of nicotine due to the delayed larger rewards 
associated with continued abstinence being discounted to a high degree during this stage. As 
discussed previously (see section 5.43. ), 75% of smokers rclaps c within the first two weeks of 
abstinence (Garvey ct al., 1992; Hughes et al., 1992; Kenford ct al., 1994; Law and Tang, 1995). 
The present findings suggest that impulsivity may, therefore, be an important aspect mediating 
the high rates of relapse during "quitting" attempts in smokers. This is further supported by 
recent findings in human research demonstrating that high levels of discounting of delayed 
reward significantly predicted relapse in smokers (Dallery and Raiff, 2007; Krislinan-Sarin et 
al., 2007; Yoon et al., 2007). Taken together, strong evidence has been provided that impulsive 
choice may be strongly associated with abstinence success. Pharmacological and bchavioural 
treatment interventions that focus upon decreasing levels of impulsive choice during this 
"critical period" of nicotine withdrawal may therefore prove to be effective future interventions 
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for smoking cessation. 
The neuronal changes that have developed as a consequence of chronic nicotine exposure are 
likely to have mediated the heightened impulsivity during this stage of abstinence. Although it 
cannot be determined from the present research what neurobiological processes are involved, 
results form brain imaging studies have demonstrated evidence of structural deficits in regions 
implicated in impulsive choice. For example, smokers have demonstrated reduced grey matter 
volumes and density in frontal regions, including the ACC, and PFC and OPFC (Gallinat et al., 
2006). Whilst it cannot be determined conclusively whether these abnormalities preceded drug 
use, or were instead a consequence of drug exposure, strong evidence for the latter of these 
theories was provided by the demonstrated inverse correlation between years of abuse and 
frontal volume. Abnormalities within these regions appear furthermore to persist following 
cessation of smoking, with abstinent smokers displaying significant hypoactivation in the PFC, 
in particular the orbitofrontal cortical areas (Neuhaus et al., 2006). Whilst the ACC and PFC 
appear to play little role in the regulation of impulsive choice (Cardinal et al., 2001), strong 
evidence has implicated the sub-region of the OPFC in delay discounting processes (Khcramin 
ct al., 2002; 2004; Mobini et al., 2002; WinstanIcy et al, 2004). It is reasonable to suggest, 
therefore, that abnormalities within the OPFC may play key role in the mediation of the 
transient heightened impulsive choice observed in the present research in the absence of 
nicotine. 
The neuronal changes involved in the mediation of heightened impulsivity during withdrawal, 
appear to however be temporary. By the third week of withdrawal, chronically nicotine treated 
animals had returned to levels of delay discounting that were similar to that of the saline 
treatment group. These data support and extend the findings of Dallcry and Loccy (2005), where 
following the termination of 65 days of chronic nicotine treatment animals remained more 
impulsive for approximately four weeks before a return to BL levels was shown. The present 
data, when considered with the results reported by Dallery and Locey (2005), suggest that with 
longer duration of nicotine exposure, the time course required for the CNS to mediate the 
strengthening of self control following termination of treatment will be greater. This research 
supports the findings of Bickel and colleagues (1999), where smokers displayed considerable 
greater levels of impulsive choice that both ex-smokers and non-smokcrs, whom displayed 
indistinguishable levels of discounting. As pre-baseline levels of impulsivity were not recorded 
in the study it could not be determined whether low levels of impulsive choice had enabled the 
ex-smokers to successfully abstain, or conversely whether impulsivity was a reversible effect of 
nicotine dependence. Based on the present research findings clear support has been provided for 
the latter of these theories. 
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8.4.4. Effects of Acute Nicotine Challenges on Impulsive Choice in Animals Previously 
Exposed to Chronic Nicotine 
Tbree weeks following the cessation of chronic nicotine treatment the effects of a series of acute 
nicotine challenges was assessed on levels of impulsive choice. Previous nicotine exposure had 
no significant effect on the response to acute nicotine on choice behaviour in the delayed reward 
task. Acute nicotine in both the nicotine and saline animal's markedly reduced overall choice of 
delayed reward in a dose related manner, with all doses differing significantly from saline 
treatment. The effect moreover was delay dependent, with no significant alterations in choice 
observed at the 0 second delay trials across all doses tested. Instead, with increasing doses of 
nicotine a greater reduction in preference for the larger reward was observed across delay 
conditions, with the highest dose reducing choice significantly at 10,20,40 and 60 second delay 
trials. No significant difference between treatments groups was furthermore observed in 
response to nicotine on speed of responding measures in the task. Nicotine had no significant 
effect on latencies to initiate trials, select rewards or collect rewards following an immediate 
choice. However, acute nicotine treatment decreased latency to collect reward following a 
delayed reward choice, although post hoc analysis failed to locate a significant difference 
between doses. 
In support of the findings of the previous chapter, these data suggest that acute nicotine can 
substantially increase levels of impulsive choice. This effect was observed in both drug nalivc 
animals and in animals previously exposed to chronic nicotine. However, no differences in 
choice behaviour were observed between groups, suggesting that chronic nicotine exposure did 
not affect subsequent response to nicotine following a three week pcriod of abstinence. Whether 
alterations in the responses to nicotine on impulsive choice would have been observed during 
earlier stages of abstinence is unknown. It could be the case that the neuronal changes resulting 
from chronic exposure that render animals more sensitive to the affects of nicotine on impulsive 
choice, recover rapidly following cessation of treatment. It is essential that future research 
examines the affects of nicotine at earlier stages of abstinence to dctcrminc whether this is 
indeed the case. 
8.4.5. High Verses Low "Trait" Impulsivity: Differences In Response to Chronic Nicotine, 
Nicotine Withdrawal and Acute Nicotine Following Abstinence 
Consistent with both the findings of Chapter 6 and previous research, extensive BL variability 
in levels of impulsive choice was indicated across animals (e. g. Cardinal et al., 2000; 
Winstanley et al., 2003a; Dellu-11agedorn, 2006). Once again the delay discounting function 
was well described by the exponential model. Based on estimates of k, a group high (k: 0.5420 
+ 0.07) and low impulsive animals (k: 0.2130 ýz 0.03) were identified. To determine whether 
differences. in trait impulsivity influenced the response to nicotine on impulsive choice; choice 
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behaviour of high and low impulsive animals were independently examined. 
Assessment of choice behaviour of low impulsive animals revealed that chronic administration 
of nicotine led to a substantial decrease in overall choice of delayed reward. Once again the 
greatest reduction was observed during the first test session. This effect was delay dependent, 
with a decrease in preference for the larger delayed reward in comparison to choice behaviour 
of saline treated animals at 10,20 and 60 second delay conditions. Cessation of drug treatment 
was associated with continued high levels of impulsive choice during withdrawal week one and 
week two. A decrease in choice of the larger reward was observed at 60 second and 40 and 60 
second delay trials, during withdrawal week one and week two respectively. This significant 
difference between treatment groups during withdrawal was aided by the coincident slight 
increased choice of delayed reward in saline treated animals in comparison to BL choice. The 
nicotine induced impulsive choice gradually returned to levels similar to that of the saline 
treatment group by the 17" day post termination of treatment. 
Consistent with previous analysis, there was no significant effect of long term nicotine on the 
subsequent responsivity to acute nicotine following a three week period of abstinence. Low 
impulsive saline and nicotine treated animals both displayed a significant reduction in overall 
choice of delayed reward across all doses tested in comparison to saline control treatment 
(0.125mg/kg, 0.25mg/kg and 0.5mg/kg). The effect was also delay dependent, with no 
significant alteration in choice behaviour during the 0 delay trials. With increasing doses of 
nicotine, a greater reduction in preference for the delayed reward was observed across the 10, 
20,40 and 60 second delay conditions. Once again, the highest nicotine dose reduced choice of 
the larger reward significantly across all delay trials with the exception of the 0 second delay 
condition. 
In contrast, high impulsive animals displayed no evidence of alterations in choice behaviour 
during chronic drug treatment. In direct opposition to the low impulsive group, during initial 
drug withdrawal an increase in choice of delayed reward from 36 to 84 hours of nicotine 
withdrawal was displayed. This effect was most prominent at the 20,40 and 60 second delay 
conditions. The enhanced choice of delayed reward was short lived and by the second week of 
withdrawal no differences between treatment groups were evident on task pcrfon-nancc. 
Conversely, during the third week of withdrawal evidence of a lower choice of delayed reward 
in comparison to the control animals was indicated between 17 and 20 days post cessation of 
treatment. The difference in reward preference across groups was at its greatest at 10 and 20 
second delay conditions. However, the difference in choice behaviour treatment groups appears 
to be due to the substantial increase in preference of the delayed reward displayed by saline 
treated animals relative to BL performance. Conversely, the choice behaviour expressed by high 
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impulsive animals ' 
in nicotine withdrawal displayed minimal deviation from BL. Caution should 
therefore be given when interpreting these findings as evidence of nicotine induced changes in 
impulsive choice. 13y 21 days post termination of drug treatment, high impulsive saline and 
nicotine treated animals displayed comparable levels of choice behaviour. 
Acute nico! ine challenges decreased overall choice of delayed reward in the task, although to a 
much lesser degree than the low impulsive group. The greatest reduction in preference for the 
larger reward was indicated at the 20 and 40 second delay trials. In further contrast to the low 
impulsive group, a greater response to acute nicotine was observed in drug naive animals in 
comparison to animals previously exposed to chronic nicotine. The apparent difference in 
response between treatment groups was most evident at the lowest 0.125mg/kg dose, where the 
animals chronically treated with nicotine animals displayed minimal alterations in choice 
behaviour in comparison to the choice behaviour following the control dose (Fig. 8.14(b)). This 
preliminary finding may suggests that neural adaptations associated with long term nicotine 
exposure may have rendered high impulsive animals more tolerant to the effects of nicotine on 
impulsive choice. 
Taken together, these findings are the first of preclinical research to suggest that low impulsive 
animals may be more sensitive to the effects of nicotine induced intolerance to delayed 
gratification. It is highly unlikely that the high impulsive group were insensitive to the effects of 
nicotine due to a floor effect. The overall choice of delayed reward of high impulsive animals 
ranged between 50-60%, therefore enabling a reduction in overall choice behaviour to still be 
observed. Indeed following acute nicotine administration, choice of the delayed has been shown 
in some animals to be reduced to below 15%. The variation in response to nicotine is instead 
most likely due to differences in the underlying ncurobiology of high and low impulsive 
animals. Research for example has demonstrated that more impulsive humans and animals 
display lower levels of 5-11T functioning (McGuire and Raleigh, 1987; Roy et al., 1988; 
Westergaard et al., 1999). Furthermore, lower D2 receptor availability has been associated with 
heightened impulsivity, as measured by levels of inhibitory control (Dalley et al., 2007). The 
effects of nicotine may therefore differ in high impulsive animals due to the drug acting upon an 
already dysfunctional neurobiological system. Indirect support for this theory has been provided 
by a recent study by Oswald ct al. (2007). In their study high impulsivity was associated with a 
blunted DA release in the right VS following the administration of amphetamine. As both DA 
and regions of the VS have been strongly implicated in the mediation of impulsive choice, the 
differences in response to chronic nicotine may be the result of the less substantial DA release in 
this region in high impulsive animals (e. g. Cardinal ct al., 2000; Winstanley ct al., 2004a; 
Pothuizcn et al., 2005; Helms ct al., 2006). 
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Interestingly, spontaneous nicotine withdrawal resulted in opposite effects on impulsivity in 
high and low impulsive animals. This most likely accounts for the lack of significant differences 
between saline and nicotine treated animals when the analysis was conducted regardless of 
"trait" impulsivity in week one of withdrawal (see section 8.4.2). The heightened impulsivity in 
low impulsive animals during nicotine deprivation is more consistent with previous prcclinical 
findings which indicated evidence of persistent heightened impulsive choice following the 
termination of chronic nicotine treatment in rodents (Dallery and Locey, 2005). Furthermore, 
the response of low impulsive animals is in agreement with the majority of human studies 
reporting an enhancement of intolerance to delayed reward in drug deprived smokers and opiate 
addicts (Giordano et al., 2002; Field et al., 2006). Taken together, these findings suggest that 
during initial nicotine withdrawal, impulsivity may be a key process underlying relapse in 
individuals who were less impulsive prior to the initiation smoking. The induced heightened 
intolerance to delay at this stage of abstinence may increase the likelihood of these individuals 
selecting the more immediate reinforcing effects of nicotine, or relief withdrawal symptoms, 
over the delayed rewards associated with a drug free lifestyle. 
The finding that high impulsive animals display a short lived improvement in self controlled 
decision making, is once again most likely attributable to differences between high and low 
impulsive in the underlying neurobiology on which nicotine acts (McGuire and Ralcigh, 1987; 
Roy et al., 1988; Westergaard et al., 1999; Dalley et al., 2007). Interestingly, these findings also 
compare, to some extent, to that of a recent study demonstrating a decrease in levels of 
impulsive disinhibition in high impulsive animals following withdrawal from self administercd 
cocaine (Dalley ct al., 2007). These findings suggest that initial nicotine deprivation may be 
associated with greater levels of self control over drug taking behaviour in highly impulsive 
individuals. It is important to note however, that despite the evidence of an increase in self 
control at this stage of withdrawal, levels of impulsivity still remained higher than that of low 
impulsive animals. 
The heightened impulsive choice continued in low impulsive subjects until the 17'h day post 
termination of treatment. These neural adaptations associated with chronic nicotine exposure 
however did not affect the response to acute nicotine in low impulsive animals following the 
return to BL performance. Conversely, in high impulsive animals neuronal changes associated 
with chronic nicotine exposure appeared to have a minimal cffect on levels impulsivity during 
longer term withdrawal. However, evidence of a developed tolerance to the subsequent acute 
administration of nicotine was however displayed. Iliese findings provide further support that 
drugs of abuse, such as nicotine, may be affecting the ncurobiology of high and low impulsive 
individuals differentially. The tolerance to nicotine in this group is most likely a reflection of the 
up regulation of nAChRs which can persist for up to a month following cessation of treatment 
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(Trauth et al., 1999). The up-regulation in nAChRs is believed to lead to a decline in nicotine 
induced DA release. (Ramussen and Czachura, 1995; Cardoni and Di Chiara, 2000). If high 
"trait" impulsivity is indeed associated with a blunted DA response to drugs of abuse, than 
tolerance to nicotine may have further exacerbated this abnormality (Oswald et al., 2007)'. 
Consequently this could have led to the high impulsive animals to more likely reflect tile 
nicotine induced tolerance to the effects of nicotine at this stage of abstinence. 
From preliminary explorations conducted, strong evidence has been presented that high and low 
trait impulsive animals differentially respond to the effects of chronic nicotine and nicotine 
withdrawal. In general, low impulsive animals appear more sensitive to nicotine induced 
sensitivity to delayed reward. These findings suggest that the heightened impulsivity in smokers 
may only be a consequence of chronic nicotine exposure in individuals who exhibited low 
"trait" impulsiveness prior to the initiation of smoking. Once individuals have begun smoking, 
the effect of nicotine and nicotine withdrawal on impulsive choice may be a fundamental 
process in the maintenance and relapse of smoking behaviour in these individuals. As high 
impulsive rodents appear to display minimal a response to chronic nicotine and nicotine 
withdrawal, a "trait" preference of immediate over delayed gratification may instead be more 
crucially a risk factor in the initiation of smoking in high impulsive individuals. In support of 
this theory high impulsive animals have been found to self administration greater levels of 
cocaine (Perry et al., 2005) and consume larger amounts of alcohol (Poulos ct al., 1995). Once 
smoking has been initiated, heightened trait impulsivity is likely to continue to be a key aspect 
in the maintenance of drug takin 
'g 
and relapse. Although evidence of a decrease in impulsive 
choice was observed during early withdrawal, the level of impulsivity still remained 
substantially greater than that of low impulsive subjects. This suggests that dysfunctional levels 
of impulsivity remain, and are therefore likely to continue to contribute relapse during early 
drug deprivation. 
8.4.6. Limitations 
A potential limitation of Experiment 7 was that assessment of performance in the delayed 
reward task only began on the second day of chronic nicotine administration. If testing had been 
initiated earlier, a more substantial effect of nicotine on impulsive behaviour may have been 
observed. However, based on experimenter observations it was felt that choice behaviour in the 
task may be sensitive to the surgical implantation of the osmotic pump. Ilierefore, the decision 
to allow animal's greater time to recover from surgery is likely to have increased the validity of 
the present findings. 
It is furthermore important to stress that the observed differences between high and low 
impulsive animals are based only on preliminary explorations, in particular in relation to choice 
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behaviour of high impulsive subjects. Due to the low number of identified high impulsive 
animals this did not permit the statistical analysis of choice data. Therefore conclusions are 
based solely on trends in the current data and should be approached with caution. The 
replication of present research with greater subject numbers would address this issue. 
8.4.7. Conclusions 
In conclusion, the present results are consistent with theory that heightened impulsivity in 
smokers is in part a consequence of nicotine induced effects of impulsive choice. When 
chronically administered, nicotine leads to a significant increase in impulsive choice in rodents. 
With continued drug exposure evidence of a developed tolerance to nicotinc's effects was 
however shown. Cessation of nicotine treatment gave rise to a spontaneous nicotine abstinence 
syndrome during which a limited effect of drug deprivation was observed on impulsive choice. 
Ilowevcr, with continued abstinence in week two of withdrawal an increase in impulsive choice 
was observed. By the third week of withdrawal the nicotine induced cffccts on impulsivity had 
recovered, with a return of choice behaviour to the levels comparable to the control group. 
Finally, chronic nicotine treatment appeared to have a minimal impact on subsequent response 
to the drug following a sustained period of abstinence. Preliminary exploration of the 
differences in response to nicotine between high and low impulsive animals tentatively suggests 
that low impulsive animals may be more sensitive to the effects of chronic nicotine on 
impulsive choice than high impulsive animals. Furthermore, these animals displayed a persistent 
intolerance delayed reward following the termination of treatment that continued for a two week 
period. In contrast, chronic nicotine had a minimal cffcct on impulsive choice in high impulsive 
animals and evidence of a slight decrease in impulsive choice was displayed during initial drug 
withdrawal. This may be related to a blunted DA response that has been reported in high 
impulsive individuals in response to drugs of abuse (Oswald, 2007). This is further supported by 
the evident tolerance to acute nicotine in high impulsive animals following a sustained period of 
abstinence. 
Taken together, these findings suggest that nicotine induced impulsive choice may be important 
in the maintenance of and relapse to smoking, in particular in low "trait" impulsive individuals. 
Exposure to nicotine during the early stages of addiction will render individuals more sensitive 
to delay reward, leading to the increased preference of the more immediate reinforcing effects 
of nicotine over the longer term health benefits associated with a drug free life style. 
Consequently, the impairment in self control will lead to the continuation of drug taking and an 
increased likelihood of the transition to and maintenance of nicotine dependence. The neural 
adaptations that then develop as a consequence of chronic nicotine exposure may rcndcr 
individuals vulnerable to relapse due to the rewards associated with continued abstinence being 
discounted to a high degree during abstinence. Future research is necessary that investigates the 
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neurobiological substrates mediating the association between impulsivity and nicotine 
dependence at these stages of addiction. Such research will facilitate the progression of the 
development of potential therapeutic agents that may focus on increasing levels of self control 




The principal aim of this thesis was to further our understanding of the relationship between 
impulsivity and addiction. Despite the accumulating evidence of heightened impulsivity across 
drug abusers, the cross sectional design of the majority of these studies does not permit 
inferences to be made regarding whether impulsivity is a cause or consequence of drug abuse 
(Vuchinich and Simpson, '1998; Bickel et al., 1999; Kirby and Petry, 2004; Dom et al., 2006). 
The experiments of this thesis were primarily concerned with exploring the latter of these 
theories, in the hope of determining the role of drug induced impulsivity in the establishment, 
maintenance and relapse of drug dependence. 
More spccif ically, Chapter 3 and Chapter 6 of this thesis involved the validation of two operant 
models, each measuring a distinct component of impulsivity. The symmetrically reinforced 
go/no-go conditional visual discrimination task assessed bchavioural disinhibition (Ilarrison ct 
al., 1999), whilst the delayed reward task measured levels of impulsive choice (Evcndcn and 
Ryan, 1996; Cardinal et al., 2000). In Chapter 4 and Chapter 7 the effects of acute nicotine on 
disinhibition and impulsive choice were examined. Furthermore, the role played by the central 
nicotinic receptors in the mediation of these effects was determined. Experiments reported in 
Chapter 5 and Chapter 8 examined longitudinally the effects chronic nicotine, nicotine 
withdrawal, and the residual sensitivity to nicotine following a sustained period of abstinence, 
on disinhibition and impulsive choice respectively. Finally, Chapter 8 involved the preliminary 
exploration of the differences in response to chronic nicotine administration, nicotine 
withdrawal, and subsequent nicotine challenges based upon basal "trait" levels of impulsive 
choice. 
As these experimental chapters included a detailed discussion of the rcsults, this chapter will 
instead focus upon summarising and more importantly comparing the overall main findings for 
each aspect of impulsivity. Exploration will then be made of the broader implications of these 
findings and future directions. 
9.1. VALIDATION OF THE SYMMETRICALLY REINFORCED GO/NOGO TASK 
AND DELAYED REWARD PARADIGM - 
The control studies of Chapter 3 and Chapter 6 demonstrated the utility of both the 
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symmetrically reinforced go/no-go task and the delayed reward task as effective models to 
explore the association between nicotine dependence and impulsivity. Extending previous 
findings, both paradigms demonstrated long term stability of levels of inhibitory control and 
impulsive choice (Harrison et al., 1999; Winstanley et al., 2003a; Ohmura ct al., 2005; Dalley et 
al., 2007). Evidence of individual differences in levels of inhibitory control and intolerance to 
delayed reward was furthermore indicated, although to a much greater extent in the model of 
delayed reward. The emergence of differences across animals, despite the receipt of identical 
training, provides strong evidence that the variability in performance at baseline may reflect 
differences in "trait" level of impulsiveness in these paradigms (Poulos et al., 1995; Perry et al., 
2005; Dellu-Hagedom, 2006; Dalley et al., 2007). 
Consistent with previous research, strong evidence was displayed that choice behaviour in the 
delayed reward task was contingent upon the delay to delivery of reward (Mazur, 1987; 
Evenden and Ryan, 1996; Cardinal et al., 2000; Isles et al., 2003; Green ct al., 2004). Rodents 
displayed a systematic shift in response from a choice of the larger delayed reward at short 
delays, to the choice of the smaller immediate reward when the delay to the delivery of the 
larger reward was increased. The pattern in choice behaviour was highly sensitive to changes in 
delay, with a reduction in delays leading to an increased preference of the larger reward. 
Crucially, the experiments of Chapter 3 furthermore provided evidence that the accuracy of 
responding in the go/no-go task was not heavily dependent on timing mechanisms. This was 
supported by the insensitivity of accuracy of responding during both Go and No-go trials to 
alterations in the duration of the stimulus presented during No-go trials. Animals clearly utiliscd 
the extroceptive cues in the task to inform them when to respond and when not to respond, 
minimising the need for timing behaviour (I larrison ct al., 1999). As nicotine is known to distort 
the perception of time (e. g. Carrasco et al., 1998), this finding importantly provided an 
empirical basis for interpreting the effects of nicotine on inhibitory control in later studies. 
As it is well established that nicotine has profound effects on appetite, a further objective of 
these chapters was to provide evidence that the observed alterations in behaviour in future 
studies were unlikely to be governed by drug induced changes in primary motivation (Grunbcrg 
1982; Grunberg, 1986; Grunberg, Bowen and Winders, 1986; Klcsgcs ct al., 1989; Miyata ct al., 
1999; Pomcrleau et al., 2000; Zhang ct al., 2001). Both models were shown to be insensitive to 
a decrease in primary motivation for food reward, achieved through prcfeeding prior to the test 
session. Conversely, increasing motivation for food reward differentially affected the two sub 
components of impulsivity. Decreasing food intake the day prior to testing led to no alterations 
in levels of inhibitory control in the go/no-go task. In contrast, consistent with previous 
research, a decrease in levels of impulsive choice was observed following both acute and long 
term increases in primary motivation (Bradshaw and Szabadi, 1992; Wogar 1992; Ho et al., 
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1997). The contrasting effects of increased deprivation, provide further support for the theory 
that impulsive choice and inhibitory control are dissociable components of impulsivity 
(Evenden, 1999). As nicotine withdrawal has been associated with an increase in appetite and 
weight gain (Grunberg et al, 1986; Miyata ct al., 1999), the observed decrease in impulsivity in 
the delayed reward task highlighted the need for caution whcn intcrprcting the cffccts of 
nicotine deprivation on task performance in this paradigm. 
9.2. ACUTE EFFECTS OF NICOTINE ON IMPULSIVITY AND THE MEDIATING 
ROLE OF THE CENTRAL NICOTINIC RECEPTOILS 
If the differences in levels of impulsivity between drug users and non-drug users arisc as a 
consequence of drug exposure, this could be due to the acute pharmacological effects of the 
drug. As such, it was important to assess the acute effects of nicotine on impulsivity. Acute 
administration of nicotine led to significant increases in levels of both disinhibition and 
impulsive choice in rodents. This effect was more pronounced when measures of impulsive 
choice were considered. Here, a dose related reduction in choicc of overall delayed rcward was 
displayed (0.125mg/kg, 0.25mg/kg, and 0.5mg/kg). Conversely, the induced disinhibition in the 
go/no-go task was only displayed at the 0.5mg/kg dose tested. These findings suggcst that wlicn 
nicotine is administered acutely, different subcomponents of impulsivity may vary in their 
sensitivity to the drug, with inhibitory control perhaps decreasing only under specific 
conditions. Indeed, previous research has suggested that nicotine only induces disinhibitcd 
responding in the 5CSRTT, at low doses (0.03-0.3mglkg) and under task conditions of high 
attentional demand (e. g. Mirza and Stolerman, 1998; Blondcl ct al., 2000; Stolcrman ct al., 
2000; Mirza and Bright, 2001; Hahn, et al., 2002; Ilahn ct al., 2003; Bizarro, ct al., 2004; Bruin 
et al., 2006; Day et al., 2007). Conversely, consistent with the present rcscarch findings, the 
single study that has assessed the effccts of acute nicotine on sensitivity to dclaycd reward 
reported a substantial increase in impulsive choice across a range of doscs tested (O. Img/kg - 
1. Omg/kg). Behavioural inactivity on choice behaviour was only displayed at the 0.03mg/kg 
dose (Dallery and Locey, 2005). 
These findings indicate that two distinct and unrelated subcomponents of impulsivity may be 
increased by nicotine (Ho et al., 1999; Reynolds et al., 2006a; Winstanley ct al., 2006; Dom ct 
al., 2007), supporting the theory that the poor inhibitory control and greater preference for 
immediate over delayed gratification exhibited by smokcrs may be, in part, a consequence of 
nicotine exposure (Bickcl et al., 1999; Mitchell, 1999; Spinclla 2002; Reynolds ct al., 2004; 
Reynolds, 2006a; Johnson et al., 2007; Yakir et al., 2007). As the findings were demonstrated in 
drug naive animals, the nicotine induced effects on impulsivity may therefore be a fundamental 
factor underlying the early stages of addiction. Initial smoking may lead to a loss of control over 
future drug seeking and taking behaviour and furthermore increase the likelihood of individuals 
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selecting the more immediate reinforcing effects of nicotine over the larger, delayed health 
benefits associated with a drug free lifestyle. As a consequence drug taking is likely to continue, 
thus increasing the likelihood of the transition to dependence. 
These findings may also extend to the relationship between impulsivity and dependence in 
abusers of other addictive substances. Consistent with the present findings, accumulating 
evidence indicates that drugs of abuse including cocaine, amphetamine, alcohol, TIIC and 
MDMA can increase impulsivity in comparable paradigms in both humans and animals (e. g. 
Cardinal et al., 2000; Fillmore et al., 2002; Isles et al., 2003; Kieres ct al., 2004; Mc Donald ct 
al., 2003; Paine and Olmstead, 2004; Hellmans et al, 2005; Cheng et al., 2006; Reynolds et al., 
2006b; van Gaalen et al., 2006). Overall findings have not always been consistent, with reports 
of both a lack of and even a decrease in impulsivity found following drug treatment, with 
factors including dose level, BL impulsivity, the presence of a reward predicting cue and the 
variation in paradigms used likely to explain the discrepancies across previous rcscarch (e. g. 
Richards et al., 1997; Cardinal ct al., 2000; Wade ct al., 2000; de Wit ct al., 2002; Mc Donald ct 
al., 2003; Fillmore et al., 2005; 2006a). Taken together, the evidcncc suggests that drug induced 
impulsivity may be a key aspect mediating the continuation of drug taking behaviour across 
drug addictive disorders. 
The experiments of Chapter 3 and Chapter 6 additionally assessed tile role of the central 
nicotinic receptors in the mediation of nicotine's cffccts on impulsivity. This was achieved 
through assessment of the effects of combination drug treatments of nicotine and the centrally 
acting nicotinic antagonist MEC (Varanda et al., 1985; Martin, 1990; 1989; Francis and Papke, 
1996). MEC successfully reversed the effects of nicotine on both impulsive choice and 
disinhibiton, which had no cffcct on either subcomponent of impulsivity when administered 
alone. These findings suggest that nicotine enhances both impulsive choice and disinhibition via 
centrally located nAhChRs. However, due to the lack of specificity of MEC, conclusions could 
not be made regarding the specific nicotinic receptor subtypes that may be involved. Although 
there is potential evidence from previous research to suggest that tile a402 and a7 may mcdiate 
nicotine induced disinhibition (Blondcl et al., 2000; Grottick and Higgins, 2000; Keller ct al., 
2005; Hoyle et al., 2006), the effect of more selective nicotinic antagonists, such as D11PE, 
have yet to be investigated in a model of delayed reward. At this stage it cannot be assumed that 
both subcomponents of impulsivity are mediated by comparable nicotinic subtypes, as 
impulsive choice and inhibitory control have often demonstrated dissociated relationships with 
addiction at the receptor subtype level (e. g. Wade ct al., 2000; Talpos ct al., 2006; van Gaalcn ct 
al., 2006). 
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9.3. CHRONIC EFFECTS OF NICOTINE ON DISINHIBITION AND IMPULSIVE 
CHOICE 
A main objective of this thesis was to adopt chronic long term research designs that could afford 
causal interpretation of the relationship between impulsivity and drug dependence. The effects 
of chronic nicotine, nicotine withdrawal and the responsitivity to nicotine following a sustained 
period of abstinence were examined utilising a longitudinal design. To mimic more precisely to 
the pattern of nicotine intake in smokers, nicotine was administered chronically via osmotic 
mini pumps. Administration of nicotine in such a manner enabled the maintenance of plasma 
levels of nicotine at approximately -44ng ml-1, a level which is similar to that of smokers who 
consume 30 cigarettes per day (Murrin, Ferrer, Zeng and Ilayley, 1987; Bcnowitz 1988). 
Evidence suggests that smokers attempt to maintain a constant blood level of nicotine, through 
varying both the quantity of cigarettes consumed and actual smoking behaviour (e. g. Chait and 
Griffiths, 1982; McMorrow and Foxx 1983; Chait, Ross and Griffiths, 1985). This cannot be 
accurately mimicked by single daily test injections of nicotine, which additionally increases the 
need for handling and induces greater stress in the animal. The one disadvantage of osmotic 
pumps, is that nicotine continues to be released during pcriods of sleep, when human smokers 
would not normally be exposed to nicotine. Ilowcvcr, the substantial advantages of osmotic 
mini pump methodology clearly outweighs this drawback. 
Chronic nicotine led to an increase in both impulsive choice and disinhibition. The effect on 
impulsive choice appeared be restricted to low "trait" impulsive animals, with high impulsive 
animals displaying limited sensitivity to chronic nicotine. A comparable finding across 
measures of impulsivity was that the greatest nicotine induced cffcct was observed during the 
initial stages of drug treatment, following which a transient strengthening in sclf control was 
observed. This pattern of effect was most likely a reflection of the development of tolerance to 
nicotine, although this was not supported statistically in either paradigm. The inactivation and 
up-regulation of nAChRs associated with longer term exposure to nicotine, is likely to have 
mediated the less substantial effects of nicotine on impulsivity with the progression of treatment 
(Collins et al., 1990; Wonnacott, 1990; Littleton, 2001). As both components of impulsivity 
demonstrated evidence of tolerance to nicotine, these findings provide some indircct support 
that each may be mediated by comparable nicotinic subtypes. Tile a4P2 and V receptors 
subunits, which display the longest duration of inactivation and greatest up-rcgulation during 
chronic nicotine exposure, are likely candidates (Olalc ct al., 1997; Quick and Lester, 2002; 
Nguyen, Ramusscn and Perry, 2003). Interestingly, these are the receptor subunits that have 
been previously implicated in behavioural disihhibition (Blondel ct al., 2000; Grottick and 
Higgins, 2000; Keller et al., 2005; Hoyle et al., 2006). 
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The induced increase in impulsivity during chronic exposure to nicotine supports not only 
previous findings of the effects of chronic nicotine in paradigms of inhibitory control and 
impulsive choice, but also previous reports of the effects of chronic cocaine and amphetamine 
(Richards et al., 1999a; Blondel et al., 2000; Jentsch et al., 2002; Paine et al., 2003; Dallery and 
Locey, 2005). Inconsistent with the present findings is the lack of effect of chronic cocaine in 
the go/no-go task reported by Paine et al. (2003). Howevcr, the reward contingencies in the 
go/no-go task differed in Paine et al. study, in that responding during No-go trials did not lead to 
the loss of reinforcement. Exploring the effects of chronic cocaine in a symmetrically reinforced 
go/no-go paradigm, as utilised in the present research, may have yielded different results. 
The demonstration that chronic drug regimes that model the pattern of drug use in dependent 
users more precisely, lead to an increase in impulsivity leaves little doubt that chronic drug 
exposure renders abusers more impulsive. With increasing drug exposure however, tolerance to 
the drug's influence on impulsivity is likely to develop. These findings suggest once again that 
drug induced impulsivity may play an important role during the early stages of addiction. 
9.4. THE EFFECTS OF NICOTINE WITHDRAWAL ON DISINHIBITION AND 
IMPULSIVE CHOICE 
The termination of treatment caused a spontaneous nicotine abstinence syndrome, that based on 
aggregated behavioural signs, continued for approximately 85 hours in both groups of animals 
in Experiment 4 and 7 (Malin et al., 1992; Hildebrand ct al., 1997; 1999; Epping-Jordan ct al, 
1998; Watkins et al., 2000a; Harrison et al., 2001; Malin et al., 2006). Initial nicotine induced 
displayed contrasting effects on each subcomponent of impulsivity. On inhibitory control, a 
rebound increase in inhibitory control was observed, an effect which was at its maximum at 12 
and 60 hours post cessation of drug treatment. In contrast, low "trait" impulsive animals 
displayed a continued level of heightened impulsive choice following termination of nicotine 
exposure. Impairments in attention and memory, alterations in primary motivation and 
diminished sensitivity to reward could not account for the increase in inhibitory control in the 
go/no-go task. Therefore, strong support was provided that the data rcflcctcd a genuine decrease 
in impulsive disinhibition during the early stages of nicotine withdrawal (Epping-Jordan ct al., 
1998; Watkins et al., 2000b; Harrsion et al., 2001; Cryan ct al., 2003; Shoiab and Bizarro, 2005; 
see also findings of Chapter 3). 
At first glance it may appear surprising that opposing effects of nicotine deprivation occur on 
impulsive choice and disinhibition. However, examination of the literature indicates that these 
two subcomponents of impulsivity have often demonstrated dissociable relationships with 
addiction at both the behavioural and neurobiological level (e. g. Reynolds et al., 2006a; Talpos 
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et al., 2006). For example, lesions to the STN, decreased impulsive choice in a delayed reward 
task whilst increasing disinhibited responding in the DRL (Winstanley ct al., 2005; Uslaner and 
Robbins, 2006). Similarly, damage to the ACC, PLC and ILC elicits profound disinhibition 
whilst having a minimal impact on preference of immediate over delayed gratification (e. g. 
Cardinal et a., 2001; Christakou et al., 2004; Chudasama et al., 2004; Picton et al., 2007). 
Furthermore, the subcomponents of impulsivity have been shown to be dissociated at the 
receptor subtype level in both serotonergic and dopamincrgic systems (Wade et al., 2000; 
Talpos et al., 2006; van Gaalen et al., 2006). As these neurobiological mechanisms are also 
arguably involved in the mediation of nicotine withdrawal, it is therefore likely that they may 
also be playing a role in modulating the opposing effects of initial withdrawal on each of these 
subcomponents of impulsivity in the present research (e. g. Fung ct al., 1996; Hildebrand et al., 
1999; Watkins et al. 2000a; Koob and Le Moal, 2001; Kenny and Markou, 2004; Raliman ct al., 
2004). 
It is important to highlight the finding that the high impulsive "trait" animals in the model of 
delayed reward displayed evidence of a decrease in impulsive choice that was more comparable 
to the increase in inhibitory control in the go/no-go task. Ilowcvcr, due to the low subject 
numbers and extensive variability in performance in the high impulsive animals it is difficult to 
make valid comparisons at this stage. It is therefore essential that future research explores 
further the difference in response of high and low impulsive animals at this stage of withdrawal. 
In contrast, the second week of withdrawal was associated with both heightened impulsive 
choice and evidence of disinhibited responding. This finding, that dysfunction in inhibitory 
control and decision making persisted in the absence of nicotine, greatly supports the theory that 
neural changes that arise during chronic drug exposure render subjects highly impulsive in the 
long term. The report that abstinent smokers display continued abnormalities in rcgions of the 
PFC that are highly implicated in both behavioural and cognitive impulsivity provides some 
support for this interpretation (Gallinat et al., 2006; Neuhaus ct al., 2006). With longer term 
abstinence a strengthening of self control was observed, suggesting that the nicotine induced 
effects on impulsivity are temporary and transient. At 21 days post termination of trcatmcnt 
levels of both inhibitory control and impulsive choice had returned to pre-drug levels of 
impulsivity. To date, human research has becn unable to elucidate whether the observed 
reduction in levels of both inhibitory control and impulsive choice in cx-smokcrs can be 
attributed to either a pre-existing trait that had enabled these individuals to successfully abstain, 
or instead, reflecte a strengthening of behavioural control following smoking cessation (Bickel 
et al,. 1999; Yakir et al., 2007). The present data provide strong support for the latter of these 
interpretations. However, it should be empliasised that these findings do not imply that trait 
impulsivity did not also aid successful abstinence. Indeed, recent research has indicated that 
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both heightened sensitivity to delayed reward and poor inhibitory control significantly predict 
relapse in smokers (Dallery and Raiff, 2007; Krishnan-Sarin et al., 2007; Yoon et al., 2007). 
Interestingly, evidence of a reduction in heightened impulsive choice following abstinence has 
also been demonstrated in ex-users of heroin, alcohol and methamphetaminc (Brcttevillc- 
Jensen, 199.9; Petry, 2001; Kirby and Petry, 2004; Bomovalova ct al., 2005). Based on the 
present findings it could be tentatively argued that the induced impulsive choice in dependent 
users of other pharmacological classes of drugs may also be a reversible drug effect. In contrast, 
chronic cocaine abuse has been associated with no evident reduction in sensitivity to delayed 
reward (Kirby and Petry, 2004; Bomovalova ct al., 2005; 11cil ct al. 2006). The lack of 
reduction following abstinence in this population of abusers may suggest that the neural 
adaptations associated with chronic cocaine exposure may be more severe. As a result, a greater 
time period might be required to recover and mediate the strengthening of self control (Lyoo ct 
al., 2004). In support of this argument, abnormalities in regions of the PFC have been found to 
persist for months following abstinence in cocaine abusers, attributed in part to a down- 
regulation of D2 receptors (Volkow et al., 1993; 1997). 
This argument may also explain the continued impaired levels of inhibitory control also 
observed in abstinent cocaine and alcohol users (Bjork et al., 2004; Goudriaan ct al., 2005; 
Verdejo-Garcia et al., 2007). It should, however, be acknowledged that many of these studies 
did not control for smoking behaviour in abstinent drug abusers. Based on the present findings, 
it could be argued that nicotine may contribute to the continued dysfunctional levels of 
impulsivity observed in past research. 
Taken together, these finding suggest that both disinhibition and impulsive choice could be 
fundamental processes underlying relapse during withdrawal. Sensitivity to delayed 
gratification, however, may play a more prominent role during early drug deprivation. 
Interestingly, the greatest percentage of smokers relapse in the first two wccks of abstinence 
(Garvey et al., 1992; Hughes et al., 1992; Kenford et al., 1994; Law and Tang, 1995), a time 
period during which, according to the present research, impulsivity appears to be at its greatest. 
During this time period, individuals are likely to display less control over drug seeking and 
taking behaviour, whilst delayed health and social benefits associated with a drug free life style 
will be discounted to the greatest degree. When combined these cffccts arc likely to render the 
individual highly vulnerable to relapse. 
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9.5. ALTERATIONS IN RESPONSIVITY TO NICOTINE FOLLOWING A 
SUSTAINED PERIOD OF ABSTINENCE 
Although early stages of abstinence are associated with the highest rates of relapse, longer term 
vulnerability after 'quitting' is well documented (Stephens and Cottrell, 1972;, Robinson and 
Berridge, 2000; 2003; Hughes et al, 2004; Piasecki, 2006; Ilser, 2007). One of the greatest 
predictors of long term relapse in smokers is the lapse of smoking a single cigarette (Brandon et 
al., 1990; Nides et al., 1995; Shiffman et al., 1996). In order to determine the possible role of 
impulsivity in longer term relapse assessment was made of the alteration in response to nicotine 
following a sustained period of abstinence. Acute administration of nicotine, in both paradigms, 
increased impulsivity in drug nalive animals in a manner that directly replicated the finding of 
Chapter 3 and 6. In the delayed reward task previous nicotine exposure had no effect on the 
subsequent response to acute nicotine. Nicotine incrcased levels of impulsive choice in a dose 
dependent manner in both saline and nicotine treated animals. Conversely, prcvious nicotine 
exposure led to a profound hypersensitivity of disinhibition in response to acute ýicotine 
administration. Animals chronically treated with nicotine displayed a bchaviourally selective 
nicotine induced loss of control across all doses tested (0.125,0.25 and 0.5mg/kg), whilst 
nicotine naYve animals displayed a reduction in inhibitory control only at the highcst dosc. 
These findings are the first to demonstrate that chronic nicotine can rcndcr subjects scnsitiscd to 
the effects of nicotine on disinhibition after a period of sustained abstinence. Unlike previous 
research, strong evidence was presented that the enhanced disinhibitcd responding was not due 
to secondary changes in locomotor activity (Clarke and Kumar, 1983; Chaudliry, Tumnis and 
Karler, 1988; Pierce and Kalivas, 1997; Grottick and Higgins, 2000; 2001). These findings have 
provided crucial evidence for the role of inhibitory control in smoking relapse. More 
specifically, an abstaining smoker that is exposed to even low levels of nicotine is at a 
substantial risk of relapsing due to the profound drug induced loss of control over future drug 
seeking and taking behaviour. Substantial research has demonstrated that the mcsocorticolimbic 
DA system becomes hypersensitive to the effects of nicotine following chronic exposure 
(Robinson and Berrdige, 1993). This in turn leads to the augmented release of DA in the NAc 
(Cadoni and Di Chiara, 2000; Olausson ct al., 2001a; Rahman, Zliang and Corrigall, 2003) and 
PFC (Vezina ct al., 1992; Nisell et al., 1996) following subsequent exposure to nicotine. As DA 
receptor activation appears to be crucial for the effects of stimulant drug induced disinhibition, 
it is therefore likely that alterations in dopaminergic systems plays an important role in these 
effects (Van Gaalen et al., 2006; Pattij et al., 2007). 
The contrasting lack of increase in responsivity to the effects of nicotine on impulsivity once 
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again supports the theory that impulsive choice and disinhibition are separate and dissociable 
components of impulsivity (Evenden, 1999). These findings do not preclude the possibility that 
impulsive choice might also play a role in long-term relapse. Indeed, impulsive choice still 
increased profoundly following nicotine administration. Rather, these data indicate that a loss of 
inhibitory control may play more of a key role in the mediation of drug relapse following 
smoking during a "quit" attempt. Interestingly, high trait impulsive animals displayed evidence 
of a contrasting tolerance to nicotine following chronic exposure. Whilst no finn conclusions 
can as yet be made, the recent evidence indicating a possible blunted DA response in high 
impulsive individuals in response to stimulant drugs, is likely to have in part mediated this 
effect (Oswald et al., 2007). 
9.6. IMPLICATIONS FOR THEORIES OF DRUG ADDICTION 
In introducing this thesis, drug addition was identified as the uncontrollable compulsive pattern 
of drug-seeking and drug-taking behaviour that takes place at the expense of most other 
activities and in the face of damaging health and social consequences (Robinson and Berridge, 
1993; West, 2006). This definition highlights the two major characteristics of drug addictive 
disorders; compulsion and the loss of control over drug intake (Koob and Le Moal, 2001; 2007). 
Compulsion is characterised in humans by intense and involuntary drug craving believed to lead 
to the desire to want to repeatedly experience the reinforcing properties of the drug of abuse 
(Markou et al., 1993; Robinson and Berridge, 1993; 2003). It is believed that compulsive drug 
seeking and taking behaviour arises due to the neuroadaPtations in the mesolimbic DA system 
that renders individuals sensitised to both the drug of abuse and drug related stimuli (Robinson 
and Berridge, 2000; 2003). This is plausible for nicotine although this compound was not 
considered in Robinson and Berridge's theory. Repeated drug use leads drug related cues to 
acquire incentive value making them increasingly 'wanted', thus giving rise to intense craving 
and the development of drug seeking and taking in their presence. The influence that these cues 
exert over behaviour is believed to be mediated by interactions between the mesolimbic DA 
system and basolateral amygdala (Everitt et al., 1999). 
Despite extensive knowledge of the neurobiological and behavioural mechanisms underlying 
compulsive drug use, the role of impulsivity in drug addiction is only now beginning to unfold. 
Whilst the mesolimbic-amygdala neural systems are believed to mediate the compulsive aspects 
of addiction, regions of the PFC have instead been implicated in the modulation of impulsivity 
(Jentsch and Taylor, 1999). Although more recent theoretical accounts of addiction are 
beginning to acknowledge the importance of impul§ivity in drug addiction (Jentsch and Taylor, 
1999; Goldstein and Volkow, 2002; Lubman et al., 2004) the precise role of impulsivity in the 
establishment, maintenance and relapse of the disorder is unclear. 
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The present thesis provides strong evidence to suggest that drug induced impulsivity is likely to 
be critically involved in both the initial and end stages of addiction (Dawe et al., 2004). More 
specifically, when drug nalive individuals are first exposed to a drug of a abuse, such as nicotine, 
this will lead to a substantial loss of control over future drug seeking and taking behaviour. 
Furthermore, a heightened sensitivity to delayed gratification will be induced. As a consequence 
the individual will be more likely to select the more immediate reinforcing effects of the drug 
over the larger, often delayed social and health benefits associated with a drug free lifestyle. The 
induced behavioural and cognitive impulsivity at this early stage is likely to lead to further drug 
taking behaviour and increase and promote the transition to addiction. 
The data of the present thesis provides evidence that with repeated drug exposure, tolerance to 
drug effects on impulsive choice and disinhibition may rapidly develop. This suggests that at 
least in terms of drug induced impulsivity, this may play a minimal role in the continued 
maintenance of addiction, suggesting that perhaps the more compulsive features of the disorder 
maintain the cycle of addiction at this stage (Koob and Le Moal, 2001). However, following the 
termination of drug use, the role of impulsivity appears to become more important once again. 
Impulsive choice and disinhibition may however be diffcrcntially involved at the end stage of 
addiction. Both initial and longer term drug withdrawal appears to be associated with a 
heightening of impulsive choice. The long term rewards associated with continued abstinence 
will, as a consequence, be discounted to a greater degree at this stage. Individuals are therefore 
more likely to select the immediate reinforcing effects of the drug or relief of withdrawal 
resulting in drug relapse. 
Disinhibition, in contrast, whilst playing a minimal role during the early stages of drug 
withdrawal appears to be a key aspect underlying relapse during longer term abstinence. The 
neural adaptations associated with chronic drug exposure appear likely to render individuals 
hypersensitive to the drug induced effects on disinhibition. Exposure to the drug at this stage 
would therefore be detrimental, as it could lead to a substantial loss of control over drug taking 
behaviour and subsequent relapse. Although the neurobiological mechanisms were not 
evaluated in the present research it is highly likely that the sensitisation of the 
mesocorticolimbic DA system is mediating the increased rcsponsivity to nicotine on 
behavioural disinhibition (kobinson and Berridge, 1993; Cadoni and Di Chiara, 2000; Olausson 
et al., 2001a; Rahman, Zhang and Corrigall, 2003). As sensitisation of this DA system is 
believed also to mediate the compulsive aspect of addiction, it may be at this end stage of 
abstinence that the two distinct traits come to interact to continue the cycle of addiction (Jentsh 
and Taylor, 1999; Koob and Le Moal, 200 1; Goldstein and Volkow, 2002). 
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The establishment of the importance of impulsivity at these stages of addiction warrants the 
need for future pharmacological and behavioural treatments to focus upon both increasing 
tolerance to delay and behavioural control. This argument is further supported by increasing 
research suggesting that both high levels of intolerance to delayed reward and disinhibition 
predicts drug relapse (Moeller et al., 2001; Dallery and Raiff, 2007; Krishnan-Sarin et al., 2007; 
Yoon et al., 2007). For example, both contingency management and motivational enhancement 
programmes that focus upon developing skills necessary to improve self control may prove to 
be successful (Higgins et al., 1986; Higgins et al., 2000). Pharmacological treatments that have 
demonstrated evidence of reducing impulsivity, such SSRIs and DI and D2 receptor 
antagonists, may also transpire to be effective treatment strategies, either alone or in 
combination with behavioural treatments (Richards et al., 1993; Schmitz et al., 1998; Killen et 
al., 2000; Wolff and Leander, 2002; van Gaalen et al., 2006; Pattij et al., 2007). 
9.7. FUTURE DIRECTIONS 
The main findings of this thesis suggest that the heightened impulsivity in smokers is, in part, a 
consequence of nicotine exposure. This however does not suggest that the relationship between 
impulsivity and drug dependence is unidirectional. Accumulating evidence in both the human 
and animal literature suggests that trait levels of impulsivity may predict future drug use, 
suggesting that impulsivity may be both a risk factor and a consequence of addiction (Poulos et 
al., 1995; Tarter et al., 2003; Perry et al., 2005; Dalley et al., 2007). Therefore, in order to gain a 
complete understanding of the nature of the relationship between nicotine addiction and 
impulsivity, future research should now focus upon investigating the role of disinhibition and 
impulsive choice as potential predictors of nicotine dependence. 
Although genetics are likely to play a role in individual differences in trait impulsivity, interest 
is increasingly focussing upon how non-genetic, environmental factors may also influence 
levels of impulsivity, and in turn, increase the vulnerability to drug abuse. For example, adverse 
early life experiences in animals, such as rearing in social isolation, has been found to lead to 
increased disinhibiton and alcohol intake (Ifigley and Linnoila, 1997; Hall, 1998). Conversely, 
rearing rodents in isolation has led to lower levels of impulsive choice being displayed 
(Hellemans et al., 2005). Taken together, these findings suggest that early adverse experiences 
may have dissociable effects on differing components of impulsivity. What this research 
importantly highlights is that additional factors may influence the nature of the relationship 
between impulsivity and addiction, and future research needs to acknowledge these to further 
our understanding. 
Whilst the present thesis has increased our understanding of the relationship between 
impulsivity and drug dependence at a behavioural level, it is crucial that future research begins 
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to elucidate the neurobiological processes that may be involved. Throughout the chapters of this 
thesis, tentative suggestions have been made regarding the possible neurobiological events that 
may be modulating the alterations in impulsivity and these may provide the preliminary basis 
for future research. Such investigations are essential if future pharmacological treatments are to 
be developed that target increasing self-control in the hope of aiding successful abstinence. 
Finally, a limitation of the research within this thesis is that the drug of abuse was passively 
administered by the experimenter, instead of being self-administered, as is the case for real life 
drug taking behaviour. Future research that investigates both the effects of chronic self 
administration on impulsivity and withdrawal from drug self administration may provide a more 
sophisticated model to assess the relationship between impulsivity and drug addiction. 
9.8. CONCLUSIONS 
Studies reported in this thesis have increased greatly our understanding of the complex 
relationship between drug addiction and impulsivity. The robustness of the data has left little 
room for doubt that the heightened impulsive choice and disinhibition in smokers is in part a 
consequence of nicotine exposure. The findings suggest that drug induced impulsivity may be a 
fundamental mechanism involved in both the initial and end stages of addiction. More 
specifically, impulsive choice and disinhibition is increased following both acute and early 
stages of chronic drug treatment, which may lead to the loss of control over future drug seeking 
and taking behaviour and the selection of the more immediate reinforcing properties of drugs of 
abuse. Following cessation of treatment a sustained heightened level of impulsive choice is 
observed in low "trait" impulsive animals, that gradually returns to pre-drug BL levels 
following a three week period. Conversely, initial drug deprivation is associated with a short- 
lived rebound increase in inhibitory control, following which an increase in disinhibition is 
observed during longer term withdrawal. Despite nicotine induced effects on inhibitory control 
diminishing 21 days following termination of treatment, subjects remained hypersensitive to 
nicotine's effects on impulsivity. Together these findings provide strong support for the role of 
impulsivity in drug relapse during the first two weeks of abstinence. This is especially important 
given indications that abstinent abusers are most vulnerable to relapse during this period 
(Gossop et al., 1989; Garvey et al., 1992; Hughes et al., 1992; Kenford ct al., 1994; Law and 
Tang, 1995). The demonstration that chronic nicotine exposure renders animals hypertensive to 
the effects of nicotine following a sustained period abstinence, further indicates that 
disinhibition is likely to be a fundamental process mediating longer term vulnerability to drug 
relapse. It is essential that future research continues to address the role of impulsivity in drug 
addiction, and more importantly the neurobiological mechanisms mediating the relationship. 
Such research should improve both our understanding of, and our ability to treat the debilitating 
disorder of drug addiction. 
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APPENDIX 1: EXPERIMENT 2 A-C 
Appendix Table 1.1: Acute Effects of Nicotine on Choice Behaviour 
Behavioural Measure Main effect dose Main effect delay Dose x delay 
interaction 
Overall % choice of F (3,30) = 30.478, N/A N/A 
delayed reward P<0.001 
% choice x delay F (3,30)= 25.6 10, F (1.653,16.528) F (12,120) - 5.016, 
P<0.001 74.188, p<0.001 P<0.00 I 
Appendix Table 1.2: Simple Effects Analysis of Nicotine Dose X Delay Interaction: 
Main Effects of Dose at Each Delay Level 
Delay level Main effect dose 
Zero seconds n. s. 
Ten seconds F(3,30) -6.550, p=0.002 
Twenty seconds F(3,30) =17.236, p<0.001 
Forty seconds F(3,30) =26.187, p<0.001 
Sixty seconds F(3,30) =1 0.592, p<0.001 
Appendix Table 1.3: Simple Effects Analysis of Nicotine Dose X Delay Interaction: 
Main Effects of Delay at Each Dose Level 
Dose level Main effect delay 
0 mg/kg - F(4,36) = 34.477, p<0.001 
0.125 mg/kg F(4,36) = 48.030, p<0.001 
0.25 mg/kg F(4,36) = 41.156, p<0.001 
0.5 mg/kg F(4,36) = 60.880, p<0.001 
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Appendix Table 1.4: Acute Effects of Nicotine on Speed of Responding 
Behavioural Measure Main effect dose 
Initiation of trial latency F(3,30) = 8.0101, p<0.001 
Immediate choice response latency n. s. 
Delayed choice response latency n. s. 
Immediate choice magazine response latency n. s. 
Delayed choice magazine response latency Xz-- 11.182, df = 3, p=0.0 II 
Appendix Table 1.5: Acute Effects of Nicotine on Omissions 
Behavioural Measure Main effect dose 
Trial initiation omissions n. s. 
Delayed choice magazine omissions XI= 9.720, df = 3, p=0.021 
Appendix Table 1.6: Acute Effects of Mecamylamine on Choice Behaviour 
Behavioural Measure Main effect dose Main effect delay Dose x delay 
interaction 
Overall % choice of F (3,27) = 4.5.8, N/A N/A 
delayed reward P=0.011 
% choice x delay F (3,37)= 3.246, 1 
p=0.037 
F (2.055,18.493) F (12,108) - 2.09 8 
3 1.10 1, p<0.00 I p=0.023 
Appendix Table 1.7: Simple Effects Analysis of Mecamylamine Dose X Delay Interaction: 
Main Effects of Dose at Each Delay Level 
Delay level Main effect dose 
Zero seconds n. s. 
Ten seconds n. s. 
Twenty seconds F(3,27) =4.063, p=0.0 17 
Forty seconds n. s. 
Sixty seconds n. s. 
Appendix Table 1.8: Simple Effects Analysis Of Mecamylamine Dose X Delay Interaction: 
Main Effects Of Delay At Each Dose Level 
Dose level Main effect delay 
0 mg/kg F(4,36) = 19.678, p<0.001 
0.1 mg/kg F(4,3 6) = 16.24 1, p<0.00 1 
0.3 mg/kg F(4,36) = 19.678, p<0.001 
1.0 mg/kg F(4,36) = 26.390, p<0.001 
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Appendix Table 1.9: Acute Effects of Mecamylamine on Speed of Responding 
Behavioural Measure Main effect dose 
Initiation of trial latency n. s. 
Immediate choice response latency n. s. 
Delayed choice response latency n. s. 
Immediate choice magazine response latency n. s. 
Delayed choice magazine response latency n. s. 
Appendix Table 1.10: Acute Effects of Mecamylamine on Omissions 
Behavioural Measure Main effect dose 
Trial initiation omissions n. s. 
Delayed choice magazine omissions n. s. 
Appendix Table 1.11: Acute Effects of Combination Treatment on Choice Behaviour 
Behavioural Measure Main effect dose Main effect delay Dose x delay 
interaction 
Overall % choice of F (4,26) = 17.487, N/A N/A 
delayed reward P<0.001 
% choice x delay F (4,3 6)= 20.248, 11 
P<0.001 
F (2.315,20.839) F (12,120) - 2.317, 
59.86 1, p<0.00 I p-0.005 
Appendix Table 1.12: Simple Effects Analysis of Combination Treatment Dose X Delay 
Interaction: Main Effects of Dose at Each Delay Level 
Delay level Main effect dose 
Zero seconds n. s. 
Ten seconds F(4,3 6) -5.959, p-0-00 I 
Twenty seconds F(3,3 6) -10.079, p<0.00 I 
Forty seconds F(3,3 6) - 12.676, p<0.00 I 
Sixty seconds F(4,36) - 4.742, p=0.004 
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Appendix Table 1.13: Simple Effects Analysis of Combination Treatment Dose X Delay 
Interaction: Main Effects of Delay at Each Dose Level 
Dose level (mecamylamine / nicotine) Main effect delay 
0 mgIkg /0 mglkg F(4,3 6) = 34.542, p<0.00 I 
0 mg/kg / 0.5 mg/kg F(4,3 6) = 23.10 1, p<0.00 I 
0.1 mg/kg / 0.5 mg/kg F(4,36) = 28.563, p<0.001 
0.3 mg/kg / 0.5 mg/kg F(4,3 6) = 29.076, p<0.00 I 
1.0 mg/kg / 0.5 mg/kg F(4,36) = 26.865, p<0.001 
Appendix Table 1.14: Acute Effects of Combination Treatment on Speed of Responding 
Behavioural Measure Main effect dose 
Initiation of trial latency F(4,36)= 4.788, p=0.003 
Immediate choice response latency n. s. 
Delayed choice response latency n. s. 
Immediate choice magazine response latency n. s. 
Dela yed choice magazine response latency n. s. 
Appendix Table 1.15: Acute Effects of Combination Treatment on Omissions 
Behavioural Measure Main effect dose 
Trial initiation omissions n. s. 
Delayed choice magazine omissions n. s. 
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APPENDIX 2: EXPERIMENT 6 A-C 
Appendix Table'2.1: Acute Effects of Nicotine on Accuracy of Responding 
I Behavioural Measure 11 Main effect dose I 
Total % Correct Trials F(4,44) w 5.769, p=0.00 I 
% Correct Go Trials F(4,44) = 12.264, p=0.000 
% Correct No-go Trials F(4,44) = 2.802, p=0.037 
I 
Appendix Table 2.2: Acute Effects of Nicotine on Anticipatory Responding 
I Behavioural Measure Main effect dose 
No. of Go trials with Early Responses F(4,44) = 9.368, p<0.001 
No. of No-go trials with Early Responses F(4,44) =3.187, p=0.022 
No. of Go trials with Magazine Entries XI = 15.159, df- 4, p-0.004 
No. of No-Go trials with Magazine Entries n. s. 
Appendix TabIe 2.3: Acute Effects of Nicotine on Speed of Responding 
Behavioural Measure Main effect dose 
Correct Response Latency F(4,44) =6.203, p<0.00 I 
Incorrect Response latency n. s. 
Go magazine Latency n. s. 
No-go Magazine Latency n. s. 
Appendix Table 2.4: Acute Effects of Mccamylamine on Accuracy of 11cspondhig 
Behavioural. Measure Main effect dose 
Total % Correct Trials n. s. 
% Correct Go Trials n. s. 
% Correct No-go Trials n. s. 
Appendix Table 2.5: Acute Effects of Mecamylamine on Anticipatory Responding 
Behavioural Measure Main effect dose 
No. of Go trials with Early Responses n. s. 
No. of No-go trials with Early Responses n. s. 
No. of Go trials with Magazine Entries n. s. 
No. of No-Go trials with Magazine Entries F(3,30) = 3.882, p=0.019 
361 
Appcndiccs 
Appendix Table 2.6: Acute Effects of Mecamylamine on Speed of Responding 
Behavioural Measure Main effect dose 
Correct Response Latency n. s. ' 
Incorrect Response latency F(3,30)= 5.577, p=0.004 
Go magazind Latency n. s. 
No-go Magazine Latency n. s. 
Appendix Table 2.7: Acute Effects of Combination Treatment on Accuracy of Responding 
Behavioural Measure Main effect dose 
Total % Correct Trials F(4,40) = 18.76 1, p<0.00 I 
" Correct Go Trials n. s. 
" Correct No-go Trials F(4,40) = 20.512, p<0.001 
Appendix Table 2.8: Acute Effects of Combination Treatment on Anticipatory 
Responding 
Behavioural Measure Main effect dose 
No. of Go trials with Early Responses n. s. 
No. of No-go trials with Early Responses n. s. 
No. of Go trials with Magazine Entries n. s. 
No. of No-Go trials with Magazine Entries n. s. 
Appendix Table 2.9: Acute Effects of Combination Treatment on Speed of Responding 
Behavioural Measure Main effect dose 
Correct Response Latency n. s. 
Incorrect Response latency F(4,40)= 5.694, p=0.00 I 
Go magazine Latency n. s. 
No-go Magazine Latency n. s. 
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APPENDIX 3: EXPERIMENTS 7&8 
Appendix Table 3.1: Individual Rat Data, Indicating Steepness of Discounting (K) and 
Goodness of Fit (R 2) 
Subject Treatment 
Group 
k value R2 value II igh or Low 
"Trait" 
I N 0.39 0.89 L 
2 N 0.16 0.87 L 
3 N 0.42 0.81 11 
4 N 0.42 0.92 11 
5 N 0.47 0.87 if 
6 N 0.27 0.70 L 
7 N 0.13 0.64 L 
8 N 0.29 0.97 L 
9 N 0.38 0.95 L 
10 N 0.11 0.83 L 
II N 0.15 0.96 L 
12 N 0.95 0.72 11 
13 N 0.08 0.88 L 
14 s 0.23 0.88 L 
15 s 0.84 0.88 If 
16 s 0.16 0.95 L 
17 s 0.40 0.93 If 
18 s 0.50 0.94 11 
19 s 0.48 0.99 11 
20 s 0.38 0.71 L 
21 s 0.40 0.75 
22 s 0.04 0.55 L 
23 s 0.21 0.94 L 
24 s 0.31 0.63 L 
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